REPORT OF THE BRAIN TUMOR REGISTRY OF JAPAN, 2001--2004
=======================================================

In 1975, the Brain Tumor Registry of Japan (BTRJ) was founded to investigate the statistical characteristics of brain tumors in Japan. The Committee of the BTRJ (Ex-Chairpersons: Keiji Sano, Kintomo Takakura, and Kazuhiro Nomura) has published 12 reports. The 12 ^th^ report of the BTRJ, which includes 82,844 primary and metastatic brain tumor cases from 1984 to 2000, was issued in 2009. Here, we publish the 13 ^th^ edition of the BTRJ. This edition contains the statistical data of 16,338 patients in Japan with primary and metastatic brain tumors from 2001 to 2004. These data were collected via the Internet Data and Information Center for Medical Research in the University Hospital Medical Information (UMIN) system, instead of via a paper registration form. We hope that these data will be more reliable, given the use of computerized systems. This edition includes the frequency, anatomical distribution, patient age and sex, and survival data for all brain tumor cases, according to the World Health Organization (WHO) 2007 brain tumor classification.

We hope that this edition will provide internationally valuable information to the fields of neurosurgery and neuro-oncology and contribute to the development of successful treatments for patients with brain tumors.
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DATA COLLECTION AND ANALYSIS
============================

Data on primary or metastatic brain tumor cases that were newly diagnosed from 2001 to 2004 were collected from 2009 until the end of 2012. Approximately 330 neurosurgeons, medical doctors, and staff from 109 institutions collected data from clinical records. These institutions included most universities, colleges, and hospitals with Japan Neurosurgical Society-authorized boards. The investigation was conducted using online questionnaire forms that were available on the UMIN system website. Data, including the birthplace, age, tumor histology according to the WHO 2007 classification, tumor sites, diagnostic method employed, performance status, therapy (surgery, radiation, or chemotherapy), and the outcome of these treatments, were collected and downloaded at the National Cancer Center Hospital. This study was approved by the internal board of the National Cancer Center.

Survival data were analyzed using the Kaplan-Meier method. A survival event was defined as all-cause death, and a progression event was defined as recurrence or death due to any cause. All data were analyzed using Microsoft Excel VBA (Microsoft Corporation, Redmond, WA, USA), SAS version 9.3, and JMP version 8 (SAS Institute Inc., Cary, NC, USA) at the Department of Mathematics, Tokyo University of Science.

This project was conducted by the Japan Neurosurgical Society (President: Takamasa Kayama).
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Online registration form
------------------------

### A. Common data

  ---- ----------------------------- --------------------------------------------------------------------
  1    Registration date             automatic
  2    Hospital                      automatic
  3    Registrant                    automatic
  4    e-mail                        automatic
  5    Patient hospital ID           
  6    Place of residence            Japanese prefecture
  7    Sex                           1\. male 2. female
  8    Birth                         year / month
  9    Race                          1\. Japanese 2. Asian 3. White 4. Black 5. others 6. Unknown
  10   Primary or Metastatic tumor   1\. primary tumor 2. brain metastasis
  11   Start of treatment            1\. initial treatment 2. 3 months from initial treatment 3. others
  ---- ----------------------------- --------------------------------------------------------------------

### B. Primary brain tumor

  ------- --------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1       Registration date                       automatic
  2       Histology                               classification of WHO 2007
  3       Number of tumors                        1\. single 2. multiple 3. dissemination 4. LMM 5. others
  4       Tumor region                            1\. frontal lobe 2. temporal lobe 3. parietal lobe 4. occipital lobe 5. insular cortex 6. Gliomatosis cerebri 7. cerebellum 8. midbrain 9. pons 10. medulla oblongata 11. lateral ventricle 12. IIIrd ventricle 13. aqueduct 14. IVth ventricle 15. basal ganglia 16. thalamus/hypothalamus 17. corpus callosum 18 pineal body 19. intra-orbita 20. pituitary gland 21. optic nerve 22. CP angle 23. clivus 24. cavernous sinus 25. cranial nerve 26. other skull base 27. skull 28. LMM 29. others
  5       Tumor side                              1\. right 2. left 3. bilateral 4. both side 5. central neuraxis 6. others
  6       Site of Meningioma                      1\. not meningioma 2. convexity 3. parasagittal 4. falx 5. sphenoid ridge 6. olfactory 7. tuberculum sellae 8. planum sphenoidale 9.middle fossa 10. ventricle 11. cavernous sinus 12. CP angle 13. tentorium 14. clivus / pertroclivus 15. cerebellar convexity 16. foramen magnum 17.optic sheath 18. others
  7       Maximum tumor diameter                  \(mm\)
  8       Existence of other cancer or tumor      1\. none 2. other cancer 3. other brain tumor 4. other cancer+brain tumor 5. unknown
  9       Diagnostic method                       1\. histology 2. diagnostic imaging 3. CSF cytology diagnosis 4. blood or CSF test 5. genetic diagnosis 6. autopsy 7. others
  10      Date of radiological finding of tumor   year / month
  11      Date of initial treatment               year / month
  12      Initial radiotherapy                    1\. surgery alone 2. surgery+RT 3. surgery+CRT 4. surgery+CTX 5. CRT 6. RT alone 7. CTX alone 8. observation 9. others
  13      Initial symptoms                        1\. no clinical symptoms (medical check-up) 2. no clinical symptoms (detailed test of brain disease) 3. subjective symptoms (headache etc.) 4. seizure 5. focal symptom 6. intracranial hyper-tension 7. cons. disturbance 8. cranial nerve symptom 9. hormonal excess or hormonal decline 10. cerebral hemorrhage 11. cerebral infarction 12. others
  14      Seizures during treatment               1\. yes 2. none 3. unknown
  15--1   Mode of major surgery                   1\. none 2. decompression 3. biopsy 4. 1--50% resection 5. 50--75% resection 6. 75--95% resection 7. 95--99% resection 8. 100% total resection 9. extended total resection 10. shunt 11. drainage
  15--2   Date of major surgery                   year / month
  16--1   Initial radiotherapy                    1\. none 2. before surgery 3. intraoperative 4. after surgery 5. at recurrence 6. others 7. unknown
  16--2   Mode of initial radiotherapy            1\. WBRT 2. WBRT+LBRT/SRT/SRS 3. LBRT 4. LBRT+SRT/SRS 5. SRS/SRT 6. internal RT 7. particle beam irradiation 8. others
  16--3   Dose of irradiation                     (Gy)
  17      Spinal radiotherapy                     1\. yes 2. none 3. unknown
  18      Radiotherapy in recurrence              1\. none 2. WBRT 3. LBRT 4. SRT/SRS 5. spinal RT 6. internal RT 7. particle beam irradiation 8. others 9. unknown
  19-1    Initial chemotherapy                    1\. yes 2. none 3. unknown
  19-2    Timing of initial chemotherapy          1\. before surgery 2. after surgery 3. surgery+CTX 4. unknown
  19-3    Chemotherapeutic agent                  1\. TMZ 2. ACNU 3. other alkylating agents 4. platinum drugs 5. vincristine 6. interferon 7. etoposide 8. ifosfamide 9. MTX 10. molecular targeting drug 11. hormone therapy 12. steroid 13. others
  20      Any treatment during treatment          1\. none 2. surgery 3. WBRT 4. LBRT 5. SRS/SRT 6. particle beam therapy 7. CTX 8. molecular targeting drug 9. dopamine agonist 10. gene therapy 11. viral therapy 12. vaccine therapy 13. immunotherapy 14. lymphocyte activation 15. steroid 16. anti-convulsants 17. others
  21      Any drug used during treatment          1\. none 2. TMZ 3. ACNU 4. other alkylating agents 5. platinum drugs 6. vincristine 7. interferon 8. etoposide 9. ifosfamide 10. MTX 11. molecular targeting drug 12. hormone therapy 13. steroid 14. anti-convulsants 15. dopamine agonist 16. others
  22      KPS before initial treatment            0--100
  23      KPS after initial treatment             0--100
  24-1    Progression                             1\. none 2. local recurrence 3. new lesion 4. unknown
  24-2    Date of recurrence                      year / month
  25      Transfer to other hospital              1\. none 2. transfer for further treatment 3. transfer for palliative care 4. other reasons
  26      Outcome                                 1\. alive 2. dead 3. unknown
  27      Last confirmation date of survival      year / month
  28      Date of death                           year / month
  29      Cause of death                          1\. neuronal death except pneumonia and LMM 2. neuronal death with pneumonia 3. LMM 4. TRD except pneumonia 5. TRD (pneumonia) 6. cancer or other organ metastases 7. accident or other disease 8. others 9. unknown
  30      Autopsy                                 1\. yes 2. none 3. unknown
  31      Complication                            1\. none 2. intracranial hemorrhage 3. cerebral infarction 4. pneumonia 5. pulmonary embolization 6. deep vein thrombosis 7. bone fracture 8. second cancer 9. others 10. unknown
  32      Place of death                          1\. hospital with NSD 2. hospital without NSD 3. hospice 4. nursing home 5. home 6. others 7. unknown
  33      Hereditary disease                      1\. none 2. NF-1 3. NF-2 4. VHL 5. Tuberous 6. LiFraumeni 7. retinoblastoma 8. unknown 9. others
  ------- --------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### C. Brain metastasis

  ------- --------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1       Registration date                       automatic
  2       Tumor origin                            1\. unknown primary 2. lung 3. breast 4. esophagus 5. stomach 6. colon 7. rectum, anus 8. liver 9. gall bladder 10. spleen 11. pancreas 12. hematopoietic 13. bone 14. soft tissue 15. skin (melanoma) 16. head and neck 17. thyroid 18. testis 19. bladder 20. uterus 21. ovary 22. kidney 23. eye 24. lymphatic gland 25. nervous tissue 26. others
  3       Histology                               1\. none 2. adenocarcinoma 3. squamous cell carcinoma 4. small cell carcinoma 5. NSCLC 6. large cell carcinoma 7. transitional cell carcinoma 8. leukemia 9. sarcoma 10. retinoblastoma 11. neuroblastoma 12. melanoma 13. lymphoma 14. clear cell carcinoma 15. others 16. unknown
  4       Date of diagnosis of original cancer    year / month
  5       Other metastases                        1\. none 2. lung 3. liver 4. other abdominal organ 5. lymph node 6. bone 7. others 8. unknown
  6       Number of tumors                        1\. single 2. 2--4 3. 5--9 4. 10- 5. LMM
  7       Maximum tumor diameter                  \(mm\)
  8       Tumor region                            1\. frontal lobe 2. temporal lobe 3. parietal lobe 4. occipital lobe 5. insular cortex 6. Gliomatosis cerebri 7. cerebellum 8. midbrain 9. pons 10. medulla oblongata 11. lateral ventricle 12. IIIrd ventricle 13. aqueduct 14. IVth ventricle 15. basal ganglia 16. thalamus/ hypothalamus 17. corpus callosum 18. pineal body 19. intra-orbita 20. pituitary gland 21. optic nerve 22. CP angle 23. clivus 24. cavernous sinus 25. cranial nerve 26. other skull base 27. skull 28. LMM 29. others
  9       Tumor side                              1\. right 2. left 3. bilateral 4. both side 5. central neuraxis 6. others 7. unknown
  10      Diagnostic method                       1\. histology 2. diagnostic imaging 3. CSF cytology diagnosis 4. blood or CSF test 5. genetic diagnosis 6. autopsy 7. others
  11      Date of radiological finding of tumor   year / month
  12      Date of initial treatment               year / month
  13      Mode of initial treatment               1\. surgery alone 2. surgery+RT 3. surgery+CRT 4. surgery+CTX 5. CRT 6. RT alone 7. CTX alone 8. observation 9. others
  14      Initial symptoms                        1\. no clinical symptoms (medical check-up) 2. no clinical symptoms (detailed test of brain disease) 3. subjective symptoms (headache etc.) 4. seizure 5. focal symptom 6. intracranial hyper-tension 7. cons. disturbance 8. cranial nerve symptom 9. hormonal excess or hormonal decline 10. cerebral hemorrhage 11. cerebral infarction 12. others
  15      Seizures during treatment               1\. yes 2. none 3. unknown
  16-1    Mode of major surgery                   1\. none 2. decompression 3. biopsy 4. 1--50% resection 5. 50--75% resection 6.75--95% resection 7. 95--99% resection 8. 100% total resection 9. extended total resection 10. shunt 11. drainage
  16-2    Date of major surgery                   year / month
  17-1    Initial radiotherapy                    1\. none 2. before surgery 3. intraoperative 4. after surgery 5. at recurrence 6. others 7. unknown
  17-2    Mode of initial radiotherapy            1\. WBRT 2. WBRT+LBRT/SRT/SRS 3. LBRT 4. LBRT+SRT/SRS 5. SRS/SRT 6. internal RT 7. particle beam irradiation 8. others
  17--3   Dose of irradiation                     (Gy)
  18      Spinal radiotherapy                     1\. no clinical symptoms (medical check-up) 2. no clinical symptoms (detailed test of brain disease) 3. subjective symptoms (headache etc.) 4. seizure 5. focal symptom 6. intracranial hyper-tension 7. cons. disturbance 8. cranial nerve symptom 9. hormonal excess or hormonal decline 10. cerebral hemorrhage 11. cerebral infarction 12. others
  19      Radiotherapy in recurrence              1\. none 2. WBRT 3. LBRT 4. SRT/SRS 5. spinal RT 6. internal RT 7. particle beam irradiation 8. others 9. unknown
  20-1    Initial chemotherapy                    1\. yes 2. none 3. unknown
  20-2    Timing of initial chemotherapy          1\. before surgery 2. after surgery 3. surgery+CTX 4. unknown
  21      Any treatment during treatment          1\. none 2. surgery 3. WBRT 4. LBRT 5. SRS/SRT 6. particle beam therapy 7. CTX 8. molecular targeting drug 9. dopamine agonist 10. gene therapy 11. viral therapy 12. vaccine therapy 13. immunotherapy 14. lymphocyte activation 15. steroid 16. anti-convulsants 17. others
  22      Any drug used during treatment          1\. none 2. TMZ 3. ACNU 4. other alkylating agents 5. platinum drugs 6. vincristine 7. interferon 8. etoposide 9. ifosfamide 10. MTX 11. molecular targeting drug 12. hormone therapy 13. steroid 14. anti-convulsants 15. dopamine agonist 16. others
  23      KPS before initial treatment            0--100
  24      KPS after initial treatment             0--100
  25-1    Progression                             1\. none 2. local recurrence 3. new lesion 4. unknown
  25-2    Date of recurrence                      year / month
  26      Transfer to other hospital              1\. none 2. transfer for further treatment 3. transfer for palliative care 4. other reasons
  27      Outcome                                 1\. alive 2. dead 3. unknown
  28      Last confirmation date of survival      year / month
  29      Date of death                           year / month
  30      Cause of death                          1\. neuronal death except pneumonia and LMM 2. neuronal death with pneumonia 3. LMM 4. TRD except pneumonia 5. TRD (pneumonia) 6. cancer or other organ metastases 7. accident or other disease 8. others 9. unknown
  31      Autopsy                                 1\. yes 2. none 3. unknown
  32      Complication                            1\. none 2. intracranial hemorrhage 3. cerebral infarction 4. pneumonia 5. pulmonary embolization 6. deep vein thrombosis 7. bone fracture 8. second cancer 9. others 10. unknown
  33      Place of death                          1\. hospital with NSD 2. hospital without NSD 3. hospice 4. nursing home 5. home 6. others 7. unknown
  34      Hereditary disease                      1\. none 2. NF-1 3. NF-2 4. VHL 5. Tuberous 6. LiFraumeni 7. retinoblastoma 8. unknown 9. others
  ------- --------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AA

:   anaplastic astrocytoma

ACNU

:   nimustine

ACTH

:   adrenocorticotropic hormone

AE

:   anaplastic ependymoma

AO

:   anaplastic oligodendroglioma

AOA

:   anaplastic oligoastrocytoma

BT

:   brain tumor

CNS

:   central nervous system

Cons.

:   consciousness

CP angle

:   cerebello-pontine angle

CRT

:   chemoadiotherapy

CTX

:   chemotherapy

DA

:   diffuse astrocytoma

GBM

:   glioblastoma

GH

:   growth hormone

GI

:   grade I

GII

:   grade II

GIII

:   grade III

GIV

:   grade IV

infratent.

:   infratentorial

KPS

:   Karnofsky performance status

LBRT

:   local brain radiotherapy

LMM

:   leptomeningeal metastases

MTX

:   methotrexate

ND

:   not determined

NF

:   nonfunctioning (pituitary adenoma)

NF-1

:   neurofibromatosis type I

NF-2

:   neurofibromatosis type II

no.

:   number

NR

:   not reached

NSCLC

:   non small cell lung carcinoma

NSD

:   neurosurgical department

OA

:   oligoastrocytoma

OL

:   oligodendroglioma

OS

:   overall survival

OS event

:   all death

PA

:   pilocytic astrocytoma

PCNSL

:   primary central nervous system lymphoma

PFS

:   progression free survival

PRL

:   prolactin

pt.

:   patient

RT

:   radiotherapy

SEGA

:   subependymal giant cell astrocytoma

SRS

:   stereotactic radiosurgery

SRT

:   stereotactic radiotherapy

supratent.

:   supratentorial

TMZ

:   temozolomide

TRD

:   treatment-related death except pneumonia

VHL

:   von Hippel--Lindau syndrome

WBRT

:   whole brain radiotherapy

1.. Total registered number of primary brain tumors and brain metastases {#S1}
========================================================================

                     1984    1985    1986    1987    1988    1989    1990    1991
  ------------------ ------- ------- ------- ------- ------- ------- ------- -------
  Primary BT         3,491   3,593   3,530   3,673   4,108   4,400   3,998   4,302
  Brain metastases   730     716     730     750     851     955     881     926
  total              4,221   4,309   4,260   4,423   4,959   5,355   4,879   5,228

  1992               1993    1994    1995    1996    1997    1998    1999    
  ------------------ ------- ------- ------- ------- ------- ------- ------- -------
  Primary BT         4,446   4,402   4,737   4,609   4,646   3,458   3,714   3,767
  Brain metastases   853     902     878     925     982     757     881     928
  total              5,299   5,304   5,615   5,534   5,628   4,215   4,595   4,695

                     2000    2001    2002    2003    2004       **2001--2004**   
  ------------------ ------- ------- ------- ------- ------- -- ---------------- --
  Primary BT         3,407   3,283   3,318   3,487   3,343      **13,431**       
  Brain metastases   918     747     703     801     656        **2,907**        
  total              4,325   4,030   4,021   4,288   3,999      **16,338**       

2.. General features of primary brain tumors (2001--2004) {#S2}
=========================================================

1). Age distribution of primary brain tumors (2001--2004) {#S2.1}
---------------------------------------------------------

           **All primary brain tumors**   **Malignant brain tumors**   **Benign brain tumors**                                                                                                                           
  -------- ------------------------------ ---------------------------- ------------------------- -------- -------- -------- ------- -------- ------- -------- ------- -------- ------- -------- ------- -------- ------- --------
  0        27                             (0.4%)                       25                        (0.3%)   52       (0.4%)   15      (0.6%)   9       (0.5%)   24      (0.5%)   11      (0.3%)   13      (0.2%)   24      (0.3%)
  1        25                             (0.4%)                       23                        (0.3%)   48       (0.4%)   16      (0.6%)   8       (0.4%)   24      (0.5%)   8       (0.2%)   12      (0.2%)   20      (0.2%)
  2        23                             (0.4%)                       14                        (0.2%)   37       (0.3%)   17      (0.6%)   7       (0.4%)   24      (0.5%)   6       (0.2%)   6       (0.1%)   12      (0.1%)
  3        23                             (0.4%)                       22                        (0.3%)   45       (0.3%)   11      (0.4%)   9       (0.5%)   20      (0.4%)   11      (0.3%)   13      (0.2%)   24      (0.3%)
  4        29                             (0.5%)                       15                        (0.2%)   44       (0.3%)   21      (0.8%)   7       (0.4%)   28      (0.6%)   7       (0.2%)   7       (0.1%)   14      (0.2%)
  5--9     150                            (2%)                         118                       (2%)     268      (2%)     92      (3%)     76      (4%)     168     (4%)     47      (1%)     38      (0.7%)   85      (1%)
  10--14   189                            (3%)                         146                       (2%)     335      (2%)     117     (4%)     65      (3%)     182     (4%)     66      (2%)     76      (1%)     142     (2%)
  15--19   202                            (3%)                         165                       (2%)     367      (3%)     124     (5%)     63      (3%)     187     (4%)     72      (2%)     97      (2%)     169     (2%)
  20--24   233                            (4%)                         247                       (3%)     480      (4%)     128     (5%)     52      (3%)     180     (4%)     99      (3%)     186     (4%)     285     (3%)
  25--29   278                            (5%)                         410                       (6%)     688      (5%)     140     (5%)     92      (5%)     232     (5%)     131     (4%)     311     (6%)     442     (5%)
  30--34   334                            (5%)                         377                       (5%)     711      (5%)     134     (5%)     105     (6%)     239     (5%)     191     (6%)     266     (5%)     457     (5%)
  35--39   377                            (6%)                         390                       (5%)     767      (6%)     154     (6%)     92      (5%)     246     (5%)     218     (7%)     284     (5%)     502     (6%)
  40--44   397                            (7%)                         443                       (6%)     840      (6%)     131     (5%)     102     (5%)     233     (5%)     258     (8%)     335     (6%)     593     (7%)
  45--49   423                            (7%)                         568                       (8%)     991      (7%)     153     (6%)     116     (6%)     269     (6%)     260     (8%)     442     (8%)     702     (8%)
  50--54   638                            (10%)                        880                       (12%)    1,518    (11%)    218     (8%)     184     (10%)    402     (9%)     403     (12%)    677     (13%)    1,080   (13%)
  55--59   638                            (10%)                        861                       (12%)    1,499    (11%)    223     (8%)     174     (9%)     397     (9%)     397     (12%)    671     (13%)    1,068   (12%)
  60--64   623                            (10%)                        835                       (11%)    1,458    (11%)    265     (10%)    189     (10%)    454     (10%)    352     (11%)    624     (12%)    976     (11%)
  65--69   621                            (10%)                        806                       (11%)    1,427    (11%)    291     (11%)    207     (11%)    498     (11%)    311     (9%)     585     (11%)    896     (10%)
  70--74   493                            (8%)                         558                       (8%)     1,051    (8%)     225     (8%)     154     (8%)     379     (8%)     255     (8%)     395     (7%)     650     (8%)
  75--79   261                            (4%)                         310                       (4%)     571      (4%)     123     (5%)     127     (7%)     250     (6%)     131     (4%)     176     (3%)     307     (4%)
  80--84   65                             (1%)                         107                       (1%)     172      (1%)     34      (1%)     48      (3%)     82      (2%)     28      (0.9%)   58      (1%)     86      (1%)
  85--89   30                             (0.5%)                       19                        (0.3%)   49       (0.4%)   17      (0.6%)   6       (0.3%)   23      (0.5%)   12      (0.4%)   13      (0.2%)   25      (0.3%)
  90--94   6                              (0.1%)                       6                         (0.1%)   12       (0.1%)   1       (0.0%)   2       (0.1%)   3       (0.1%)   5       (0.2%)   4       (0.1%)   9       (0.1%)
  95--00   1                              (0.0%)                       \-                        (-)      1        (0.0%)   1       (0.0%)   \-      (-)      1       (0.0%)   \-      (-)      \-      (-)      \-      (-)
  total    6,086                          (100%)                       7,345                     (100%)   13,431   (100%)   2,651   (100%)   1,894   (100%)   4,545   (100%)   3,279   (100%)   5,289   (100%)   8,568   (100%)
  mean     48.9                           50.8                         49.9                      47.2     49.7     48.2     50.5    51.3     51.0                                                                        

2). Resident area: All primary brain tumors (2001--2004) {#S2.2}
--------------------------------------------------------

       prefecture        All primary brain tumors   Malignant brain tumors   Benign brain tumors                         
  ---- ----------------- -------------------------- ------------------------ --------------------- --------- ----------- ---------
  1    Hokkaido          648                        (4.8%)                   233                   (5.1%)    404         (4.7%)
  2    Aomori            186                        (1.4%)                   54                    (1.2%)    125         (1.5%)
  3    Iwate             179                        (1.3%)                   65                    (1.4%)    114         (1.3%)
  4    Miyagi            337                        (2.5%)                   137                   (3.0%)    199         (2.3%)
  5    Akita             264                        (2.0%)                   88                    (1.9%)    173         (2.0%)
  6    Yamagata          197                        (1.5%)                   65                    (1.4%)    127         (1.5%)
  7    Fukushima         187                        (1.4%)                   62                    (1.4%)    114         (1.3%)
  8    Ibaraki           260                        (1.9%)                   113                   (2.5%)    142         (1.7%)
  9    Tochigi           33                         (0.2%)                   10                    (0.2%)    23          (0.3%)
  10   Gunma             212                        (1.6%)                   41                    (0.9%)    168         (2.0%)
  11   Saitama           701                        (5.2%)                   226                   (5.0%)    466         (5.4%)
  12   Chiba             427                        (3.2%)                   150                   (3.3%)    272         (3.2%)
  13   Tokyo             1,955                      (14.6%)                  631                   (13.9%)   1,264       (14.8%)
  14   Kanagawa          943                        (7.0%)                   357                   (7.9%)    571         (6.7%)
  15   Niigata           306                        (2.3%)                   94                    (2.1%)    204         (2.4%)
  16   Toyama            228                        (1.7%)                   84                    (1.8%)    144         (1.7%)
  17   Ishikawa          252                        (1.9%)                   66                    (1.5%)    177         (2.1%)
  18   Fukui             119                        (0.9%)                   45                    (1.0%)    72          (0.8%)
  19   Yamanashi         154                        (1.1%)                   57                    (1.3%)    94          (1.1%)
  20   Nagano            64                         (0.5%)                   24                    (0.5%)    40          (0.5%)
  21   Gifu              242                        (1.8%)                   74                    (1.6%)    166         (1.9%)
  22   Shizuoka          204                        (1.5%)                   80                    (1.8%)    123         (1.4%)
  23   Aichi             506                        (3.8%)                   150                   (3.3%)    351         (4.1%)
  24   Mie               33                         (0.2%)                   8                     (0.2%)    25          (0.3%)
  25   Shiga             156                        (1.2%)                   61                    (1.3%)    93          (1.1%)
  26   Kyoto             149                        (1.1%)                   45                    (1.0%)    103         (1.2%)
  27   Osaka             869                        (6.5%)                   213                   (4.7%)    604         (7.0%)
  28   Hyogo             372                        (2.8%)                   97                    (2.1%)    266         (3.1%)
  29   Nara              185                        (1.4%)                   52                    (1.1%)    123         (1.4%)
  30   Wakayama          253                        (1.9%)                   73                    (1.6%)    166         (1.9%)
  31   Tottori           17                         (0.1%)                   7                     (0.2%)    10          (0.1%)
  32   Shimane           11                         (0.1%)                   4                     (0.1%)    7           (0.1%)
  33   Okayama           205                        (1.5%)                   71                    (1.6%)    131         (1.5%)
  34   Hiroshima         430                        (3.2%)                   150                   (3.3%)    268         (3.1%)
  35   Yamaguchi         209                        (1.6%)                   73                    (1.6%)    132         (1.5%)
  36   Tokushima         127                        (0.9%)                   47                    (1.0%)    75          (0.9%)
  37   Kagawa            131                        (1.0%)                   49                    (1.1%)    81          (0.9%)
  38   Ehime             265                        (2.0%)                   91                    (2.0%)    163         (1.9%)
  39   Kochi             84                         (0.6%)                   31                    (0.7%)    53          (0.6%)
  40   Fukuoka           216                        (1.6%)                   61                    (1.3%)    150         (1.8%)
  41   Saga              152                        (1.1%)                   50                    (1.1%)    101         (1.2%)
  42   Nagasaki          142                        (1.1%)                   51                    (1.1%)    90          (1.1%)
  43   Kumamoto          134                        (1.0%)                   119                   (2.6%)    14          (0.2%)
  44   Oita              86                         (0.6%)                   28                    (0.6%)    56          (0.7%)
  45   Miyazaki          167                        (1.2%)                   54                    (1.2%)    109         (1.3%)
  46   Kagoshima         297                        (2.2%)                   142                   (3.1%)    145         (1.7%)
  47   Okinawa           103                        (0.8%)                   48                    (1.1%)    52          (0.6%)
  48   foreign country   8                          (0.1%)                   2                     (0.0%)    6           (0.1%)
  49   unknown           26                         (0.2%)                   12                    (0.3%)    12          (0.1%)
                                                                                                                         
       total             **13,431**                 (100%)                   **4,545**             (100%)    **8,568**   (100%)

3). Initial symptoms {#S2.3}
--------------------

                                                                 All primary brain tumors   Malignant brain tumors   Benign brain tumors                    
  -------------------------------------------------------------- -------------------------- ------------------------ --------------------- -------- ------- --------
  no clinical symptoms (medical check-up)                        774                        (6%)                     96                    (2%)     660     (8%)
  no clinical symptoms (detailed examination of brain disease)   672                        (5%)                     102                   (2%)     550     (6%)
  subjective symptoms (headache, etc)                            3,294                      (25%)                    1,196                 (26%)    2,001   (23%)
  seizure                                                        1,204                      (9%)                     803                   (18%)    385     (4%)
  focal symptom                                                  3,142                      (23%)                    1,924                 (42%)    1,164   (14%)
  intracranial hypertension                                      859                        (6%)                     552                   (12%)    290     (3%)
  disturbance of consciousness                                   704                        (5%)                     522                   (11%)    169     (2%)
  cranial nerve symptom                                          3,439                      (26%)                    381                   (8%)     2,983   (35%)
  hormonal decline or excess                                     1,365                      (10%)                    101                   (2%)     1,250   (15%)
  intracerebral hemorrhage                                       72                         (1%)                     33                    (1%)     39      (0.5%)
  cerebral infarction                                            10                         (0.1%)                   4                     (0.1%)   6       (0.1%)
  others                                                         593                        (4%)                     251                   (6%)     301     (4%)
                                                                                                                                                            
  **patient number**                                             **13,431**                 **4,545**                **8,568**                              

4). Diagnostic methods {#S2.4}
----------------------

                                      All primary brain tumors   Malignant brain tumors   Benign brain tumors                        
  ----------------------------------- -------------------------- ------------------------ --------------------- -------- ----------- --------
  histopathology                      12,265                     (91%)                    4,222                 (93%)    7,844       (92%)
  diagnostic imaging                  1,061                      (8%)                     285                   (6%)     661         (8%)
  cerebrospinal fluid cytology        9                          (0.1%)                   9                     (0.2%)   \-          ( - )
  blood or cerebrospinal fluid test   74                         (1%)                     20                    (0.4%)   54          (1%)
  genetic diagnosis                   \-                         ( - )                    \-                    ( - )    \-          ( - )
  autopsy                             4                          (0.0%)                   3                     (0.1%)   1           (0.0%)
  others                              18                         (0.1%)                   6                     (0.1%)   8           (0.1%)
                                                                                                                                     
  **total**                           **13,431**                 (100%)                   **4,545**             (100%)   **8,568**   (100%)

5). Multiplicity {#S2.5}
----------------

                  All primary brain tumors   Malignant brain tumors   Benign brain tumors                        
  --------------- -------------------------- ------------------------ --------------------- -------- ----------- --------
  single          12,589                     (94%)                    3,958                 (87%)    8,338       (97%)
  multiple        732                        (5%)                     498                   (11%)    214         (2%)
  dissemination   65                         (0.5%)                   60                    (1%)     3           (0.0%)
  LMM             4                          (0.0%)                   4                     (0.1%)   \-          ( - )
  others          41                         (0.3%)                   25                    (1%)     13          (0.2%)
                                                                                                                 
  **total**       **13,431**                 (100%)                   **4,545**             (100%)   **8,568**   (100%)

6). Laterality {#S2.6}
--------------

                      All primary brain tumors   Malignant brain tumors   Benign brain tumors                        
  ------------------- -------------------------- ------------------------ --------------------- -------- ----------- --------
  right               3,961                      (29%)                    1,648                 (36%)    2,219       (26%)
  left                4,061                      (30%)                    1,650                 (36%)    2,319       (27%)
  across both sides   804                        (6%)                     407                   (9%)     375         (4%)
  on both sides       293                        (2%)                     189                   (4%)     93          (1%)
  central neuraxis    4,221                      (31%)                    621                   (14%)    3,509       (41%)
  others              91                         (1%)                     30                    (1%)     53          (1%)
                                                                                                                     
  **total**           **13,431**                 (100%)                   **4,545**             (100%)   **8,568**   (100%)

7). Tumor location {#S2.7}
------------------

                            All primary brain tumors   Malignant brain tumors   Benign brain tumors                    
  ------------------------- -------------------------- ------------------------ --------------------- -------- ------- --------
  frontal lobe              2,643                      (20%)                    1,542                 (34%)    1,067   (12%)
  temporal lobe             1,149                      (9%)                     854                   (19%)    277     (3%)
  parietal lobe             836                        (6%)                     515                   (11%)    311     (4%)
  occipital lobe            316                        (2%)                     191                   (4%)     118     (1%)
  insular gyri              89                         (1%)                     84                    (2%)     4       (0.0%)
  gliomatosis cerebri       34                         (0.3%)                   33                    (1%)     \-      (-)
  cerebellum                625                        (5%)                     216                   (5%)     398     (5%)
  midbrain                  86                         (1%)                     63                    (1%)     22      (0.3%)
  pons                      163                        (1%)                     128                   (3%)     29      (0.3%)
  medulla oblongata         76                         (1%)                     38                    (1%)     33      (0.4%)
  lateral ventricle         299                        (2%)                     194                   (4%)     99      (1%)
  third ventricle           154                        (1%)                     56                    (1%)     89      (1%)
  cerebral aqueduct         4                          (0.0%)                   \-                    (-)      3       (0.0%)
  fourth ventricle          159                        (1%)                     119                   (3%)     37      (0.4%)
  basal ganglia             234                        (2%)                     216                   (5%)     13      (0.2%)
  thalamus. hypothalamus    347                        (3%)                     232                   (5%)     110     (1%)
  corpus callosum           148                        (1%)                     138                   (3%)     9       (0.1%)
  pineal region             252                        (2%)                     211                   (5%)     34      (0.4%)
  intraorbital              118                        (1%)                     21                    (0.5%)   56      (1%)
  pituitary gland           3,182                      (24%)                    59                    (1%)     3,078   (36%)
  optic nerve               51                         (0.4%)                   13                    (0.3%)   37      (0.4%)
  cerebello-pontine angle   1,511                      (11%)                    30                    (1%)     1,450   (17%)
  clivus                    209                        (2%)                     53                    (1%)     145     (2%)
  cavernous sinus           102                        (1%)                     14                    (0.3%)   82      (1%)
  cranial nerve             200                        (1%)                     5                     (0.1%)   193     (2%)
  other skull base          708                        (5%)                     56                    (1%)     640     (7%)
  skull bone                97                         (1%)                     11                    (0.2%)   54      (1%)
  LMM                       14                         (0.1%)                   11                    (0.2%)   1       (0.0%)
  others                    408                        (3%)                     70                    (2%)     313     (4%)
                                                                                                                       
  **patient number**        **13,431**                 **4,545**                **8,568**                              

8). Mode of therapy {#S2.8}
-------------------

                      All primary brain tumors   Malignant brain tumors   Benign brain tumors                        
  ------------------- -------------------------- ------------------------ --------------------- -------- ----------- --------
  surgery             8,036                      (60%)                    827                   (18%)    7,031       (82%)
  surgery + RT        1,317                      (10%)                    833                   (18%)    466         (5%)
  surgery + CRT       2,411                      (18%)                    2,332                 (51%)    72          (1%)
  surgery + CTX       627                        (5%)                     246                   (5%)     373         (4%)
  CRT                 121                        (1%)                     113                   (2%)     6           (0.1%)
  RT                  330                        (2%)                     75                    (2%)     233         (3%)
  CTX                 66                         (0.5%)                   17                    (0.4%)   46          (1%)
  observation alone   457                        (3%)                     61                    (1%)     323         (4%)
  others              66                         (0.5%)                   41                    (1%)     18          (0.2%)
                                                                                                                     
  **total**           **13,431**                 (100%)                   **4,545**             (100%)   **8,568**   (100%)

9). Initial surgery {#S2.9}
-------------------

                              All primary brain tumors   Malignant brain tumors   Benign brain tumors                        
  --------------------------- -------------------------- ------------------------ --------------------- -------- ----------- --------
  none                        1,018                      (8%)                     296                   (7%)     616         (7%)
  decompressive craniectomy   16                         (0.1%)                   12                    (0.3%)   3           (0.0%)
  biopsy                      1,154                      (9%)                     1,017                 (22%)    106         (1%)
  1--50% resection            593                        (4%)                     295                   (6%)     280         (3%)
  50--75% resection           1,055                      (8%)                     470                   (10%)    578         (7%)
  75--95% resection           2,206                      (16%)                    795                   (17%)    1,391       (16%)
  95--99% resection           2,500                      (19%)                    668                   (15%)    1,800       (21%)
  100% total resection        4,460                      (33%)                    853                   (19%)    3,519       (41%)
  extended tumor resection    32                         (0.2%)                   24                    (1%)     8           (0.1%)
  shunt                       44                         (0.3%)                   22                    (0.5%)   20          (0.2%)
  drainage                    49                         (0.4%)                   9                     (0.2%)   39          (0.5%)
  others                      304                        (2%)                     84                    (2%)     208         (2%)
                                                                                                                             
  **total**                   **13,431**                 (100%)                   **4,545**             (100%)   **8,568**   (100%)

10). Seizures during the whole treatment {#S2.10}
----------------------------------------

              All primary brain tumors   Malignant brain tumors   Benign brain tumors                        
  ----------- -------------------------- ------------------------ --------------------- -------- ----------- --------
  ( + )       2,036                      (15%)                    1,331                 (29%)    677         (8%)
  ( − )       10,209                     (76%)                    2,584                 (57%)    7,368       (86%)
  unknown     1,186                      (9%)                     630                   (14%)    523         (6%)
                                                                                                             
  **tota1**   **13,431**                 (100%)                   **4,545**             (100%)   **8,568**   (100%)

3.. General features of WHO2007 primary brain tumors?(2001--2004) {#S3}
=================================================================

1). Number of Primary Brain Tumors according to WHO2007 Classification {#S3.1}
----------------------------------------------------------------------

  classification                                ID                                                         histology                                                   number    WHO code          
  --------------------------------------------- ---------------------------------------------------------- ----------------------------------------------------------- --------- ---------- ------ ---
  **Astrocytic tumors**                         1                                                          Pilocytic astrocytoma                                       193       (1.4%)     9421   1
  2                                                 Pilomyxoid astrocytoma                                 14                                                          (0.1%)    9425       3      
  3                                             Subependymal giant cell astrocytoma                        9                                                           (0.1%)    9384       1      
  4                                             Pleomorphic xanthoastrocytoma                              31                                                          (0.2%)    9424       3      
  5                                             Diffuse astrocytoma                                        269                                                         (2.0%)    9400       3      
  6                                                 Fibrillary astrocytoma                                 71                                                          (0.5%)    9420       3      
  7                                                 Gemistocytic astrocytoma                               29                                                          (0.2%)    9411       3      
  8                                                 Protoplasmic astrocytoma                               13                                                          (0.1%)    9410       3      
  9                                             Anaplastic astrocytoma                                     513                                                         (3.8%)    9401       3      
  10                                            Glioblastoma                                               1,455                                                       (10.8%)   9440       3      
  11                                                Giant cell glioblastoma                                14                                                          (0.1%)    9441       3      
  12                                                Gliosarcoma                                            20                                                          (0.1%)    9442       3      
  13                                            Gliomatosis cerebri                                        47                                                          (0.3%)    9381       3      
  **Oligodendroglial tumors**                   14                                                         Oligodendroglioma                                           121       (0.9%)     9450   3
  15                                            Anaplastic oligodendroglioma                               126                                                         (0.9%)    9451       3      
  **Oligoastrocytic tumors**                    16                                                         Oligoastrocytoma                                            90        (0.7%)     9382   3
  17                                            Anaplastic oligoastrocytoma                                106                                                         (0.8%)    9382       3      
  **Ependymal tumors**                          18                                                         Subependymoma                                               21        (0.2%)     9383   1
  19                                            Myxopapillary ependymoma                                   1                                                           (0.0%)    9394       1      
  20                                            Ependymoma                                                 72                                                          (0.5%)    9391       3      
  21                                                Cellular ependymoma                                    2                                                           (0.0%)    9391       3      
  22                                                Papillary ependymoma                                   1                                                           (0.0%)    9393       3      
  23                                                Clear cell ependymoma                                  3                                                           (0.0%)    9391       3      
  24                                                Tanycytic ependymoma                                   1                                                           (0.0%)    9391       3      
  25                                            Anaplastic ependymoma                                      55                                                          (0.4%)    9392       3      
  **Unclassified gliomas**                      26                                                         Unclassified gliomas including brainstem gliomas            115       (0.9%)            
  **Choroid plexus tumors**                     27                                                         Choroid plexus papilloma                                    30        (0.2%)     9390   0
  28                                            Atypical choroid plexus papilloma                          1                                                           (0.0%)    9390       1      
  29                                            Choroid plexus carcinoma                                   4                                                           (0.0%)    9390       3      
  **Other neuroepithelial tumors**              30                                                         Astroblastoma                                               1         (0.0%)     9430   3
  31                                            Chordoid glioma of the third ventricle                     5                                                           (0.0%)    9444       1      
  32                                            Angiocentric glioma                                        1                                                           (0.0%)    9431       1      
  **Neuronal and mixed neuronalglial tumors**   33                                                         Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)   1         (0.0%)     9493   0
  34                                            Desmoplastic infantile astrocytoma/ganglioglioma           1                                                           (0.0%)    9412       1      
  35                                            Dysembryoplastic neuroepithelial tumor                     26                                                          (0.2%)    9413       0      
  36                                            Gangliocytoma                                              7                                                           (0.1%)    9492       0      
  37                                            Ganglioglioma                                              60                                                          (0.4%)    9505       1      
  38                                            Anaplastic ganglioglioma                                   8                                                           (0.1%)    9505       3      
  39                                            Central neurocytoma                                        65                                                          (0.5%)    9506       1      
  40                                            Extraventricular neurocytoma                               2                                                           (0.0%)    9506       1      
  41                                            Cerebellar liponeurocytoma                                 \-                                                          ( - )     9506       1      
  42                                            Papillary glioneuronal tumor                               3                                                           (0.0%)    9509       1      
  43                                            Rosette-forming glioneuronal tumor                         2                                                           (0.0%)    9509       1      
  44                                            Paraganglioma                                              6                                                           (0.0%)    8680       1      
  **Tumors of the pineal region**               45                                                         Pineocytoma                                                 20        (0.1%)     9361   1
  46                                            Pineal parenchymal tumor of intermediate differentiation   6                                                           (0.0%)    9362       3      
  47                                            Pineoblastoma                                              9                                                           (0.1%)    9362       3      
  48                                            Papillary tumor of the pineal region                       \-                                                          ( - )     9395       3      
  **Embryonal tumors**                          49                                                         Medulloblastoma                                             98        (0.7%)     9470   3
  50                                                Desmoplastic/nodular medulloblastoma                   3                                                           (0.0%)    9471       3      
  51                                                Medulloblastoma with extensive nodularity              \-                                                          ( - )     9471       3      
  52                                                Anaplastic medulloblastoma                             \-                                                          ( - )     9474       3      
  53                                                Large cell medulloblastoma                             \-                                                          ( - )     9474       3      
  54                                            CNS primitive neuroectodermal tumor (CNS PNET)             23                                                          (0.2%)    9473       3      
  55                                                CNS neuroblastoma                                      13                                                          (0.1%)    9500       3      
  56                                                CNS ganglioneuroblastoma                               1                                                           (0.0%)    9490       3      
  57                                                Medulloepithelioma                                     \-                                                          ( - )     9501       3      
  58                                                Ependymoblastoma                                       2                                                           (0.0%)    9392       3      
  59                                            Atypical teratoid/rhabdoid tumor                           10                                                          (0.1%)    9508       3      
  **Tumors of cranial and paraspinal nerves**   60                                                         Schwannoma (neurilemoma, neurinoma)                         1,344     (10.0%)    9560   0
  61                                                Cellular schwannoma                                    7                                                           (0.1%)    9560       0      
  62                                                Plexiform schwannoma                                   1                                                           (0.0%)    9560       0      
  63                                                Melanotic schwannoma                                   \-                                                          ( - )     9560       0      
  64                                            Neurofibroma                                               15                                                          (0.1%)    9540       0      
  65                                                Plexiform neurofibroma                                 \-                                                          ( - )     9550       0      
  66                                            Perineurioma                                               \-                                                          ( - )                       
  67                                                Perineurioma, NOS                                      \-                                                          ( - )     9571       0      
  68                                                Malignant perineurioma                                 1                                                           (0.0%)    9571       3      
  69                                            Malignant peripheral nerve sheath tumor (MPNST)            1                                                           (0.0%)                      
  70                                                Epithelioid MPNST                                      \-                                                          ( - )     9540       3      
  71                                                MPNST with mesenchymal differentiation                 \-                                                          ( - )     9540       3      
  72                                                Melanotic MPNST                                        \-                                                          ( - )     9540       3      
  73                                                MPNST with glandular differentiation                   \-                                                          ( - )     9540       3      
  **Tumors of meningothelial cells**            74                                                         Meningioma                                                  1,093     (8.1%)     9530   0
  75                                                Meningothelial meningioma                              1,007                                                       (7.5%)    9531       0      
  76                                                Fibrous (fibroblastic) meningioma                      336                                                         (2.5%)    9532       0      
  77                                                Transitional (mixed) meningioma                        385                                                         (2.9%)    9537       0      
  78                                                Psammomatous meningioma                                76                                                          (0.6%)    9533       0      
  79                                                Angiomatous meningioma                                 101                                                         (0.8%)    9534       0      
  80                                                Microcystic meningioma                                 40                                                          (0.3%)    9530       0      
  81                                                Secretory meningioma                                   17                                                          (0.1%)    9530       0      
  82                                                Lymphoplasmacyte-rich meningioma                       5                                                           (0.0%)    9530       0      
  83                                                Metaplastic meningioma                                 5                                                           (0.0%)    9530       0      
  84                                                Chordoid meningioma                                    13                                                          (0.1%)    9538       1      
  85                                                Clear cell meningioma                                  6                                                           (0.0%)    9538       1      
  86                                                Atypical meningioma                                    154                                                         (1.1%)    9539       1      
  87                                                Papillary meningioma                                   4                                                           (0.0%)    9538       3      
  88                                                Rhabdoid meningioma                                    4                                                           (0.0%)    9538       3      
  89                                                Anaplastic (malignant) meningioma                      32                                                          (0.2%)    9530       3      
  **Mesenchymal tumors**                        90                                                         Lipoma                                                      7         (0.1%)     8850   0
  91                                            Angiolipoma                                                \-                                                          ( - )     8861       0      
  92                                            Hibernoma                                                  \-                                                          ( - )     8880       0      
  93                                            Liposarcoma                                                1                                                           (0.0%)    8850       3      
  94                                            Solitary fibrous tumor                                     10                                                          (0.1%)    8815       0      
  95                                            Fibrosarcoma                                               2                                                           (0.0%)    8810       3      
  96                                            Malignant fibrous histiocytoma                             1                                                           (0.0%)    8830       3      
  97                                            Leiomyoma                                                  \-                                                          ( - )     8890       0      
  98                                            Leiomyosarcoma                                             \-                                                          ( - )     8890       3      
  99                                            Rhabdomyoma                                                \-                                                          ( - )     8900       0      
  100                                           Rhabdomyosarcoma                                           6                                                           (0.0%)    8900       3      
  101                                           Chordoma                                                   58                                                          (0.4%)                      
  102                                           Chondroma                                                  4                                                           (0.0%)    9220       0      
  103                                           Chondrosarcoma                                             17                                                          (0.1%)    9220       3      
  104                                           Osteoma                                                    22                                                          (0.2%)    9180       0      
  105                                           Osteosarcoma                                               5                                                           (0.0%)    9180       3      
  106                                           Osteochondroma                                             1                                                           (0.0%)    9210       0      
  107                                           Hemangioma, capillary, cavernous                           160                                                         (1.2%)    9120       0      
  108                                           Epithelioid hemangioendothelioma                           1                                                           (0.0%)    9133       1      
  109                                           Hemangiopericytoma                                         19                                                          (0.1%)    9150       1      
  110                                           Anaplastic hemangiopericytoma                              1                                                           (0.0%)    9150       3      
  111                                           Angiosarcoma                                               3                                                           (0.0%)    9120       3      
  112                                           Kaposi sarcoma                                             \-                                                          ( - )     9140       3      
  113                                           Ewing sarcoma -PNET                                        4                                                           (0.0%)    9364       3      
  **Primary melanocytic lesions**               114                                                        Diffuse melanocytosis                                       \-        ( - )      8728   0
  115                                           Melanocytoma                                               2                                                           (0.0%)    8728       1      
  116                                           Malignant melanoma                                         3                                                           (0.0%)    8720       3      
  117                                           Meningeal melanomatosis                                    3                                                           (0.0%)    8728       3      
  **Other neoplasms related to the meninges**   118                                                        Hemangioblastoma                                            187       (1.4%)     9161   1
  **Lymphomas and hematopoietic neoplasms**     119                                                        Malignant lymphoma (B cell type )                           433       (3.2%)     9590   3
  120                                           Malignant lymphoma (T cell type )                          11                                                          (0.1%)                      
  121                                           Other malignant lymphomas                                  31                                                          (0.2%)                      
  122                                           Plasmacytoma                                               8                                                           (0.1%)    9731       3      
  123                                           Granulocytic sarcoma                                       1                                                           (0.0%)    9930       3      
  **Germ cell tumors**                          124                                                        Pure germinoma                                              200       (1.5%)     9064   3
  125                                           HCG producing germinoma                                    35                                                          (0.3%)                      
  126                                           Embryonal carcinoma                                        5                                                           (0.0%)    9070       3      
  127                                           Yolk sac tumor                                             16                                                          (0.1%)    9071       3      
  128                                           Choriocarcinoma                                            4                                                           (0.0%)    9100       3      
  129                                           Teratoma                                                   2                                                           (0.0%)    9080       1      
  130                                               Mature teratoma                                        10                                                          (0.1%)    9080       0      
  131                                               Immature teratoma                                      14                                                          (0.1%)    9080       3      
  132                                               Teratoma with malignant transformation                 \-                                                          ( - )     9084       3      
  133                                           Mixed germ cell tumor                                      26                                                          (0.2%)    9085       3      
  **Tumors of the sellar region**               134                                                        Craniopharyngioma                                           280       (2.1%)     9350   1
  135                                               Adamantinomatous craniopharyngioma                     42                                                          (0.3%)    9351       1      
  136                                               Papillary craniopharyngioma                            9                                                           (0.1%)    9352       1      
  137                                           Granular cell tumor of the neurohypophysis                 2                                                           (0.0%)    9582       0      
  138                                           Pituicytoma                                                13                                                          (0.1%)    9432       1      
  139                                           Spindle cell oncocytoma of the adenohypophysis             \-                                                          ( - )     8291       0      
  **Pituitary adenoma**                         140                                                        Rathke's cleft cyst                                         284       (2.1%)            
  141                                           GH producing adenoma                                       480                                                         (3.6%)                      
  142                                           PRL producing adenoma                                      487                                                         (3.6%)                      
  143                                           GH-PRL producing adenoma                                   39                                                          (0.3%)                      
  144                                           TSH producing adenoma                                      34                                                          (0.3%)                      
  145                                           ACTH producing adenoma                                     139                                                         (1.0%)                      
  146                                           Gonadotropin producing adenoma                             198                                                         (1.5%)                      
  147                                           Null cell adenoma                                          1,204                                                       (9.0%)                      
  **Other tumor**                               148                                                        Epidermoid cyst                                             122       (0.9%)            
  149                                           Dermoid cyst                                               17                                                          (0.1%)                      
  150                                           Plurihormonal adenoma                                      3                                                           (0.0%)                      
  151                                           Pseudotumor                                                24                                                          (0.2%)                      
  152                                           Other tumors                                               169                                                         (1.3%)                      
  153                                           Unknown diagnosis                                          125                                                         (0.9%)                      
  total (%)                                     **13,431**                                                 (100%)                                                                                  

2). Age distribution of WHO2007 brain tumors (2001--2004) {#S3.2}
---------------------------------------------------------

  age      Pilocytic astrocytoma   Pilomyxoid astrocytoma   Subependymal giant cell astrocytoma   Pleomorphic xanthoastrocytoma   Diffuse astrocytoma                                                                                                           
  -------- ----------------------- ------------------------ ------------------------------------- ------------------------------- --------------------- ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ----- ----- ----- ---------
  0        1                       \-                       1                                     (0.5)                           2                     1      3      (21.4)    \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-    \-    \-    ( - )
  1        4                       3                        7                                     (3.6)                           \-                    1      1      (7.1)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     1     \-    1     (0.4)
  2        1                       1                        2                                     (1.0)                           1                     \-     1      (7.1)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-    \-    \-    ( - )
  3        6                       9                        15                                    (7.8)                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-    1     1     (0.4)
  4        1                       3                        4                                     (2.1)                           1                     1      2      (14.3)    1      \-     1      (11.1)    \-     \-     \-     ( - )     2     \-    2     (0.7)
                                                                                                                                                                                                                                                                
  5--9     13                      10                       23                                    (11.9)                          \-                    1      1      (7.1)     1      1      2      (22.2)    \-     3      3      (9.7)     4     9     13    (4.8)
  10--14   21                      24                       45                                    (23.3)                          \-                    2      2      (14.3)    \-     1      1      (11.1)    4      1      5      (16.1)    5     4     9     (3.4)
  15--19   11                      2                        13                                    (6.7)                           1                     1      2      (14.3)    1      \-     1      (11.1)    \-     \-     \-     ( - )     6     6     12    (4.5)
  20--24   9                       15                       24                                    (12.4)                          \-                    \-     \-     ( - )     \-     \-     \-     ( - )     2      1      3      (9.7)     12    8     20    (7.4)
  25--29   7                       9                        16                                    (8.3)                           \-                    \-     \-     ( - )     1      1      2      (22.2)    1      3      4      (12.9)    19    14    33    (12.3)
                                                                                                                                                                                                                                                                
  30--34   6                       1                        7                                     (3.6)                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     17    18    35    (13.0)
  35--39   1                       5                        6                                     (3.1)                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     3      3      6      (19.4)    22    13    35    (13.0)
  40--44   3                       2                        5                                     (2.6)                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     1      1      (3.2)     13    14    27    (10.0)
  45--49   2                       5                        7                                     (3.6)                           \-                    \-     \-     ( - )     1      \-     1      (11.1)    2      1      3      (9.7)     5     5     10    (3.7)
  50--54   1                       2                        3                                     (1.6)                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     2      \-     2      (6.5)     8     9     17    (6.3)
                                                                                                                                                                                                                                                                
  55--59   3                       1                        4                                     (2.1)                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     1      \-     1      (3.2)     7     9     16    (6.0)
  60--64   1                       1                        2                                     (1.0)                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     5     9     14    (5.2)
  65--69   1                       1                        2                                     (1.0)                           2                     \-     2      (14.3)    1      \-     1      (11.1)    \-     2      2      (6.5)     4     5     9     (3.4)
  70--74   \-                      4                        4                                     (2.1)                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     1      1      (3.2)     4     7     11    (4.1)
  75--79   2                       \-                       2                                     (1.0)                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     2     2     4     (1.5)
                                                                                                                                                                                                                                                                
  80--84   \-                      1                        1                                     (0.5)                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-    \-    \-    ( - )
  85--89   \-                      \-                       \-                                    ( - )                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-    \-    \-    ( - )
  90--94   \-                      \-                       \-                                    ( - )                           \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-    \-    \-    ( - )
                                                                                                                                                                                                                                                                
  total    94                      99                       193                                   (100.0)                         7                     7      14     (100.0)   6      3      9      (100.0)   15     16     31     (100.0)   136   133   269   (100.0)
                                                                                                                                                                                                                                                                
  mean     20                      22.9                     21.7                                  22.6                            7.3                   14.9   28.5   15.7      24.3   35.2   32.9   34.0      36.8   39.7   38.2                               

  age      Fibrillary astrocytoma   Gemistocytic astrocytoma   Protoplasmic astrocytoma   Anaplastic astrocytoma   Glioblastoma                                                                                                             
  -------- ------------------------ -------------------------- -------------------------- ------------------------ -------------- ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ----- ----- ------- ---------
  0        \-                       \-                         \-                         ( - )                    1              \-     1      (3.5)     \-     \-     \-     ( - )     1      \-     1      (0.2)     1     2     3       (0.2)
  1        2                        \-                         2                          (2.8)                    \-             \-     \-     ( - )     \-     \-     \-     ( - )     1      \-     1      (0.2)     \-    \-    \-      ( - )
  2        \-                       \-                         \-                         ( - )                    \-             \-     \-     ( - )     \-     \-     \-     ( - )     1      \-     1      (0.2)     1     \-    1       (0.1)
  3        \-                       \-                         \-                         ( - )                    \-             \-     \-     ( - )     \-     \-     \-     ( - )     \-     1      1      (0.2)     \-    \-    \-      ( - )
  4        \-                       1                          1                          (1.4)                    \-             \-     \-     ( - )     \-     \-     \-     ( - )     2      1      3      (0.6)     \-    \-    \-      ( - )
                                                                                                                                                                                                                                            
  5--9     2                        3                          5                          (7.0)                    \-             \-     \-     ( - )     \-     \-     \-     ( - )     5      6      11     (2.1)     9     5     14      (1.0)
  10--14   2                        3                          5                          (7.0)                    \-             \-     \-     ( - )     1      \-     1      (7.7)     4      5      9      (1.8)     9     9     18      (1.2)
  15--19   2                        \-                         2                          (2.8)                    \-             \-     \-     ( - )     1      \-     1      (7.7)     5      5      10     (2.0)     8     6     14      (1.0)
  20--24   3                        2                          5                          (7.0)                    1              \-     1      (3.5)     1      \-     1      (7.7)     12     4      16     (3.1)     15    8     23      (1.6)
  25--29   5                        2                          7                          (9.9)                    3              2      5      (17.2)    1      2      3      (23.1)    18     16     34     (6.6)     18    12    30      (2.1)
                                                                                                                                                                                                                                            
  30--34   5                        8                          13                         (18.3)                   2              \-     2      (6.9)     1      \-     1      (7.7)     25     16     41     (8.0)     16    15    31      (2.1)
  35--39   5                        2                          7                          (9.9)                    1              \-     1      (3.5)     \-     1      1      (7.7)     25     16     41     (8.0)     34    16    50      (3.4)
  40--44   3                        3                          6                          (8.5)                    \-             2      2      (6.9)     1      1      2      (15.4)    18     16     34     (6.6)     37    21    58      (4.0)
  45--49   4                        4                          8                          (11.3)                   1              \-     1      (3.5)     \-     2      2      (15.4)    21     16     37     (7.2)     50    30    80      (5.5)
  50--54   \-                       3                          3                          (4.2)                    3              2      5      (17.2)    \-     \-     \-     ( - )     28     20     48     (9.4)     86    62    148     (10.2)
                                                                                                                                                                                                                                            
  55--59   1                        3                          4                          (5.6)                    3              1      4      (13.7)    \-     \-     \-     ( - )     31     20     51     (9.9)     102   66    168     (11.6)
  60--64   \-                       1                          1                          (1.4)                    4              1      5      (17.2)    \-     \-     \-     ( - )     29     32     61     (11.9)    124   82    206     (14.2)
  65--69   \-                       \-                         \-                         ( - )                    1              1      2      (6.9)     1      \-     1      (7.7)     29     15     44     (8.6)     146   101   247     (17.0)
  70--74   1                        \-                         1                          (1.4)                    \-             \-     \-     ( - )     \-     \-     \-     ( - )     20     14     34     (6.6)     115   83    198     (13.6)
  75--79   \-                       1                          1                          (1.4)                    \-             \-     \-     ( - )     \-     \-     \-     ( - )     11     12     23     (4.5)     65    55    120     (8.3)
                                                                                                                                                                                                                                            
  80--84   \-                       \-                         \-                         ( - )                    \-             \-     \-     ( - )     \-     \-     \-     ( - )     7      2      9      (1.8)     14    20    34      (2.3)
  85--89   \-                       \-                         \-                         ( - )                    \-             \-     \-     ( - )     \-     \-     \-     ( - )     3      \-     3      (0.6)     8     2     10      (0.7)
  90--94   \-                       \-                         \-                         ( - )                    \-             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     1     1     2       (0.1)
                                                                                                                                                                                                                                            
  total    35                       36                         71                         (100.0)                  20             9      29     (100.0)   7      6      13     (100.0)   296    217    513    (100.0)   859   596   1,455   (100.0)
                                                                                                                                                                                                                                            
  mean     30.9                     35.5                       33.3                       45.2                     48.2           46.2   31.2   37.2      34.0   49.5   49.0   49.3      58.5   59.4   58.8                                 

  age      Giant cell glioblastoma   Gliosarcoma   Gliomatosis cerebri   Oligodendroglioma   Anaplastic oligodendroglioma                                                                                                         
  -------- ------------------------- ------------- --------------------- ------------------- ------------------------------ ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ---- ---- ----- ---------
  0        \-                        \-            \-                    ( - )               \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  1        \-                        \-            \-                    ( - )               \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  2        \-                        \-            \-                    ( - )               \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  3        \-                        \-            \-                    ( - )               \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  4        \-                        \-            \-                    ( - )               \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
                                                                                                                                                                                                                                  
  5--9     \-                        \-            \-                    ( - )               \-                             \-     \-     ( - )     1      \-     1      (2.1)     2      \-     2      (1.7)     \-   \-   \-    ( - )
  10--14   \-                        \-            \-                    ( - )               \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     2      2      (1.7)     \-   \-   \-    ( - )
  15--19   \-                        \-            \-                    ( - )               \-                             \-     \-     ( - )     \-     3      3      (6.4)     \-     2      2      (1.7)     1    \-   1     (0.8)
  20--24   \-                        1             1                     (7.1)               \-                             \-     \-     ( - )     1      \-     1      (2.1)     3      3      6      (5.0)     1    1    2     (1.6)
  25--29   \-                        1             1                     (7.1)               2                              \-     2      (10.0)    \-     \-     \-     ( - )     6      6      12     (9.9)     4    1    5     (4.0)
                                                                                                                                                                                                                                  
  30--34   1                         2             3                     (21.4)              \-                             \-     \-     ( - )     \-     1      1      (2.1)     9      6      15     (12.4)    \-   4    4     (3.2)
  35--39   \-                        \-            \-                    ( - )               1                              \-     1      (5.0)     2      \-     2      (4.3)     8      9      17     (14.1)    14   4    18    (14.3)
  40--44   1                         \-            1                     (7.1)               1                              \-     1      (5.0)     2      2      4      (8.5)     10     4      14     (11.6)    9    6    15    (11.9)
  45--49   \-                        \-            \-                    ( - )               1                              \-     1      (5.0)     3      1      4      (8.5)     4      6      10     (8.3)     9    6    15    (11.9)
  50--54   \-                        1             1                     (7.1)               \-                             \-     \-     ( - )     1      3      4      (8.5)     8      7      15     (12.4)    12   9    21    (16.7)
                                                                                                                                                                                                                                  
  55--59   1                         \-            1                     (7.1)               3                              \-     3      (15.0)    4      5      9      (19.2)    4      5      9      (7.4)     8    8    16    (12.7)
  60--64   \-                        1             1                     (7.1)               1                              1      2      (10.0)    5      1      6      (12.8)    5      4      9      (7.4)     6    4    10    (7.9)
  65--69   3                         1             4                     (28.6)              1                              1      2      (10.0)    2      4      6      (12.8)    2      2      4      (3.3)     6    5    11    (8.7)
  70--74   \-                        \-            \-                    ( - )               4                              \-     4      (20.0)    3      3      6      (12.8)    2      2      4      (3.3)     3    1    4     (3.2)
  75--79   \-                        1             1                     (7.1)               1                              3      4      (20.0)    \-     \-     \-     ( - )     \-     \-     \-     ( - )     2    2    4     (3.2)
                                                                                                                                                                                                                                  
  80--84   \-                        \-            \-                    ( - )               \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  85--89   \-                        \-            \-                    ( - )               \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  90--94   \-                        \-            \-                    ( - )               \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
                                                                                                                                                                                                                                  
  total    6                         8             14                    (100.0)             15                             5      20     (100.0)   24     23     47     (100.0)   63     58     121    (100.0)   75   51   126   (100.0)
                                                                                                                                                                                                                                  
  mean     56.1                      46.2          50.4                  56.5                72.4                           60.5   53.6   52.7      53.1   42.5   42.6   42.6      49.5   51.3   50.2                             

  age      Oligoastrocytoma   Anaplastic oligoastrocytoma   Subependymoma   Myxopapillary ependymoma   Ependymoma                                                                                                      
  -------- ------------------ ----------------------------- --------------- -------------------------- ------------ ------ ------ --------- ------ ------ ---- --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-                 \-                            \-              ( - )                      1            1      2      (1.9)     \-     \-     \-   ( - )     \-     \-     \-     ( - )     1    \-   1    (1.4)
  1        1                  \-                            1               (1.1)                      \-           \-     \-     ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     2    2    4    (5.6)
  2        \-                 \-                            \-              ( - )                      \-           \-     \-     ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     1    \-   1    (1.4)
  3        \-                 \-                            \-              ( - )                      \-           \-     \-     ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     2    \-   2    (2.8)
  4        \-                 \-                            \-              ( - )                      \-           \-     \-     ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     1    1    2    (2.8)
                                                                                                                                                                                                                       
  5--9     \-                 1                             1               (1.1)                      \-           \-     \-     ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     7    3    10   (13.9)
  10--14   1                  1                             2               (2.2)                      \-           \-     \-     ( - )     \-     \-     \-   ( - )     1      \-     1      (100.0)   2    3    5    (6.9)
  15--19   1                  \-                            1               (1.1)                      1            \-     1      (0.9)     \-     \-     \-   ( - )     \-     \-     \-     ( - )     3    4    7    (9.7)
  20--24   2                  1                             3               (3.3)                      1            4      5      (4.7)     \-     1      1    (4.8)     \-     \-     \-     ( - )     1    1    2    (2.8)
  25--29   \-                 4                             4               (4.4)                      4            1      5      (4.7)     1      \-     1    (4.8)     \-     \-     \-     ( - )     2    3    5    (6.9)
                                                                                                                                                                                                                       
  30--34   12                 9                             21              (23.3)                     6            9      15     (14.2)    1      \-     1    (4.8)     \-     \-     \-     ( - )     3    \-   3    (4.2)
  35--39   9                  3                             12              (13.3)                     5            4      9      (8.5)     2      1      3    (14.3)    \-     \-     \-     ( - )     3    2    5    (6.9)
  40--44   3                  5                             8               (8.9)                      7            5      12     (11.3)    1      \-     1    (4.8)     \-     \-     \-     ( - )     \-   2    2    (2.8)
  45--49   7                  5                             12              (13.3)                     7            5      12     (11.3)    2      2      4    (19.1)    \-     \-     \-     ( - )     1    2    3    (4.2)
  50--54   9                  4                             13              (14.4)                     11           6      17     (16.0)    \-     \-     \-   ( - )     \-     \-     \-     ( - )     1    1    2    (2.8)
                                                                                                                                                                                                                       
  55--59   2                  2                             4               (4.4)                      4            3      7      (6.6)     3      1      4    (19.1)    \-     \-     \-     ( - )     1    7    8    (11.1)
  60--64   \-                 1                             1               (1.1)                      8            4      12     (11.3)    \-     \-     \-   ( - )     \-     \-     \-     ( - )     6    2    8    (11.1)
  65--69   2                  3                             5               (5.6)                      1            4      5      (4.7)     2      1      3    (14.3)    \-     \-     \-     ( - )     1    \-   1    (1.4)
  70--74   \-                 2                             2               (2.2)                      1            1      2      (1.9)     1      1      2    (9.5)     \-     \-     \-     ( - )     1    \-   1    (1.4)
  75--79   \-                 \-                            \-              ( - )                      \-           \-     \-     ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                       
  80--84   \-                 \-                            \-              ( - )                      1            1      2      (1.9)     \-     1      1    (4.8)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-                 \-                            \-              ( - )                      \-           \-     \-     ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-                 \-                            \-              ( - )                      \-           \-     \-     ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                       
  total    49                 41                            90              (100.0)                    58           48     106    (100.0)   13     8      21   (100.0)   1      \-     1      (100.0)   39   33   72   (100.0)
                                                                                                                                                                                                                       
  mean     40.8               42.6                          41.6            46.6                       45.5         46.1   50.0   53.8      51.4   13.4   \-   13.4      28.4   32.6   30.3                            

  age      Cellular ependymoma   Papillary ependymoma   Clear cell ependymoma   Tanycytic ependymoma   Anaplastic ependymoma                                                                                                     
  -------- --------------------- ---------------------- ----------------------- ---------------------- ----------------------- ------ ------ --------- ------ ----- ---- --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     1    \-   1    (1.8)
  1        \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     2    1    3    (5.5)
  2        \-                    1                      1                       (50.0)                 \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     2    2    4    (7.3)
  3        \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     3    \-   3    (5.5)
  4        \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     2    2    4    (7.3)
                                                                                                                                                                                                                                 
  5--9     \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     1      \-     1      (100.0)   4    3    7    (12.7)
  10--14   \-                    1                      1                       (50.0)                 \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     3    1    4    (7.3)
  15--19   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   1    1    (1.8)
  20--24   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     2    1    3    (5.5)
  25--29   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     2    2    4    (7.3)
                                                                                                                                                                                                                                 
  30--34   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     1    1    2    (3.6)
  35--39   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     1    2    3    (5.5)
  40--44   \-                    \-                     \-                      ( - )                  \-                      1      1      (100.0)   \-     \-    \-   ( - )     \-     \-     \-     ( - )     1    2    3    (5.5)
  45--49   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     1      \-    1    (33.3)    \-     \-     \-     ( - )     2    1    3    (5.5)
  50--54   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     1     1    (33.3)    \-     \-     \-     ( - )     1    1    2    (3.6)
                                                                                                                                                                                                                                 
  55--59   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     1      \-    1    (33.3)    \-     \-     \-     ( - )     1    \-   1    (1.8)
  60--64   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     4    1    5    (9.1)
  65--69   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     1    \-   1    (1.8)
  70--74   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  75--79   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                 
  80--84   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   1    1    (1.8)
  90--94   \-                    \-                     \-                      ( - )                  \-                      \-     \-     ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                 
  total    \-                    2                      2                       (100.0)                \-                      1      1      (100.0)   2      1     3    (100.0)   1      \-     1      (100.0)   33   22   55   (100.0)
                                                                                                                                                                                                                                 
  mean     \-                    8.6                    8.6                     \-                     42.4                    42.4   50.4   55.0      51.9   8.6   \-   8.6       25.3   26.4   25.7                            

  age      Unclassified Glioma   Choroid plexus papilloma   Atypical choroid plexus papilloma   Choroid plexus carcinoma   Astroblastoma                                                                                                    
  -------- --------------------- -------------------------- ----------------------------------- -------------------------- --------------- ------ ------ --------- ------ ----- ------ --------- ---- ------ ----- --------- ---- ---- ---- ---------
  0        \-                    \-                         \-                                  ( - )                      1               2      3      (10.0)    \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  1        \-                    \-                         \-                                  ( - )                      2               4      6      (20.0)    \-     \-    \-     ( - )     \-   1      1     (25.0)    \-   \-   \-   ( - )
  2        \-                    \-                         \-                                  ( - )                      \-              \-     \-     ( - )     \-     \-    \-     ( - )     1    \-     1     (25.0)    \-   \-   \-   ( - )
  3        \-                    2                          2                                   (1.7)                      \-              1      1      (3.3)     \-     \-    \-     ( - )     1    \-     1     (25.0)    \-   \-   \-   ( - )
  4        2                     1                          3                                   (2.6)                      \-              \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                            
  5--9     13                    10                         23                                  (20.0)                     2               \-     2      (6.7)     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  10--14   9                     4                          13                                  (11.3)                     \-              1      1      (3.3)     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  15--19   3                     4                          7                                   (6.1)                      1               \-     1      (3.3)     1      \-    1      (100.0)   \-   \-     \-    ( - )     \-   1    1    (100.0)
  20--24   2                     1                          3                                   (2.6)                      \-              \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  25--29   4                     3                          7                                   (6.1)                      \-              1      1      (3.3)     \-     \-    \-     ( - )     \-   1      1     (25.0)    \-   \-   \-   ( - )
                                                                                                                                                                                                                                            
  30--34   4                     2                          6                                   (5.2)                      \-              2      2      (6.7)     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  35--39   2                     4                          6                                   (5.2)                      \-              4      4      (13.3)    \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  40--44   1                     1                          2                                   (1.7)                      \-              2      2      (6.7)     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  45--49   2                     2                          4                                   (3.5)                      1               1      2      (6.7)     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  50--54   6                     4                          10                                  (8.7)                      1               2      3      (10.0)    \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                            
  55--59   2                     \-                         2                                   (1.7)                      \-              1      1      (3.3)     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  60--64   4                     \-                         4                                   (3.5)                      \-              \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  65--69   2                     7                          9                                   (7.8)                      \-              1      1      (3.3)     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  70--74   1                     2                          3                                   (2.6)                      \-              \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  75--79   5                     1                          6                                   (5.2)                      \-              \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                            
  80--84   \-                    3                          3                                   (2.6)                      \-              \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  85--89   1                     1                          2                                   (1.7)                      \-              \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
  90--94   \-                    \-                         \-                                  ( - )                      \-              \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-     \-    ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                            
  total    63                    52                         115                                 (100.0)                    8               22     30     (100.0)   1      \-    1      (100.0)   2    2      4     (100.0)   \-   1    1    (100.0)
                                                                                                                                                                                                                                            
  mean     33.8                  36.5                       35.0                                17.0                       28.7            25.6   16.5   \-        16.5   2.8   13.4   8.1       \-   16.4   6.4                            

  age      Chordoid glioma of the third ventricle   Angiocentric glioma   Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)   Desmoplastic infantile astrocytoma/ganglioglioma   Dysembryoplastic neuroepithelial tumor                                                                                                   
  -------- ---------------------------------------- --------------------- ----------------------------------------------------------- -------------------------------------------------- ---------------------------------------- ------ ---- --------- ------ ----- ---- --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  1        \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  2        \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  3        \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  4        \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                                                                                  
  5--9     \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     1      \-     1      (100.0)   \-   5    5    (19.2)
  10--14   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     4    2    6    (23.1)
  15--19   \-                                       \-                    \-                                                          ( - )                                              1                                        \-     1    (100.0)   \-     \-    \-   ( - )     \-     \-     \-     ( - )     1    1    2    (7.7)
  20--24   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     4    \-   4    (15.4)
  25--29   1                                        \-                    1                                                           (20.0)                                             \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     1    2    3    (11.5)
                                                                                                                                                                                                                                                                                                                                  
  30--34   \-                                       1                     1                                                           (20.0)                                             \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   2    2    (7.7)
  35--39   1                                        \-                    1                                                           (20.0)                                             \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   2    2    (7.7)
  40--44   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  45--49   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  50--54   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     1    1    2    (7.7)
                                                                                                                                                                                                                                                                                                                                  
  55--59   \-                                       2                     2                                                           (40.0)                                             \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  60--64   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  65--69   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  70--74   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     1     1    (100.0)   \-     \-     \-     ( - )     \-   \-   \-   ( - )
  75--79   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                                                                                  
  80--84   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-                                       \-                    \-                                                          ( - )                                              \-                                       \-     \-   ( - )     \-     \-    \-   ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                                                                                  
  total    2                                        3                     5                                                           (100.0)                                            1                                        \-     1    (100.0)   \-     1     1    (100.0)   1      \-     1      (100.0)   11   15   26   (100.0)
                                                                                                                                                                                                                                                                                                                                  
  mean     30.9                                     47.8                  41.0                                                        18.2                                               \-                                       18.2   \-   70.4      70.4   9.7   \-   9.7       21.4   21.9   21.7                            

  age      Gangliocytoma   Ganglioglioma   Anaplastic ganglioglioma   Central neurocytoma   Extraventricular neurocytoma                                                                                                        
  -------- --------------- --------------- -------------------------- --------------------- ------------------------------ ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-              \-              \-                         ( - )                 \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  1        \-              \-              \-                         ( - )                 \-                             1      1      (1.7)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  2        1               \-              1                          (14.3)                \-                             2      2      (3.3)     1      \-     1      (12.5)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
  3        \-              \-              \-                         ( - )                 \-                             1      1      (1.7)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  4        \-              \-              \-                         ( - )                 \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                
  5--9     1               \-              1                          (14.3)                3                              \-     3      (5.0)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  10--14   \-              1               1                          (14.3)                3                              3      6      (10.0)    \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  15--19   \-              \-              \-                         ( - )                 7                              4      11     (18.3)    \-     \-     \-     ( - )     5      3      8      (12.3)    \-   \-   \-   ( - )
  20--24   \-              1               1                          (14.3)                7                              1      8      (13.3)    \-     \-     \-     ( - )     12     4      16     (24.6)    \-   \-   \-   ( - )
  25--29   \-              \-              \-                         ( - )                 3                              1      4      (6.7)     1      \-     1      (12.5)    8      5      13     (20.0)    \-   \-   \-   ( - )
                                                                                                                                                                                                                                
  30--34   \-              1               1                          (14.3)                4                              1      5      (8.3)     2      \-     2      (25.0)    2      3      5      (7.7)     \-   \-   \-   ( - )
  35--39   \-              1               1                          (14.3)                \-                             4      4      (6.7)     \-     \-     \-     ( - )     4      4      8      (12.3)    \-   \-   \-   ( - )
  40--44   \-              \-              \-                         ( - )                 \-                             3      3      (5.0)     1      \-     1      (12.5)    4      3      7      (10.8)    \-   \-   \-   ( - )
  45--49   \-              \-              \-                         ( - )                 2                              \-     2      (3.3)     \-     \-     \-     ( - )     \-     1      1      (1.5)     \-   \-   \-   ( - )
  50--54   \-              \-              \-                         ( - )                 1                              3      4      (6.7)     \-     \-     \-     ( - )     \-     2      2      (3.1)     1    1    2    (100.0)
                                                                                                                                                                                                                                
  55--59   \-              \-              \-                         ( - )                 \-                             1      1      (1.7)     \-     \-     \-     ( - )     1      1      2      (3.1)     \-   \-   \-   ( - )
  60--64   \-              \-              \-                         ( - )                 \-                             1      1      (1.7)     \-     1      1      (12.5)    3      \-     3      (4.6)     \-   \-   \-   ( - )
  65--69   \-              \-              \-                         ( - )                 \-                             1      1      (1.7)     1      \-     1      (12.5)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
  70--74   \-              1               1                          (14.3)                1                              \-     1      (1.7)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  75--79   \-              \-              \-                         ( - )                 2                              \-     2      (3.3)     1      \-     1      (12.5)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                
  80--84   \-              \-              \-                         ( - )                 \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-              \-              \-                         ( - )                 \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-              \-              \-                         ( - )                 \-                             \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                
  total    2               5               7                          (100.0)               33                             27     60     (100.0)   7      1      8      (100.0)   39     26     65     (100.0)   1    1    2    (100.0)
                                                                                                                                                                                                                                
  mean     5.8             34.8            26.5                       28.5                  30.2                           29.3   39.9   63.8      42.9   31.1   33.2   32.0      53.8   54.0   53.9                            

  age      Papillary glioneuronal tumor   Rosette-forming glioneuronal tumor   Paraganglioma   Pineocytoma   Pineal parenchymal tumor of intermediate differentiation                                                                                                        
  -------- ------------------------------ ------------------------------------ --------------- ------------- ---------------------------------------------------------- ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     1      \-     1      (16.7)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
  1        \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  2        \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  3        \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  4        \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                             
  5--9     \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  10--14   \-                             \-                                   \-              ( - )         \-                                                         1      1      (50.0)    \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  15--19   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     1      1      2      (10.0)    \-   \-   \-   ( - )
  20--24   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     2      \-     2      (10.0)    \-   \-   \-   ( - )
  25--29   \-                             1                                    1               (33.3)        \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     1      \-     1      (5.0)     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                             
  30--34   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     1      1      (16.7)    \-     1      1      (5.0)     1    \-   1    (16.7)
  35--39   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     1      \-     1      (5.0)     \-   \-   \-   ( - )
  40--44   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     1      1      (16.7)    1      1      2      (10.0)    \-   1    1    (16.7)
  45--49   1                              \-                                   1               (33.3)        \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   1    1    (16.7)
  50--54   \-                             1                                    1               (33.3)        \-                                                         1      1      (50.0)    \-     1      1      (16.7)    \-     3      3      (15.0)    \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                             
  55--59   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     1      1      (5.0)     2    \-   2    (33.3)
  60--64   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     2      \-     2      (33.3)    \-     3      3      (15.0)    \-   \-   \-   ( - )
  65--69   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     2      2      (10.0)    1    \-   1    (16.7)
  70--74   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     1      1      2      (10.0)    \-   \-   \-   ( - )
  75--79   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                             
  80--84   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-                             \-                                   \-              ( - )         \-                                                         \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                             
  total    1                              2                                    3               (100.0)       \-                                                         2      2      (100.0)   3      3      6      (100.0)   7      13     20     (100.0)   4    2    6    (100.0)
                                                                                                                                                                                                                                                                             
  mean     48.3                           41.4                                 43.7            \-            31.4                                                       31.4   42.7   44.2      43.4   35.9   53.6   47.4      53.7   45.3   50.9                            

  age      Pineoblastoma   Medulloblastoma   Desmoplastic/nodular medulloblastoma   CNS primitive neuroectodermal tumor (CNS PNET)   CNS neuroblastoma                                                                                                        
  -------- --------------- ----------------- -------------------------------------- ------------------------------------------------ ------------------- ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        1               1                 2                                      (22.2)                                           1                   \-     1      (1.0)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  1        \-              \-                \-                                     ( - )                                            4                   3      7      (7.1)     \-     \-     \-     ( - )     1      \-     1      (4.4)     1    \-   1    (7.7)
  2        \-              \-                \-                                     ( - )                                            9                   2      11     (11.2)    \-     \-     \-     ( - )     \-     1      1      (4.4)     \-   \-   \-   ( - )
  3        \-              1                 1                                      (11.1)                                           2                   4      6      (6.1)     \-     \-     \-     ( - )     1      \-     1      (4.4)     \-   \-   \-   ( - )
  4        \-              \-                \-                                     ( - )                                            7                   \-     7      (7.1)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                              
  5--9     1               1                 2                                      (22.2)                                           20                  10     30     (30.6)    \-     \-     \-     ( - )     1      1      2      (8.7)     \-   1    1    (7.7)
  10--14   1               1                 2                                      (22.2)                                           9                   9      18     (18.4)    1      1      2      (66.7)    \-     1      1      (4.4)     \-   \-   \-   ( - )
  15--19   \-              \-                \-                                     ( - )                                            7                   1      8      (8.2)     \-     1      1      (33.3)    2      5      7      (30.4)    \-   1    1    (7.7)
  20--24   \-              \-                \-                                     ( - )                                            3                   1      4      (4.1)     \-     \-     \-     ( - )     1      1      2      (8.7)     \-   \-   \-   ( - )
  25--29   \-              \-                \-                                     ( - )                                            \-                  \-     \-     ( - )     \-     \-     \-     ( - )     1      1      2      (8.7)     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                              
  30--34   \-              \-                \-                                     ( - )                                            1                   \-     1      (1.0)     \-     \-     \-     ( - )     1      \-     1      (4.4)     1    \-   1    (7.7)
  35--39   \-              \-                \-                                     ( - )                                            \-                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     1    \-   1    (7.7)
  40--44   \-              \-                \-                                     ( - )                                            2                   \-     2      (2.0)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   1    1    (7.7)
  45--49   1               \-                1                                      (11.1)                                           \-                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     3    \-   3    (23.1)
  50--54   1               \-                1                                      (11.1)                                           \-                  \-     \-     ( - )     \-     \-     \-     ( - )     1      1      2      (8.7)     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                              
  55--59   \-              \-                \-                                     ( - )                                            \-                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     1      1      (4.4)     1    \-   1    (7.7)
  60--64   \-              \-                \-                                     ( - )                                            \-                  3      3      (3.1)     \-     \-     \-     ( - )     \-     1      1      (4.4)     1    \-   1    (7.7)
  65--69   \-              \-                \-                                     ( - )                                            \-                  \-     \-     ( - )     \-     \-     \-     ( - )     1      \-     1      (4.4)     1    1    2    (15.4)
  70--74   \-              \-                \-                                     ( - )                                            \-                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  75--79   \-              \-                \-                                     ( - )                                            \-                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                              
  80--84   \-              \-                \-                                     ( - )                                            \-                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-              \-                \-                                     ( - )                                            \-                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-              \-                \-                                     ( - )                                            \-                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                              
  total    5               4                 9                                      (100.0)                                          65                  33     98     (100.0)   1      2      3      (100.0)   10     13     23     (100.0)   9    4    13   (100.0)
                                                                                                                                                                                                                                                              
  mean     24.7            5.9               16.4                                   9.6                                              13.1                10.8   12.3   13.1      12.8   25.0   24.8   24.9      43.8   33.4   40.6                            

  age      CNS ganglioneuroblastoma   Ependymoblastoma   Atypical teratoid/rhabdoid tumor   Schwannoma (neurilemoma, neurinoma)   Cellular schwannoma                                                                                                       
  -------- -------------------------- ------------------ ---------------------------------- ------------------------------------- --------------------- ------ ----- --------- ----- ------ ------ --------- ------ ------ ------- --------- ---- ---- ---- ---------
  0        \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     3     1      4      (40.0)    1      2      3       (0.2)     \-   1    1    (14.3)
  1        \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     1     \-     1      (10.0)    \-     \-     \-      ( - )     \-   \-   \-   ( - )
  2        \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-      ( - )     \-   \-   \-   ( - )
  3        \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-      ( - )     \-   \-   \-   ( - )
  4        \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-      ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                            
  5--9     \-                         \-                 \-                                 ( - )                                 \-                    1      1     (50.0)    1     1      2      (20.0)    \-     2      2       (0.2)     \-   \-   \-   ( - )
  10--14   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     5      3      8       (0.6)     \-   \-   \-   ( - )
  15--19   \-                         1                  1                                  (100.0)                               \-                    \-     \-    ( - )     1     \-     1      (10.0)    8      12     20      (1.5)     \-   \-   \-   ( - )
  20--24   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     1     1      2      (20.0)    9      19     28      (2.1)     \-   \-   \-   ( - )
  25--29   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     22     26     48      (3.6)     \-   1    1    (14.3)
                                                                                                                                                                                                                                                            
  30--34   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     38     43     81      (6.0)     \-   \-   \-   ( - )
  35--39   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     43     60     103     (7.7)     \-   \-   \-   ( - )
  40--44   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     61     51     112     (8.3)     \-   \-   \-   ( - )
  45--49   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     44     80     124     (9.2)     1    1    2    (28.6)
  50--54   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     82     129    211     (15.7)    1    \-   1    (14.3)
                                                                                                                                                                                                                                                            
  55--59   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     79     108    187     (13.9)    \-   \-   \-   ( - )
  60--64   \-                         \-                 \-                                 ( - )                                 1                     \-     1     (50.0)    \-    \-     \-     ( - )     68     84     152     (11.3)    \-   1    1    (14.3)
  65--69   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     53     83     136     (10.1)    \-   1    1    (14.3)
  70--74   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     38     46     84      (6.3)     \-   \-   \-   ( - )
  75--79   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     15     16     31      (2.3)     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                            
  80--84   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     1      10     11      (0.8)     \-   \-   \-   ( - )
  85--89   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     2      1      3       (0.2)     \-   \-   \-   ( - )
  90--94   \-                         \-                 \-                                 ( - )                                 \-                    \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-      ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                            
  total    \-                         1                  1                                  (100.0)                               1                     1      2     (100.0)   7     3      10     (100.0)   569    775    1,344   (100.0)   2    5    7    (100.0)
                                                                                                                                                                                                                                                            
  mean     \-                         15.9               15.9                               60.9                                  8.3                   34.6   7.3   10.3      8.2   51.7   52.1   51.9      50.1   40.6   43.3                             

  age      Plexiform schwannoma   Neurofibroma   Malignant perineurioma   Malignant peripheral nerve sheath tumor (MPNST)   Meningioma                                                                                                         
  -------- ---------------------- -------------- ------------------------ ------------------------------------------------- ------------ ------ ---- --------- ------ ------ ---- --------- ------ ------ ------ --------- ----- ----- ------- ---------
  0        \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     \-    4     4       (0.4)
  1        \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     \-    \-    \-      ( - )
  2        \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     1     \-    1       (0.1)
  3        \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     \-    \-    \-      ( - )
  4        \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     \-    \-    \-      ( - )
                                                                                                                                                                                                                                               
  5--9     \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     \-    1     1       (0.1)
  10--14   \-                     \-             \-                       ( - )                                             1            1      2    (13.3)    \-     \-     \-   ( - )     \-     \-     \-     ( - )     3     3     6       (0.6)
  15--19   \-                     \-             \-                       ( - )                                             1            1      2    (13.3)    \-     \-     \-   ( - )     \-     \-     \-     ( - )     1     \-    1       (0.1)
  20--24   \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     5     6     11      (1.0)
  25--29   \-                     \-             \-                       ( - )                                             1            1      2    (13.3)    \-     \-     \-   ( - )     \-     \-     \-     ( - )     4     13    17      (1.6)
                                                                                                                                                                                                                                               
  30--34   \-                     \-             \-                       ( - )                                             2            2      4    (26.7)    \-     \-     \-   ( - )     \-     \-     \-     ( - )     5     6     11      (1.0)
  35--39   \-                     \-             \-                       ( - )                                             \-           1      1    (6.7)     \-     \-     \-   ( - )     \-     \-     \-     ( - )     9     21    30      (2.7)
  40--44   \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     19    51    70      (6.4)
  45--49   \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     1      \-     1      (100.0)   24    64    88      (8.1)
  50--54   \-                     \-             \-                       ( - )                                             1            2      3    (20.0)    \-     \-     \-   ( - )     \-     \-     \-     ( - )     33    111   144     (13.2)
                                                                                                                                                                                                                                               
  55--59   \-                     \-             \-                       ( - )                                             1            \-     1    (6.7)     \-     \-     \-   ( - )     \-     \-     \-     ( - )     38    115   153     (14.0)
  60--64   1                      \-             1                        (100.0)                                           \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     41    125   166     (15.2)
  65--69   \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     1      1    (100.0)   \-     \-     \-     ( - )     34    114   148     (13.5)
  70--74   \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     38    88    126     (11.5)
  75--79   \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     36    40    76      (7.0)
                                                                                                                                                                                                                                               
  80--84   \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     10    17    27      (2.5)
  85--89   \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     5     5     10      (0.9)
  90--94   \-                     \-             \-                       ( - )                                             \-           \-     \-   ( - )     \-     \-     \-   ( - )     \-     \-     \-     ( - )     1     2     3       (0.3)
                                                                                                                                                                                                                                               
  total    1                      \-             1                        (100.0)                                           7            8      15   (100.0)   \-     1      1    (100.0)   1      \-     1      (100.0)   307   786   1,093   (100.0)
                                                                                                                                                                                                                                               
  mean     60.4                   \-             60.4                     33.4                                              32.8         33.1   \-   68.9      68.9   45.5   \-   45.5      60.0   58.8   59.1                                 

  age      Meningothelial meningioma   Fibrous (fibroblastic) meningioma   Transitional (mixed) meningioma   Psammomatous meningioma   Angiomatous meningioma                                                                                                         
  -------- --------------------------- ----------------------------------- --------------------------------- ------------------------- ------------------------ ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ---- ---- ----- ---------
  0        \-                          1                                   1                                 (0.1)                     \-                       \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  1        \-                          \-                                  \-                                ( - )                     \-                       \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  2        \-                          \-                                  \-                                ( - )                     \-                       \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  3        \-                          \-                                  \-                                ( - )                     \-                       \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  4        \-                          \-                                  \-                                ( - )                     \-                       \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
                                                                                                                                                                                                                                                                      
  5--9     \-                          2                                   2                                 (0.2)                     \-                       \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  10--14   1                           3                                   4                                 (0.4)                     \-                       \-     \-     ( - )     \-     1      1      (0.3)     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  15--19   \-                          3                                   3                                 (0.3)                     1                        1      2      (0.6)     \-     2      2      (0.5)     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  20--24   3                           4                                   7                                 (0.7)                     1                        2      3      (0.9)     1      1      2      (0.5)     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  25--29   5                           12                                  17                                (1.7)                     2                        6      8      (2.4)     1      6      7      (1.8)     \-     \-     \-     ( - )     \-   \-   \-    ( - )
                                                                                                                                                                                                                                                                      
  30--34   10                          15                                  25                                (2.4)                     1                        4      5      (1.5)     1      3      4      (1.0)     \-     \-     \-     ( - )     1    2    3     (3.0)
  35--39   14                          30                                  44                                (4.4)                     3                        8      11     (3.3)     1      14     15     (3.9)     \-     1      1      (1.3)     2    \-   2     (2.0)
  40--44   20                          44                                  64                                (6.4)                     8                        14     22     (6.6)     6      14     20     (5.2)     1      1      2      (2.6)     4    1    5     (5.0)
  45--49   20                          82                                  102                               (10.1)                    8                        13     21     (6.3)     7      27     34     (8.8)     \-     7      7      (9.2)     4    5    9     (8.9)
  50--54   43                          113                                 156                               (15.5)                    13                       29     42     (12.5)    17     38     55     (14.3)    \-     10     10     (13.2)    4    9    13    (12.9)
                                                                                                                                                                                                                                                                      
  55--59   47                          109                                 156                               (15.5)                    4                        48     52     (15.5)    14     34     48     (12.5)    3      5      8      (10.5)    5    9    14    (13.9)
  60--64   30                          101                                 131                               (13.0)                    8                        45     53     (15.8)    12     49     61     (15.8)    1      16     17     (22.4)    7    8    15    (14.9)
  65--69   39                          98                                  137                               (13.6)                    5                        44     49     (14.6)    14     37     51     (13.3)    2      15     17     (22.4)    6    4    10    (9.9)
  70--74   35                          51                                  86                                (8.5)                     5                        31     36     (10.7)    17     39     56     (14.6)    3      4      7      (9.2)     7    6    13    (12.9)
  75--79   17                          37                                  54                                (5.4)                     4                        16     20     (6.0)     2      20     22     (5.7)     1      5      6      (7.9)     3    8    11    (10.9)
                                                                                                                                                                                                                                                                      
  80--84   6                           11                                  17                                (1.7)                     \-                       6      6      (1.8)     2      2      4      (1.0)     \-     \-     \-     ( - )     2    1    3     (3.0)
  85--89   \-                          1                                   1                                 (0.1)                     1                        2      3      (0.9)     1      2      3      (0.8)     \-     \-     \-     ( - )     1    \-   1     (1.0)
  90--94   \-                          \-                                  \-                                ( - )                     3                        \-     3      (0.9)     \-     \-     \-     ( - )     \-     1      1      (1.3)     1    1    2     (2.0)
                                                                                                                                                                                                                                                                      
  total    290                         717                                 1,007                             (100.0)                   67                       269    336    (100.0)   96     289    385    (100.0)   11     65     76     (100.0)   47   54   101   (100.0)
                                                                                                                                                                                                                                                                      
  mean     57.6                        56.6                                56.9                              55.6                      59.7                     58.9   60.0   58.7      59.0   63.3   61.9   62.1      61.5   61.3   61.4                             

  age      Microcystic meningioma   Secretory meningioma   Lymphoplasmacyterich meningioma   Metaplastic meningioma   Chordoid meningioma                                                                                                        
  -------- ------------------------ ---------------------- --------------------------------- ------------------------ --------------------- ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-                       \-                     \-                                ( - )                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     1      \-     1      (20.0)    \-   \-   \-   ( - )
  1        \-                       \-                     \-                                ( - )                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  2        \-                       \-                     \-                                ( - )                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  3        \-                       \-                     \-                                ( - )                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  4        \-                       \-                     \-                                ( - )                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                 
  5--9     \-                       \-                     \-                                ( - )                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     3    \-   3    (23.1)
  10--14   \-                       \-                     \-                                ( - )                    \-                    \-     \-     ( - )     1      \-     1      (20.0)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
  15--19   \-                       1                      1                                 (2.5)                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     1    \-   1    (7.7)
  20--24   \-                       \-                     \-                                ( - )                    \-                    \-     \-     ( - )     1      1      2      (40.0)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
  25--29   1                        \-                     1                                 (2.5)                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                 
  30--34   1                        1                      2                                 (5.0)                    1                     \-     1      (5.9)     \-     1      1      (20.0)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
  35--39   2                        1                      3                                 (7.5)                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     1    \-   1    (7.7)
  40--44   2                        3                      5                                 (12.5)                   \-                    1      1      (5.9)     \-     \-     \-     ( - )     \-     1      1      (20.0)    \-   \-   \-   ( - )
  45--49   \-                       1                      1                                 (2.5)                    \-                    1      1      (5.9)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   2    2    (15.4)
  50--54   2                        4                      6                                 (15.0)                   \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   1    1    (7.7)
                                                                                                                                                                                                                                                 
  55--59   1                        \-                     1                                 (2.5)                    \-                    5      5      (29.4)    \-     1      1      (20.0)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
  60--64   5                        3                      8                                 (20.0)                   1                     \-     1      (5.9)     \-     \-     \-     ( - )     1      \-     1      (20.0)    \-   1    1    (7.7)
  65--69   3                        1                      4                                 (10.0)                   1                     3      4      (23.5)    \-     \-     \-     ( - )     \-     1      1      (20.0)    1    2    3    (23.1)
  70--74   \-                       5                      5                                 (12.5)                   1                     1      2      (11.8)    \-     \-     \-     ( - )     \-     \-     \-     ( - )     1    \-   1    (7.7)
  75--79   1                        1                      2                                 (5.0)                    1                     1      2      (11.8)    \-     \-     \-     ( - )     \-     1      1      (20.0)    \-   \-   \-   ( - )
                                                                                                                                                                                                                                                 
  80--84   \-                       1                      1                                 (2.5)                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-                       \-                     \-                                ( - )                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-                       \-                     \-                                ( - )                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                 
  total    18                       22                     40                                (100.0)                  5                     12     17     (100.0)   2      3      5      (100.0)   2      3      5      (100.0)   7    6    13   (100.0)
                                                                                                                                                                                                                                                 
  mean     54.6                     57.2                   56.0                              62.4                     61.0                  61.4   16.3   38.1      29.4   31.4   61.9   49.7      31.4   56.7   43.1                            

  age      Clear cell meningioma   Atypical meningioma   Papillary meningioma   Rhabdoid meningioma   Anaplastic (malignant) meningioma                                                                                                        
  -------- ----------------------- --------------------- ---------------------- --------------------- ----------------------------------- ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-                      \-                    \-                     ( - )                 \-                                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  1        \-                      \-                    \-                     ( - )                 \-                                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  2        \-                      \-                    \-                     ( - )                 \-                                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  3        \-                      \-                    \-                     ( - )                 \-                                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  4        \-                      \-                    \-                     ( - )                 1                                   \-     1      (0.7)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                               
  5--9     \-                      \-                    \-                     ( - )                 1                                   \-     1      (0.7)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  10--14   \-                      \-                    \-                     ( - )                 \-                                  \-     \-     ( - )     1      \-     1      (25.0)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
  15--19   \-                      1                     1                      (16.7)                2                                   \-     2      (1.3)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   1    1    (3.1)
  20--24   \-                      1                     1                      (16.7)                1                                   2      3      (2.0)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  25--29   \-                      \-                    \-                     ( - )                 2                                   2      4      (2.6)     \-     1      1      (25.0)    1      \-     1      (25.0)    \-   \-   \-   ( - )
                                                                                                                                                                                                                                               
  30--34   \-                      \-                    \-                     ( - )                 3                                   3      6      (3.9)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   1    1    (3.1)
  35--39   \-                      \-                    \-                     ( - )                 \-                                  1      1      (0.7)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  40--44   \-                      \-                    \-                     ( - )                 5                                   4      9      (5.8)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   1    1    (3.1)
  45--49   \-                      \-                    \-                     ( - )                 8                                   8      16     (10.4)    \-     \-     \-     ( - )     \-     \-     \-     ( - )     1    2    3    (9.4)
  50--54   \-                      1                     1                      (16.7)                6                                   8      14     (9.1)     \-     1      1      (25.0)    \-     1      1      (25.0)    3    3    6    (18.8)
                                                                                                                                                                                                                                               
  55--59   \-                      \-                    \-                     ( - )                 6                                   10     16     (10.4)    \-     \-     \-     ( - )     \-     \-     \-     ( - )     2    3    5    (15.6)
  60--64   \-                      1                     1                      (16.7)                6                                   7      13     (8.4)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     2    1    3    (9.4)
  65--69   \-                      \-                    \-                     ( - )                 14                                  16     30     (19.5)    \-     \-     \-     ( - )     1      1      2      (50.0)    2    2    4    (12.5)
  70--74   \-                      \-                    \-                     ( - )                 10                                  8      18     (11.7)    1      \-     1      (25.0)    \-     \-     \-     ( - )     3    2    5    (15.6)
  75--79   \-                      1                     1                      (16.7)                6                                   10     16     (10.4)    \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   2    2    (6.3)
                                                                                                                                                                                                                                               
  80--84   \-                      1                     1                      (16.7)                1                                   3      4      (2.6)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   1    1    (3.1)
  85--89   \-                      \-                    \-                     ( - )                 \-                                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-                      \-                    \-                     ( - )                 \-                                  \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                               
  total    \-                      6                     6                      (100.0)               72                                  82     154    (100.0)   2      2      4      (100.0)   2      2      4      (100.0)   13   19   32   (100.0)
                                                                                                                                                                                                                                               
  mean     \-                      53.1                  53.1                   56.3                  59.9                                58.2   43.1   39.9      41.5   49.2   61.5   55.4      61.0   57.5   58.9                            

  age      Lipoma   Liposarcoma   Solitary fibrous tumor   Fibrosarcoma   Malignant fibrous histiocytoma                                                                                                      
  -------- -------- ------------- ------------------------ -------------- -------------------------------- ------ ------ --------- ------ ------ ------ --------- ---- ------ ------ --------- ---- ---- ---- ---------
  0        \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  1        \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  2        \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  3        \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  4        \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                              
  5--9     \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  10--14   \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  15--19   \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  20--24   \-       1             1                        (14.3)         \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  25--29   \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   1    1    (100.0)
                                                                                                                                                                                                              
  30--34   \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  35--39   \-       1             1                        (14.3)         \-                               1      1      (100.0)   \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  40--44   \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     3      3      (30.0)    \-   \-     \-     ( - )     \-   \-   \-   ( - )
  45--49   1        \-            1                        (14.3)         \-                               \-     \-     ( - )     \-     3      3      (30.0)    \-   \-     \-     ( - )     \-   \-   \-   ( - )
  50--54   1        \-            1                        (14.3)         \-                               \-     \-     ( - )     \-     1      1      (10.0)    \-   \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                              
  55--59   \-       1             1                        (14.3)         \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   1      1      (50.0)    \-   \-   \-   ( - )
  60--64   1        \-            1                        (14.3)         \-                               \-     \-     ( - )     2      \-     2      (20.0)    1    \-     1      (50.0)    \-   \-   \-   ( - )
  65--69   \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     1      1      (10.0)    \-   \-     \-     ( - )     \-   \-   \-   ( - )
  70--74   1        \-            1                        (14.3)         \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  75--79   \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                              
  80--84   \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-       \-            \-                       ( - )          \-                               \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                              
  total    4        3             7                        (100.0)        \-                               1      1      (100.0)   2      8      10     (100.0)   1    1      2      (100.0)   \-   1    1    (100.0)
                                                                                                                                                                                                              
  mean     58.9     40.1          50.8                     \-             39.9                             39.9   63.0   49.3      52.0   64.1   58.9   61.5      \-   28.4   28.4                            

  age      Rhabdomyosarcoma   Chordoma   Chondroma   Chondrosarcoma   Osteoma                                                                                                        
  -------- ------------------ ---------- ----------- ---------------- --------- ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-                 \-         \-          ( - )            \-        1      1      (1.7)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  1        \-                 \-         \-          ( - )            \-        \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  2        \-                 1          1           (16.7)           \-        \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  3        1                  \-         1           (16.7)           \-        \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  4        \-                 \-         \-          ( - )            \-        \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                     
  5--9     1                  \-         1           (16.7)           \-        \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  10--14   \-                 \-         \-          ( - )            2         1      3      (5.2)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  15--19   \-                 \-         \-          ( - )            1         3      4      (6.9)     \-     \-     \-     ( - )     \-     1      1      (5.9)     \-   1    1    (4.6)
  20--24   1                  \-         1           (16.7)           \-        1      1      (1.7)     \-     \-     \-     ( - )     \-     2      2      (11.8)    \-   1    1    (4.6)
  25--29   \-                 \-         \-          ( - )            5         1      6      (10.3)    \-     1      1      (25.0)    2      2      4      (23.5)    2    \-   2    (9.1)
                                                                                                                                                                                     
  30--34   \-                 \-         \-          ( - )            3         1      4      (6.9)     \-     1      1      (25.0)    \-     3      3      (17.7)    1    4    5    (22.7)
  35--39   \-                 \-         \-          ( - )            3         1      4      (6.9)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     2    2    4    (18.2)
  40--44   \-                 \-         \-          ( - )            \-        \-     \-     ( - )     \-     \-     \-     ( - )     \-     2      2      (11.8)    \-   4    4    (18.2)
  45--49   1                  \-         1           (16.7)           3         3      6      (10.3)    \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   1    1    (4.6)
  50--54   \-                 \-         \-          ( - )            3         3      6      (10.3)    \-     \-     \-     ( - )     2      1      3      (17.7)    1    1    2    (9.1)
                                                                                                                                                                                     
  55--59   \-                 \-         \-          ( - )            4         \-     4      (6.9)     \-     \-     \-     ( - )     \-     1      1      (5.9)     \-   1    1    (4.6)
  60--64   \-                 \-         \-          ( - )            6         1      7      (12.1)    1      \-     1      (25.0)    \-     \-     \-     ( - )     \-   1    1    (4.6)
  65--69   1                  \-         1           (16.7)           2         1      3      (5.2)     \-     1      1      (25.0)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
  70--74   \-                 \-         \-          ( - )            2         2      4      (6.9)     \-     \-     \-     ( - )     \-     1      1      (5.9)     \-   \-   \-   ( - )
  75--79   \-                 \-         \-          ( - )            1         3      4      (6.9)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                     
  80--84   \-                 \-         \-          ( - )            \-        \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-                 \-         \-          ( - )            \-        1      1      (1.7)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-                 \-         \-          ( - )            \-        \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                     
  total    5                  1          6           (100.0)          35        23     58     (100.0)   1      3      4      (100.0)   4      13     17     (100.0)   6    16   22   (100.0)
                                                                                                                                                                                     
  mean     29.9               2.1        25.3        47.1             46.7      46.9   63.3   43.4      48.4   40.3   37.5   38.1      36.1   39.4   38.5                            

  age      Osteosarcoma   Osteochondroma   Hemangioma, capillary, cavernous   Epithelioid hemangioendothelioma   Hemangiopericytoma                                                                                                      
  -------- -------------- ---------------- ---------------------------------- ---------------------------------- -------------------- ----- ------ --------- ------ ------ ----- --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     2      \-     2     (1.3)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  1        \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     \-     1      1     (0.6)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  2        \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     1      1      2     (1.3)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  3        \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     1      \-     1     (0.6)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  4        \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     \-     \-     \-    ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                         
  5--9     \-             \-               \-                                 ( - )                              1                    \-    1      (100.0)   3      4      7     (4.4)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  10--14   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     3      \-     3     (1.9)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  15--19   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     4      3      7     (4.4)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  20--24   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     3      7      10    (6.3)     \-     \-     \-     ( - )     3    \-   3    (15.8)
  25--29   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     3      8      11    (6.9)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                         
  30--34   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     5      9      14    (8.8)     \-     \-     \-     ( - )     \-   1    1    (5.3)
  35--39   1              2                3                                  (60.0)                             \-                   \-    \-     ( - )     5      3      8     (5.0)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  40--44   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     6      7      13    (8.1)     \-     \-     \-     ( - )     1    \-   1    (5.3)
  45--49   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     7      7      14    (8.8)     \-     \-     \-     ( - )     1    \-   1    (5.3)
  50--54   \-             1                1                                  (20.0)                             \-                   \-    \-     ( - )     6      12     18    (11.3)    \-     \-     \-     ( - )     2    \-   2    (10.5)
                                                                                                                                                                                                                                         
  55--59   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     4      10     14    (8.8)     1      \-     1      (100.0)   3    1    4    (21.1)
  60--64   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     9      4      13    (8.1)     \-     \-     \-     ( - )     \-   2    2    (10.5)
  65--69   \-             1                1                                  (20.0)                             \-                   \-    \-     ( - )     2      7      9     (5.6)     \-     \-     \-     ( - )     1    3    4    (21.1)
  70--74   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     3      5      8     (5.0)     \-     \-     \-     ( - )     1    \-   1    (5.3)
  75--79   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     2      2      4     (2.5)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                         
  80--84   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     \-     1      1     (0.6)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     \-     \-     \-    ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-             \-               \-                                 ( - )                              \-                   \-    \-     ( - )     \-     \-     \-    ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                         
  total    1              4                5                                  (100.0)                            1                    \-    1      (100.0)   69     91     160   (100.0)   1      \-     1      (100.0)   12   7    19   (100.0)
                                                                                                                                                                                                                                         
  mean     39.4           48.2             46.4                               5.3                                \-                   5.3   41.3   44.2      42.8   59.5   \-    59.5      48.4   59.0   52.3                            

  age      Anaplastic hemangiopericytoma   Angiosarcoma   Ewing sarcoma-PNET   Melanocytoma   Malignant melanoma                                                                                                      
  -------- ------------------------------- -------------- -------------------- -------------- -------------------- ------ ----- --------- ----- ------ ------ --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     1     \-     1      (25.0)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
  1        \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  2        \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  3        \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  4        \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     1     \-     1      (25.0)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                      
  5--9     \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     1     1      2      (50.0)    \-     \-     \-     ( - )     \-   1    1    (33.3)
  10--14   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  15--19   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     1      1      (50.0)    \-   \-   \-   ( - )
  20--24   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     1      \-     1      (50.0)    \-   \-   \-   ( - )
  25--29   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                      
  30--34   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   1    1    (33.3)
  35--39   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  40--44   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  45--49   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  50--54   \-                              \-             \-                   ( - )          2                    \-     2     (66.7)    \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                      
  55--59   \-                              1              1                    (100.0)        \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     1    \-   1    (33.3)
  60--64   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  65--69   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  70--74   \-                              \-             \-                   ( - )          1                    \-     1     (33.3)    \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  75--79   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                      
  80--84   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-                              \-             \-                   ( - )          \-                   \-     \-    ( - )     \-    \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                      
  total    \-                              1              1                    (100.0)        3                    \-     3     (100.0)   3     1      4      (100.0)   1      1      2      (100.0)   1    2    3    (100.0)
                                                                                                                                                                                                                      
  mean     \-                              56.8           56.8                 59.0           \-                   59.0   4.3   6.3       4.8   23.5   19.0   21.3      58.4   21.8   34.0                            

  age      Meningeal melanomatosis   Hemangioblastoma   Malignant lymphoma (B cell type)   Malignant lymphoma (T cell type)   Other malignant lymphomas                                                                                                        
  -------- ------------------------- ------------------ ---------------------------------- ---------------------------------- --------------------------- ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-                        \-                 \-                                 ( - )                              \-                          \-     \-     ( - )     1      \-     1      (0.2)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  1        \-                        \-                 \-                                 ( - )                              \-                          \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  2        \-                        \-                 \-                                 ( - )                              \-                          \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  3        \-                        \-                 \-                                 ( - )                              \-                          \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  4        \-                        \-                 \-                                 ( - )                              \-                          \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                               
  5--9     \-                        \-                 \-                                 ( - )                              \-                          \-     \-     ( - )     \-     1      1      (0.2)     \-     \-     \-     ( - )     1    \-   1    (3.2)
  10--14   \-                        \-                 \-                                 ( - )                              1                           2      3      (1.6)     1      1      2      (0.5)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  15--19   \-                        \-                 \-                                 ( - )                              1                           7      8      (4.3)     3      \-     3      (0.7)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  20--24   1                         \-                 1                                  (33.3)                             5                           3      8      (4.3)     1      \-     1      (0.2)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  25--29   \-                        \-                 \-                                 ( - )                              13                          9      22     (11.8)    4      2      6      (1.4)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                               
  30--34   \-                        \-                 \-                                 ( - )                              7                           10     17     (9.1)     1      \-     1      (0.2)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  35--39   \-                        \-                 \-                                 ( - )                              7                           4      11     (5.9)     2      2      4      (0.9)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  40--44   \-                        \-                 \-                                 ( - )                              9                           7      16     (8.6)     5      1      6      (1.4)     1      \-     1      (9.1)     \-   \-   \-   ( - )
  45--49   \-                        \-                 \-                                 ( - )                              6                           7      13     (7.0)     13     9      22     (5.1)     \-     \-     \-     ( - )     1    \-   1    (3.2)
  50--54   1                         \-                 1                                  (33.3)                             12                          9      21     (11.2)    19     22     41     (9.5)     1      1      2      (18.2)    1    1    2    (6.5)
                                                                                                                                                                                                                                                               
  55--59   \-                        \-                 \-                                 ( - )                              15                          10     25     (13.4)    25     22     47     (10.9)    \-     1      1      (9.1)     1    1    2    (6.5)
  60--64   \-                        \-                 \-                                 ( - )                              3                           6      9      (4.8)     40     24     64     (14.8)    2      1      3      (27.3)    \-   2    2    (6.5)
  65--69   \-                        \-                 \-                                 ( - )                              10                          7      17     (9.1)     55     25     80     (18.5)    \-     2      2      (18.2)    4    1    5    (16.1)
  70--74   \-                        \-                 \-                                 ( - )                              7                           6      13     (7.0)     45     22     67     (15.5)    1      1      2      (18.2)    5    2    7    (22.6)
  75--79   \-                        1                  1                                  (33.3)                             2                           2      4      (2.1)     27     32     59     (13.6)    \-     \-     \-     ( - )     2    1    3    (9.7)
                                                                                                                                                                                                                                                               
  80--84   \-                        \-                 \-                                 ( - )                              \-                          \-     \-     ( - )     10     14     24     (5.5)     \-     \-     \-     ( - )     1    3    4    (12.9)
  85--89   \-                        \-                 \-                                 ( - )                              \-                          \-     \-     ( - )     3      \-     3      (0.7)     \-     \-     \-     ( - )     2    1    3    (9.7)
  90--94   \-                        \-                 \-                                 ( - )                              \-                          \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   1    1    (3.2)
  95-      \-                        \-                 \-                                 ( - )                              \-                          \-     \-     ( - )     1      \-     1      (0.2)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                               
  total    2                         1                  3                                  (100.0)                            98                          89     187    (100.0)   256    177    433    (100.0)   5      6      11     (100.0)   18   13   31   (100.0)
                                                                                                                                                                                                                                                               
  mean     37.4                      75.3               50.1                               47.5                               45.5                        46.6   63.8   64.6      64.1   58.5   64.0   61.5      67.3   73.5   69.9                            

  age      Plasmacytoma   Granulocytic sarcoma   Pure germinoma   HCG producing germinoma   Embryonal carcinoma                                                                                                       
  -------- -------------- ---------------------- ---------------- ------------------------- --------------------- ------ ------ --------- ------ ------ ------ --------- ------ ----- ------ --------- ---- ---- ---- ---------
  0        \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  1        \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  2        \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  3        \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  4        \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     1      \-     1      (0.5)     \-     \-    \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                      
  5--9     \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     6      7      13     (6.5)     3      \-    3      (8.6)     \-   1    1    (20.0)
  10--14   \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     38     13     51     (25.5)    10     1     11     (31.4)    \-   \-   \-   ( - )
  15--19   \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     48     8      56     (28.0)    8      1     9      (25.7)    2    \-   2    (40.0)
  20--24   \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     36     2      38     (19.0)    3      \-    3      (8.6)     1    \-   1    (20.0)
  25--29   \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     16     3      19     (9.5)     4      1     5      (14.3)    \-   \-   \-   ( - )
                                                                                                                                                                                                                      
  30--34   \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     11     \-     11     (5.5)     4      \-    4      (11.4)    \-   \-   \-   ( - )
  35--39   \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     6      2      8      (4.0)     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  40--44   \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     1      \-     1      (0.5)     \-     \-    \-     ( - )     1    \-   1    (20.0)
  45--49   \-             1                      1                (12.5)                    \-                    \-     \-     ( - )     \-     1      1      (0.5)     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  50--54   \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     1      \-     1      (0.5)     \-     \-    \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                      
  55--59   1              2                      3                (37.5)                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  60--64   1              \-                     1                (12.5)                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  65--69   \-             \-                     \-               ( - )                     \-                    1      1      (100.0)   \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  70--74   1              1                      2                (25.0)                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  75--79   1              \-                     1                (12.5)                    \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                      
  80--84   \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  85--89   \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  90--94   \-             \-                     \-               ( - )                     \-                    \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                      
  total    4              4                      8                (100.0)                   \-                    1      1      (100.0)   164    36     200    (100.0)   32     3     35     (100.0)   4    1    5    (100.0)
                                                                                                                                                                                                                      
  mean     67.2           59.0                   63.1             \-                        67.0                  67.0   20.0   16.4      19.4   18.4   18.3   18.4      26.0   8.3   22.5                            

  age      Yolk sac tumor   Choriocarcinoma   Teratoma with malignant transformation   Mature teratoma   Immature teratoma                                                                                                    
  -------- ---------------- ----------------- ---------------------------------------- ----------------- ------------------- ------ ------ --------- ----- ----- ----- --------- ------ ----- ------ --------- ---- ---- ---- ---------
  0        \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    1     1     (50.0)    \-     1     1      (10.0)    \-   1    1    (7.1)
  1        \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  2        \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     1      \-    1      (10.0)    \-   \-   \-   ( - )
  3        \-               \-                \-                                       ( - )             1                   \-     1      (25.0)    \-    \-    \-    ( - )     1      \-    1      (10.0)    \-   \-   \-   ( - )
  4        1                \-                1                                        (6.3)             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                              
  5--9     4                \-                4                                        (25.0)            \-                  \-     \-     ( - )     \-    \-    \-    ( - )     2      \-    2      (20.0)    1    1    2    (14.3)
  10--14   1                \-                1                                        (6.3)             1                   1      2      (50.0)    1     \-    1     (50.0)    2      1     3      (30.0)    2    \-   2    (14.3)
  15--19   3                \-                3                                        (18.8)            1                   \-     1      (25.0)    \-    \-    \-    ( - )     2      \-    2      (20.0)    3    1    4    (28.6)
  20--24   \-               1                 1                                        (6.3)             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     3    \-   3    (21.4)
  25--29   2                \-                2                                        (12.5)            \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     2    \-   2    (14.3)
                                                                                                                                                                                                                              
  30--34   1                \-                1                                        (6.3)             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  35--39   \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  40--44   3                \-                3                                        (18.8)            \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  45--49   \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  50--54   \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                              
  55--59   \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  60--64   \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  65--69   \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  70--74   \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  75--79   \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                              
  80--84   \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  85--89   \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
  90--94   \-               \-                \-                                       ( - )             \-                  \-     \-     ( - )     \-    \-    \-    ( - )     \-     \-    \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                              
  total    15               1                 16                                       (100.0)           3                   1      4      (100.0)   1     1     2     (100.0)   8      2     10     (100.0)   11   3    14   (100.0)
                                                                                                                                                                                                                              
  mean     21.0             21.8              21.1                                     10.8              10.1                10.6   11.8   0.0       5.9   9.3   7.3   8.9       18.8   8.2   16.5                            

  age      Mixed germ cell tumor   Craniopharyngioma   Adamantinomatous craniopharyngioma   Papillary craniopharyngioma   Granular cell tumor of the neurohypophysis                                                                                                        
  -------- ----------------------- ------------------- ------------------------------------ ----------------------------- -------------------------------------------- ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ---- ---- ---- ---------
  0        \-                      \-                  \-                                   ( - )                         1                                            \-     1      (0.4)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  1        \-                      \-                  \-                                   ( - )                         1                                            \-     1      (0.4)     1      1      2      (4.8)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  2        \-                      \-                  \-                                   ( - )                         1                                            2      3      (1.1)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  3        \-                      \-                  \-                                   ( - )                         3                                            \-     3      (1.1)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  4        \-                      \-                  \-                                   ( - )                         4                                            2      6      (2.1)     \-     2      2      (4.8)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                            
  5--9     1                       5                   6                                    (23.1)                        13                                           10     23     (8.2)     2      2      4      (9.5)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  10--14   9                       \-                  9                                    (34.6)                        8                                            9      17     (6.1)     4      2      6      (14.3)    1      \-     1      (11.1)    \-   \-   \-   ( - )
  15--19   4                       2                   6                                    (23.1)                        4                                            7      11     (3.9)     1      \-     1      (2.4)     \-     \-     \-     ( - )     1    \-   1    (50.0)
  20--24   2                       \-                  2                                    (7.7)                         6                                            8      14     (5.0)     1      \-     1      (2.4)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  25--29   2                       \-                  2                                    (7.7)                         4                                            7      11     (3.9)     1      \-     1      (2.4)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                            
  30--34   1                       \-                  1                                    (3.9)                         8                                            5      13     (4.6)     1      \-     1      (2.4)     \-     \-     \-     ( - )     \-   1    1    (50.0)
  35--39   \-                      \-                  \-                                   ( - )                         13                                           4      17     (6.1)     3      1      4      (9.5)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  40--44   \-                      \-                  \-                                   ( - )                         9                                            6      15     (5.4)     1      \-     1      (2.4)     \-     1      1      (11.1)    \-   \-   \-   ( - )
  45--49   \-                      \-                  \-                                   ( - )                         11                                           8      19     (6.8)     5      \-     5      (11.9)    1      \-     1      (11.1)    \-   \-   \-   ( - )
  50--54   \-                      \-                  \-                                   ( - )                         12                                           13     25     (8.9)     \-     1      1      (2.4)     1      1      2      (22.2)    \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                            
  55--59   \-                      \-                  \-                                   ( - )                         12                                           12     24     (8.6)     \-     1      1      (2.4)     \-     2      2      (22.2)    \-   \-   \-   ( - )
  60--64   \-                      \-                  \-                                   ( - )                         14                                           14     28     (10.0)    2      1      3      (7.1)     1      1      2      (22.2)    \-   \-   \-   ( - )
  65--69   \-                      \-                  \-                                   ( - )                         13                                           16     29     (10.4)    1      4      5      (11.9)    \-     \-     \-     ( - )     \-   \-   \-   ( - )
  70--74   \-                      \-                  \-                                   ( - )                         7                                            3      10     (3.6)     2      1      3      (7.1)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  75--79   \-                      \-                  \-                                   ( - )                         2                                            3      5      (1.8)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                            
  80--84   \-                      \-                  \-                                   ( - )                         1                                            3      4      (1.4)     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  85--89   \-                      \-                  \-                                   ( - )                         \-                                           1      1      (0.4)     \-     1      1      (2.4)     \-     \-     \-     ( - )     \-   \-   \-   ( - )
  90--94   \-                      \-                  \-                                   ( - )                         \-                                           \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-   ( - )
                                                                                                                                                                                                                                                                            
  total    19                      7                   26                                   (100.0)                       147                                          133    280    (100.0)   25     17     42     (100.0)   4      5      9      (100.0)   1    1    2    (100.0)
                                                                                                                                                                                                                                                                            
  mean     16.8                    9.9                 14.9                                 40.9                          43.0                                         41.9   35.2   40.4      37.3   43.3   54.3   49.4      18.8   34.1   26.5                            

  age      Pituicytoma   Rathke's cleft cyst   Null cell adenoma   GH producing adenoma   PRL producing adenoma                                                                                                            
  -------- ------------- --------------------- ------------------- ---------------------- ----------------------- ------ ------ --------- ------ ------ ------- --------- ------ ------ ------ --------- ----- ----- ----- ---------
  0        \-            \-                    \-                  ( - )                  \-                      \-     \-     ( - )     2      \-     2       (0.2)     \-     \-     \-     ( - )     \-    1     1     (0.2)
  1        \-            \-                    \-                  ( - )                  \-                      \-     \-     ( - )     \-     \-     \-      ( - )     \-     \-     \-     ( - )     \-    \-    \-    ( - )
  2        \-            \-                    \-                  ( - )                  \-                      \-     \-     ( - )     \-     \-     \-      ( - )     \-     \-     \-     ( - )     \-    \-    \-    ( - )
  3        \-            \-                    \-                  ( - )                  \-                      \-     \-     ( - )     \-     \-     \-      ( - )     \-     \-     \-     ( - )     \-    \-    \-    ( - )
  4        \-            \-                    \-                  ( - )                  \-                      \-     \-     ( - )     \-     \-     \-      ( - )     \-     \-     \-     ( - )     \-    \-    \-    ( - )
                                                                                                                                                                                                                           
  5--9     \-            \-                    \-                  ( - )                  1                       \-     1      (0.4)     \-     \-     \-      ( - )     \-     \-     \-     ( - )     \-    \-    \-    ( - )
  10--14   \-            \-                    \-                  ( - )                  \-                      7      7      (2.5)     2      3      5       (0.4)     2      3      5      (1.0)     2     \-    2     (0.4)
  15--19   \-            \-                    \-                  ( - )                  6                       8      14     (4.9)     3      5      8       (0.7)     3      \-     3      (0.6)     5     32    37    (7.6)
  20--24   \-            \-                    \-                  ( - )                  4                       18     22     (7.8)     7      12     19      (1.6)     12     5      17     (3.5)     11    68    79    (16.2)
  25--29   \-            \-                    \-                  ( - )                  6                       37     43     (15.1)    10     31     41      (3.4)     20     13     33     (6.9)     12    107   119   (24.4)
                                                                                                                                                                                                                           
  30--34   \-            \-                    \-                  ( - )                  9                       13     22     (7.8)     28     26     54      (4.5)     22     22     44     (9.2)     24    67    91    (18.7)
  35--39   \-            1                     1                   (7.7)                  6                       7      13     (4.6)     34     39     73      (6.1)     31     15     46     (9.6)     16    29    45    (9.2)
  40--44   1             \-                    1                   (7.7)                  8                       10     18     (6.3)     46     39     85      (7.1)     19     22     41     (8.5)     11    18    29    (6.0)
  45--49   2             \-                    2                   (15.4)                 9                       13     22     (7.8)     42     57     99      (8.2)     22     27     49     (10.2)    10    6     16    (3.3)
  50--54   \-            1                     1                   (7.7)                  9                       12     21     (7.4)     77     84     161     (13.4)    33     40     73     (15.2)    20    7     27    (5.5)
                                                                                                                                                                                                                           
  55--59   2             1                     3                   (23.1)                 10                      8      18     (6.3)     96     90     186     (15.5)    21     50     71     (14.8)    9     5     14    (2.9)
  60--64   \-            1                     1                   (7.7)                  12                      22     34     (12.0)    78     74     152     (12.6)    15     28     43     (9.0)     9     2     11    (2.3)
  65--69   1             \-                    1                   (7.7)                  8                       23     31     (10.9)    79     76     155     (12.9)    11     17     28     (5.8)     7     3     10    (2.1)
  70--74   1             2                     3                   (23.1)                 6                       7      13     (4.6)     59     53     112     (9.3)     9      15     24     (5.0)     1     4     5     (1.0)
  75--79   \-            \-                    \-                  ( - )                  4                       1      5      (1.8)     29     14     43      (3.6)     1      \-     1      (0.2)     \-    1     1     (0.2)
                                                                                                                                                                                                                           
  80--84   \-            \-                    \-                  ( - )                  \-                      \-     \-     ( - )     4      3      7       (0.6)     1      1      2      (0.4)     \-    \-    \-    ( - )
  85--89   \-            \-                    \-                  ( - )                  \-                      \-     \-     ( - )     2      \-     2       (0.2)     \-     \-     \-     ( - )     \-    \-    \-    ( - )
  90--94   \-            \-                    \-                  ( - )                  \-                      \-     \-     ( - )     \-     \-     \-      ( - )     \-     \-     \-     ( - )     \-    \-    \-    ( - )
                                                                                                                                                                                                                           
  total    7             6                     13                  (100.0)                98                      186    284    (100.0)   598    606    1,204   (100.0)   222    258    480    (100.0)   137   350   487   (100.0)
                                                                                                                                                                                                                           
  mean     56.0          59.2                  57.5                48.4                   43.0                    44.8   55.9   53.5      54.7   45.4   50.7    48.2      41.7   30.5   33.7                               

  age      GH-PRL producing adenoma   TSH producing adenoma   ACTH producing adenoma   Gonadotropin producing adenoma   Epidermoid cyst                                                                                                         
  -------- -------------------------- ----------------------- ------------------------ -------------------------------- ----------------- ------ ------ --------- ------ ------ ------ --------- ------ ------ ------ --------- ---- ---- ----- ---------
  0        1                          \-                      1                        (2.6)                            \-                \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   1    1     (0.8)
  1        \-                         \-                      \-                       ( - )                            \-                \-     \-     \-        \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  2        \-                         \-                      \-                       ( - )                            \-                \-     \-     \-        \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  3        \-                         \-                      \-                       ( - )                            \-                \-     \-     \-        \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  4        \-                         \-                      \-                       ( - )                            \-                \-     \-     \-        \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
                                                                                                                                                                                                                                                
  5--9     \-                         \-                      \-                       ( - )                            \-                \-     \-     ( - )     1      \-     1      (0.7)     \-     \-     \-     ( - )     2    1    3     (2.5)
  10--14   \-                         1                       1                        (2.6)                            \-                \-     \-     ( - )     1      \-     1      (0.7)     \-     \-     \-     ( - )     \-   2    2     (1.6)
  15--19   2                          \-                      2                        (5.1)                            \-                \-     \-     ( - )     \-     4      4      (2.9)     3      \-     3      (1.5)     3    1    4     (3.3)
  20--24   1                          1                       2                        (5.1)                            \-                \-     \-     ( - )     1      5      6      (4.3)     \-     1      1      (0.5)     5    2    7     (5.7)
  25--29   1                          2                       3                        (7.7)                            \-                2      2      (5.9)     1      7      8      (5.8)     1      1      2      (1.0)     6    5    11    (9.0)
                                                                                                                                                                                                                                                
  30--34   \-                         4                       4                        (10.3)                           3                 \-     3      (8.8)     6      12     18     (13.0)    2      2      4      (2.0)     4    4    8     (6.6)
  35--39   2                          1                       3                        (7.7)                            3                 1      4      (11.8)    5      11     16     (11.5)    8      8      16     (8.1)     5    4    9     (7.4)
  40--44   1                          3                       4                        (10.3)                           2                 2      4      (11.8)    5      7      12     (8.6)     8      11     19     (9.6)     5    7    12    (9.8)
  45--49   \-                         2                       2                        (5.1)                            4                 \-     4      (11.8)    2      9      11     (7.9)     15     9      24     (12.1)    5    5    10    (8.2)
  50--54   4                          5                       9                        (23.1)                           2                 3      5      (14.7)    1      13     14     (10.1)    15     13     28     (14.1)    9    2    11    (9.0)
                                                                                                                                                                                                                                                
  55--59   1                          1                       2                        (5.1)                            1                 5      6      (17.7)    4      12     16     (11.5)    13     11     24     (12.1)    9    9    18    (14.8)
  60--64   1                          2                       3                        (7.7)                            1                 2      3      (8.8)     5      12     17     (12.2)    14     12     26     (13.1)    7    5    12    (9.8)
  65--69   1                          1                       2                        (5.1)                            1                 \-     1      (2.9)     \-     6      6      (4.3)     15     8      23     (11.6)    \-   9    9     (7.4)
  70--74   \-                         1                       1                        (2.6)                            \-                2      2      (5.9)     \-     7      7      (5.0)     11     5      16     (8.1)     \-   4    4     (3.3)
  75--79   \-                         \-                      \-                       ( - )                            \-                \-     \-     ( - )     1      1      2      (1.4)     5      6      11     (5.6)     \-   1    1     (0.8)
                                                                                                                                                                                                                                                
  80--84   \-                         \-                      \-                       ( - )                            \-                \-     \-     ( - )     \-     \-     \-     ( - )     1      \-     1      (0.5)     \-   \-   \-    ( - )
  85--89   \-                         \-                      \-                       ( - )                            \-                \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
  90--94   \-                         \-                      \-                       ( - )                            \-                \-     \-     ( - )     \-     \-     \-     ( - )     \-     \-     \-     ( - )     \-   \-   \-    ( - )
                                                                                                                                                                                                                                                
  total    15                         24                      39                       (100.0)                          17                17     34     (100.0)   33     106    139    (100.0)   111    87     198    (100.0)   60   62   122   (100.0)
                                                                                                                                                                                                                                                
  mean     39.5                       44.9                    42.8                     45.5                             52.1              48.8   43.0   47.3      46.3   55.7   54.5   55.2      42.5   47.5   45.0                             

  age      Dermoid cyst   Plurihormonal adenoma   Pseudotumor                                                           
  -------- -------------- ----------------------- ------------- --------- ---- ------ ------ --------- ------ ---- ---- ---------
  0        \-             \-                      \-            ( - )     \-   \-     \-     ( - )     \-     \-   \-   ( - )
  1        \-             2                       2             (11.8)    \-   \-     \-     ( - )     \-     \-   \-   ( - )
  2        \-             \-                      \-            ( - )     \-   \-     \-     ( - )     \-     \-   \-   ( - )
  3        \-             2                       2             (11.8)    \-   \-     \-     ( - )     \-     \-   \-   ( - )
  4        1              \-                      1             (5.9)     \-   \-     \-     ( - )     \-     \-   \-   ( - )
                                                                                                                        
  5--9     \-             \-                      \-            ( - )     \-   \-     \-     ( - )     \-     \-   \-   ( - )
  10--14   \-             2                       2             (11.8)    \-   \-     \-     ( - )     \-     \-   \-   ( - )
  15--19   \-             \-                      \-            ( - )     \-   \-     \-     ( - )     \-     1    1    (4.2)
  20--24   \-             3                       3             (17.7)    \-   \-     \-     ( - )     \-     1    1    (4.2)
  25--29   1              1                       2             (11.8)    \-   \-     \-     ( - )     \-     \-   \-   ( - )
                                                                                                                        
  30--34   \-             \-                      \-            ( - )     \-   \-     \-     ( - )     \-     1    1    (4.2)
  35--39   \-             \-                      \-            ( - )     \-   \-     \-     ( - )     1      \-   1    (4.2)
  40--44   1              1                       2             (11.8)    \-   \-     \-     ( - )     \-     \-   \-   ( - )
  45--49   \-             1                       1             (5.9)     1    \-     1      (33.3)    1      3    4    (16.7)
  50--54   \-             1                       1             (5.9)     \-   \-     \-     ( - )     1      4    5    (20.8)
                                                                                                                        
  55--59   \-             1                       1             (5.9)     1    \-     1      (33.3)    3      1    4    (16.7)
  60--64   \-             \-                      \-            ( - )     \-   \-     \-     ( - )     \-     1    1    (4.2)
  65--69   \-             \-                      \-            ( - )     1    \-     1      (33.3)    2      2    4    (16.7)
  70--74   \-             \-                      \-            ( - )     \-   \-     \-     ( - )     \-     1    1    (4.2)
  75--79   \-             \-                      \-            ( - )     \-   \-     \-     ( - )     \-     1    1    (4.2)
                                                                                                                        
  80--84   \-             \-                      \-            ( - )     \-   \-     \-     ( - )     \-     \-   \-   ( - )
  85--89   \-             \-                      \-            ( - )     \-   \-     \-     ( - )     \-     \-   \-   ( - )
  90--94   \-             \-                      \-            ( - )     \-   \-     \-     ( - )     \-     \-   \-   ( - )
                                                                                                                        
  total    3              14                      17            (100.0)   3    \-     3      (100.0)   8      16   24   (100.0)
                                                                                                                        
  mean     25.0           23.7                    23.9          58.4      \-   58.4   56.4   51.5      53.2             

3). Overall survival and progression free survival {#S3.3}
--------------------------------------------------

  ID                         Histology                                                  total   Overall survival   Progression free survival                                                          
  -------------------------- ---------------------------------------------------------- ------- ------------------ --------------------------- ------- ------ ------- ------- ------- ------- ------- -------
  1                          Pilocytic astrocytoma                                      193     14                 124.1                       0.0     NR     92.1    45      124.1   0.0     NR      73.8
  2                          Pilomyxoid astrocytoma                                     14      1                  120.1                       0.9     NR     92.3    5       108.1   0.9     NR      61.5
  3                          Subependymal giant cell astrocytoma                        9       0                  124.0                       27.0    NR     100.0   1       124.0   7.0     NR      87.5
  4                          Pleomorphic xanthoastrocytoma                              31      8                  120.1                       0.0     NR     70.2    11      120.1   0.0     NR      60.8
  5                          Diffuse astrocytoma                                        269     69                 128.1                       0.0     NR     73.4    103     128.1   0.0     87.1    57.6
  6                          Fibrillary astrocytoma                                     71      15                 115.1                       0.0     NR     81.0    26      115.1   0.0     NR      60.8
  7                          Gemistocytic astrocytoma                                   29      9                  103.0                       0.9     76.1   70.4    14      103.0   0.9     36.0    31.6
  8                          Protoplasmic astrocytoma                                   13      1                  101.1                       1.0     NR     88.9    4       101.1   1.0     89.0    76.2
  9                          Anaplastic astrocytoma                                     513     230                129.0                       0.0     38.0   41.1    271     129.0   0.0     19.0    28.7
  10                         Glioblastoma                                               1,455   904                119.0                       0.0     15.0   9.9     865     119.0   0.0     8.1     9.3
  11                         Giant cell glioblastoma                                    14      12                 92.1                        3.0     NR     17.9    10      92.1    1.0     14.0    9.4
  12                         Gliosarcoma                                                20      13                 67.1                        1.0     18.0   17.9    13      37.1    0.9     12.0    0.0
  13                         Gliomatosis cerebri                                        47      24                 108.1                       0.0     17.0   21.2    22      108.1   0.0     12.0    25.9
                                                                                                                                                                                                      
  14                         Oligodendroglioma                                          121     15                 122.1                       0.9     NR     90.6    38      122.1   0.0     109.1   76.5
  15                         Anaplastic oligodendroglioma                               126     44                 120.1                       0.0     102    67.8    57      119.0   0.0     52.0    49.9
                                                                                                                                                                                                      
  16                         Oligoastrocytoma                                           90      14                 114.1                       1.0     NR     89.3    26      114.1   1.0     NR      72.2
  17                         Anaplastic oligoastrocytoma                                106     32                 120.1                       0.0     NR     68.7    50      120.1   0.0     80.1    58.6
                                                                                                                                                                                                      
  18                         Subependymoma                                              21      0                  109.1                       1.0     NR     100.0   0       109.1   1.0     NR      100.0
  19                         Myxopapillary ependymoma                                   1       0                  49.0                        49.0    NR     ND      0       49.0    49.0    NR      ND
  20                         Ependymoma                                                 72      7                  119.0                       0.0     NR     88.5    16      117.0   0.0     117.0   73.1
  21                         Cellular ependymoma                                        2       2                  26.0                        7.0     16.5   0.0     2       14.0    6.0     10.0    0.0
  22                         Papillary ependymoma                                       1       0                  92.1                        92.1    NR     100.0   0       92.1    92.1    NR      100.0
  23                         Clear cell ependymoma                                      3       0                  123.1                       29.0    NR     100.0   0       123.1   29.0    NR      100.0
  24                         Tanycytic ependymoma                                       1       0                  105.1                       105     NR     100.0   1       17.0    17.0    17.0    0.0
  25                         Anaplastic ependymoma                                      55      19                 119.0                       0.0     NR     58.1    29      119.0   0.0     22.0    35.1
                                                                                                                                                                                                      
  26                         Unclassified gliomas                                       115     50                 119.0                       0.0     43.0   47.1    37      119.0   0.0     NR      56.1
                                                                                                                                                                                                      
  27                         Choroid plexus papilloma                                   30      1                  107.0                       0.0     NR     96.7    2       104.1   0.0     NR      91.7
  28                         Atypical choroid plexus papilloma                          1       0                  108.1                       108     NR     100.0   1       21.0    21.0    21.0    0.0
  29                         Choroid plexus carcinoma                                   4       2                  101.1                       8.0     101    66.7    2       98.1    8.0     37.1    33.3
                                                                                                                                                                                                      
  30                         Astroblastoma                                              1       0                  84.1                        84.1    NR     100.0   0       84.1    84.1    NR      100.0
  31                         Chordoid glioma of the third ventricle                     5       1                  102.1                       15.0    NR     80.0    1       102.1   15.0    NR      66.7
  32                         Angiocentric glioma                                        1       0                  76.0                        76.0    NR     100.0   0       76.0    76.0    NR      100.0
                                                                                                                                                                                                      
  33                         Dysplastic gangliocytoma of cerebellum(LHermitte-Duclos)   1       0                  16.0                        16.0    NR     ND      0       16.0    16.0    NR      ND
  34                         Desmoplastic infantile astrocytoma/ganglioglioma           1       0                  106.1                       106.1   NR     100.0   0       106.1   106.1   NR      100.0
  35                         Dysembryoplastic neuroepithelial tumor                     26      1                  116.1                       0.0     NR     95.0    2       116.1   0.0     NR      95.8
  36                         Gangliocytoma                                              7       0                  112.1                       1.0     NR     100.0   1       112.1   1.0     NR      83.3
  37                         Ganglioglioma                                              60      3                  123.1                       0.0     NR     98.1    10      119.0   0.0     NR      78.9
  38                         Anaplastic ganglioglioma                                   8       4                  105.1                       2.0     99.1   68.6    4       105.1   2.0     50.1    42.9
  39                         Central neurocytoma                                        65      1                  123.1                       0.0     NR     98.4    15      123.1   0.0     NR      79.0
  40                         Extraventricular neurocytoma                               2       1                  78.0                        60.0    NR     50.0    2       50.0    0.0     25.0    0.0
  42                         Papillary glioneuronal tumor                               3       0                  81.0                        22.0    NR     100.0   0       81.0    22.0    NR      100.0
  43                         Rosette-forming glioneuronal tumor                         2       0                  97.1                        10.0    NR     100.0   1       56.0    10.0    56.0    0.0
  44                         Paraganglioma                                              6       0                  84.0                        0.0     NR     100.0   1       83.1    0.0     83.1    100.0
                                                                                                                                                                                                      
  45                         Pineocytoma                                                20      2                  106.1                       1.0     NR     87.7    3       106.1   1.0     NR      82.9
  46                         Pineal parenchymal tumor of intermediate differentiation   6       0                  85.1                        32.0    NR     100.0   0       85.1    32.0    NR      100.0
  47                         Pineoblastoma                                              9       5                  121.0                       0.0     33.0   29.6    4       121.0   0.0     33.0    35.0
                                                                                                                                                                                                      
  49                         Medulloblastoma                                            98      27                 121.0                       0.0     NR     69.2    33      121.0   0.0     NR      63.2
  50                         Desmoplastic/nodular medulloblastoma                       3       1                  96.1                        4.9     NR     50.0    1       96.1    4.9     NR      50.0
  54                         CNS primitive neuroectodermal tumor (CNS PNET)             23      9                  115.0                       0.0     78.1   53.8    14      102.1   0.0     24.0    27.9
  55                         CNS neuroblastoma                                          13      6                  99.1                        1.0     64.0   57.5    9       99.1    1.0     64.0    53.5
  56                         CNS ganglioneuroblastoma                                   1       0                  92.1                        92.1    NR     100.0   0       92.1    92.1    NR      100.0
  58                         Ependymoblastoma                                           2       1                  77.1                        3.0     NR     50.0    1       34.0    3.0     34.0    0.0
  59                         Atypical teratoid/rhabdoid tumor                           10      7                  105.1                       3.0     NR     30.0    7       105.1   2.0     13.0    14.0
                                                                                                                                                                                                      
  60                         Schwannoma (neurilemoma, neurinoma)                        1,344   15                 130.1                       0.0     NR     98.8    122     130.1   0.0     NR      89.5
  61                         Cellular schwannoma                                        7       0                  98.1                        18.0    NR     100.0   1       86.1    12.0    NR      85.7
  62                         Plexiform schwannoma                                       1       0                  98.1                        98.1    NR     100.0   1       86.1    86.1    86.1    100.0
  64                         Neurofibroma                                               15      2                  120.1                       0.0     NR     84.8    2       120.1   0.0     NR      80.8
  68                         Malignant perineurioma                                     1       1                  0.0                         0.0     0.0    0.0     0       0.0     0.0     NR      ND
  69                         Malignant peripheral nerve sheath tumor (MPNST)            1       0                  67.0                        67.0    NR     100.0   0       67.0    67.0    NR      100.0
                                                                                                                                                                                                      
  74                         Meningioma                                                 1,093   28                 125.0                       0.0     NR     97.5    92      125.0   0.0     NR      89.5
  75                         Meningothelial meningioma                                  1,007   21                 129.1                       0.0     NR     98.3    109     129.0   0.0     NR      88.5
  76                         Fibrous (fibroblastic) meningioma                          336     3                  121.1                       0.0     NR     98.8    14      121.1   0.0     NR      96.1
  77                         Transitional (mixed) meningioma                            385     11                 126.1                       0.0     NR     96.7    28      121.1   0.0     NR      92.3
  78                         Psammomatous meningioma                                    76      0                  116.1                       0.0     NR     100.0   6       116.1   0.0     NR      96.0
  79                         Angiomatous meningioma                                     101     2                  120.1                       0.0     NR     98.7    7       120.1   0.0     NR      91.7
  80                         Microcystic meningioma                                     40      2                  113.0                       0.0     NR     96.2    4       113.0   0.0     NR      87.6
  81                         Secretory meningioma                                       17      0                  122.0                       1.0     NR     100.0   2       112.1   1.0     NR      90.9
  82                         Lymphoplasmacyte-rich meningioma                           5       0                  98.1                        29.0    NR     100.0   1       98.1    29.0    NR      75.0
  83                         Metaplastic meningioma                                     5       0                  113.1                       5.0     NR     100.0   0       113.1   5.0     NR      100.0
  84                         Chordoid meningioma                                        13      0                  121.0                       0.0     NR     100.0   3       121.0   0.0     NR      70.7
  85                         Clear cell meningioma                                      6       0                  101.0                       0.9     NR     100.0   0       101.0   0.9     NR      100.0
  86                         Atypical meningioma                                        154     15                 122.1                       0.0     NR     90.1    58      120.1   0.0     86.1    57.9
  87                         Papillary meningioma                                       4       0                  85.0                        25.0    NR     100.0   1       84.1    15.0    NR      75.0
  88                         Rhabdoid meningioma                                        4       1                  112.1                       9.0     NR     75.0    1       112.1   6.0     NR      75.0
  89                         Anaplastic (malignant) meningioma                          32      4                  115.1                       0.0     NR     86.1    15      105.0   0.0     45.0    45.3
                                                                                                                                                                                                      
  90                         Lipoma                                                     7       0                  93.1                        0.0     NR     100.0   0       93.1    0.0     NR      100.0
  93                         Liposarcoma                                                1       0                  82.1                        82.1    NR     100.0   1       70.1    70.1    70.1    100.0
  94                         Solitary fibrous tumor                                     10      3                  86.1                        0.0     NR     57.1    3       86.1    0.0     NR      54.0
  95                         Fibrosarcoma                                               2       1                  35.0                        3.0     35.0   0.0     1       9.0     3.0     9.0     0.0
  96                         Malignant fibrous histiocytoma                             1       0                  88.1                        88.1    NR     100.0   0       88.1    88.1    NR      100.0
  100                        Rhabdomyosarcoma                                           6       1                  121.1                       1.0     NR     75.0    1       121.1   1.0     NR      83.3
  101                        Chordoma                                                   58      6                  120.1                       0.0     NR     89.1    26      107.1   0.0     50.1    48.1
  102                        Chondroma                                                  4       0                  76.1                        64.1    NR     100.0   3       70.0    5.0     NR      50.0
  103                        Chondrosarcoma                                             17      2                  110.1                       1.0     NR     84.6    4       110.1   1.0     NR      76.6
  104                        Osteoma                                                    22      0                  105.1                       0.0     NR     100.0   1       97.1    0.0     NR      83.3
  105                        Osteosarcoma                                               5       2                  109.1                       0.0     70.0   66.7    2       109.1   0.0     10.0    33.3
  106                        Osteochondroma                                             1       0                  2.0                         2.0     NR     ND      1       2.0     2.0     2.0     0.0
  107                        Hemangioma, capillary, cavernous                           160     1                  130.1                       0.0     NR     98.9    8       130.1   0.0     NR      93.6
                                                                                                                                                                                                      
  108                        Epithelioid hemangioendothelioma                           1       0                  90.1                        90.1    NR     100.0   0       90.1    90.1    NR      100.0
  109                        Hemangiopericytoma                                         19      1                  111.1                       1.0     NR     91.7    8       111.1   1.0     79.0    77.1
  110                        Anaplastic hemangiopericytoma                              1       0                  87.0                        87.0    NR     100.0   1       57.1    57.1    57.1    0.0
  111                        Angiosarcoma                                               3       0                  20.0                        0.9     NR     ND      0       20.0    0.9     NR      ND
  113                        Ewing sarcoma -PNET                                        4       0                  95.0                        69.0    NR     100.0   0       95.0    69.0    NR      100.0
                                                                                                                                                                                                      
  115                        Melanocytoma                                               2       1                  34.0                        5.0     34.0   0.0     1       7.1     5.0     7.1     0.0
  116                        Malignant melanoma                                         3       1                  29.0                        6.0     NR     ND      2       22.1    6.0     15.0    0.0
  117                        Meningeal melanomatosis                                    3       1                  6.0                         1.9     6.0    0.0     1       2.0     1.0     NR      ND
                                                                                                                                                                                                      
  118                        Hemangioblastoma                                           187     4                  122.1                       0.0     NR     96.3    20      120.1   0.0     NR      86.8
                                                                                                                                                                                                      
  119                        Malignant lymphoma (B cell type)                           433     166                117.0                       0.0     41.1   41.8    158     117.0   0.0     34.0    33.3
  120                        Malignant lymphoma (T cell type)                           11      6                  93.0                        1.0     61.1   51.1    3       93.0    1.0     NR      50.0
  121                        Other malignant lymphotmas                                 31      9                  97.1                        0.0     41.0   48.8    7       97.1    0.0     NR      55.5
  122                        Plasmacytoma                                               8       2                  99.0                        2.0     NR     85.7    4       99.0    0.0     20.0    37.5
  123                        Granulocytic sarcoma                                       1       1                  19.0                        19.0    19.0   0.0     1       19.0    19.0    19.0    0.0
  124                        Pure germinoma                                             200     5                  120.1                       0.0     NR     97.6    22      120.1   0.0     NR      89.8
  125                        HCG producing germinoma                                    35      4                  120.1                       1.0     NR     93.9    4       120.1   1.0     NR      90.0
  126                        Embryonal carcinoma                                        5       1                  108.1                       1.0     NR     75.0    1       108.1   1.0     NR      75.0
  127                        Yolk sac tumor                                             16      4                  108.1                       10.0    NR     74.5    5       108.1   4.0     NR      68.8
  128                        Choriocarcinoma                                            4       0                  93.1                        7.0     NR     100.0   0       93.1    7.0     NR      100.0
  129                        Teratoma                                                   2       1                  5.0                         1.0     NR     ND      0       5.0     1.0     NR      ND
  130                        Mature teratoma                                            10      2                  116.1                       8.0     NR     76.2    4       116.1   6.0     NR      52.5
  131                        Immature teratoma                                          14      3                  121.1                       2.0     NR     73.3    5       121.1   2.0     NR      51.9
  133                        Mixed germ cell tumor                                      26      6                  111.1                       1.0     NR     73.3    5       111.1   1.0     NR      76.1
                                                                                                                                                                                                      
  134                        Craniopharyngioma                                          280     11                 120.1                       0.0     NR     96.6    77      119.0   0.0     NR      69.9
  135                        Adamantinomatous craniopharyngioma                         42      1                  122.0                       0.0     NR     97.1    13      122.0   0.0     NR      69.8
  136                        Papillary craniopharyngioma                                9       1                  111.1                       1.0     NR     88.9    4       103.1   1.0     76.0    64.8
  137                        Granular cell tumor of the neurohypophysis                 2       0                  52.1                        1.0     NR     ND      0       52.1    1.0     NR      ND
  138                        Pituicytoma                                                13      1                  103.1                       0.0     NR     91.7    0       103.1   0.0     NR      100.0
                                                                                                                                                                                                      
  140                        Rathke's cleft cyst                                        284     2                  122.0                       0.0     NR     99.4    27      122.0   0.0     NR      88.7
  141                        GH producing adenoma                                       480     4                  121.0                       0.0     NR     99.2    19      121.0   0.0     NR      95.7
  142                        PRL producing adenoma                                      487     3                  120.1                       0.0     NR     99.4    24      120.1   0.0     NR      94.2
  143                        GH-PRL producing adenoma                                   39      1                  114.1                       0.0     NR     100.0   1       114.1   0.0     NR      96.6
  144                        TSH producing adenoma                                      34      0                  119.1                       0.0     NR     100.0   3       119.1   0.0     NR      93.2
  145                        ACTH producing adenoma                                     139     6                  119.1                       0.0     NR     97.2    21      119.1   0.0     NR      85.0
  146                        Gonadotropin producing adenoma                             198     6                  117.1                       0.0     NR     98.0    23      117.0   0.0     NR      88.9
  147                        Null cell adenoma                                          1,204   21                 130.1                       0.0     NR     98.3    174     130.1   0.0     NR      84.5
                                                                                                                                                                                                      
  148                        Epidermoid cyst                                            122     1                  122.1                       0.0     NR     98.8    6       122.1   0.0     NR      93.0
                                                                                                                                                                                                      
  149                        Dermoid cyst                                               17      0                  114.1                       0.0     NR     100.0   1       114.1   0.0     NR      87.5
  150                        Plurihormonal adenoma                                      3       0                  89.1                        11.0    NR     100.0   0       89.1    11.0    NR      100.0
  151                        Pseudotumor (inflammation)                                 24      0                  125.1                       0.0     NR     100.0   3       117.0   0.0     NR      89.6
                                                                                                                                                                                                      
  All primary brain tumors   13,431                                                     1,977   130.1              0.0                         NR      82.1   2,962   130.1   0.0     NR      73.2    
                                                                                                                                                                                                      
  Malignant brain tumors     4,545                                                      1,779   129.0              0.0                         65.1    51.1   2,032   129.0   0.0     33.0    42.5    
                                                                                                                                                                                                      
  Benign brain tumors        8,568                                                      173     130.1              0.0                         NR      98.0   891     130.1   0.0     NR      88.3    

4.. General features of top 25 tumors (2001--2004) {#S4}
==================================================

1). Definition of top 25 tumors (total 11,925) {#S4.1}
----------------------------------------------

                                total   ID         histology
  ---- ------------------------ ------- ---------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1    Pilocytic astrocytoma    193     1          Pilocytic astrocytoma
  2    GII DA                   382     5--8       Diffuse astrocytoma, Fibrillary astrocytoma, Gemistocytic astrocytoma, Protoplasmic astroctyoma
  3    GII OL & OA              211     14, 16     Oligodendroglioma, Oligoastrocytoma
  4    GIII AA                  513     9          Anaplastic astrocytoma
  5    GIII AO & AOA            232     15, 17     Anaplastic oligodendroglioma, Anaplastic oligoastrocytoma
  6    Glioblastoma             1,489   10--12     Glioblastoma, Giant cell glioblastoma, Gliosarcoma
  7    Ependymoma               78      20--23     Ependymoma, Cellular ependymoma, Papillary ependymoma, Clear cell ependymoma
  8    AE                       55      25         Anaplastic ependymoma
  9    Ganglioglioma            60      37         Ganglioglioma
  10   Central neurocytoma      65      39         Central neurocytoma
  11   Medulloblastoma          101     49--53     Medulloblastoma, Desmoplastic/nodular medulloblastoma
  12   Germinoma                235     124,125    Pure germinoma, HCG producing germinoma
  13   PCNSL                    475     119--121   Malignant lymphoma-B cell, Malignant lymphoma-T cell, Other malignant lymphoma
  14   GI Meningioma            3,065   74--83     Meningioma, Meningothelial, Fibrous (fibroblastic), Transitional (mixed), Psammomatous, Angiomatous, Secretory, Lymphoplasmacyte-rich , Microcystic, Metaplastic
  15   GII Meningioma           173     84--86     Chordoid, Clear cell, Atypical
  16   GIII Meningioma          40      87--89     Papillary meningioma, Rhabdoid meningioma, Anaplastic
  17   Schwannoma               1,352   60--63     Schwannoma, Celluar, Plexiform, Melanotic
  18   GH pituitary adenoma     480     141        GH producing pituitary adenoma
  19   PRL pituitary adenoma    487     142        PRL producing pituitary adenoma
  20   ACTH pituitary adenoma   139     145        ACTH producing pituitary adenoma
  21   NF pituitary adenoma     1,402   146, 147   Gonadotropin producing pituitary adenoma, Null cell pituitary adenoma
  22   Craniopharyngioma        331     134--136   Craniopharyngioma, Adamantinomatous, Papillary
  23   Chordoma                 58      101        Chordoma
  24   Hemangioblastoma         187     118        Hemangioblastoma
  25   Epidermoid               122     148        Epidermoid cyst

2). Age distribution {#S4.2}
--------------------

  age      Pilocytic astrocytoma   GII Diffuse astrocytoma   GII OL&OA   GIII Anaplastic astrocytoma   GIII AO&AOA                                                                                                                                             
  -------- ----------------------- ------------------------- ----------- ----------------------------- ------------- --------- --------- --------- --------- -------- --------- --------- --------- --------- --------- --------- --------- -------- --------- ---------
  0        1                       \-                        1           (0.5)                         1             \-        1         (0.3)     \-        \-       \-        ( - )     1         \-        1         (0.2)     1         1        2         (0.9)
  1        4                       3                         7           (3.6)                         3             \-        3         (0.8)     1         \-       1         (0.5)     1         \-        1         (0.2)     \-        \-       \-        ( - )
  2        1                       1                         2           (1.0)                         \-            \-        \-        ( - )     \-        \-       \-        ( - )     1         \-        1         (0.2)     \-        \-       \-        ( - )
  3        6                       9                         15          (7.8)                         \-            1         1         (0.3)     \-        \-       \-        ( - )     \-        1         1         (0.2)     \-        \-       \-        ( - )
  4        1                       3                         4           (2.1)                         2             1         3         (0.8)     \-        \-       \-        ( - )     2         1         3         (0.6)     \-        \-       \-        ( - )
                                                                                                                                                                                                                                                               
  5--9     13                      10                        23          (11.9)                        6             12        18        (4.7)     2         1        3         (1.4)     5         6         11        (2.1)     \-        \-       \-        ( - )
  10--14   21                      24                        45          (23.3)                        8             7         15        (3.9)     1         3        4         (1.9)     4         5         9         (1.8)     \-        \-       \-        ( - )
  15--19   11                      2                         13          (6.7)                         9             6         15        (3.9)     1         2        3         (1.4)     5         5         10        (2.0)     2         \-       2         (0.9)
  20--24   9                       15                        24          (12.4)                        17            10        27        (7.1)     5         4        9         (4.3)     12        4         16        (3.1)     2         5        7         (3.0)
  25--29   7                       9                         16          (8.3)                         28            20        48        (12.6)    6         10       16        (7.6)     18        16        34        (6.6)     8         2        10        (4.3)
                                                                                                                                                                                                                                                               
  30--34   6                       1                         7           (3.6)                         25            26        51        (13.4)    21        15       36        (17.1)    25        16        41        (8.0)     6         13       19        (8.2)
  35--39   1                       5                         6           (3.1)                         28            16        44        (11.5)    17        12       29        (13.7)    25        16        41        (8.0)     19        8        27        (11.6)
  40--44   3                       2                         5           (2.6)                         17            20        37        (9.7)     13        9        22        (10.4)    18        16        34        (6.6)     16        11       27        (11.6)
  45--49   2                       5                         7           (3.6)                         10            11        21        (5.5)     11        11       22        (10.4)    21        16        37        (7.2)     16        11       27        (11.6)
  50--54   1                       2                         3           (1.6)                         11            14        25        (6.5)     17        11       28        (13.3)    28        20        48        (9.4)     23        15       38        (16.4)
                                                                                                                                                                                                                                                               
  55--59   3                       1                         4           (2.1)                         11            13        24        (6.3)     6         7        13        (6.2)     31        20        51        (9.9)     12        11       23        (9.9)
  60--64   1                       1                         2           (1.0)                         9             11        20        (5.2)     5         5        10        (4.7)     29        32        61        (11.9)    14        8        22        (9.5)
  65--69   1                       1                         2           (1.0)                         6             6         12        (3.1)     4         5        9         (4.3)     29        15        44        (8.6)     7         9        16        (6.9)
  70--74   \-                      4                         4           (2.1)                         5             7         12        (3.1)     2         4        6         (2.8)     20        14        34        (6.6)     4         2        6         (2.6)
  75--79   2                       \-                        2           (1.0)                         2             3         5         (1.3)     \-        \-       \-        ( - )     11        12        23        (4.5)     2         2        4         (1.7)
                                                                                                                                                                                                                                                               
  80--84   \-                      1                         1           (0.5)                         \-            \-        \-        ( - )     \-        \-       \-        ( - )     7         2         9         (1.8)     1         1        2         (0.9)
  85--89   \-                      \-                        \-          ( - )                         \-            \-        \-        ( - )     \-        \-       \-        ( - )     3         \-        3         (0.6)     \-        \-       \-        ( - )
  90--94   \-                      \-                        \-          ( - )                         \-            \-        \-        ( - )     \-        \-       \-        ( - )     \-        \-        \-        ( - )     \-        \-       \-        ( - )
                                                                                                                                                                                                                                                               
  total    **94**                  **99**                    **193**     (100.0)                       **198**       **184**   **382**   (100.0)   **112**   **99**   **211**   (100.0)   **296**   **217**   **513**   (100.0)   **133**   **99**   **232**   (100.0)
                                                                                                                                                                                                                                                               
  mean     20.4                    22.9                      21.7        36.4                          39.2          37.8      41.7      42.6      42.2      49.5     49.0      49.3      48.2      48.5      48.3                                             

  age      Glioblastoma   Ependymoma   Anaplastic ependymoma   Ganglioglioma   Central neurocytoma                                                                                                                                    
  -------- -------------- ------------ ----------------------- --------------- --------------------- -------- -------- --------- -------- -------- -------- --------- -------- -------- -------- --------- -------- -------- -------- ---------
  0        1              2            3                       (0.2)           1                     \-       1        (1.3)     1        \-       1        (1.8)     \-       \-       \-       ( - )     \-       \-       \-       ( - )
  1        \-             \-           \-                      ( - )           2                     2        4        (5.1)     2        1        3        (5.5)     \-       1        1        (1.7)     \-       \-       \-       ( - )
  2        1              \-           1                       (0.1)           1                     1        2        (2.6)     2        2        4        (7.3)     \-       2        2        (3.3)     \-       \-       \-       ( - )
  3        \-             \-           \-                      ( - )           2                     \-       2        (2.6)     3        \-       3        (5.5)     \-       1        1        (1.7)     \-       \-       \-       ( - )
  4        \-             \-           \-                      ( - )           1                     1        2        (2.6)     2        2        4        (7.3)     \-       \-       \-       ( - )     \-       \-       \-       ( - )
                                                                                                                                                                                                                                      
  5--9     9              5            14                      (0.9)           7                     3        10       (12.8)    4        3        7        (12.7)    3        \-       3        (5.0)     \-       \-       \-       ( - )
  10--14   9              9            18                      (1.2)           2                     4        6        (7.7)     3        1        4        (7.3)     3        3        6        (10.0)    \-       \-       \-       ( - )
  15--19   8              6            14                      (0.9)           3                     4        7        (9.0)     \-       1        1        (1.8)     7        4        11       (18.3)    5        3        8        (12.3)
  20--24   15             9            24                      (1.6)           1                     1        2        (2.6)     2        1        3        (5.5)     7        1        8        (13.3)    12       4        16       (24.6)
  25--29   20             13           33                      (2.2)           2                     3        5        (6.4)     2        2        4        (7.3)     3        1        4        (6.7)     8        5        13       (20.0)
                                                                                                                                                                                                                                      
  30--34   17             17           34                      (2.3)           3                     \-       3        (3.9)     1        1        2        (3.6)     4        1        5        (8.3)     2        3        5        (7.7)
  35--39   35             16           51                      (3.4)           3                     2        5        (6.4)     1        2        3        (5.5)     \-       4        4        (6.7)     4        4        8        (12.3)
  40--44   39             21           60                      (4.0)           \-                    3        3        (3.9)     1        2        3        (5.5)     \-       3        3        (5.0)     4        3        7        (10.8)
  45--49   51             30           81                      (5.4)           2                     2        4        (5.1)     2        1        3        (5.5)     2        \-       2        (3.3)     \-       1        1        (1.5)
  50--54   86             63           149                     (10.0)          1                     2        3        (3.9)     1        1        2        (3.6)     1        3        4        (6.7)     \-       2        2        (3.1)
                                                                                                                                                                                                                                      
  55--59   106            66           172                     (11.6)          2                     7        9        (11.5)    1        \-       1        (1.8)     \-       1        1        (1.7)     1        1        2        (3.1)
  60--64   125            84           209                     (14.0)          6                     2        8        (10.3)    4        1        5        (9.1)     \-       1        1        (1.7)     3        \-       3        (4.6)
  65--69   150            103          253                     (17.0)          1                     \-       1        (1.3)     1        \-       1        (1.8)     \-       1        1        (1.7)     \-       \-       \-       ( - )
  70--74   119            83           202                     (13.6)          1                     \-       1        (1.3)     \-       \-       \-       ( - )     1        \-       1        (1.7)     \-       \-       \-       ( - )
  75--79   66             59           125                     (8.4)           \-                    \-       \-       ( - )     \-       \-       \-       ( - )     2        \-       2        (3.3)     \-       \-       \-       ( - )
                                                                                                                                                                                                                                      
  80--84   14             20           34                      (2.3)           \-                    \-       \-       ( - )     \-       \-       \-       ( - )     \-       \-       \-       ( - )     \-       \-       \-       ( - )
  85--89   8              2            10                      (0.7)           \-                    \-       \-       ( - )     \-       1        1        (1.8)     \-       \-       \-       ( - )     \-       \-       \-       ( - )
  90--94   1              1            2                       (0.1)           \-                    \-       \-       ( - )     \-       \-       \-       ( - )     \-       \-       \-       ( - )     \-       \-       \-       ( - )
                                                                                                                                                                                                                                      
  total    **880**        **609**      **1,489**               (100.0)         **41**                **37**   **78**   (100.0)   **33**   **22**   **55**   (100.0)   **33**   **27**   **60**   (100.0)   **39**   **26**   **65**   (100.0)
                                                                                                                                                                                                                                      
  mean     58.4           59.3         58.8                    29.4            32.1                  30.7     25.3     26.4      25.7     28.5     30.2     29.3      31.1     33.2     32.0                                          

  age      Medulloblastoma   Germinoma   PCNSL     GI Meningioma   GII Meningioma                                                                                                                                                
  -------- ----------------- ----------- --------- --------------- ---------------- -------- --------- --------- --------- --------- --------- --------- --------- ----------- ----------- --------- -------- -------- --------- ---------
  0        1                 \-          1         (1.0)           \-               \-       \-        ( - )     1         \-        1         (0.2)     1         5           6           (0.2)     \-       \-       \-        ( - )
  1        4                 3           7         (6.9)           \-               \-       \-        ( - )     \-        \-        \-        ( - )     \-        \-          \-          ( - )     \-       \-       \-        ( - )
  2        9                 2           11        (10.9)          \-               \-       \-        ( - )     \-        \-        \-        ( - )     1         \-          1           (0.0)     \-       \-       \-        ( - )
  3        2                 4           6         (5.9)           \-               \-       \-        ( - )     \-        \-        \-        ( - )     \-        \-          \-          ( - )     \-       \-       \-        ( - )
  4        7                 \-          7         (6.9)           1                \-       1         (0.4)     \-        \-        \-        ( - )     \-        \-          \-          ( - )     1        \-       1         (0.6)
                                                                                                                                                                                                                                 
  5--9     20                10          30        (29.7)          9                7        16        (6.8)     1         1         2         (0.4)     \-        3           3           (0.1)     4        \-       4         (2.3)
  10--14   10                10          20        (19.8)          48               14       62        (26.4)    1         1         2         (0.4)     5         7           12          (0.4)     \-       \-       \-        ( - )
  15--19   7                 2           9         (8.9)           56               9        65        (27.7)    3         \-        3         (0.6)     2         7           9           (0.3)     3        1        4         (2.3)
  20--24   3                 1           4         (4.0)           39               2        41        (17.5)    1         \-        1         (0.2)     11        14          25          (0.8)     1        3        4         (2.3)
  25--29   \-                \-          \-        ( - )           20               4        24        (10.2)    4         2         6         (1.3)     13        37          50          (1.6)     2        2        4         (2.3)
                                                                                                                                                                                                                                 
  30--34   1                 \-          1         (1.0)           15               \-       15        (6.4)     1         \-        1         (0.2)     20        32          52          (1.7)     3        3        6         (3.5)
  35--39   \-                \-          \-        ( - )           6                2        8         (3.4)     2         2         4         (0.8)     31        75          106         (3.5)     1        1        2         (1.2)
  40--44   2                 \-          2         (2.0)           1                \-       1         (0.4)     6         1         7         (1.5)     60        130         190         (6.2)     5        4        9         (5.2)
  45--49   \-                \-          \-        ( - )           \-               1        1         (0.4)     14        9         23        (4.8)     63        200         263         (8.6)     8        10       18        (10.4)
  50--54   \-                \-          \-        ( - )           1                \-       1         (0.4)     21        24        45        (9.5)     112       314         426         (13.9)    6        10       16        (9.3)
                                                                                                                                                                                                                                 
  55--59   \-                \-          \-        ( - )           \-               \-       \-        ( - )     26        24        50        (10.5)    112       326         438         (14.3)    6        10       16        (9.3)
  60--64   \-                3           3         (3.0)           \-               \-       \-        ( - )     42        27        69        (14.5)    106       347         453         (14.8)    6        9        15        (8.7)
  65--69   \-                \-          \-        ( - )           \-               \-       \-        ( - )     59        28        87        (18.3)    104       317         421         (13.7)    15       18       33        (19.1)
  70--74   \-                \-          \-        ( - )           \-               \-       \-        ( - )     51        25        76        (16.0)    106       225         331         (10.8)    11       8        19        (11.0)
  75--79   \-                \-          \-        ( - )           \-               \-       \-        ( - )     29        33        62        (13.1)    65        129         194         (6.3)     6        11       17        (9.8)
                                                                                                                                                                                                                                 
  80--84   \-                \-          \-        ( - )           \-               \-       \-        ( - )     11        17        28        (5.9)     20        38          58          (1.9)     1        4        5         (2.9)
  85--89   \-                \-          \-        ( - )           \-               \-       \-        ( - )     5         1         6         (1.3)     8         10          18          (0.6)     \-       \-       \-        ( - )
  90--94   \-                \-          \-        ( - )           \-               \-       \-        ( - )     \-        1         1         (0.2)     5         4           9           (0.3)     \-       \-       \-        ( - )
  95-      \-                \-          \-        ( - )           \-               \-       \-        ( - )     1         \-        1         (0.2)     \-        \-          \-          ( - )     \-       \-       \-        ( - )
                                                                                                                                                                                                                                 
  total    **66**            **35**      **101**   (100.0)         **196**          **39**   **235**   (100.0)   **279**   **196**   **475**   (100.0)   **845**   **2,220**   **3,065**   (100.0)   **79**   **94**   **173**   (100.0)
                                                                                                                                                                                                                                 
  mean     9.7               13.1        10.9      19.8            16.6             19.2     63.9      65.2      64.4      58.8      58.3      58.4      54.1      59.3        56.9                                              

  age      GIII Meningioma   Schwannoma   GH producing adenoma   PRL pituitary adenoma   ACTH pituitary adenoma                                                                                                                                                
  -------- ----------------- ------------ ---------------------- ----------------------- ------------------------ --------- ----------- --------- --------- --------- --------- --------- --------- --------- --------- --------- -------- --------- --------- ---------
  0        \-                \-           \-                     ( - )                   1                        3         4           (0.3)     \-        \-        \-        ( - )     \-        1         1         (0.2)     \-       \-        \-        ( - )
  1        \-                \-           \-                     ( - )                   \-                       \-        \-          ( - )     \-        \-        \-        ( - )     \-        \-        \-        ( - )     \-       \-        \-        ( - )
  2        \-                \-           \-                     ( - )                   \-                       \-        \-          ( - )     \-        \-        \-        ( - )     \-        \-        \-        ( - )     \-       \-        \-        ( - )
  3        \-                \-           \-                     ( - )                   \-                       \-        \-          ( - )     \-        \-        \-        ( - )     \-        \-        \-        ( - )     \-       \-        \-        ( - )
  4        \-                \-           \-                     ( - )                   \-                       \-        \-          ( - )     \-        \-        \-        ( - )     \-        \-        \-        ( - )     \-       \-        \-        ( - )
                                                                                                                                                                                                                                                               
  5--9     \-                \-           \-                     ( - )                   \-                       2         2           (0.2)     \-        \-        \-        ( - )     \-        \-        \-        ( - )     1        \-        1         (0.7)
  10--14   1                 \-           1                      (2.5)                   5                        3         8           (0.6)     2         3         5         (1.0)     2         \-        2         (0.4)     1        \-        1         (0.7)
  15--19   \-                1            1                      (2.5)                   8                        12        20          (1.5)     3         \-        3         (0.6)     5         32        37        (7.6)     \-       4         4         (2.9)
  20--24   \-                \-           \-                     ( - )                   9                        19        28          (2.1)     12        5         17        (3.5)     11        68        79        (16.2)    1        5         6         (4.3)
  25--29   1                 1            2                      (5.0)                   22                       27        49          (3.6)     20        13        33        (6.9)     12        107       119       (24.4)    1        7         8         (5.8)
                                                                                                                                                                                                                                                               
  30--34   \-                1            1                      (2.5)                   38                       43        81          (6.0)     22        22        44        (9.2)     24        67        91        (18.7)    6        12        18        (13.0)
  35--39   \-                \-           \-                     ( - )                   43                       60        103         (7.6)     31        15        46        (9.6)     16        29        45        (9.2)     5        11        16        (11.5)
  40--44   \-                1            1                      (2.5)                   61                       51        112         (8.3)     19        22        41        (8.5)     11        18        29        (6.0)     5        7         12        (8.6)
  45--49   1                 2            3                      (7.5)                   45                       81        126         (9.3)     22        27        49        (10.2)    10        6         16        (3.3)     2        9         11        (7.9)
  50--54   3                 5            8                      (20.0)                  83                       129       212         (15.7)    33        40        73        (15.2)    20        7         27        (5.5)     1        13        14        (10.1)
                                                                                                                                                                                                                                                               
  55--59   2                 3            5                      (12.5)                  79                       108       187         (13.8)    21        50        71        (14.8)    9         5         14        (2.9)     4        12        16        (11.5)
  60--64   2                 1            3                      (7.5)                   69                       85        154         (11.4)    15        28        43        (9.0)     9         2         11        (2.3)     5        12        17        (12.2)
  65--69   3                 3            6                      (15.0)                  53                       84        137         (10.1)    11        17        28        (5.8)     7         3         10        (2.1)     \-       6         6         (4.3)
  70--74   4                 2            6                      (15.0)                  38                       46        84          (6.2)     9         15        24        (5.0)     1         4         5         (1.0)     \-       7         7         (5.0)
  75--79   \-                2            2                      (5.0)                   15                       16        31          (2.3)     1         \-        1         (0.2)     \-        1         1         (0.2)     1        1         2         (1.4)
                                                                                                                                                                                                                                                               
  80--84   \-                1            1                      (2.5)                   1                        10        11          (0.8)     1         1         2         (0.4)     \-        \-        \-        ( - )     \-       \-        \-        ( - )
  85--89   \-                \-           \-                     ( - )                   2                        1         3           (0.2)     \-        \-        \-        ( - )     \-        \-        \-        ( - )     \-       \-        \-        ( - )
  90--94   \-                \-           \-                     ( - )                   \-                       \-        \-          ( - )     \-        \-        \-        ( - )     \-        \-        \-        ( - )     \-       \-        \-        ( - )
                                                                                                                                                                                                                                                               
  total    **17**            **23**       **40**                 (100.0)                 **572**                  **780**   **1,352**   (100.0)   **222**   **258**   **480**   (100.0)   **137**   **350**   **487**   (100.0)   **33**   **106**   **139**   (100.0)
                                                                                                                                                                                                                                                               
  mean     57.5              56.4         56.8                   51.7                    52.0                     51.9      45.4        50.7      48.2      41.7      30.5      33.7      43.0      47.3      46.3                                             

  age      NF pituitary adenoma   Craniopharyngioma   Chordoma    Hemangioblastoma   Epidermoid                                                                                                                                        
  -------- ---------------------- ------------------- ----------- ------------------ ------------ --------- --------- --------- -------- -------- -------- --------- -------- -------- --------- --------- -------- -------- --------- ---------
  0        2                      \-                  2           (0.1)              1            \-        1         (0.3)     \-       1        1        (1.7)     \-       \-       \-        ( - )     \-       1        1         (0.8)
  1        \-                     \-                  \-          ( - )              2            1         3         (0.9)     \-       \-       \-       ( - )     \-       \-       \-        ( - )     \-       \-       \-        ( - )
  2        \-                     \-                  \-          ( - )              1            2         3         (0.9)     \-       \-       \-       ( - )     \-       \-       \-        ( - )     \-       \-       \-        ( - )
  3        \-                     \-                  \-          ( - )              3            \-        3         (0.9)     \-       \-       \-       ( - )     \-       \-       \-        ( - )     \-       \-       \-        ( - )
  4        \-                     \-                  \-          ( - )              4            4         8         (2.4)     \-       \-       \-       ( - )     \-       \-       \-        ( - )     \-       \-       \-        ( - )
                                                                                                                                                                                                                                       
  5--9     \-                     \-                  \-          ( - )              15           12        27        (8.2)     \-       \-       \-       ( - )     \-       \-       \-        ( - )     2        1        3         (2.5)
  10--14   2                      3                   5           (0.4)              13           11        24        (7.3)     2        1        3        (5.2)     1        2        3         (1.6)     \-       2        2         (1.6)
  15--19   6                      5                   11          (0.8)              5            7         12        (3.6)     1        3        4        (6.9)     1        7        8         (4.3)     3        1        4         (3.3)
  20--24   7                      13                  20          (1.4)              7            8         15        (4.5)     \-       1        1        (1.7)     5        3        8         (4.3)     5        2        7         (5.7)
  25--29   11                     32                  43          (3.1)              5            7         12        (3.6)     5        1        6        (10.3)    13       9        22        (11.8)    6        5        11        (9.0)
                                                                                                                                                                                                                                       
  30--34   30                     28                  58          (4.1)              9            5         14        (4.2)     3        1        4        (6.9)     7        10       17        (9.1)     4        4        8         (6.6)
  35--39   42                     47                  89          (6.4)              16           5         21        (6.3)     3        1        4        (6.9)     7        4        11        (5.9)     5        4        9         (7.4)
  40--44   54                     50                  104         (7.4)              10           7         17        (5.1)     \-       \-       \-       ( - )     9        7        16        (8.6)     5        7        12        (9.8)
  45--49   57                     66                  123         (8.8)              17           8         25        (7.6)     3        3        6        (10.3)    6        7        13        (7.0)     5        5        10        (8.2)
  50--54   92                     97                  189         (13.5)             13           15        28        (8.5)     3        3        6        (10.3)    12       9        21        (11.2)    9        2        11        (9.0)
                                                                                                                                                                                                                                       
  55--59   109                    101                 210         (15.0)             12           15        27        (8.2)     4        \-       4        (6.9)     15       10       25        (13.4)    9        9        18        (14.8)
  60--64   92                     86                  178         (12.7)             17           16        33        (10.0)    6        1        7        (12.1)    3        6        9         (4.8)     7        5        12        (9.8)
  65--69   94                     84                  178         (12.7)             14           20        34        (10.3)    2        1        3        (5.2)     10       7        17        (9.1)     \-       9        9         (7.4)
  70--74   70                     58                  128         (9.1)              9            4         13        (3.9)     2        2        4        (6.9)     7        6        13        (7.0)     \-       4        4         (3.3)
  75--79   34                     20                  54          (3.6)              2            3         5         (1.5)     1        3        4        (6.9)     2        2        4         (2.1)     \-       1        1         (0.8)
                                                                                                                                                                                                                                       
  80--84   5                      3                   8           (0.6)              1            3         4         (1.2)     \-       \-       \-       ( - )     \-       \-       \-        ( - )     \-       \-       \-        ( - )
  85--89   2                      \-                  2           (0.1)              \-           2         2         (0.6)     \-       1        1        (1.7)     \-       \-       \-        ( - )     \-       \-       \-        ( - )
  90--94   \-                     \-                  \-          ( - )              \-           \-        \-        ( - )     \-       \-       \-       ( - )     \-       \-       \-        ( - )     \-       \-       \-        ( - )
  95-      \-                     \-                  \-          ( - )              \-           \-        \-        ( - )     \-       \-       \-       ( - )     \-       \-       \-        ( - )     \-       \-       \-        ( - )
                                                                                                                                                                                                                                       
  total    **709**                **693**             **1,402**   (100.0)            **176**      **155**   **331**   (100.0)   **35**   **23**   **58**   (100.0)   **98**   **89**   **187**   (100.0)   **60**   **62**   **122**   (100.0)
                                                                                                                                                                                                                                       
  mean     55.9                   53.6                54.8        40.2               43.1         41.5      47.1      46.7      46.9     47.5     45.5     46.6      42.5     47.5     45.0                                            

3). Initial symptoms {#S4.3}
--------------------

                           pt. no.   no clinical symptoms (medical check-up)   no clinical symptoms (detailed test of brain disease)   subjective symptoms (headache etc.)   seizure   focal symptom   intracranial hypertension   cons, disturbance   cranial nerve symptom   hormonal excess or hormonal decline   intracranial hemorrhage   cerebral infarction   others                                                                                    
  ------------------------ --------- ----------------------------------------- ------------------------------------------------------- ------------------------------------- --------- --------------- --------------------------- ------------------- ----------------------- ------------------------------------- ------------------------- --------------------- -------- ----- -------- ------- -------- ----- -------- ---- -------- ---- -------- ----- -------
  GI PA                    193       5                                         (3%)                                                    8                                     (4%)      68              (35%)                       23                  (12%)                   52                                    (27%)                     39                    (20%)    5     (3%)     24      (12%)    3     (2%)     \-   (-)      \-   (-)      17    (9%)
  GII DA                   382       13                                        (3%)                                                    19                                    (5%)      96              (25%)                       145                 (38%)                   95                                    (25%)                     19                    (5%)     19    (5%)     23      (6%)     3     (1%)     2    (1%)     \-   (-)      11    (3%)
  GII OL&OA                211       14                                        (7%)                                                    7                                     (3%)      38              (18%)                       126                 (60%)                   34                                    (16%)                     3                     (1%)     11    (5%)     1       (0.5%)   \-    (-)      \-   (-)      \-   (-)      4     (2%)
  GIII AA                  513       12                                        (2%)                                                    6                                     (1%)      105             (20%)                       146                 (28%)                   226                                   (44%)                     39                    (8%)     44    (9%)     30      (6%)     1     (0.2%)   2    (0.4%)   1    (0.2%)   32    (6%)
  GIII AO&AOA              232       9                                         (4%)                                                    2                                     (1%)      52              (22%)                       72                  (31%)                   78                                    (34%)                     21                    (9%)     10    (4%)     5       (2%)     1     (0.4%)   5    (2%)     \-   (-)      39    (17%)
  Glioblastoma             1,489     13                                        (1%)                                                    24                                    (2%)      398             (27%)                       195                 (13%)                   883                                   (59%)                     159                   (11%)    228   (15%)    60      (4%)     \-    (-)      17   (1%)     \-   (-)      77    (5%)
  Ependymoma               78        1                                         (1%)                                                    3                                     (4%)      36              (46%)                       6                   (8%)                    17                                    (22%)                     18                    (23%)    5     (6%)     11      (14%)    \-    (-)      \-   (-)      \-   (-)      2     (3%)
  AE                       55        \-                                        (-)                                                     1                                     (2%)      21              (38%)                       7                   (13%)                   24                                    (44%)                     18                    (33%)    7     (13%)    2       (4%)     \-    (-)      \-   (-)      \-   (-)      2     (4%)
  Ganglioglioma            60        6                                         (10%)                                                   5                                     (8%)      9               (15%)                       31                  (52%)                   10                                    (17%)                     2                     (3%)     3     (5%)     2       (3%)     \-    (-)      \-   (-)      \-   (-)      1     (2%)
  Central neurocytoma      65        5                                         (8%)                                                    3                                     (5%)      33              (51%)                       4                   (6%)                    5                                     (8%)                      23                    (35%)    8     (12%)    4       (6%)     \-    (-)      1    (2%)     \-   (-)      1     (2%)
  Medulloblastoma          101       \-                                        (-)                                                     \-                                    (-)       38              (38%)                       \-                  (-)                     29                                    (29%)                     61                    (60%)    4     (4%)     9       (9%)     1     (1%)     1    (1%)     \-   (-)      5     (5%)
  Germinoma                235       1                                         (0.4%)                                                  3                                     (1%)      82              (35%)                       4                   (2%)                    50                                    (21%)                     52                    (22%)    10    (4%)     39      (17%)    77    (33%)    \-   (-)      1    (0.4%)   11    (5%)
  PCNSL                    475       2                                         (0.4%)                                                  5                                     (1%)      96              (20%)                       25                  (5%)                    261                                   (55%)                     40                    (8%)     128   (27%)    35      (7%)     3     (1%)     \-   (-)      2    (0.4%)   31    (7%)
  GI Meningioma            3,065     400                                       (13%)                                                   307                                   (10%)     869             (28%)                       248                 (8%)                    636                                   (21%)                     114                   (4%)     84    (3%)     689     (22%)    4     (0.1%)   \-   (-)      3    (0.1%)   102   (3%)
  GII Meningioma           173       12                                        (7%)                                                    6                                     (3%)      60              (35%)                       22                  (13%)                   69                                    (40%)                     7                     (4%)     8     (5%)     25      (14%)    \-    (-)      \-   (-)      \-   (-)      12    (7%)
  GIII Meningioma          40        \-                                        (-)                                                     3                                     (8%)      11              (28%)                       6                   (15%)                   12                                    (30%)                     1                     (3%)     \-    (-)      8       (20%)    \-    (-)      1    (3%)     \-   (-)      5     (13%)
  Schwannoma               1,352     38                                        (3%)                                                    30                                    (2%)      219             (16%)                       2                   (0.1%)                  144                                   (11%)                     34                    (3%)     5     (0.4%)   1,010   (75%)    1     (0.1%)   \-   (-)      \-   (-)      34    (3%)
  GH pituitary adenoma     480       16                                        (3%)                                                    17                                    (4%)      51              (11%)                       \-                  (-)                     5                                     (1%)                      2                     (0.4%)   \-    (-)      35      (7%)     404   (84%)    2    (0.4%)   1    (0.2%)   16    (3%)
  PRL pituitary adenoma    487       10                                        (2%)                                                    4                                     (1%)      55              (11%)                       1                   (0.2%)                  15                                    (3%)                      3                     (1%)     4     (1%)     80      (16%)    360   (74%)    \-   (-)      \-   (-)      23    (5%)
  ACTH pituitary adenoma   139       3                                         (2%)                                                    1                                     (1%)      10              (7%)                        \-                  (-)                     \-                                    (-)                       1                     (1%)     1     (1%)     12      (9%)     122   (88%)    \-   (-)      \-   (-)      9     (6%)
  NF pituitary adenoma     1,402     105                                       (7%)                                                    97                                    (7%)      282             (20%)                       4                   (0.3%)                  114                                   (8%)                      5                     (0.4%)   20    (1%)     750     (53%)    160   (11%)    6    (0.4%)   1    (0.1%)   30    (2%)
  Craniopharyngioma        331       8                                         (2%)                                                    10                                    (3%)      89              (27%)                       3                   (1%)                    26                                    (8%)                      32                    (10%)    19    (6%)     151     (46%)    74    (22%)    \-   (-)      1    (0.3%)   10    (3%)
  Chordoma                 58        5                                         (9%)                                                    1                                     (2%)      10              (17%)                       \-                  (-)                     6                                     (10%)                     \-                    (-)      \-    (-)      39      (67%)    1     (2%)     \-   (-)      \-   (-)      3     (5%)
  Hemangioblastoma         187       11                                        (6%)                                                    13                                    (7%)      89              (48%)                       2                   (1%)                    71                                    (38%)                     21                    (11%)    5     (3%)     15      (8%)     \-    (-)      4    (2%)     \-   (-)      7     (4%)
  Epidermoid               122       9                                         (7%)                                                    2                                     (2%)      33              (27%)                       1                   (1%)                    14                                    (11%)                     1                     (1%)     2     (2%)     64      (52%)    \-    (-)      \-   (-)      \-   (-)      10    (8%)

4). Diagnostic methods {#S4.4}
----------------------

                           histology   diagnostic imaging   cerebrospinal fluid cytology diagnosis   blood or cerebrospinal fluid test   genetic diagnosis   autopsy   others   total                                                  
  ------------------------ ----------- -------------------- ---------------------------------------- ----------------------------------- ------------------- --------- -------- ------- ---- ----- ---- -------- ---- -------- ------- --------
  Pilocytic astrocytoma    190         (98%)                3                                        (2%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      193     (100%)
  GII DA                   359         (94%)                22                                       (6%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      1    (0.3%)   382     (100%)
  GII OL&OA                210         (100%)               1                                        (0.5%)                              \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      211     (100%)
  GIII AA                  501         (98%)                10                                       (2%)                                \-                  (-)       \-       (-)     \-   (-)   1    (0.2%)   1    (0.2%)   513     (100%)
  GIII AO&AOA              229         (99%)                3                                        (1%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      232     (100%)
  Glioblastoma             1,440       (97%)                49                                       (3%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      1,489   (100%)
  Ependymoma               76          (97%)                2                                        (3%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      78      (100%)
  Anaplastic ependymoma    55          (100%)               \-                                       (-)                                 \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      55      (100%)
  Ganglioglioma            57          (95%)                3                                        (5%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      60      (100%)
  Central neurocytoma      63          (97%)                2                                        (3%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      65      (100%)
  Medulloblastoma          101         (100%)               \-                                       (-)                                 \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      101     (100%)
  Germinoma                194         (83%)                26                                       (11%)                               1                   (0.4%)    14       (6%)    \-   (-)   \-   (-)      \-   (-)      235     (100%)
  PCNSL                    393         (83%)                65                                       (14%)                               7                   (1%)      4        (1%)    \-   (-)   2    (0.4%)   4    (1%)     475     (100%)
  GI Meningioma            2,760       (90%)                304                                      (10%)                               \-                  (-)       \-       (-)     \-   (-)   \-   (-)      1    (0.0%)   3,065   (100%)
  GII Meningioma           172         (99%)                1                                        (1%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      173     (100%)
  GIII Meningioma          40          (100%)               \-                                       (-)                                 \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      40      (100%)
  Schwannoma               1,213       (90%)                139                                      (10%)                               \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      1,352   (100%)
  GH pituitary adenoma     461         (96%)                9                                        (2%)                                \-                  (-)       10       (2.1)   \-   (-)   \-   (-)      \-   (-)      480     (100%)
  PRL pituitary adenoma    434         (89%)                32                                       (7%)                                \-                  (-)       19       (3.9)   \-   (-)   \-   (-)      2    (0.4%)   487     (100%)
  ACTH pituitary adenoma   132         (95%)                2                                        (1%)                                \-                  (-)       4        (2.9)   \-   (-)   \-   (-)      1    (1%)     139     (100%)
  NF pituitary adenoma     1,330       (95%)                51                                       (4%)                                \-                  (-)       21       (1.5)   \-   (-)   \-   (-)      \-   (-)      1,402   (100%)
  Craniopharyngioma        322         (97%)                9                                        (3%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      331     (100%)
  Chordoma                 56          (97%)                2                                        (3%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      58      (100%)
  Hemangioblastoma         183         (98%)                4                                        (2%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      \-   (-)      187     (100%)
  Epidermoid               118         (97%)                3                                        (2%)                                \-                  (-)       \-       (-)     \-   (-)   \-   (-)      1    (1%)     122     (100%)

5). Multiplicity {#S4.5}
----------------

                           single   multiple   dissemination   LMM      others   total                                        
  ------------------------ -------- ---------- --------------- -------- -------- -------- ---- -------- ---- -------- ------- --------
  Pilocytic astrocytoma    184      (95%)      7               (4%)     2        (1%)     \-   ( - )    \-   ( - )    193     (100%)
  GII DA                   361      (95%)      19              (5%)     \-       ( - )    1    (0.3%)   1    (0.3%)   382     (100%)
  GII OL&OA                208      (99%)      2               (1%)     \-       ( - )    \-   ( - )    1    (0.5%)   211     (100%)
  GIII AA                  473      (92%)      35              (7%)     3        (1%)     \-   ( - )    2    (0.4%)   513     (100%)
  GIII AO&AOA              222      (96%)      9               (4%)     1        (0.4%)   \-   ( - )    \-   ( - )    232     (100%)
  Glioblastoma             1,331    (89%)      139             (9%)     15       (1%)     1    (0.1%)   3    (0.2%)   1,489   (100%)
  Ependymoma               74       (95%)      3               (4%)     1        (1%)     \-   ( - )    \-   ( - )    78      (100%)
  Anaplastic ependymoma    52       (95%)      2               (4%)     1        (2%)     \-   ( - )    \-   ( - )    55      (100%)
  Ganglioglioma            58       (97%)      2               (3%)     \-       ( - )    \-   ( - )    \-   ( - )    60      (100%)
  Central neurocytoma      65       (100%)     \-              ( - )    \-       ( - )    \-   ( - )    \-   ( - )    65      (100%)
  Medulloblastoma          90       (89%)      5               (5%)     6        (6%)     \-   ( - )    \-   ( - )    101     (100%)
  Germinoma                165      (70%)      62              (26%)    6        (3%)     \-   ( - )    2    (1%)     235     (100%)
  PCNSL                    278      (59%)      176             (37%)    12       (3%)     1    (0.2%)   8    (2%)     475     (100%)
  GI Meningioma            2,958    (97%)      100             (3%)     \-       ( - )    \-   ( - )    7    (0.2%)   3,065   (100%)
  GII Meningioma           162      (94%)      10              (6%)     1        (1%)     \-   ( - )    \-   ( - )    173     (100%)
  GIII Meningioma          38       (95%)      1               (3%)     1        (3%)     \-   ( - )    \-   ( - )    40      (100%)
  Schwannoma               1,306    (97%)      43              (3%)     \-       ( - )    \-   ( - )    3    (0.2%)   1,352   (100%)
  GH pituitary adenoma     479      (100%)     \-              ( - )    \-       ( - )    \-   ( - )    1    (0.2%)   480     (100%)
  PRL pituitary adenoma    485      (100%)     \-              ( - )    \-       ( - )    \-   ( - )    2    (0.4%)   487     (100%)
  ACTH pituitary adenoma   139      (100%)     \-              ( - )    \-       ( - )    \-   ( - )    \-   ( - )    139     (100%)
  NF pituitary adenoma     1,401    (100%)     1               (0.1%)   \-       ( - )    \-   ( - )    \-   ( - )    1,402   (100%)
  Craniopharyngioma        331      (100%)     \-              ( - )    \-       ( - )    \-   ( - )    \-   ( - )    331     (100%)
  Chordoma                 58       (100%)     \-              ( - )    \-       ( - )    \-   ( - )    \-   ( - )    58      (100%)
  Hemangioblastoma         171      (91%)      16              (9%)     \-       ( - )    \-   ( - )    \-   ( - )    187     (100%)
  Epidermoid               122      (100%)     \-              ( - )    \-       ( - )    \-   ( - )    \-   ( - )    122     (100%)

6). Laterality {#S4.6}
--------------

                           right   left     across both sides   on both sides   central neuraxis   others   total                                                 
  ------------------------ ------- -------- ------------------- --------------- ------------------ -------- ------- ------- ------- ------- ---- -------- ------- --------
  Pilocytic astrocytoma    68      (35%)    50                  (26%)           25                 (13%)    2       (1%)    46      (24%)   2    (1%)     193     (100%)
  GII DA                   142     (37%)    174                 (46%)           24                 (6%)     10      (3%)    31      (8%)    1    (0.3%)   382     (100%)
  GII OL&OA                101     (48%)    106                 (50%)           4                  (2%)     \-      ( - )   \-      ( - )   \-   ( - )    211     (100%)
  GIII AA                  208     (41%)    207                 (40%)           44                 (9%)     20      (4%)    34      (7%)    \-   ( - )    513     (100%)
  GIII AO&AOA              116     (50%)    100                 (43%)           11                 (5%)     2       (1%)    3       (1%)    \-   ( - )    232     (100%)
  Glioblastoma             659     (44%)    646                 (43%)           116                (8%)     38      (3%)    28      (2%)    2    (0.1%)   1,489   (100%)
  Ependymoma               14      (18%)    15                  (19%)           8                  (10%)    \-      ( - )   39      (50%)   2    (3%)     78      (100%)
  Anaplastic ependymoma    23      (42%)    14                  (25%)           3                  (5%)     \-      ( - )   13      (24%)   2    (4%)     55      (100%)
  Ganglioglioma            24      (40%)    30                  (50%)           \-                 ( - )    \-      ( - )   6       (10%)   \-   ( - )    60      (100%)
  Central neurocytoma      23      (35%)    22                  (34%)           9                  (14%)    \-      ( - )   11      (17%)   \-   ( - )    65      (100%)
  Medulloblastoma          4       (4%)     7                   (7%)            11                 (11%)    4       (4%)    74      (73%)   1    (1%)     101     (100%)
  Germinoma                11      (5%)     12                  (5%)            22                 (9%)     14      (6%)    171     (73%)   5    (2%)     235     (100%)
  PCNSL                    148     (31%)    145                 (31%)           60                 (13%)    83      (17%)   32      (7%)    7    (1%)     475     (100%)
  GI Meningioma            1,201   (39%)    1,319               (43%)           224                (7%)     33      (1%)    271     (9%)    17   (1%)     3,065   (100%)
  GII Meningioma           70      (40%)    85                  (49%)           9                  (5%)     3       (2%)    5       (3%)    1    (1%)     173     (100%)
  GIII Meningioma          22      (55%)    11                  (28%)           3                  (8%)     1       (3%)    3       (8%)    \-   ( - )    40      (100%)
  Schwannoma               642     (47%)    658                 (49%)           6                  (0.4%)   25      (2%)    13      (1%)    8    (1%)     1,352   (100%)
  GH pituitary adenoma     1       (0.2%)   6                   (1%)            10                 (2%)     \-      ( - )   459     (96%)   4    (1%)     480     (100%)
  PRL pituitary adenoma    8       (2%)     7                   (1%)            13                 (3%)     \-      ( - )   459     (94%)   \-   ( - )    487     (100%)
  ACTH pituitary adenoma   5       (4%)     3                   (2%)            3                  (2%)     \-      ( - )   127     (91%)   1    (1%)     139     (100%)
  NF pituitary adenoma     6       (0.4%)   1                   (0.1%)          38                 (3%)     \-      ( - )   1,345   (96%)   12   (1%)     1,402   (100%)
  Craniopharyngioma        1       (0.3%)   2                   (1%)            11                 (3%)     \-      ( - )   316     (95%)   1    (0.3%)   331     (100%)
  Chordoma                 1       (2%)     6                   (10%)           10                 (17%)    \-      ( - )   39      (67%)   2    (3%)     58      (100%)
  Hemangioblastoma         68      (36%)    65                  (35%)           9                  (5%)     11      (6%)    30      (16%)   4    (2%)     187     (100%)
  Epidermoid               55      (45%)    53                  (43%)           5                  (4%)     \-      ( - )   9       (7%)    \-   ( - )    122     (100%)

7). Tumor location of each top 25 tumors {#S4.7}
----------------------------------------

                             GI PA   GII DA   GII OL&OA   GIII AA   GIII AO&AOA   GBM      Ependymoma   AE       Ganglioglioma   Central neurocytoma   Medulloblastoma   Germinoma   PCNSL                                                                                    
  -------------------------- ------- -------- ----------- --------- ------------- -------- ------------ -------- --------------- --------------------- ----------------- ----------- ------- ------- ---- ------- ---- ------- ---- ------- ---- ------- ----- -------- ----- --------
  frontal lobe               12      (6%)     157         (41%)     144           (68%)    195          (38%)    145             (63%)                 541               (36%)       3       (4%)    7    (13%)   11   (18%)   2    (3%)    1    (1%)    1     (0.4%)   192   (40%)
  temporal lobe              15      (8%)     66          (17%)     30            (14%)    106          (21%)    42              (18%)                 436               (29%)       2       (3%)    6    (11%)   20   (33%)   4    (6%)    1    (1%)    \-    (-)      89    (19%)
  parietal lobe              3       (2%)     27          (7%)      21            (10%)    52           (10%)    29              (13%)                 249               (17%)       5       (6%)    9    (16%)   9    (15%)   \-   (-)     1    (1%)    \-    (-)      67    (14%)
  occipital lobe             6       (3%)     8           (2%)      5             (2%)     14           (3%)     6               (3%)                  87                (6%)        3       (4%)    6    (11%)   5    (8%)    1    (2%)    \-   (-)     \-    (-)      41    (9%)
  insular gyri               1       (1%)     23          (6%)      5             (2%)     15           (3%)     7               (3%)                  24                (2%)        \-      (-)     \-   (-)     1    (2%)    \-   (-)     \-   (-)     \-    (-)      2     (0.4%)
  gliomatosis cerebri        \-      (-)      2           (1%)      1             (0.5%)   4            (1%)     \-              (-)                   4                 (0.3%)      \-      (-)     \-   (-)     \-   (-)     \-   (-)     \-   (-)     \-    (-)      \-    (-)
  cerebellum                 69      (36%)    15          (4%)      \-            (-)      23           (4%)     3               (1%)                  42                (3%)        6       (8%)    7    (13%)   6    (10%)   \-   (-)     57   (56%)   2     (1%)     35    (7%)
  midbrain                   5       (3%)     12          (3%)      \-            (-)      9            (2%)     \-              (-)                   10                (1%)        1       (1%)    \-   (-)     2    (3%)    \-   (-)     \-   (-)     3     (1%)     18    (4%)
  pons                       4       (2%)     25          (7%)      \-            (-)      26           (5%)     1               (0%)                  16                (1%)        \-      (-)     \-   (-)     1    (2%)    \-   (-)     \-   (-)     \-    (-)      10    (2%)
  medulla oblongata          7       (4%)     5           (1%)      \-            (-)      7            (1%)     \-              (-)                   3                 (0.2%)      5       (6%)    \-   (-)     3    (5%)    \-   (-)     \-   (-)     5     (2%)     1     (0%)
  lateral ventricle          8       (4%)     9           (2%)      3             (1%)     7            (1%)     2               (1%)                  25                (2%)        8       (10%)   5    (9%)    1    (2%)    58   (89%)   \-   (-)     21    (9%)     32    (7%)
  third ventricle            6       (3%)     5           (1%)      \-            (-)      1            (0.2%)   1               (0.4%)                3                 (0.2%)      2       (3%)    1    (2%)    \-   (-)     \-   (-)     1    (1%)    20    (9%)     9     (2%)
  cerebral aqueduct          3       (2%)     \-          (-)       \-            (-)      \-           (-)      \-              (-)                   \-                (-)         \-      (-)     \-   (-)     \-   (-)     \-   (-)     \-   (-)     \-    (-)      \-    (-)
  fourth ventricle           4       (2%)     2           (1%)      \-            (-)      6            (1%)     \-              (-)                   1                 (0.1%)      40      (51%)   12   (22%)   \-   (-)     \-   (-)     45   (45%)   3     (1%)     6     (1%)
  basal ganglia              8       (4%)     13          (3%)      \-            (-)      24           (5%)     1               (0.4%)                54                (4%)        \-      (-)     \-   (-)     3    (5%)    \-   (-)     \-   (-)     23    (10%)    83    (17%)
  thalamus · hypothalamus    23      (12%)    25          (7%)      2             (1%)     39           (8%)     2               (1%)                  55                (4%)        1       (1%)    1    (2%)    1    (2%)    \-   (-)     \-   (-)     42    (18%)    35    (7%)
  corpus callosum            2       (1%)     3           (1%)      1             (0.5%)   9            (2%)     3               (1%)                  54                (4%)        \-      (-)     \-   (-)     \-   (-)     \-   (-)     \-   (-)     6     (3%)     53    (11%)
  pineal region              \-      (-)      1           (0.3%)    \-            (-)      6            (1%)     \-              (-)                   4                 (0.3%)      1       (1%)    \-   (-)     \-   (-)     \-   (-)     1    (1%)    133   (57%)    3     (1%)
  intraorbital               1       (1%)     \-          (-)       \-            (-)      \-           (-)      \-              (-)                   \-                (-)         \-      (-)     \-   (-)     \-   (-)     \-   (-)     \-   (-)     \-    (-)      13    (3%)
  pituitary gland            \-      (-)      1           (0.3%)    \-            (-)      \-           (-)      \-              (-)                   1                 (0.1%)      \-      (-)     \-   (-)     \-   (-)     \-   (-)     \-   (-)     42    (18%)    5     (1%)
  optic nerve                19      (10%)    2           (1%)      \-            (-)      2            (0.4%)   \-              (-)                   3                 (0.2%)      \-      (-)     \-   (-)     \-   (-)     \-   (-)     \-   (-)     2     (1%)     \-    (-)
  cerebello-pontine angle    1       (1%)     1           (0.3%)    1             (0.5%)   7            (1%)     \-              (-)                   1                 (0.1%)      3       (4%)    \-   (-)     \-   (-)     \-   (-)     1    (1%)    1     (0.4%)   2     (0.4%)
  clivus                     \-      (-)      \-          (-)       \-            (-)      \-           (-)      \-              (-)                   \-                (-)         \-      (-)     \-   (-)     \-   (-)     \-   (-)     \-   (-)     \-    (-)      \-    (-)
  cavernous sinus            \-      (-)      \-          (-)       \-            (-)      \-           (-)      \-              (-)                   \-                (-)         \-      (-)     \-   (-)     \-   (-)     \-   (-)     1    (1%)    \-    (-)      2     (0.4%)
  cranial nerve              \-      (-)      \-          (-)       \-            (-)      \-           (-)      \-              (-)                   \-                (-)         \-      (-)     \-   (-)     \-   (-)     \-   (-)     \-   (-)     \-    (-)      \-    (-)
  other skull base           1       (1%)     \-          (-)       \-            (-)      \-           (-)      \-              (-)                   2                 (0.1%)      \-      (-)     \-   (-)     \-   (-)     \-   (-)     \-   (-)     5     (2%)     \-    (-)
  skull bone                 \-      (-)      \-          (-)       \-            (-)      \-           (-)      \-              (-)                   \-                (-)         \-      (-)     \-   (-)     \-   (-)     \-   (-)     \-   (-)     \-    (-)      \-    (-)
  carcinomatous meningitis   1       (1%)     1           (0.3%)    \-            (-)      \-           (-)      \-              (-)                   2                 (0.1%)      \-      (-)     \-   (-)     \-   (-)     \-   (-)     1    (1%)    \-    (-)      5     (1%)
  others                     \-      (-)      3           (1%)      \-            (-)      4            (1%)     \-              (-)                   10                (1%)        2       (3%)    1    (2%)    \-   (-)     \-   (-)     1    (1%)    8     (3%)     14    (3%)

                             GI Meningioma   GII Meningioma   GIII Meningioma   Schwannoma   GH pituitary adenoma   PRL pituitary adenoma   ACTH pituitary adenoma   NF pituitary adenoma   Craniopharyngioma   Chordoma   Hemangioblastoma   Epidermoid                                                                                
  -------------------------- --------------- ---------------- ----------------- ------------ ---------------------- ----------------------- ------------------------ ---------------------- ------------------- ---------- ------------------ ------------ ----- ------ ------- -------- ----- -------- ---- ------- ----- ------- ---- -------
  frontal lobe               989             (32%)            66                (38%)        14                     (35%)                   1                        (0.1%)                 \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      1     (0.3%)   \-   (-)     1     (1%)    2    (2%)
  temporal lobe              185             (6%)             24                (14%)        2                      (5%)                    7                        (1%)                   \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     \-    (-)     1    (1%)
  parietal lobe              271             (9%)             24                (14%)        1                      (3%)                    \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     \-    (-)     \-   (-)
  occipital lobe             98              (3%)             6                 (3%)         3                      (8%)                    1                        (0.1%)                 \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     2     (1%)    \-   (-)
  insular gyri               \-              (-)              \-                (-)          \-                     (-)                     \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     \-    (-)     \-   (-)
  gliomatosis cerebri        \-              (-)              \-                (-)          \-                     (-)                     \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     \-    (-)     \-   (-)
  cerebellum                 124             (4%)             4                 (2%)         3                      (8%)                    5                        (0.4%)                 \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      1     (0.3%)   \-   (-)     165   (88%)   5    (4%)
  midbrain                   1               (0.0%)           \-                (-)          \-                     (-)                     \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     2     (1%)    1    (1%)
  pons                       3               (0.1%)           \-                (-)          1                      (3%)                    2                        (0.1%)                 \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     4     (2%)    \-   (-)
  medulla oblongata          4               (0.1%)           \-                (-)          \-                     (-)                     2                        (0.1%)                 \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     12    (6%)    1    (1%)
  lateral ventricle          47              (2%)             5                 (3%)         3                      (8%)                    2                        (0.1%)                 \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     \-    (-)     1    (1%)
  third ventricle            4               (0.1%)           \-                (-)          1                      (3%)                    \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    2       (0.1%)   67    (20%)    \-   (-)     \-    (-)     1    (1%)
  cerebral aqueduct          \-              (-)              \-                (-)          \-                     (-)                     \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     \-    (-)     \-   (-)
  fourth ventricle           3               (0.1%)           \-                (-)          \-                     (-)                     \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     5     (3%)    6    (5%)
  basal ganglia              1               (0.0%)           \-                (-)          \-                     (-)                     \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     \-    (-)     \-   (-)
  thalamus · hypothalamus    8               (0.3%)           1                 (1%)         \-                     (-)                     \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      66    (20%)    \-   (-)     \-    (-)     1    (1%)
  corpus callosum            3               (0.1%)           \-                (-)          \-                     (-)                     \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     \-    (-)     \-   (-)
  pineal region              6               (0.2%)           \-                (-)          \-                     (-)                     \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      1     (0.3%)   \-   (-)     1     (1%)    \-   (-)
  intraorbital               21              (1%)             1                 (1%)         1                      (3%)                    13                       (1%)                   \-                  (-)        \-                 (-)          \-    (-)    1       (0.1%)   \-    (-)      \-   (-)     \-    (-)     1    (1%)
  pituitary gland            33              (1%)             \-                (-)          1                      (3%)                    \-                       (-)                    480                 (100%)     486                (100%)       138   99%)   1,397   (100%)   174   (53%)    \-   (-)     \-    (-)     1    (1%)
  optic nerve                16              (1%)             \-                (-)          \-                     (-)                     2                        (0.1%)                 \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     \-    (-)     \-   (-)
  cerebello-pontine angle    299             (10%)            6                 (3%)         3                      (8%)                    1,047                    (77%)                  \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     3     (2%)    83   (68%)
  clivus                     132             (4%)             2                 (1%)         \-                     (-)                     1                        (0.1%)                 \-                  (-)        \-                 (-)          1     (1%)   2       (0.1%)   1     (0.3%)   46   (79%)   \-    (-)     1    (1%)
  cavernous sinus            53              (2%)             2                 (1%)         1                      (3%)                    15                       (1%)                   \-                  (-)        \-                 (-)          \-    (-)    1       (0.1%)   \-    (-)      3    (5%)    \-    (-)     \-   (-)
  cranial nerve              7               (0.2%)           \-                (-)          \-                     (-)                     185                      (14%)                  \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     \-    (-)     \-   (-)
  other skull base           550             (18%)            22                (13%)        5                      (13%)                   54                       (4%)                   \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      17    (5%)     7    (12%)   \-    (-)     7    (6%)
  skull bone                 13              (0.4%)           2                 (1%)         \-                     (-)                     \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      1    (2%)    \-    (-)     5    (4%)
  carcinomatous meningitis   \-              (-)              \-                (-)          \-                     (-)                     \-                       (-)                    \-                  (-)        \-                 (-)          \-    (-)    \-      (-)      \-    (-)      \-   (-)     \-    (-)     \-   (-)
  others                     257             (8%)             13                (8%)         5                      (13%)                   29                       (2%)                   \-                  (-)        1                  (0.2%)       \-    (-)    \-      (-)      3     (1%)     1    (2%)    4     (2%)    5    (4%)

8). Ranking of top 25 tumors depending on original region {#S4.8}
---------------------------------------------------------

  number of region          1       2                      3       4        5                                                                                                                                             
  ------------------------- ------- ---------------------- ------- -------- ----------------------- ----- ------- ----------------------- ----- ------- ------------------- ----- -------- ------------------------ ----- -------
  frontal lobe              2,485   GI Meningioma          989     (40%)    Glioblastoma            541   (22%)   GIII AA                 195   (8%)    PCNSL               192   (8%)     GII DA                   157   (6%)
  temporal lobe             1,036   Glioblastoma           436     (42%)    GI Meningioma           185   (18%)   GIII AA                 106   (10%)   PCNSL               89    (9%)     GII DA                   66    (6%)
  parietal lobe             768     GI Meningioma          271     (35%)    Glioblastoma            249   (32%)   PCNSL                   67    (9%)    GIII AA             52    (7%)     GIII AO&AOA              29    (4%)
  occipital lobe            292     GI Meningioma          98      (34%)    Glioblastoma            87    (30%)   PCNSL                   41    (14%)   GIII AA             14    (5%)     GII DA                   8     (3%)
  insular gyri              78      Glioblastoma           24      (31%)    GII DA                  23    (29%)   GIII AA                 15    (19%)   GIII AO&AOA         7     (9%)     GII OL&OA                5     (6%)
  gliomatosis cerebri       11      GIII AA                4       (36%)    Glioblastoma            4     (36%)   GII DA                  2     (18%)   GII OL&OA           1     (9%)                              \-    (-)
  cerebellum                572     Hemangioblastoma       165     (29%)    GI Meningioma           124   (22%)   GI PA                   69    (12%)   Medulloblastoma     57    (10%)    Glioblastoma             42    (7%)
  midbrain                  64      PCNSL                  18      (28%)    GII DA                  12    (19%)   Glioblastoma            10    (16%)   GIII AA             9     (14%)    GI PA                    5     (8%)
  pons                      93      GIII AA                26      (28%)    GII DA                  25    (27%)   Glioblastoma            16    (17%)   PCNSL               10    (11%)    GI PA                    4     (4%)
  medulla oblongata         55      Hemangioblastoma       12      (22%)    GI PA                   7     (13%)   GIII AA                 7     (13%)   GII DA              5     (9%)     Ependymoma               5     (9%)
  lateral ventricle         237     Central neurocytoma    58      (24%)    GI Meningioma           47    (20%)   PCNSL                   32    (14%)   Glioblastoma        25    (11%)    Germinoma                21    (9%)
  third ventricle           124     Craniopharyngioma      67      (54%)    Germinoma               20    (16%)   PCNSL                   9     (7%)    GI PA               6     (5%)     GII DA                   5     (4%)
  cerebral aqueduct         3       GI PA                  3       (100%)                           \-    (-)                             \-    (-)                         \-    (-)                               \-    (-)
  fourth ventricle          133     Medulloblastoma        45      (34%)    Ependymoma              40    (30%)   Anaplastic ependymoma   12    (9%)    GIII AA             6     (5%)     PCNSL                    6     (5%)
  basal ganglia             210     PCNSL                  83      (40%)    Glioblastoma            54    (26%)   GIII AA                 24    (11%)   Germinoma           23    (11%)    GII DA                   13    (6%)
  thalamus • hypothalamus   302     Craniopharyngioma      66      (22%)    Glioblastoma            55    (18%)   Germinoma               42    (14%)   GIII AA             39    (13%)    PCNSL                    35    (12%)
  corpus callosum           134     Glioblastoma           54      (40%)    PCNSL                   53    (40%)   GIII AA                 9     (7%)    Germinoma           6     (4%)     GII DA                   3     (2%)
  pineal region             157     Germinoma              133     (85%)    GIII AA                 6     (4%)    GI Meningioma           6     (4%)    Glioblastoma        4     (3%)     PCNSL                    3     (2%)
  intraorbital              52      GI Meningioma          21      (40%)    PCNSL                   13    (25%)   Schwannoma              13    (25%)   GI PA               1     (2%)     GII Meningioma           1     (2%)
  pituitary gland           2,759   NF pituitary adenoma   1,397   (51%)    PRL pituitary adenoma   486   (18%)   GH pituitary adenoma    480   (17%)   Craniopharyngioma   174   (6%)     ACTH pituitary adenoma   138   (5%)
  optic nerve               46      GI PA                  19      (41%)    GI Meningioma           16    (35%)   Glioblastoma            3     (7%)    GII DA              2     (4%)     GIII AA                  2     (4%)
  cerebello-pontine angle   1,459   Schwannoma             1047    (72%)    GI Meningioma           299   (20%)   Epidermoid              83    (6%)    GIII AA             7     (0.5%)   GII Meningioma           6     (0%)
  clivus                    186     GI Meningioma          132     (71%)    Chordoma                46    (25%)   GII Meningioma          2     (1%)    NF adenoma          2     (1%)     Schwannoma               1     (1%)
  cavernous sinus           78      GI Meningioma          53      (68%)    Schwannoma              15    (19%)   Chordoma                3     (4%)    PCNSL               2     (3%)     GII Meningioma           2     (3%)
  cranial nerve             192     Schwannoma             185     (96%)    GI Meningioma           7     (4%)                            \-    (-)                         \-    (-)                               \-    (-)
  other skull base          670     GI Meningioma          550     (82%)    Schwannoma              54    (8%)    GII Meningioma          22    (3%)    Craniopharyngioma   17    (3%)     Chordoma                 7     (1%)
  skull bone                21      GI Meningioma          13      (62%)    Epidermoid              5     (24%)   GII Meningioma          2     (10%)   Chordoma            1     (5%)                              \-    (-)
  LMM                       10      PCNSL                  5       (50%)    Glioblastoma            2     (20%)   GI PA                   1     (10%)   GII DA              1     (10%)    Medulloblastoma          1     (10%)

9). Tumor origin of meningiomas {#S4.9}
-------------------------------

                         ALL Meningioma   GI Meningioma   GII Meningioma   GIII Meningioma                       
  ---------------------- ---------------- --------------- ---------------- ----------------- ----- -------- ---- --------
  convexity              807              (25%)           744              (24%)             52    (30%)    11   (28%)
  parasagittal           361              (11%)           318              (10%)             35    (20%)    8    (20%)
  falx                   309              (9%)            291              (9%)              18    (10%)    \-   ( - )
  sphenoid ridge         347              (11%)           324              (11%)             19    (11%)    4    (10%)
  olfactory              147              (4%)            145              (5%)              2     (1%)     \-   ( - )
  tuberculum sellae      250              (8%)            247              (8%)              3     (2%)     \-   ( - )
  planum sphenoidale     60               (2%)            58               (2%)              2     (1%)     \-   ( - )
  middle fossa           93               (3%)            77               (3%)              14    (8%)     2    (5%)
  ventricle              62               (2%)            53               (2%)              6     (3%)     3    (8%)
  cavernous sinus        61               (2%)            59               (2%)              1     (1%)     1    (3%)
  CP angle               261              (8%)            253              (8%)              6     (3%)     2    (5%)
  tentorium              187              (6%)            173              (6%)              9     (5%)     5    (13%)
  clivus/petroclivus     197              (6%)            195              (6%)              2     (1%)     \-   ( - )
  cerebellar convexity   55               (2%)            52               (2%)              1     (1%)     2    (5%)
  foramen magnum         37               (1%)            35               (1%)              2     (1%)     \-   ( - )
  optic sheath           30               (1%)            28               (1%)              1     (1%)     1    (3%)
  others                 107              (3%)            96               (3%)              7     (4%)     4    (10%)
                                                                                                                 
  patient number         3,278            (100%)          3,065            (100%)            173   (100%)   40   (100%)

10). Initial KPS before treatment {#S4.10}
---------------------------------

  Histology/KPS            0    10       20   30       40   50       60   70       80   90       100   unknown   total                                                                                           
  ------------------------ ---- -------- ---- -------- ---- -------- ---- -------- ---- -------- ----- --------- ------- ------- ----- ------- ----- ------- ----- ------- ------- ------- ----- ------- ------- --------
  Pilocytic astrocytoma    \-   ( - )    \-   ( - )    1    (1%)     2    (1%)     5    (3%)     6     (3%)      17      (9%)    22    (11%)   28    (15%)   45    (23%)   56      (29%)   11    (6%)    193     (100%)
  GII DA                   \-   ( - )    1    (0.3%)   2    (1%)     2    (1%)     4    (1%)     11    (3%)      16      (4%)    14    (4%)    51    (13%)   100   (26%)   150     (39%)   31    (8%)    382     (100%)
  GII OL&OA                \-   ( - )    2    (1%)     1    (0.5%)   \-   ( - )    3    (1%)     2     (1%)      2       (1%)    8     (4%)    18    (9%)    59    (28%)   110     (52%)   6     (3%)    211     (100%)
  GIII AA                  1    (0.2%)   1    (0.2%)   3    (1%)     3    (1%)     23   (4%)     23    (4%)      46      (9%)    72    (14%)   114   (22%)   120   (23%)   82      (16%)   25    (5%)    513     (100%)
  GIII AO&AOA              \-   ( - )    3    (1%)     1    (0.4%)   \-   ( - )    3    (1%)     8     (3%)      16      (7%)    14    (6%)    39    (17%)   59    (25%)   74      (32%)   15    (6%)    232     (100%)
  Glioblastoma             \-   ( - )    11   (1%)     26   (2%)     31   (2%)     88   (6%)     144   (10%)     206     (14%)   224   (15%)   279   (19%)   266   (18%)   106     (7%)    108   (7%)    1,489   (100%)
  Ependymoma               1    (1%)     1    (1%)     1    (1%)     \-   ( - )    2    (3%)     2     (3%)      2       (3%)    7     (9%)    16    (21%)   27    (35%)   17      (22%)   2     (3%)    78      (100%)
  Anaplastic ependymoma    \-   ( - )    \-   ( - )    2    (4%)     1    (2%)     6    (11%)    3     (5%)      7       (13%)   6     (11%)   12    (22%)   12    (22%)   4       (7%)    2     (4%)    55      (100%)
  Ganglioglioma            \-   ( - )    \-   ( - )    \-   ( - )    \-   ( - )    1    (2%)     2     (3%)      2       (3%)    2     (3%)    9     (15%)   17    (28%)   25      (42%)   2     (3%)    60      (100%)
  Central neurocytoma      \-   ( - )    \-   ( - )    \-   ( - )    \-   ( - )    2    (3%)     2     (3%)      4       (6%)    3     (5%)    11    (17%)   18    (28%)   21      (32%)   4     (6%)    65      (100%)
  Medulloblastoma          \-   ( - )    1    (1%)     3    (3%)     4    (4%)     8    (8%)     8     (8%)      8       (8%)    12    (12%)   13    (13%)   18    (18%)   9       (9%)    17    (17%)   101     (100%)
  Germinoma                \-   ( - )    1    (0.4%)   2    (1%)     \-   ( - )    8    (3%)     11    (5%)      16      (7%)    25    (11%)   53    (23%)   68    (29%)   38      (16%)   13    (6%)    235     (100%)
  PCNSL                    \-   ( - )    2    (0.4%)   9    (2%)     16   (3%)     43   (9%)     71    (15%)     73      (15%)   62    (13%)   82    (17%)   57    (12%)   16      (3%)    44    (9%)    475     (100%)
  GI Meningioma            9    (0.3%)   2    (0.1%)   9    (0.3%)   10   (0.3%)   21   (1%)     74    (2%)      91      (3%)    129   (4%)    398   (13%)   910   (30%)   1,221   (40%)   191   (6%)    3,065   (100%)
  GII Meningioma           \-   ( - )    4    (2%)     1    (1%)     3    (2%)     3    (2%)     9     (5%)      14      (8%)    13    (8%)    39    (23%)   40    (23%)   39      (23%)   8     (5%)    173     (100%)
  GIII Meningioma          \-   ( - )    \-   ( - )    1    (3%)     \-   ( - )    \-   ( - )    3     (8%)      1       (3%)    3     (8%)    10    (25%)   11    (28%)   10      (25%)   1     (3%)    40      (100%)
  Schwannoma               \-   ( - )    2    (0.1%)   3    (0.2%)   1    (0.1%)   5    (0.4%)   7     (1%)      36      (3%)    44    (3%)    183   (14%)   651   (48%)   363     (27%)   57    (4%)    1,352   (100%)
  GH pituitary adenoma     1    (0.2%)   \-   ( - )    \-   ( - )    \-   ( - )    1    (0.2%)   \-    ( - )     4       (1%)    15    (3%)    44    (9%)    201   (42%)   201     (42%)   13    (3%)    480     (100%)
  PRL pituitary adenoma    \-   ( - )    \-   ( - )    \-   ( - )    \-   ( - )    2    (0.4%)   2     (0.4%)    4       (1%)    7     (1%)    47    (10%)   207   (43%)   209     (43%)   9     (2%)    487     (100%)
  ACTH pituitary adenoma   \-   ( - )    \-   ( - )    \-   ( - )    1    (1%)     1    (1%)     3     (2%)      3       (2%)    22    (16%)   23    (17%)   45    (32%)   38      (27%)   3     (2%)    139     (100%)
  NF pituitary adenoma     \-   ( - )    \-   ( - )    \-   ( - )    3    (0.2%)   7    (0.5%)   15    (1%)      18      (1%)    64    (5%)    196   (14%)   561   (40%)   500     (36%)   38    (3%)    1,402   (100%)
  Craniopharyngioma        1    (0.3%)   \-   ( - )    2    (1%)     \-   ( - )    8    (2%)     10    (3%)      24      (7%)    31    (9%)    68    (21%)   105   (32%)   68      (21%)   14    (4%)    331     (100%)
  Chordoma                 \-   ( - )    \-   ( - )    \-   ( - )    \-   ( - )    \-   ( - )    2     (3%)      2       (3%)    5     (9%)    11    (19%)   26    (45%)   7       (12%)   5     (9%)    58      (100%)
  Hemangioblastoma         1    (1%)     2    (1%)     1    (1%)     1    (1%)     6    (3%)     4     (2%)      10      (5%)    7     (4%)    36    (19%)   64    (34%)   46      (25%)   9     (5%)    187     (100%)
  Epidermoid               \-   ( - )    \-   ( - )    \-   ( - )    \-   ( - )    1    (1%)     \-    ( - )     1       (1%)    8     (7%)    17    (14%)   57    (47%)   31      (25%)   7     (6%)    122     (100%)

11). KPS after initial treatment {#S4.11}
--------------------------------

  Histology/KPS            0    10       20   30       40   50       60   70       80    90       100   unknown   total                                                                                            
  ------------------------ ---- -------- ---- -------- ---- -------- ---- -------- ----- -------- ----- --------- ------- -------- ----- ------- ----- ------- ----- ------- ------- ------- ----- ------- ------- --------
  Pilocytic astrocytoma    \-   ( - )    \-   ( - )    1    (1%)     \-   ( - )    3     (2%)     5     (3%)      5       (3%)     7     (4%)    17    (9%)    48    (25%)   96      (50%)   11    (6%)    193     (100%)
  GII DA                   4    (1%)     \-   ( - )    1    (0.3%)   7    (2%)     5     (1%)     13    (3%)      8       (2%)     17    (4%)    43    (11%)   98    (26%)   157     (41%)   29    (8%)    382     (100%)
  GII OL&OA                \-   ( - )    1    (0.5%)   1    (0.5%)   \-   ( - )    1     (0.5%)   1     (0.5%)    2       (1%)     11    (5%)    16    (8%)    65    (31%)   106     (50%)   7     (3%)    211     (100%)
  GIII AA                  15   (3%)     2    (0.4%)   9    (2%)     5    (1%)     31    (6%)     29    (6%)      43      (8%)     60    (12%)   103   (20%)   99    (19%)   83      (16%)   34    (7%)    513     (100%)
  GIII AO&AOA              3    (1%)     1    (0.4%)   2    (1%)     1    (0.4%)   2     (1%)     8     (3%)      9       (4%)     15    (6%)    31    (13%)   57    (25%)   85      (37%)   18    (8%)    232     (100%)
  Glioblastoma             69   (5%)     9    (1%)     33   (2%)     46   (3%)     104   (7%)     128   (9%)      169     (11%)    168   (11%)   215   (14%)   261   (18%)   136     (9%)    151   (10%)   1,489   (100%)
  Ependymoma               4    (5%)     \-   ( - )    \-   ( - )    \-   ( - )    1     (1%)     3     (4%)      2       (3%)     4     (5%)    13    (17%)   26    (33%)   24      (31%)   1     (1%)    78      (100%)
  Anaplastic ependymoma    3    (5%)     \-   ( - )    \-   ( - )    \-   ( - )    4     (7%)     2     (4%)      5       (9%)     5     (9%)    14    (25%)   13    (24%)   7       (13%)   2     (4%)    55      (100%)
  Ganglioglioma            \-   ( - )    \-   ( - )    \-   ( - )    \-   ( - )    1     (2%)     \-    ( - )     2       (3%)     4     (7%)    5     (8%)    15    (25%)   32      (53%)   1     (2%)    60      (100%)
  Central neurocytoma      1    (2%)     \-   ( - )    1    (2%)     1    (2%)     \-    ( - )    \-    ( - )     4       (6%)     4     (6%)    2     (3%)    16    (25%)   33      (51%)   3     (5%)    65      (100%)
  Medulloblastoma          3    (3%)     1    (1%)     1    (1%)     \-   ( - )    1     (1%)     4     (4%)      7       (7%)     6     (6%)    14    (14%)   18    (18%)   28      (28%)   18    (18%)   101     (100%)
  Germinoma                1    (0.4%)   \-   ( - )    \-   ( - )    \-   ( - )    3     (1%)     4     (2%)      3       (1%)     9     (4%)    30    (13%)   81    (34%)   90      (38%)   14    (6%)    235     (100%)
  PCNSL                    35   (7%)     2    (0.4%)   12   (3%)     15   (3%)     32    (7%)     38    (8%)      62      (13%)    46    (10%)   79    (17%)   73    (15%)   41      (9%)    40    (8%)    475     (100%)
  GI Meningioma            20   (1%)     2    (0.1%)   8    (0.3%)   8    (0.3%)   22    (1%)     44    (1%)      81      (3%)     104   (3%)    298   (10%)   803   (26%)   1,441   (47%)   234   (8%)    3,065   (100%)
  GII Meningioma           4    (2%)     1    (1%)     2    (1%)     2    (1%)     7     (4%)     9     (5%)      9       (5%)     12    (7%)    26    (15%)   42    (24%)   50      (29%)   9     (5%)    173     (100%)
  GIII Meningioma          2    (5%)     \-   ( - )    \-   ( - )    1    (3%)     1     (3%)     \-    ( - )     2       (5%)     2     (5%)    6     (15%)   11    (28%)   13      (33%)   2     (5%)    40      (100%)
  Schwannoma               4    (0.3%)   1    (0.1%)   4    (0.3%)   1    (0.1%)   6     (0.4%)   13    (1%)      28      (2%)     40    (3%)    231   (17%)   608   (45%)   353     (26%)   63    (5%)    1,352   (100%)
  GH pituitary adenoma     \-   ( - )    1    (0.2%)   1    (0.2%)   \-   ( - )    1     (0.2%)   1     (0.2%)    1       (0.2%)   6     (1%)    14    (3%)    139   (29%)   301     (63%)   15    (3%)    480     (100%)
  PRL pituitary adenoma    \-   ( - )    1    (0.2%)   \-   ( - )    \-   ( - )    \-    ( - )    1     (0.2%)    2       (0.4%)   3     (1%)    14    (3%)    109   (22%)   343     (70%)   14    (3%)    487     (100%)
  ACTH pituitary adenoma   1    (1%)     \-   ( - )    \-   ( - )    1    (1%)     \-    ( - )    1     (1%)      3       (2%)     6     (4%)    16    (12%)   42    (30%)   65      (47%)   4     (3%)    139     (100%)
  NF pituitary adenoma     5    (0.4%)   \-   ( - )    1    (0.1%)   1    (0.1%)   3     (0.2%)   2     (0.1%)    14      (1%)     23    (2%)    80    (6%)    370   (26%)   855     (61%)   48    (3%)    1,402   (100%)
  Craniopharyngioma        2    (1%)     1    (0.3%)   \-   ( - )    3    (1%)     4     (1%)     10    (3%)      12      (4%)     21    (6%)    52    (16%)   106   (32%)   108     (33%)   12    (4%)    331     (100%)
  Chordoma                 \-   ( - )    \-   ( - )    \-   ( - )    \-   ( - )    \-    ( - )    2     (3%)      2       (3%)     3     (5%)    14    (24%)   21    (36%)   12      (21%)   4     (7%)    58      (100%)
  Hemangioblastoma         2    (1%)     \-   ( - )    1    (1%)     \-   ( - )    3     (2%)     3     (2%)      4       (2%)     10    (5%)    21    (11%)   48    (26%)   90      (48%)   5     (3%)    187     (100%)
  Epidermoid               \-   ( - )    \-   ( - )    \-   ( - )    \-   ( - )    2     (2%)     1     (1%)      \-      ( - )    3     (2%)    13    (11%)   42    (34%)   55      (45%)   6     (5%)    122     (100%)

12). Seizures during the whole treatment {#S4.12}
----------------------------------------

  seizure                  seizure (+)   seizure (--)   unknown   total                         
  ------------------------ ------------- -------------- --------- ------- ----- ------- ------- --------
  Pilocytic astrocytoma    37            (19%)          135       (70%)   21    (11%)   193     (100%)
  GII DA                   172           (45%)          173       (45%)   37    (10%)   382     (100%)
  GII OL&OA                136           (64%)          62        (29%)   13    (6%)    211     (100%)
  GIII AA                  211           (41%)          227       (44%)   75    (15%)   513     (100%)
  GIII AO&AOA              106           (46%)          72        (31%)   54    (23%)   232     (100%)
  Glioblastoma             441           (30%)          800       (54%)   248   (17%)   1,489   (100%)
  Ependymoma               9             (12%)          60        (77%)   9     (12%)   78      (100%)
  AE                       16            (29%)          35        (64%)   4     (7%)    55      (100%)
  Ganglioglioma            29            (48%)          29        (48%)   2     (3%)    60      (100%)
  Central neurocytoma      15            (23%)          40        (62%)   10    (15%)   65      (100%)
  Medulloblastoma          8             (8%)           84        (83%)   9     (9%)    101     (100%)
  Germinoma                12            (5%)           197       (84%)   26    (11%)   235     (100%)
  PCNSL                    65            (14%)          341       (72%)   69    (15%)   475     (100%)
  GI Meningioma            414           (14%)          2,368     (77%)   283   (9%)    3,065   (100%)
  GII Meningioma           39            (23%)          118       (68%)   16    (9%)    173     (100%)
  GIII Meningioma          10            (25%)          26        (65%)   4     (10%)   40      (100%)
  Schwannoma               35            (3%)           1,261     (93%)   56    (4%)    1,352   (100%)
  GH pituitary adenoma     5             (1%)           462       (96%)   13    (3%)    480     (100%)
  PRL pituitary adenoma    9             (2%)           459       (94%)   19    (4%)    487     (100%)
  ACTH pituitary adenoma   1             (1%)           138       (99%)   0     (0%)    139     (100%)
  NF pituitary adenoma     18            (1%)           1,343     (96%)   41    (3%)    1,402   (100%)
  Craniopharyngioma        19            (6%)           289       (87%)   23    (7%)    331     (100%)
  Chordoma                 \-            ( - )          51        (88%)   7     (12%)   58      (100%)
  Hemangioblastoma         9             (5%)           169       (90%)   9     (5%)    187     (100%)
  Epidermoid               2             (2%)           102       (84%)   18    (15%)   122     (100%)

13). Incidence of other CNS tumor or systemic cancers {#S4.13}
-----------------------------------------------------

                           none    other cancers   CNS tumor   Other CNS tumor + cancers   unknown   total                                       
  ------------------------ ------- --------------- ----------- --------------------------- --------- -------- ---- -------- ---- ------- ------- --------
  Pilocytic astrocytoma    186     (96%)           1           (1%)                        2         (1%)     \-   ( - )    4    (2%)    193     (100%)
  GII DA                   362     (95%)           4           (1%)                        5         (1%)     2    (1%)     9    (2%)    382     (100%)
  GII OL&OA                204     (97%)           4           (2%)                        1         (0.5%)   \-   ( - )    2    (1%)    211     (100%)
  GIII AA                  493     (96%)           10          (2%)                        2         (0.4%)   \-   ( - )    8    (2%)    513     (100%)
  GIII AO&AOA              218     (94%)           9           (4%)                        1         (0.4%)   \-   ( - )    4    (2%)    232     (100%)
  Glioblastoma             1,399   (94%)           50          (3%)                        9         (1%)     1    (0.1%)   30   (2%)    1,489   (100%)
  Ependymoma               76      (97%)           \-          ( - )                       1         (1%)     \-   ( - )    1    (1%)    78      (100%)
  AE                       52      (95%)           \-          ( - )                       2         (4%)     \-   ( - )    1    (2%)    55      (100%)
  Ganglioglioma            59      (98%)           1           (2%)                        \-        ( - )    \-   ( - )    \-   ( - )   60      (100%)
  Central neurocytoma      62      (95%)           \-          ( - )                       1         (2%)     \-   ( - )    2    (3%)    65      (100%)
  Medulloblastoma          96      (95%)           1           (1%)                        1         (1%)     \-   ( - )    3    (3%)    101     (100%)
  Germinoma                227     (97%)           \-          ( - )                       \-        ( - )    1    (0.4%)   7    (3%)    235     (100%)
  PCNSL                    424     (89%)           31          (7%)                        \-        ( - )    1    (0.2%)   19   (4%)    475     (100%)
  GI Meningioma            2,812   (92%)           122         (4%)                        34        (1%)     3    (0.1%)   94   (3%)    3,065   (100%)
  GII Meningioma           154     (89%)           12          (7%)                        4         (2%)     \-   ( - )    3    (2%)    173     (100%)
  GIII Meningioma          34      (85%)           3           (8%)                        \-        ( - )    \-   ( - )    3    (8%)    40      (100%)
  Schwannoma               1,277   (94%)           20          (1%)                        27        (2%)     2    (0.1%)   26   (2%)    1,352   (100%)
  GH pituitary adenoma     459     (96%)           16          (3%)                        \-        ( - )    \-   ( - )    5    (1%)    480     (100%)
  PRL pituitary adenoma    471     (97%)           4           (1%)                        2         (0.4%)   \-   ( - )    10   (2%)    487     (100%)
  ACTH pituitary adenoma   129     (93%)           8           (6%)                        \-        ( - )    \-   ( - )    2    (1%)    139     (100%)
  NF pituitary adenoma     1,331   (95%)           42          (3%)                        4         (0.3%)   2    (0.1%)   23   (2%)    1,402   (100%)
  Craniopharyngioma        323     (98%)           6           (2%)                        \-        ( - )    \-   ( - )    2    (1%)    331     (100%)
  Chordoma                 55      (95%)           2           (3%)                        \-        ( - )    \-   ( - )    1    (2%)    58      (100%)
  Hemangioblastoma         161     (86%)           12          (6%)                        4         (2%)     3    (2%)     7    (4%)    187     (100%)
  Epidermoid               114     (93%)           2           (2%)                        \-        ( - )    \-   ( - )    6    (5%)    122     (100%)

14). Incidence of hereditary cancer syndrome (LiFraumeni syndrome and retinoblastoma were not reported) {#S4.14}
-------------------------------------------------------------------------------------------------------

                           none     NF-1    NF-2   VHL      Tuberous Sclerosis   MEN-I    others   unknown   total                                                                
  ------------------------ -------- ------- ------ -------- -------------------- -------- -------- --------- ------- -------- ---- -------- ---- -------- ----- -------- -------- --------
  Total number             12,410   (92%)   37     (0.3%)   54                   (0.4%)   25       (0.2%)    6       (0.0%)   9    (0.1%)   22   (0.2%)   868   (6.5%)   13,431   (100%)
                                                                                                                                                                                  
  Pilocytic astrocytoma    173      (90%)   6      (3%)     \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    \-   ( - )    14    (7%)     193      (100%)
  GII DA                   348      (91%)   5      (1%)     1                    (0.3%)   \-       ( - )     \-      ( - )    \-   ( - )    1    (0.3%)   27    (7%)     382      (100%)
  GII OL&OA                206      (98%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    \-   ( - )    5     (2%)     211      (100%)
  GIII AA                  477      (93%)   3      (1%)     1                    (0.2%)   \-       ( - )     \-      ( - )    \-   ( - )    2    (0.4%)   30    (6%)     513      (100%)
  GIII AO&AOA              221      (95%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    2    (1%)     9     (4%)     232      (100%)
  Glioblastoma             1,418    (95%)   7      (0.5%)   \-                   ( - )    \-       ( - )     1       (0.1%)   \-   ( - )    3    (0.2%)   60    (4%)     1,489    (100%)
  Ependymoma               75       (96%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    \-   ( - )    3     (4%)     78       (100%)
  AE                       52       (95%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    1    (2%)     2     (4%)     55       (100%)
  Ganglioglioma            58       (97%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    \-   ( - )    2     (3%)     60       (100%)
  Central neurocytoma      61       (94%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    \-   ( - )    4     (6%)     65       (100%)
  Medulloblastoma          93       (92%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    \-   ( - )    8     (8%)     101      (100%)
  Germinoma                218      (93%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    1    (0.4%)   16    (7%)     235      (100%)
  PCNSL                    433      (91%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    1    (0.2%)   41    (9%)     475      (100%)
  GI Meningioma            2,809    (92%)   1      (0.0%)   12                   (0.4%)   \-       ( - )     \-      ( - )    2    (0.1%)   5    (0.2%)   236   (8%)     3,065    (100%)
  GII Meningioma           156      (90%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    1    (1%)     16    (9%)     173      (100%)
  GIII Meningioma          33       (83%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    \-   ( - )    7     (18%)    40       (100%)
  Schwannoma               1,206    (89%)   2      (0.1%)   33                   (2%)     \-       ( - )     \-      ( - )    \-   ( - )    1    (0.1%)   110   (8%)     1,352    (100%)
  GH pituitary adenoma     467      (97%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    1    (0.2%)   \-   ( - )    12    (3%)     480      (100%)
  PRL pituitary adenoma    460      (94%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    1    (0.2%)   \-   ( - )    26    (5%)     487      (100%)
  ACTH pituitary adenoma   132      (95%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    1    (1%)     \-   ( - )    6     (4%)     139      (100%)
  NF pituitary adenoma     1,334    (95%)   \-     ( - )    \-                   ( - )    1        (0.1%)    \-      ( - )    4    (0.3%)   \-   ( - )    63    (4%)     1,402    (100%)
  Craniopharyngioma        321      (97%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    \-   ( - )    10    (3%)     331      (100%)
  Chordoma                 56       (97%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    \-   ( - )    2     (3%)     58       (100%)
  Hemangioblastoma         141      (75%)   \-     ( - )    \-                   ( - )    22       (12%)     \-      ( - )    \-   ( - )    2    (1%)     22    (12%)    187      (100%)
  Epidermoid               110      (90%)   \-     ( - )    \-                   ( - )    \-       ( - )     \-      ( - )    \-   ( - )    \-   ( - )    12    (10%)    122      (100%)

15). Initial treatment {#S4.15}
----------------------

                           surgery   surgery + RT   surgery + CRT   surgery + CTX   CRT   RT       CTX   observation alone   others   total                                                                      
  ------------------------ --------- -------------- --------------- --------------- ----- -------- ----- ------------------- -------- -------- ----- -------- ---- -------- ----- -------- ---- -------- ------- --------
  Pilocytic astrocytoma    144       (75%)          17              (9%)            13    (7%)     17    (9%)                1        (1%)     \-    ( - )    \-   ( - )    1     (1%)     \-   ( - )    193     (100%)
  GII DA                   142       (37%)          91              (24%)           111   (29%)    17    (4%)                5        (1%)     7     (2%)     \-   ( - )    7     (2%)     2    (1%)     382     (100%)
  GII OL&OA                60        (28%)          43              (20%)           66    (31%)    40    (19%)               1        (0.5%)   \-    ( - )    1    (0.5%)   \-    ( - )    \-   ( - )    211     (100%)
  GIII AA                  42        (8%)           67              (13%)           381   (74%)    10    (2%)                6        (1%)     4     (1%)     1    (0.2%)   2     (0.4%)   \-   ( - )    513     (100%)
  GIII AO&AOA              21        (9%)           18              (8%)            163   (70%)    25    (11%)               3        (1%)     \-    ( - )    \-   ( - )    \-    ( - )    2    (1%)     232     (100%)
  Glioblastoma             144       (10%)          272             (18%)           991   (67%)    25    (2%)                11       (1%)     15    (1%)     \-   ( - )    17    (1%)     14   (1%)     1,489   (100%)
  Ependymoma               43        (55%)          26              (33%)           3     (4%)     5     (6%)                \-       ( - )    1     (1%)     \-   ( - )    \-    ( - )    \-   ( - )    78      (100%)
  AE                       5         (9%)           19              (35%)           25    (45%)    6     (11%)               \-       ( - )    \-    ( - )    \-   ( - )    \-    ( - )    \-   ( - )    55      (100%)
  Ganglioglioma            49        (82%)          5               (8%)            3     (5%)     2     (3%)                \-       ( - )    \-    ( - )    \-   ( - )    1     (2%)     \-   ( - )    60      (100%)
  Central neurocytoma      45        (69%)          18              (28%)           \-    ( - )    \-    ( - )               \-       ( - )    2     (3%)     \-   ( - )    \-    ( - )    \-   ( - )    65      (100%)
  Medulloblastoma          3         (3%)           2               (2%)            85    (84%)    9     (9%)                \-       ( - )    1     (1%)     \-   ( - )    \-    ( - )    1    (1%)     101     (100%)
  Germinoma                2         (1%)           22              (9%)            165   (70%)    15    (6%)                25       (11%)    1     (0.4%)   4    (2%)     \-    ( - )    1    (0.4%)   235     (100%)
  PCNSL                    44        (9%)           92              (19%)           197   (41%)    58    (12%)               24       (5%)     27    (6%)     9    (2%)     7     (1%)     17   (4%)     475     (100%)
  GI Meningioma            2,642     (86%)          132             (4%)            \-    ( - )    1     (0%)                \-       ( - )    119   (4%)     \-   ( - )    158   (5%)     13   (0.4%)   3,065   (100%)
  GII Meningioma           117       (68%)          51              (29%)           2     (1%)     2     (1%)                \-       ( - )    \-    ( - )    \-   ( - )    \-    ( - )    1    (1%)     173     (100%)
  GIII Meningioma          23        (58%)          16              (40%)           1     (3%)     \-    ( - )               \-       ( - )    \-    ( - )    \-   ( - )    \-    ( - )    \-   ( - )    40      (100%)
  Schwannoma               1,121     (83%)          100             (7%)            \-    ( - )    \-    ( - )               \-       ( - )    100   (7%)     \-   ( - )    31    (2%)     \-   ( - )    1,352   (100%)
  GH pituitary adenoma     332       (69%)          13              (3%)            26    (5%)     99    (21%)               3        (1%)     \-    ( - )    4    (1%)     3     (1%)     \-   ( - )    480     (100%)
  PRL pituitary adenoma    296       (61%)          5               (1%)            6     (1%)     136   (28%)               2        (0.4%)   \-    ( - )    35   (7%)     4     (1%)     3    (1%)     487     (100%)
  ACTH pituitary adenoma   107       (77%)          11              (8%)            3     (2%)     14    (10%)               \-       ( - )    1     (1%)     1    (1%)     2     (1%)     \-   ( - )    139     (100%)
  NF pituitary adenoma     1,229     (88%)          69              (5%)            2     (0.1%)   55    (4%)                \-       ( - )    6     (0.4%)   \-   ( - )    41    (3%)     \-   ( - )    1,402   (100%)
  Craniopharyngioma        211       (64%)          87              (26%)           6     (2%)     17    (5%)                \-       ( - )    1     (0.3%)   1    (0.3%)   7     (2%)     1    (0.3%)   331     (100%)
  Chordoma                 32        (55%)          25              (43%)           \-    ( - )    \-    ( - )               \-       ( - )    \-    ( - )    \-   ( - )    1     (2%)     \-   ( - )    58      (100%)
  Hemangioblastoma         178       (95%)          5               (3%)            \-    ( - )    \-    ( - )               \-       ( - )    1     (1%)     \-   ( - )    3     (2%)     \-   ( - )    187     (100%)
  Epidermoid               119       (98%)          \-              ( - )           \-    ( - )    \-    ( - )               \-       ( - )    \-    ( - )    \-   ( - )    2     (2%)     1    (1%)     122     (100%)

16). Initial surgery {#S4.16}
--------------------

  extent of resection      none   decompressive craniectomy   biopsy   1--50% resection   50--75% resection   75--95% resection   95--99% resection   100% total resection   extended total resection   shunt   drainage   others   total                                                                                          
  ------------------------ ------ --------------------------- -------- ------------------ ------------------- ------------------- ------------------- ---------------------- -------------------------- ------- ---------- -------- ------- ------- ------- ------- ---- -------- ---- -------- ---- -------- ---- ------- ------- --------
  Pilocytic astrocytoma    2      (1%)                        1        (1%)               27                  (14%)               22                  (11%)                  12                         (6%)    31         (16%)    30      (16%)   63      (33%)   \-   ( - )    \-   ( - )    \-   ( - )    5    (3%)    193     (100%)
  GII DA                   20     (5%)                        1        (0.3%)             111                 (29%)               36                  (9%)                   36                         (9%)    58         (15%)    52      (14%)   53      (14%)   5    (1%)     2    (1%)     \-   ( - )    8    (2%)    382     (100%)
  GII OL&OA                2      (1%)                        1        (0.5%)             17                  (8%)                14                  (7%)                   17                         (8%)    39         (18%)    42      (20%)   74      (35%)   2    (1%)     1    (0.5%)   \-   ( - )    2    (1%)    211     (100%)
  GIII AA                  13     (3%)                        1        (0.2%)             169                 (33%)               41                  (8%)                   60                         (12%)   86         (17%)    67      (13%)   61      (12%)   1    (0.2%)   3    (1%)     \-   ( - )    11   (2%)    513     (100%)
  GIII AO&AOA              5      (2%)                        1        (0.4%)             9                   (4%)                12                  (5%)                   39                         (17%)   53         (23%)    39      (17%)   69      (30%)   2    (1%)     \-   ( - )    \-   ( - )    3    (1%)    232     (100%)
  Glioblastoma             52     (3%)                        2        (0.1%)             229                 (15%)               106                 (7%)                   203                        (14%)   362        (24%)    251     (17%)   248     (17%)   12   (1%)     3    (0.2%)   1    (0.1%)   20   (1%)    1,489   (100%)
  Ependymoma               1      (1%)                        \-       ( - )              2                   (3%)                1                   (1%)                   3                          (4%)    18         (23%)    17      (22%)   32      (41%)   \-   ( - )    \-   ( - )    1    (1%)     3    (4%)    78      (100%)
  AE                       \-     ( - )                       \-       ( - )              1                   (2%)                1                   (2%)                   5                          (9%)    13         (24%)    12      (22%)   21      (38%)   \-   ( - )    \-   ( - )    \-   ( - )    2    (4%)    55      (100%)
  Ganglioglioma            1      (2%)                        \-       ( - )              5                   (8%)                2                   (3%)                   4                          (7%)    6          (10%)    3       (5%)    39      (65%)   \-   ( - )    \-   ( - )    \-   ( - )    \-   ( - )   60      (100%)
  Central neurocytoma      2      (3%)                        \-       ( - )              4                   (6%)                4                   (6%)                   5                          (8%)    12         (18%)    15      (23%)   22      (34%)   \-   ( - )    \-   ( - )    \-   ( - )    1    (2%)    65      (100%)
  Medulloblastoma          1      (1%)                        \-       ( - )              1                   (1%)                \-                  ( - )                  6                          (6%)    13         (13%)    28      (28%)   50      (50%)   \-   ( - )    \-   ( - )    \-   ( - )    2    (2%)    101     (100%)
  Germinoma                31     (13%)                       \-       ( - )              119                 (51%)               21                  (9%)                   18                         (8%)    14         (6%)     11      (5%)    5       (2%)    \-   ( - )    5    (2%)     5    (2%)     6    (3%)    235     (100%)
  PCNSL                    81     (17%)                       1        (0.2%)             266                 (56%)               25                  (5%)                   23                         (5%)    28         (6%)     20      (4%)    24      (5%)    \-   ( - )    \-   ( - )    \-   ( - )    7    (1%)    475     (100%)
  GI Meningioma            281    (9%)                        1        (0.0%)             24                  (1%)                52                  (2%)                   118                        (4%)    286        (9%)     639     (21%)   1,593   (52%)   4    (0.1%)   1    (0.0%)   1    (0.0%)   65   (2%)    3,065   (100%)
  GII Meningioma           1      (1%)                        \-       ( - )              2                   (1%)                2                   (1%)                   9                          (5%)    25         (14%)    45      (26%)   85      (49%)   1    (1%)     \-   ( - )    \-   ( - )    3    (2%)    173     (100%)
  GIII Meningioma          \-     ( - )                       \-       ( - )              \-                  ( - )               1                   (3%)                   5                          (13%)   6          (15%)    8       (20%)   18      (45%)   \-   ( - )    \-   ( - )    \-   ( - )    2    (5%)    40      (100%)
  Schwannoma               131    (10%)                       \-       ( - )              6                   (0.4%)              38                  (3%)                   99                         (7%)    311        (23%)    308     (23%)   421     (31%)   3    (0.2%)   10   (1%)     \-   ( - )    25   (2%)    1,352   (100%)
  GH pituitary adenoma     10     (2%)                        \-       ( - )              2                   (0.4%)              13                  (3%)                   31                         (6%)    107        (22%)    97      (20%)   208     (43%)   \-   ( - )    \-   ( - )    \-   ( - )    12   (3%)    480     (100%)
  PRL pituitary adenoma    43     (9%)                        \-       ( - )              8                   (2%)                12                  (2%)                   38                         (8%)    87         (18%)    77      (16%)   201     (41%)   \-   ( - )    2    (0.4%)   \-   ( - )    19   (4%)    487     (100%)
  ACTH pituitary adenoma   4      (3%)                        \-       ( - )              2                   (1%)                1                   (1%)                   9                          (6%)    17         (12%)    27      (19%)   75      (54%)   \-   ( - )    \-   ( - )    \-   ( - )    4    (3%)    139     (100%)
  NF pituitary adenoma     47     (3%)                        \-       ( - )              6                   (0.4%)              70                  (5%)                   170                        (12%)   386        (28%)    352     (25%)   343     (24%)   \-   ( - )    \-   ( - )    \-   ( - )    28   (2%)    1,402   (100%)
  Craniopharyngioma        10     (3%)                        \-       ( - )              2                   (1%)                29                  (9%)                   38                         (11%)   78         (24%)    92      (28%)   73      (22%)   \-   ( - )    1    (0.3%)   2    (1%)     6    (2%)    331     (100%)
  Chordoma                 1      (2%)                        \-       ( - )              4                   (7%)                9                   (16%)                  11                         (19%)   18         (31%)    9       (16%)   3       (5%)    \-   ( - )    2    (3%)     \-   ( - )    1    (2%)    58      (100%)
  Hemangioblastoma         4      (2%)                        1        (1%)               \-                  ( - )               \-                  ( - )                  6                          (3%)    7          (4%)     20      (11%)   146     (78%)   \-   ( - )    1    (1%)     \-   ( - )    2    (1%)    187     (100%)
  Epidermoid               3      (2%)                        \-       ( - )              \-                  ( - )               3                   (2%)                   11                         (9%)    21         (17%)    26      (21%)   54      (44%)   \-   ( - )    \-   ( - )    \-   ( - )    4    (3%)    122     (100%)

17). Initial radiotherapy {#S4.17}
-------------------------

  radiotherapy             none    RT (+)   patient number   timing of radiotherapy                                                                                    
  ------------------------ ------- -------- ---------------- ------------------------ ------- -------- ----- -------- ---- -------- ------- ------- ---- -------- ---- --------
  Pilocytic astrocytoma    162     (84%)    31               (16%)                    193     (100%)   1     (1%)     \-   ( - )    30      (16%)   \-   ( - )    \-   ( - )
  GII DA                   167     (44%)    215              (56%)                    382     (100%)   15    (4%)     \-   ( - )    196     (51%)   2    (1%)     2    (1%)
  GII OL&OA                101     (48%)    110              (52%)                    211     (100%)   2     (1%)     \-   ( - )    108     (51%)   \-   ( - )    \-   ( - )
  GIII AA                  55      (11%)    458              (89%)                    513     (100%)   13    (3%)     1    (0.2%)   441     (86%)   1    (0.2%)   2    (0.4%)
  GIII AO&AOA              48      (21%)    184              (79%)                    232     (100%)   4     (2%)     \-   ( - )    180     (78%)   \-   ( - )    \-   ( - )
  Glioblastoma             199     (13%)    1,290            (87%)                    1,489   (100%)   29    (2%)     2    (0.1%)   1,254   (84%)   4    (0.3%)   1    (0.1%)
  Ependymoma               48      (62%)    30               (38%)                    78      (100%)   1     (1%)     \-   ( - )    29      (37%)   \-   ( - )    \-   ( - )
  AE                       11      (20%)    44               (80%)                    55      (100%)   3     (5%)     \-   ( - )    40      (73%)   1    (2%)     \-   ( - )
  Ganglioglioma            52      (87%)    8                (13%)                    60      (100%)   1     (2%)     \-   ( - )    7       (12%)   \-   ( - )    \-   ( - )
  Central neurocytoma      45      (69%)    20               (31%)                    65      (100%)   1     (2%)     \-   ( - )    17      (26%)   2    (3%)     \-   ( - )
  Medulloblastoma          12      (12%)    89               (88%)                    101     (100%)   1     (1%)     \-   ( - )    86      (85%)   1    (1%)     1    (1%)
  Germinoma                22      (9%)     213              (91%)                    235     (100%)   28    (12%)    \-   ( - )    182     (77%)   1    (0.4%)   2    (1%)
  PCNSL                    130     (27%)    345              (73%)                    475     (100%)   50    (11%)    \-   ( - )    288     (61%)   4    (1%)     3    (1%)
  GI Meningioma            2,810   (92%)    255              (8%)                     3,065   (100%)   122   (4%)     \-   ( - )    121     (4%)    7    (0.2%)   5    (0.2%)
  GII Meningioma           119     (69%)    54               (31%)                    173     (100%)   1     (1%)     \-   ( - )    50      (29%)   1    (1%)     2    (1%)
  GIII Meningioma          23      (58%)    17               (43%)                    40      (100%)   \-    ( - )    \-   ( - )    16      (40%)   1    (3%)     \-   ( - )
  Schwannoma               1,152   (85%)    200              (15%)                    1,352   (100%)   101   (7%)     \-   ( - )    92      (7%)    5    (0.4%)   2    (0.1%)
  GH pituitary adenoma     438     (91%)    42               (9%)                     480     (100%)   3     (1%)     \-   ( - )    39      (8%)    \-   ( - )    \-   ( - )
  PRL pituitary adenoma    473     (97%)    14               (3%)                     487     (100%)   2     (0.4%)   \-   ( - )    11      (2%)    \-   ( - )    1    (0.2%)
  ACTH pituitary adenoma   124     (89%)    15               (11%)                    139     (100%)   1     (1%)     \-   ( - )    13      (9%)    1    (1%)     \-   ( - )
  NF pituitary adenoma     1,325   (95%)    77               (5%)                     1,402   (100%)   6     (0.4%)   \-   ( - )    71      (5%)    \-   ( - )    \-   ( - )
  Craniopharyngioma        236     (71%)    95               (29%)                    331     (100%)   2     (1%)     \-   ( - )    92      (28%)   1    (0.3%)   \-   ( - )
  Chordoma                 33      (57%)    25               (43%)                    58      (100%)   \-    ( - )    \-   ( - )    24      (41%)   \-   ( - )    1    (2%)
  Hemangioblastoma         181     (97%)    6                (3%)                     187     (100%)   2     (1%)     \-   ( - )    3       (2%)    1    (1%)     \-   ( - )
  Epidermoid               122     (100%)   \-               ( - )                    122     (100%)   \-    ( - )    \-   ( - )    \-      ( - )   \-   ( - )    \-   ( - )

18). Mode of initial radiotherapy {#S4.18}
---------------------------------

  mode                     pt no.   WBRT   LBRT     WBRT+ LBRT/SRT/SRS   LBRT+ LBRT/SRT/SRS   SRS/SRT   internal RT   particle beam irradiation   others                                                   
  ------------------------ -------- ------ -------- -------------------- -------------------- --------- ------------- --------------------------- -------- ----- -------- ---- -------- ---- -------- ---- --------
  Pilocytic astrocytoma    193      1      (1%)     22                   (11%)                1         (1%)          \-                          ( - )    7     (4%)     \-   ( - )    \-   ( - )    \-   ( - )
  GII DA                   382      12     (3%)     174                  (46%)                10        (3%)          7                           (2%)     10    (3%)     \-   ( - )    \-   ( - )    2    (1%)
  GII OL&OA                211      9      (4%)     96                   (45%)                2         (1%)          2                           (1%)     1     (0.5%)   \-   ( - )    \-   ( - )    \-   ( - )
  GIII AA                  513      45     (9%)     351                  (68%)                26        (5%)          20                          (4%)     12    (2%)     1    (0.2%)   1    (0.2%)   2    (0.4%)
  GIII AO&AOA              232      14     (6%)     146                  (63%)                14        (6%)          6                           (3%)     3     (1%)     \-   ( - )    1    (0.4%)   \-   ( - )
  Glioblastoma             1,489    158    (11%)    870                  (58%)                120       (8%)          86                          (6%)     28    (2%)     2    (0.1%)   16   (1%)     10   (1%)
  Ependymoma               78       2      (3%)     21                   (27%)                1         (1%)          \-                          ( - )    5     (6%)     \-   ( - )    \-   ( - )    1    (1%)
  AE                       55       4      (7%)     28                   (51%)                8         (15%)         \-                          ( - )    4     (7%)     \-   ( - )    \-   ( - )    \-   ( - )
  Ganglioglioma            60       \-     ( - )    6                    (10%)                \-        ( - )         \-                          ( - )    2     (3%)     \-   ( - )    \-   ( - )    \-   ( - )
  Central neurocytoma      65       \-     ( - )    9                    (14%)                \-        ( - )         \-                          ( - )    9     (14%)    \-   ( - )    2    (3%)     \-   ( - )
  Medulloblastoma          101      23     (23%)    10                   (10%)                53        (52%)         \-                          ( - )    1     (1%)     \-   ( - )    \-   ( - )    2    (2%)
  Germinoma                235      35     (15%)    126                  (54%)                30        (13%)         6                           (3%)     1     (0.4%)   \-   ( - )    \-   ( - )    15   (6%)
  PCNSL                    475      158    (33%)    55                   (12%)                110       (23%)         1                           (0.2%)   15    (3%)     \-   ( - )    \-   ( - )    6    (1%)
  GI Meningioma            3,065    1      (0.0%)   25                   (1%)                 1         (0.0%)        \-                          ( - )    224   (7%)     \-   ( - )    1    (0.0%)   3    (0.1%)
  GII Meningioma           173      1      (1%)     32                   (18%)                \-        ( - )         \-                          ( - )    20    (12%)    \-   ( - )    \-   ( - )    1    (1%)
  GIII Meningioma          40       1      (3%)     12                   (30%)                \-        ( - )         \-                          ( - )    4     (10%)    \-   ( - )    \-   ( - )    \-   ( - )
  Schwannoma               1,352    \-     ( - )    3                    (0.2%)               \-        ( - )         \-                          ( - )    196   (14%)    \-   ( - )    \-   ( - )    1    (0.1%)
  GH pituitary adenoma     480      \-     ( - )    \-                   ( - )                \-        ( - )         1                           (0.2%)   41    (9%)     \-   ( - )    \-   ( - )    \-   ( - )
  PRL pituitary adenoma    487      \-     ( - )    6                    (1%)                 \-        ( - )         \-                          ( - )    7     (1%)     \-   ( - )    \-   ( - )    1    (0.2%)
  ACTH pituitary adenoma   139      \-     ( - )    1                    (1%)                 \-        ( - )         \-                          ( - )    14    (10%)    \-   ( - )    \-   ( - )    \-   ( - )
  NF pituitary adenoma     1,402    \-     ( - )    34                   (2%)                 \-        ( - )         1                           (0.1%)   42    (3%)     \-   ( - )    \-   ( - )    \-   ( - )
  Craniopharyngioma        331      \-     ( - )    46                   (14%)                \-        ( - )         1                           (0.3%)   47    (14%)    \-   ( - )    1    (0.3%)   \-   ( - )
  Chordoma                 58       \-     ( - )    3                    (5%)                 \-        ( - )         1                           (2%)     9     (16%)    \-   ( - )    12   (21%)    \-   ( - )
  Hemangioblastoma         187      \-     ( - )    \-                   ( - )                \-        ( - )         \-                          ( - )    6     (3%)     \-   ( - )    \-   ( - )    \-   ( - )
  Epidermoid               122      \-     ( - )    \-                   ( - )                \-        ( - )         \-                          ( - )    \-    ( - )    \-   ( - )    \-   ( - )    \-   ( - )

19). Spinal irradiation in initial treatment {#S4.19}
--------------------------------------------

  Spinal irradiation       ( - )   ( + )    unknown   total                          
  ------------------------ ------- -------- --------- -------- ---- -------- ------- --------
  Pilocytic astrocytoma    192     (99%)    1         (1%)     \-   ( - )    193     (100%)
  GII DA                   379     (99%)    1         (0.3%)   2    (1%)     382     (100%)
  GII OL&OA                211     (100%)   \-        ( - )    \-   ( - )    211     (100%)
  GIII AA                  500     (97%)    8         (2%)     5    (1%)     513     (100%)
  GIII AO&AOA              227     (98%)    4         (2%)     1    (0.4%)   232     (100%)
  Glioblastoma             1,457   (98%)    21        (1%)     11   (1%)     1,489   (100%)
  Ependymoma               74      (95%)    4         (5%)     \-   ( - )    78      (100%)
  AE                       47      (85%)    7         (13%)    1    (2%)     55      (100%)
  Ganglioglioma            60      (100%)   \-        ( - )    \-   ( - )    60      (100%)
  Central neurocytoma      64      (98%)    1         (2%)     \-   ( - )    65      (100%)
  Medulloblastoma          23      (23%)    75        (74%)    3    (3%)     101     (100%)
  Germinoma                195     (83%)    35        (15%)    5    (2%)     235     (100%)
  PCNSL                    460     (97%)    8         (2%)     7    (1%)     475     (100%)
  GI Meningioma            3,059   (100%)   2         (0.1%)   4    (0.1%)   3,065   (100%)
  GII Meningioma           172     (99%)    1         (1%)     \-   ( - )    173     (100%)
  GIII Meningioma          38      (95%)    2         (5%)     \-   ( - )    40      (100%)
  Schwannoma               1,352   (100%)   \-        ( - )    \-   ( - )    1,352   (100%)
  GH pituitary adenoma     479     (100%)   1         (0.2%)   \-   ( - )    480     (100%)
  PRL pituitary adenoma    486     (100%)   \-        ( - )    1    (0.2%)   487     (100%)
  ACTH pituitary adenoma   139     (100%)   \-        ( - )    \-   ( - )    139     (100%)
  NF pituitary adenoma     1,401   (100%)   1         (0.1%)   \-   ( - )    1,402   (100%)
  Craniopharyngioma        330     (100%)   \-        ( - )    1    (0.3%)   331     (100%)
  Chordoma                 57      (98%)    \-        ( - )    1    (2%)     58      (100%)
  Hemangioblastoma         187     (100%)   \-        ( - )    \-   ( - )    187     (100%)
  Epidermoid               122     (100%)   \-        ( - )    \-   ( - )    122     (100%)

20). Radiotherapy for recurrent tumor {#S4.20}
-------------------------------------

  mode                     none    WBRT    LBRT   SRS/SRT   spinal cord irradiation   particle beam irradiation   others   unknown   total                                                              
  ------------------------ ------- ------- ------ --------- ------------------------- --------------------------- -------- --------- ------- -------- ---- -------- ---- -------- ----- ------- ------- --------
  Pilocytic astrocytoma    171     (89%)   3      (2%)      6                         (3%)                        1        (1%)      \-      ( - )    \-   ( - )    1    (1%)     11    (6%)    193     (100%)
  GII DA                   298     (78%)   6      (2%)      31                        (8%)                        18       (5%)      1       (0.3%)   \-   ( - )    2    (1%)     26    (7%)    382     (100%)
  GII OL&OA                181     (86%)   \-     ( - )     13                        (6%)                        6        (3%)      \-      ( - )    2    (1%)     \-   ( - )    9     (4%)    211     (100%)
  GIII AA                  414     (81%)   5      (1%)      25                        (5%)                        28       (5%)      2       (0.4%)   3    (1%)     2    (0.4%)   34    (7%)    513     (100%)
  GIII AO&AOA              188     (81%)   5      (2%)      13                        (6%)                        7        (3%)      1       (0.4%)   \-   ( - )    2    (1%)     16    (7%)    232     (100%)
  Glioblastoma             1,204   (81%)   4      (0.3%)    45                        (3%)                        106      (7%)      8       (1%)     5    (0.3%)   4    (0.3%)   113   (8%)    1,489   (100%)
  Ependymoma               61      (78%)   2      (3%)      5                         (6%)                        2        (3%)      \-      ( - )    \-   ( - )    \-   ( - )    8     (10%)   78      (100%)
  AE                       35      (64%)   1      (2%)      5                         (9%)                        7        (13%)     1       (2%)     \-   ( - )    1    (2%)     5     (9%)    55      (100%)
  Ganglioglioma            56      (93%)   \-     ( - )     3                         (5%)                        1        (2%)      \-      ( - )    \-   ( - )    \-   ( - )    \-    ( - )   60      (100%)
  Central neurocytoma      52      (80%)   \-     ( - )     2                         (3%)                        4        (6%)      1       (2%)     \-   ( - )    \-   ( - )    6     (9%)    65      (100%)
  Medulloblastoma          67      (66%)   5      (5%)      3                         (3%)                        10       (10%)     5       (5%)     \-   ( - )    \-   ( - )    11    (11%)   101     (100%)
  Germinoma                194     (83%)   9      (4%)      4                         (2%)                        1        (0.4%)    6       (3%)     \-   ( - )    \-   ( - )    21    (9%)    235     (100%)
  PCNSL                    339     (71%)   23     (5%)      19                        (4%)                        35       (7%)      4       (1%)     \-   ( - )    \-   ( - )    55    (12%)   475     (100%)
  GI Meningioma            2,799   (91%)   1      (0.0%)    24                        (1%)                        90       (3%)      \-      ( - )    \-   ( - )    6    (0.2%)   145   (5%)    3,065   (100%)
  GII Meningioma           133     (77%)   \-     ( - )     10                        (6%)                        22       (13%)     \-      ( - )    \-   ( - )    1    (1%)     7     (4%)    173     (100%)
  GIII Meningioma          25      (63%)   1      (3%)      3                         (8%)                        8        (20%)     \-      ( - )    \-   ( - )    \-   ( - )    3     (8%)    40      (100%)
  Schwannoma               1,229   (91%)   \-     ( - )     5                         (0.4%)                      56       (4%)      \-      ( - )    \-   ( - )    2    (0.1%)   60    (4%)    1,352   (100%)
  GH pituitary adenoma     458     (95%)   \-     ( - )     \-                        ( - )                       6        (1%)      \-      ( - )    \-   ( - )    \-   ( - )    16    (3%)    480     (100%)
  PRL pituitary adenoma    469     (96%)   \-     ( - )     2                         (0.4%)                      2        (0.4%)    \-      ( - )    1    (0.2%)   1    ( - )    12    (2%)    487     (100%)
  ACTH pituitary adenoma   128     (92%)   1      (1%)      1                         (1%)                        3        (2%)      \-      ( - )    \-   ( - )    \-   ( - )    6     (4%)    139     (100%)
  NF pituitary adenoma     1,323   (94%)   \-     ( - )     5                         (0.4%)                      37       (3%)      \-      ( - )    \-   ( - )    \-   ( - )    37    (3%)    1,402   (100%)
  Craniopharyngioma        286     (86%)   \-     ( - )     13                        (4%)                        19       (6%)      \-      ( - )    1    (0.3%)   \-   ( - )    12    (4%)    331     (100%)
  Chordoma                 37      (64%)   \-     ( - )     5                         (9%)                        7        (12%)     \-      ( - )    3    (5%)     \-   ( - )    6     (10%)   58      (100%)
  Hemangioblastoma         175     (94%)   \-     ( - )     \-                        ( - )                       5        (3%)      1       (1%)     \-   ( - )    \-   ( - )    6     (3%)    187     (100%)
  Epidermoid               114     (93%)   \-     ( - )     \-                        ( - )                       2        (2%)      \-      ( - )    \-   ( - )    \-   ( - )    6     (5%)    122     (100%)

21). Drug therapy in initial treatment number of CTX = 15): (surgery+CRT)+(surgery+CTX)+(CRT alone)+(CTX alone) {#S4.21}
---------------------------------------------------------------------------------------------------------------

  Drug                     patient number   number of CTX   TMZ      ACNU   other alkylating agents   platinum drugs   vincristine   interferon   etoposide   ifosfamide   MTX     molecular targeting drug   hormone therapy   steroid   others                                                                                               
  ------------------------ ---------------- --------------- -------- ------ ------------------------- ---------------- ------------- ------------ ----------- ------------ ------- -------------------------- ----------------- --------- -------- ----- ------- ---- -------- ----- -------- ---- -------- ----- -------- ----- -------- ---- --------
  Pilocytic astrocytoma    193              31              (16%)    \-     ( - )                     8                (4%)          2            (1%)        18           (9%)    14                         (7%)              3         (2%)     9     (5%)    \-   ( - )    \-    ( - )    \-   ( - )    \-    ( - )    \-    ( - )    2    (1%)
  GII DA                   382              133             (35%)    5      (1%)                      96               (25%)         10           (3%)        19           (5%)    43                         (11%)             45        (12%)    17    (4%)    1    (0.3%)   1     (0.3%)   \-   ( - )    \-    ( - )    25    (7%)     4    (1%)
  GII OL&OA                211              108             (51%)    \-     ( - )                     93               (44%)         54           (26%)       15           (7%)    79                         (37%)             9         (4%)     11    (5%)    1    (0.5%)   1     (0.5%)   \-   ( - )    \-    ( - )    9     (4%)     6    (3%)
  GIII AA                  513              398             (78%)    8      (2%)                      328              (64%)         34           (7%)        83           (16%)   115                        (22%)             154       (30%)    83    (16%)   1    (0.2%)   2     (0.4%)   \-   ( - )    1     (0.2%)   76    (15%)    12   (2%)
  GIII AO&AOA              232              191             (82%)    1      (0.4%)                    163              (70%)         82           (35%)       28           (12%)   107                        (46%)             24        (10%)    25    (11%)   3    (1%)     4     (2%)     \-   ( - )    \-    ( - )    26    (11%)    9    (4%)
  Glioblastoma             1,489            1,027           (69%)    13     (1%)                      790              (53%)         120          (8%)        226          (15%)   279                        (19%)             370       (25%)    191   (13%)   7    (0.5%)   32    (2%)     1    (0.1%)   \-    ( - )    243   (16%)    34   (2%)
  Ependymoma               78               8               (10%)    \-     ( - )                     2                (3%)          \-           ( - )       2            (3%)    2                          (3%)              2         (3%)     3     (4%)    1    (1%)     \-    ( - )    \-   ( - )    \-    ( - )    3     (4%)     \-   ( - )
  AE                       55               31              (56%)    2      (4%)                      11               (20%)         2            (4%)        19           (35%)   5                          (9%)              3         (5%)     18    (33%)   9    (16%)    2     (4%)     \-   ( - )    \-    ( - )    5     (9%)     1    (2%)
  Ganglioglioma            60               5               (8%)     \-     ( - )                     3                (5%)          \-           ( - )       1            (2%)    3                          (5%)              1         (2%)     \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    \-    ( - )    \-    ( - )    1    (2%)
  Central neurocytoma      65               \-              ( - )    \-     ( - )                     \-               ( - )         \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    \-    ( - )    \-    ( - )    \-   ( - )
  Medulloblastoma          101              94              (93%)    \-     ( - )                     9                (9%)          16           (16%)       83           (82%)   36                         (36%)             5         (5%)     71    (70%)   41   (41%)    8     (8%)     \-   ( - )    1     (1%)     18    (18%)    10   (10%)
  Germinoma                235              209             (89%)    \-     ( - )                     3                (1%)          19           (8%)        196          (83%)   10                         (4%)              2         (1%)     189   (80%)   53   (23%)    4     (2%)     \-   ( - )    5     (2%)     17    (7%)     17   (7%)
  PCNSL                    475              288             (61%)    \-     ( - )                     11               (2%)          33           (7%)        32           (7%)    58                         (12%)             \-        ( - )    31    (7%)    7    (1%)     228   (48%)    2    (0.4%)   \-    ( - )    120   (25%)    58   (12%)
  GI Meningioma            3,065            1               (0.0%)   \-     ( - )                     \-               ( - )         \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    \-    ( - )    \-    ( - )    4    (0.1%)
  GII Meningioma           173              4               (2%)     1      (1%)                      2                (1%)          \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    \-    ( - )    1     (1%)     \-   ( - )
  GIII Meningioma          40               1               (3%)     \-     ( - )                     \-               ( - )         \-           ( - )       1            (3%)    \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    \-    ( - )    \-    ( - )    \-   ( - )
  Schwannoma               1,352            \-              ( - )    \-     ( - )                     \-               ( - )         \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    \-    ( - )    \-    ( - )    \-   ( - )
  GH pituitary adenoma     480              132             (28%)    \-     ( - )                     \-               ( - )         \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    235   (49%)    180   (38%)    28   (6%)
  PRL pituitary adenoma    487              179             (37%)    \-     ( - )                     \-               ( - )         \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    256   (53%)    83    (17%)    16   (3%)
  ACTH pituitary adenoma   139              18              (13%)    \-     ( - )                     \-               ( - )         \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    54    (39%)    1     (1%)     9    (6%)
  NF pituitary adenoma     1,402            57              (4%)     \-     ( - )                     \-               ( - )         \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    275   (20%)    7     (0.5%)   37   (3%)
  Craniopharyngioma        331              24              (7%)     \-     ( - )                     \-               ( - )         \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    98    (30%)    81    (24%)    2    (1%)
  Chordoma                 58               \-              ( - )    \-     ( - )                     \-               ( - )         \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    1     (2%)     \-    ( - )    \-   ( - )
  Hemangioblastoma         187              \-              ( - )    \-     ( - )                     \-               ( - )         \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    \-    ( - )    \-    ( - )    \-   ( - )
  Epidermoid               122              \-              ( - )    \-     ( - )                     \-               ( - )         \-           ( - )       \-           ( - )   \-                         ( - )             \-        ( - )    \-    ( - )   \-   ( - )    \-    ( - )    \-   ( - )    \-    ( - )    \-    ( - )    \-   ( - )

22). Any therapy during the whole treatment {#S4.22}
-------------------------------------------

  mode of therapy          patient number   surgery   WBRT    LBRT   SRS/SRT   particle beam therapy   CTX     molecular targeting drug   dopamine agonist   vaccine therapy   immunotherapy   steroid   anti-convulsants                                                                                
  ------------------------ ---------------- --------- ------- ------ --------- ----------------------- ------- -------------------------- ------------------ ----------------- --------------- --------- ------------------ ---- -------- ----- -------- ---- -------- ---- -------- ----- ------- ----- --------
  Pilocytic astrocytoma    193              165       (85%)   5      (3%)      25                      (13%)   6                          (3%)               \-                ( - )           32        (17%)              \-   ( - )    \-    ( - )    \-   ( - )    \-   ( - )    33    (17%)   41    (21%)
  GII DA                   382              321       (84%)   23     (6%)      184                     (48%)   25                         (7%)               1                 (0.3%)          164       (43%)              1    (0.3%)   \-    ( - )    3    (1%)     4    (1%)     105   (27%)   200   (52%)
  GII OL&OA                211              189       (90%)   10     (5%)      107                     (51%)   8                          (4%)               2                 (1%)            115       (55%)              \-   ( - )    \-    ( - )    1    (0.5%)   3    (1%)     58    (27%)   140   (66%)
  GIII AA                  513              438       (85%)   66     (13%)     348                     (68%)   45                         (9%)               6                 (1%)            359       (70%)              2    (0.4%)   \-    ( - )    9    (2%)     13   (3%)     231   (45%)   268   (52%)
  GIII AO&AOA              232              203       (88%)   24     (10%)     156                     (67%)   17                         (7%)               1                 (0.4%)          182       (78%)              2    (1%)     \-    ( - )    1    (0.4%)   3    (1%)     85    (37%)   131   (56%)
  Glioblastoma             1,489            1,275     (86%)   234    (16%)     951                     (64%)   186                        (12%)              22                (1%)            919       (62%)              2    (0.1%)   1     (0.1%)   36   (2%)     81   (5%)     782   (53%)   856   (57%)
  Ependymoma               78               66        (85%)   5      (6%)      25                      (32%)   7                          (9%)               \-                ( - )           9         (12%)              \-   ( - )    \-    ( - )    \-   ( - )    \-   ( - )    17    (22%)   15    (19%)
  AE                       55               48        (87%)   12     (22%)     31                      (56%)   10                         (18%)              \-                ( - )           28        (51%)              \-   ( - )    \-    ( - )    \-   ( - )    \-   ( - )    19    (35%)   25    (45%)
  Ganglioglioma            60               56        (93%)   \-     ( - )     9                       (15%)   3                          (5%)               \-                ( - )           8         (13%)              1    (2%)     \-    ( - )    \-   ( - )    \-   ( - )    6     (10%)   39    (65%)
  Central neurocytoma      65               57        (88%)   1      (2%)      11                      (17%)   10                         (15%)              2                 (3%)            2         (3%)               \-   ( - )    \-    ( - )    \-   ( - )    \-   ( - )    8     (12%)   29    (45%)
  Medulloblastoma          101              92        (91%)   73     (72%)     57                      (56%)   10                         (10%)              \-                ( - )           85        (84%)              \-   ( - )    \-    ( - )    \-   ( - )    1    (1%)     41    (41%)   14    (14%)
  Germinoma                235              182       (77%)   67     (29%)     156                     (66%)   7                          (3%)               \-                ( - )           189       (80%)              \-   ( - )    6     (3%)     \-   ( - )    \-   ( - )    59    (25%)   31    (13%)
  PCNSL                    475              335       (71%)   241    (51%)     137                     (29%)   49                         (10%)              1                 (0.2%)          248       (52%)              7    (1%)     \-    ( - )    \-   ( - )    2    ( - )    286   (60%)   150   (32%)
  GI Meningioma            3,065            2,272     (74%)   4      (0.1%)    44                      (1%)    197                        (6%)               2                 (0.1%)          4         (0.1%)             \-   ( - )    \-    ( - )    \-   ( - )    1    (0.0%)   509   (17%)   947   (31%)
  GII Meningioma           173              151       (87%)   3      (2%)      34                      (20%)   32                         (18%)              \-                ( - )           3         (2%)               \-   ( - )    \-    ( - )    \-   ( - )    \-   ( - )    53    (31%)   80    (46%)
  GIII Meningioma          40               36        (90%)   2      (5%)      14                      (35%)   10                         (25%)              1                 (3%)            1         (3%)               \-   ( - )    \-    ( - )    \-   ( - )    \-   ( - )    9     (23%)   14    (35%)
  Schwannoma               1,352            991       (73%)   \-     ( - )     9                       (1%)    199                        (15%)              \-                ( - )           1         (0.1%)             \-   ( - )    \-    ( - )    \-   ( - )    \-   ( - )    226   (17%)   44    (3%)
  GH pituitary adenoma     480              388       (81%)   \-     ( - )     \-                      ( - )   38                         (8%)               \-                ( - )           3         (1%)               \-   ( - )    151   (31%)    \-   ( - )    \-   ( - )    132   (28%)   2     (0.4%)
  PRL pituitary adenoma    487              372       (76%)   \-     ( - )     7                       (1%)    7                          (1%)               1                 (0.2%)          6         (1%)               \-   ( - )    183   (38%)    \-   ( - )    \-   ( - )    115   (24%)   6     (1%)
  ACTH pituitary adenoma   139              122       (88%)   \-     ( - )     2                       (1%)    13                         (9%)               \-                ( - )           1         (1%)               \-   ( - )    18    (13%)    \-   ( - )    \-   ( - )    43    (31%)   4     (3%)
  NF pituitary adenoma     1,402            1,089     (78%)   \-     ( - )     38                      (3%)    73                         (5%)               \-                ( - )           3         (0.2%)             \-   ( - )    46    (3%)     \-   ( - )    1    (0.1%)   430   (31%)   37    (3%)
  Craniopharyngioma        331              266       (80%)   2      (1%)      54                      (16%)   53                         (16%)              2                 (1%)            4         (1%)               \-   ( - )    7     (2%)     \-   ( - )    \-   ( - )    126   (38%)   57    (17%)
  Chordoma                 58               51        (88%)   \-     ( - )     10                      (17%)   14                         (24%)              12                (21%)           1         (2%)               \-   ( - )    \-    ( - )    \-   ( - )    \-   ( - )    8     (14%)   1     (2%)
  Hemangioblastoma         187              148       (79%)   \-     ( - )     \-                      ( - )   11                         (6%)               \-                ( - )           \-        ( - )              \-   ( - )    \-    ( - )    \-   ( - )    \-   ( - )    32    (17%)   14    (7%)
  Epidermoid               122              95        (78%)   \-     ( - )     \-                      ( - )   2                          (2%)               \-                ( - )           \-        ( - )              \-   ( - )    \-    ( - )    \-   ( - )    \-   ( - )    13    (11%)   12    (10%)

23). Any drug therapy during the whole treatment {#S4.23}
------------------------------------------------

  drug therapy             patient number   none    TMZ     ACNU   other alkylating agents   platinum drug   vincristine   IFN   etoposide   ifosfamide   MTX      molecular target drug   hormone therapy   steroid   anti-convulsants   dopamine agonist                                                                                                         
  ------------------------ ---------------- ------- ------- ------ ------------------------- --------------- ------------- ----- ----------- ------------ -------- ----------------------- ----------------- --------- ------------------ ------------------ -------- ---- ------- ----- -------- ---- -------- ----- -------- ----- ------- ------- ------- ----- --------
  Pilocytic astrocytoma    193              105     (54%)   2      (1%)                      12              (6%)          4     (2%)        24           (12%)    17                      (9%)              1         (1%)               11                 (6%)     \-   ( - )   \-    ( - )    \-   ( - )    2     (1%)     39    (20%)   43      (22%)   \-    ( - )
  GII DA                   382              86      (23%)   48     (13%)                     117             (31%)         18    (5%)        28           (7%)     56                      (15%)             53        (14%)              28                 (7%)     2    (1%)    4     (1%)     1    (0.3%)   \-    ( - )    110   (29%)   207     (54%)   \-    ( - )
  GII OL&OA                211              21      (10%)   18     (9%)                      100             (47%)         56    (27%)       17           (8%)     82                      (39%)             15        (7%)               13                 (6%)     3    (1%)    1     (0.5%)   \-   ( - )    \-    ( - )    55    (26%)   140     (66%)   \-    ( - )
  GIII AA                  513              45      (9%)    74     (14%)                     305             (59%)         39    (8%)        101          (20%)    113                     (22%)             153       (30%)              103                (20%)    13   (3%)    5     (1%)     2    (0.4%)   \-    ( - )    248   (48%)   288     (56%)   1     (0.2%)
  GIII AO&AOA              232              13      (6%)    43     (19%)                     162             (70%)         82    (35%)       41           (18%)    107                     (46%)             25        (11%)              39                 (17%)    11   (5%)    6     (3%)     1    (0.4%)   \-    ( - )    87    (38%)   130     (56%)   \-    ( - )
  Glioblastoma             1,489            149     (10%)   110    (7%)                      765             (51%)         129   (9%)        284          (19%)    280                     (19%)             391       (26%)              254                (17%)    51   (3%)    38    (3%)     \-   ( - )    2     (0.1%)   812   (55%)   908     (61%)   5     (0.3%)
  Ependymoma               78               39      (50%)   1      (1%)                      2               (3%)          \-    ( - )       6            (8%)     1                       (1%)              2         (3%)               5                  (6%)     3    (4%)    \-    ( - )    \-   ( - )    \-    ( - )    20    (26%)   19      (24%)   \-    ( - )
  AE                       55               12      (22%)   2      (4%)                      10              (18%)         4     (7%)        19           (35%)    6                       (11%)             3         (5%)               20                 (36%)    13   (24%)   5     (9%)     \-   ( - )    \-    ( - )    22    (40%)   24      (44%)   \-    ( - )
  Ganglioglioma            60               18      (30%)   2      (3%)                      7               (12%)         \-    ( - )       2            (3%)     3                       (5%)              1         (2%)               1                  (2%)     \-   ( - )   \-    ( - )    1    (2%)     \-    ( - )    7     (12%)   41      (68%)   \-    ( - )
  Central neurocytoma      65               29      (45%)   1      (2%)                      \-              ( - )         \-    ( - )       1            (2%)     \-                      ( - )             \-        ( - )              1                  (2%)     1    (2%)    \-    ( - )    \-   ( - )    \-    ( - )    10    (15%)   31      (48%)   \-    ( - )
  Medulloblastoma          101              7       (7%)    3      (3%)                      15              (15%)         20    (20%)       82           (81%)    40                      (40%)             7         (7%)               72                 (71%)    47   (47%)   11    (11%)    \-   ( - )    1     (1%)     43    (43%)   15      (15%)   \-    ( - )
  Germinoma                235              25      (11%)   1      (0.4%)                    6               (3%)          14    (6%)        182          (77%)    11                      (5%)              \-        ( - )              179                (76%)    53   (23%)   4     (2%)     \-   ( - )    27    (11%)    64    (27%)   31      (13%)   1     (0.4%)
  PCNSL                    475              68      (14%)   2      (0.4%)                    11              (2%)          40    (8%)        42           (9%)     57                      (12%)             1         (0.2%)             45                 (9%)     10   (2%)    215   (45%)    9    (2%)     1     (0.2%)   308   (65%)   171     (36%)   2     (0.4%)
  GI Meningioma            3,065            1,754   (57%)   \-     ( - )                     \-              ( - )         \-    ( - )       \-           ( - )    \-                      ( - )             \-        ( - )              2                  (0.1%)   \-   ( - )   \-    ( - )    \-   ( - )    8     (0.3%)   561   (18%)   1,098   (36%)   2     (0.1%)
  GII Meningioma           173              70      (40%)   1      (1%)                      2               (1%)          \-    ( - )       \-           ( - )    \-                      ( - )             \-        ( - )              \-                 ( - )    \-   ( - )   \-    ( - )    \-   ( - )    1     (1%)     55    (32%)   89      (51%)   \-    ( - )
  GIII Meningioma          40               17      (43%)   \-     ( - )                     \-              ( - )         \-    ( - )       1            (3%)     \-                      ( - )             \-        ( - )              \-                 ( - )    \-   ( - )   \-    ( - )    \-   ( - )    \-    ( - )    10    (25%)   17      (43%)   \-    ( - )
  Schwannoma               1,352            1,039   (77%)   \-     ( - )                     \-              ( - )         1     (0.1%)      \-           ( - )    1                       (0.1%)            1         (0.1%)             \-                 ( - )    \-   ( - )   1     (0.1%)   \-   ( - )    \-    ( - )    263   (19%)   53      (4%)    \-    ( - )
  GH pituitary adenoma     480              193     (40%)   \-     ( - )                     \-              ( - )         \-    ( - )       \-           ( - )    \-                      ( - )             \-        ( - )              1                  (0.2%)   \-   ( - )   \-    ( - )    1    (0.2%)   123   (26%)    162   (34%)   6       (1%)    145   (30%)
  PRL pituitary adenoma    487              169     (35%)   \-     ( - )                     \-              ( - )         \-    ( - )       \-           ( - )    \-                      ( - )             1         (0.2%)             1                  (0.2%)   \-   ( - )   \-    ( - )    1    (0.2%)   100   (21%)    153   (31%)   9       (2%)    174   (36%)
  ACTH pituitary adenoma   139              48      (35%)   1      (1%)                      \-              ( - )         \-    ( - )       2            (1%)     \-                      ( - )             1         (1%)               2                  (1%)     \-   ( - )   \-    ( - )    \-   ( - )    44    (32%)    64    (46%)   3       (2%)    23    (17%)
  NF pituitary adenoma     1,402            778     (55%)   \-     ( - )                     \-              ( - )         1     (0.1%)      1            (0.1%)   \-                      ( - )             \-        ( - )              \-                 ( - )    \-   ( - )   \-    ( - )    \-   ( - )    247   (18%)    509   (36%)   43      (3%)    124   (9%)
  Craniopharyngioma        331              132     (40%)   1      (0.3%)                    \-              ( - )         \-    ( - )       \-           ( - )    \-                      ( - )             \-        ( - )              \-                 ( - )    \-   ( - )   \-    ( - )    \-   ( - )    96    (29%)    141   (43%)   67      (20%)   8     (2%)
  Chordoma                 58               45      (78%)   \-     ( - )                     \-              ( - )         1     (2%)        \-           ( - )    \-                      ( - )             \-        ( - )              \-                 ( - )    \-   ( - )   1     (2%)     \-   ( - )    1     (2%)     12    (21%)   1       (2%)    \-    ( - )
  Hemangioblastoma         187              139     (74%)   \-     ( - )                     \-              ( - )         \-    ( - )       \-           ( - )    \-                      ( - )             \-        ( - )              \-                 ( - )    \-   ( - )   \-    ( - )    \-   ( - )    \-    ( - )    40    (21%)   15      (8%)    \-    ( - )
  Epidermoid               122              98      (80%)   \-     ( - )                     \-              ( - )         \-    ( - )       \-           ( - )    \-                      ( - )             \-        ( - )              \-                 ( - )    \-   ( - )   \-    ( - )    \-   ( - )    \-    ( - )    13    (11%)   12      (10%)   \-    ( - )

24). Overall survival and progression free survival {#S4.24}
---------------------------------------------------

                           total   Overall survival   Progression free survival                                                                                                            
  ------------------------ ------- ------------------ --------------------------- ----- ------ ------- ------ ------ ------ ------ ----- ------- ----- ------- ------ ------ ------ ------ ------
  Pilocytic astrocytoma    193     14                 124                         0.0   NR     98.2    96.3   93.6   92.9   92.1   45    124     0.0   NR      91.5   82.5   77.8   76.3   73.8
  GII DA                   382     94                 128                         0.0   NR     95.4    84.2   78.7   78.0   75.0   147   128     0.0   84.1    84.0   71.8   66.5   61.6   57.0
  GII OL&OA                211     29                 122                         0.9   NR     98.0    95.9   93.0   91.2   90.0   64    122     0.0   NR      94.9   87.6   78.8   76.4   74.6
  GIII AA                  513     230                129.0                       0.0   38.0   80.8    63.1   51.8   44.8   41.1   271   129.0   0.0   19.0    60.7   45.1   36.9   32.8   28.7
  GIII AO&AOA              232     76                 120                         0.0   NR     92.3    82.5   78.7   75.4   68.2   107   120     0.0   71.0    79.0   69.9   60.4   55.9   54.0
  Glioblastoma             1,489   929                119.0                       0.0   15.0   60.3    25.4   15.9   11.1   10.1   888   119.0   0.0   8.1     34.7   17.5   13.1   11.9   9.2
  Ependymoma               78      9                  123                         0.0   NR     92.7    92.7   90.9   90.9   86.3   18    123     0.0   117.0   89.2   78.7   76.8   74.7   72.5
  AE                       55      19                 119.0                       0.0   NR     86.0    70.6   68.3   60.8   58.1   29    119.0   0.0   22.0    70.4   49.4   37.6   37.6   35.1
  Ganglioglioma            60      3                  123                         0.0   NR     100.0   98.1   98.1   98.1   98.1   10    119.0   0.0   NR      94.5   92.5   86.4   84.0   78.9
  Central neurocytoma      65      1                  123                         0.0   NR     98.4    98.4   98.4   98.4   98.4   15    123     0.0   NR      87.1   85.2   79.0   79.0   79.0
  Medulloblastoma          101     28                 121.0                       0.0   NR     93.6    86.7   77.3   74.9   68.7   34    121.0   0.0   NR      84.8   74.2   69.2   65.5   62.9
  Germinoma                235     9                  120                         0.0   NR     98.7    98.7   98.2   98.2   97.1   26    120     0.0   NR      97.6   95.7   92.6   91.5   89.9
  PCNSL                    475     181                117.0                       0.0   41.1   73.4    64.1   54.4   44.9   42.3   168   117.0   0.0   35.0    70.6   56.9   48.4   40.4   34.7
  GI Meningioma            3,065   67                 129                         0.0   NR     99.2    98.7   98.6   98.4   97.9   263   129.0   0.0   NR      98.1   96.4   93.8   92.4   90.5
  GII Meningioma           173     15                 122                         0.0   NR     96.7    94.6   93.0   91.2   91.2   61    121.0   0.0   87.0    87.1   79.7   71.8   64.2   60.6
  GIII Meningioma          40      5                  115                         0.0   NR     90.2    90.2   86.6   86.6   86.6   17    112     0.0   65.1    85.2   68.1   57.5   53.4   53.4
  Schwannoma               1,352   15                 130                         0.0   NR     99.5    99.4   99.2   99.0   98.8   124   130     0.0   NR      97.7   95.6   93.3   91.2   89.5
  GH pituitary adenoma     480     4                  121.0                       0.0   NR     99.8    99.8   99.5   99.5   99.2   19    121.0   0.0   NR      97.6   96.8   96.5   95.7   95.7
  PRL pituitary adenoma    487     3                  120                         0.0   NR     100.0   99.7   99.7   99.4   99.4   24    120     0.0   NR      98.0   97.0   96.1   94.5   94.2
  ACTH pituitary adenoma   139     6                  119                         0.0   NR     99.2    98.2   98.2   97.2   97.2   21    119     0.0   NR      97.4   92.5   90.5   87.2   85.0
  NF pituitary adenoma     1,402   27                 130                         0.0   NR     99.5    99.0   98.9   98.5   98.3   197   130     0.0   NR      96.7   94.4   92.5   88.7   85.1
  Craniopharyngioma        331     13                 122.0                       0.0   NR     98.1    97.3   97.3   96.9   96.5   94    122.0   0.0   NR      88.6   82.7   78.0   73.5   69.7
  Chordoma                 58      6                  120                         0.0   NR     100.0   97.6   95.1   95.1   89.1   26    107     0.0   50.1    69.1   59.9   53.0   50.6   48.1
  Hemangioblastoma         187     4                  122                         0.0   NR     100.0   99.2   96.3   96.3   96.3   20    120     0.0   NR      96.3   94.5   91.4   89.2   86.8
  Epidermoid               122     1                  122                         0.0   NR     98.8    98.8   98.8   98.8   98.8   6     122     0.0   NR      98.8   97.5   96.1   93.0   93.0

25). Outcome at investigation {#S4.25}
-----------------------------

                           alive   dead    unknown   total                           
  ------------------------ ------- ------- --------- ------- ------- ------- ------- --------
  Pilocytic astrocytoma    116     (60%)   14        (7%)    63      (33%)   193     (100%)
  GII DA                   177     (46%)   94        (25%)   111     (29%)   382     (100%)
  GII OL&OA                124     (59%)   29        (14%)   58      (27%)   211     (100%)
  GIII AA                  104     (20%)   230       (45%)   179     (35%)   513     (100%)
  GIII AO&AOA              105     (45%)   76        (33%)   51      (22%)   232     (100%)
  Glioblastoma             109     (7%)    929       (62%)   451     (30%)   1,489   (100%)
  Ependymoma               37      (47%)   9         (12%)   32      (41%)   78      (100%)
  AE                       22      (40%)   19        (35%)   14      (25%)   55      (100%)
  Ganglioglioma            39      (65%)   3         (5%)    18      (30%)   60      (100%)
  Central neurocytoma      38      (58%)   1         (2%)    26      (40%)   65      (100%)
  Medulloblastoma          52      (51%)   28        (28%)   21      (21%)   101     (100%)
  Germinoma                170     (72%)   9         (4%)    56      (24%)   235     (100%)
  PCNSL                    67      (14%)   181       (38%)   227     (48%)   475     (100%)
  GI Meningioma            1,686   (55%)   67        (2%)    1,312   (43%)   3,065   (100%)
  GII Meningioma           88      (51%)   15        (9%)    70      (40%)   173     (100%)
  GIII Meningioma          17      (43%)   5         (13%)   18      (45%)   40      (100%)
  Schwannoma               844     (62%)   15        (1%)    493     (36%)   1,352   (100%)
  GH pituitary adenoma     359     (75%)   4         (1%)    117     (24%)   480     (100%)
  PRL pituitary adenoma    325     (67%)   3         (1%)    159     (33%)   487     (100%)
  ACTH pituitary adenoma   105     (76%)   6         (4%)    28      (20%)   139     (100%)
  NF pituitary adenoma     939     (67%)   27        (2%)    436     (31%)   1,402   (100%)
  Craniopharyngioma        220     (66%)   13        (4%)    98      (30%)   331     (100%)
  Chordoma                 28      (48%)   6         (10%)   24      (41%)   58      (100%)
  Hemangioblastoma         82      (44%)   4         (2%)    101     (54%)   187     (100%)
  Epidermoid               57      (47%)   1         (1%)    64      (52%)   122     (100%)

26). Pattern of recurrence at investigation {#S4.26}
-------------------------------------------

                           no recurrence   local recurrence   new lesions   unknown   total                                  
  ------------------------ --------------- ------------------ ------------- --------- ------- -------- ----- ------- ------- --------
  Pilocytic astrocytoma    120             (62%)              43            (22%)     2       (1%)     28    (15%)   193     (100%)
  GII DA                   169             (44%)              131           (34%)     16      (4%)     66    (17%)   382     (100%)
  GII OL&OA                117             (55%)              60            (28%)     4       (2%)     30    (14%)   211     (100%)
  GIII AA                  137             (27%)              240           (47%)     31      (6%)     105   (20%)   513     (100%)
  GIII AO&AOA              96              (41%)              93            (40%)     14      (6%)     29    (13%)   232     (100%)
  Glioblastoma             260             (17%)              784           (53%)     104     (7%)     341   (23%)   1,489   (100%)
  Ependymoma               40              (51%)              14            (18%)     4       (5%)     20    (26%)   78      (100%)
  AE                       15              (27%)              24            (44%)     5       (9%)     11    (20%)   55      (100%)
  Ganglioglioma            41              (68%)              10            (17%)     \-      ( - )    9     (15%)   60      (100%)
  Central neurocytoma      38              (58%)              14            (22%)     1       (2%)     12    (18%)   65      (100%)
  Medulloblastoma          51              (50%)              12            (12%)     22      (22%)    16    (16%)   101     (100%)
  Germinoma                176             (75%)              17            (7%)      9       (4%)     33    (14%)   235     (100%)
  PCNSL                    133             (28%)              62            (13%)     106     (22%)    174   (37%)   475     (100%)
  GI Meningioma            2,182           (71%)              248           (8%)      15      (0.5%)   620   (20%)   3,065   (100%)
  GII Meningioma           85              (49%)              58            (34%)     3       (2%)     27    (16%)   173     (100%)
  GIII Meningioma          18              (45%)              15            (38%)     2       (5%)     5     (13%)   40      (100%)
  Schwannoma               958             (71%)              121           (9%)      3       (0.2%)   270   (20%)   1,352   (100%)
  GH pituitary adenoma     407             (85%)              19            (4%)      \-      ( - )    54    (11%)   480     (100%)
  PRL pituitary adenoma    395             (81%)              23            (5%)      1       (0.2%)   68    (14%)   487     (100%)
  ACTH pituitary adenoma   98              (71%)              20            (14%)     1       (1%)     20    (14%)   139     (100%)
  NF pituitary adenoma     1,027           (73%)              196           (14%)     1       (0.1%)   178   (13%)   1,402   (100%)
  Craniopharyngioma        195             (59%)              93            (28%)     1       (0.3%)   42    (13%)   331     (100%)
  Chordoma                 23              (40%)              26            (45%)     \-      ( - )    9     (16%)   58      (100%)
  Hemangioblastoma         128             (68%)              14            (7%)      6       (3%)     39    (21%)   187     (100%)
  Epidermoid               82              (67%)              6             (5%)      \-      ( - )    34    (28%)   122     (100%)

27). Overall survival and progression free survival depending on initial treatment {#S4.27}
----------------------------------------------------------------------------------

                           total     Overall survival   Progression free survival                                                                  
  ------------------------ --------- ------------------ --------------------------- ------- ------- ------- ------- ------- ------- ------ ------- ------
  Pilocytic astrocytoma    surgery   144                6                           122.1   0.0     NR      94.4    26      122.1   0.0    NR      79.5
  surgery + RT             17        2                  124.1                       3.0     NR      87.8    2       124.1   0.0     NR     87.1    
  surgery + CRT            13        4                  122.0                       3.0     NR      64.2    5       122.0   3.0     NR     56.2    
  surgery + CTX            17        2                  112.0                       1.9     112.0   100.0   12      89.1    1.9     31.1   34.7    
  CRT                      1         0                  100.1                       100.1   ND      ND      0       100.1   100.1   ND     ND      
  RT                       0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        1         0                  0.0                         0.0     \-      \-      0       0.0     0.0     \-     \-      
                                                                                                                                                   
  GII DA                   surgery   142                20                          116.1   0.0     NR      86.7    51      116.1   0.0    NR      58.4
  surgery + RT             91        25                 116.0                       0.0     NR      68.8    33      116.0   0.0     84.1   61.0    
  surgery + CRT            111       37                 128.1                       1.0     NR      68.2    47      128.1   1.0     73.0   55.8    
  surgery + CTX            17        3                  116.1                       0.0     NR      85.1    5       116.1   0.0     NR     64.0    
  CRT                      5         3                  81.0                        9.0     ND      ND      4       81.0    7.0     ND     ND      
  RT                       7         5                  118.1                       2.0     ND      ND      6       118.1   2.0     ND     ND      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        7         0                  92.1                        0.0     \-      \-      0       92.1    0.0     \-     \-      
                                                                                                                                                   
  GII OL&OA                surgery   60                 4                           122.1   0.9     NR      96.6    15      122.1   0.0    NR      85.5
  surgery + RT             43        11                 122.0                       2.0     NR      77.4    11      122.0   2.0     NR     77.3    
  surgery + CRT            66        11                 116.1                       2.0     116     88.1    24      116.1   1.0     NR     69.4    
  surgery + CTX            40        3                  111.1                       2.0     NR      96.7    13      109.1   0.0     NR     66.5    
  CRT                      1         0                  12.0                        12.0    ND      ND      0       12.0    12.0    ND     ND      
  RT                       0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CTX                      1         0                  24.0                        24.0    ND      ND      1       0.0     0.0     ND     ND      
  observation alone        0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
                                                                                                                                                   
  GIII AA                  surgery   42                 15                          109.1   0.0     14.0    41.3    13      109.1   0.0    16.0    40.4
  surgery + RT             67        33                 129.0                       0.0     28.0    34.5    34      129.0   0.0     16.0   22.3    
  surgery + CRT            381       173                121.1                       0.0     41.0    42.5    214     121.0   0.0     19.0   29.1    
  surgery + CTX            10        2                  107.0                       0.0     NR      66.7    2       107.0   0.0     NR     60.0    
  CRT                      6         5                  31.0                        2.0     ND      ND      5       7.0     0.0     ND     ND      
  RT                       4         1                  24.0                        0.0     ND      ND      1       20.0    0.0     ND     ND      
  CTX                      1         0                  28.0                        28.0    ND      ND      1       22.1    22.1    ND     ND      
  observation alone        2         1                  7.0                         0.9     ND      ND      1       5.0     0.9     ND     ND      
                                                                                                                                                   
  GIII AO&AOA              surgery   21                 10                          115.0   0.0     64.1    54.2    10      92.1    0.0    31.0    45.8
  surgery + RT             18        8                  102.1                       1.0     77.1    79.1    10      102.0   0.0     52.0   46.2    
  surgery + CRT            163       51                 120.1                       0.0     NR      66.7    69      120.1   0.0     83.1   57.4    
  surgery + CTX            25        6                  120.1                       3.0     NR      81.5    14      119.0   0.0     69.0   51.3    
  CRT                      3         0                  74.0                        11.0    ND      ND      2       74.0    9.0     ND     ND      
  RT                       0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
                                                                                                                                                   
  Glioblastoma             surgery   144                72                          65.1    0.0     7.0     5.7     46      65.1    0.0    7.0     12.6
  surgery + RT             272       168                109.1                       0.0     12.0    3.3     152     108.1   0.0     8.0    4.3     
  surgery + CRT            991       655                119.0                       0.0     17.0    11.9    663     119.0   0.0     9.0    9.8     
  surgery + CTX            25        12                 97.1                        0.0     9.0     19.8    9       97.1    0.0     14.0   12.9    
  CRT                      11        7                  110.0                       2.0     11.0    13.6    8       110.0   0.0     6.0    12.5    
  RT                       15        6                  18.0                        0.0     15.0    0.0     7       13.0    0.0     9.0    0.0     
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        17        4                  6.0                         0.0     5.0     0.0     1       6.0     0.0     NR     ND      
                                                                                                                                                   
  Ependymoma               surgery   43                 6                           119.0   0.0     NR      85.1    11      117.0   0.0    117.0   71.5
  surgery + RT             26        3                  113.1                       2.0     NR      83.0    6       113.1   2.0     NR     68.8    
  surgery + CRT            3         0                  98.1                        5.0     ND      ND      0       98.1    5.0     ND     ND      
  surgery + CTX            5         0                  101.1                       35.0    ND      ND      1       101.1   20.0    ND     ND      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       1         0                  123.1                       123.1   ND      ND      0       123.1   123.1   ND     ND      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
                                                                                                                                                   
  Anaplastic ependymoma    surgery   5                  2                           76.1    0.0     ND      ND      3       68.0    0.0    ND      ND
  surgery + RT             19        7                  119.0                       1.9     NR      59.2    8       119.0   1.9     NR     51.3    
  surgery + CRT            25        10                 108.1                       3.0     44.1    47.7    16      108.1   2.0     21.0   20.7    
  surgery + CTX            6         0                  114.0                       2.9     ND      ND      2       114.0   2.9     ND     ND      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
                                                                                                                                                   
  Ganglioglioma            surgery   49                 0                           123.1   0.0     NR      100.0   5       119.0   0.0    NR      86.6
  surgery + RT             5         1                  80.1                        1.0     ND      ND      2       80.1    1.0     ND     ND      
  surgery + CRT            3         2                  85.1                        15.0    ND      ND      3       48.0    3.0     ND     ND      
  surgery + CTX            2         0                  92.1                        58.0    ND      ND      0       92.1    49.0    ND     ND      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        1         0                  11.0                        11.0    ND      ND      0       11.0    11.0    ND     ND      
                                                                                                                                                   
  Central neurocytoma      surgery   45                 1                           123.1   0.0     NR      97.7    12      123.1   0.0    NR      78.0
  surgery + RT             18        0                  115.0                       2.0     NR      100.0   3       115.0   2.0     NR     80.0    
  surgery + CRT            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  surgery + CTX            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       2         0                  100.0                       6.0     ND      ND      0       100.0   6.0     ND     ND      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
                                                                                                                                                   
  Medulloblastoma          surgery   3                  1                           90.0    2.0     ND      ND      0       12.0    0.0    ND      ND
  surgery + RT             2         0                  4.9                         3.0     ND      ND      1       4.9     2.0     ND     ND      
  surgery + CRT            85        25                 121.0                       1.0     NR      68.3    29      121.0   1.0     NR     64.5    
  surgery + CTX            9         2                  98.1                        1.0     \-      \-      4       81.1    1.0     ND     ND      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       1         0                  0.0                         0.0     ND      ND      0       0.0     0.0     ND     ND      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
                                                                                                                                                   
  Germinoma                surgery   2                  0                           36.0    0.0     ND      ND      0       36.0    0.0    ND      ND
  surgery + RT             22        2                  105.0                       0.0     NR      90.2    2       105.0   0.0     NR     89.5    
  surgery + CRT            165       5                  120.1                       1.9     NR      97.8    20      120.1   0.0     NR     90.1    
  surgery + CTX            15        0                  115.1                       1.0     NR      100.0   3       115.1   1.0     NR     74.1    
  CRT                      25        1                  109.0                       4.0     NR      100.0   1       109.0   4.0     NR     95.0    
  RT                       1         0                  120.1                       120     ND      ND      0       120.1   120     ND     ND      
  CTX                      4         1                  96.1                        1.0     ND      ND      0       96.1    1.0     ND     ND      
  observation alone        0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
                                                                                                                                                   
  PCNSL                    surgery   44                 9                           99.0    0.0     NR      57.0    3       99.0    0.0    NR      81.5
  surgery + RT             92        34                 103.0                       0.0     29.0    32.8    20      101.0   0.0     30.0   45.7    
  surgery + CRT            197       75                 117.0                       0.0     57.1    48.5    89      117.0   0.0     44.0   34.5    
  surgery + CTX            58        29                 111.1                       0.0     27.0    41.7    28      108.1   0.0     14.0   21.3    
  CRT                      24        12                 91.0                        1.0     32.1    23.0    15      91.0    1.0     18.0   9.7     
  RT                       27        7                  64.0                        0.0     36.0    42.6    4       64.0    0.0     NR     51.5    
  CTX                      9         5                  65.1                        0.0     ND      ND      4       65.1    0.0     ND     ND      
  observation alone        7         4                  84.0                        0.0     ND      ND      2       77.1    0.0     ND     ND      
                                                                                                                                                   
  GI Meningioma            surgery   2,642              54                          129.1   0.0     NR      98.0    224     129.0   0.0    NR      90.6
  surgery + RT             132       4                  119.1                       0.0     NR      98.0    26      119.1   0.0     118    80.7    
  surgery + CRT            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  surgery + CTX            1         0                  97.1                        97.1    ND      ND      0       97.1    97.1    ND     ND      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       119       3                  125.0                       0.0     NR      97.8    6       125.0   0.0     NR     95.7    
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        158       6                  112.1                       0.0     NR      96.8    6       112.1   0.0     NR     95.0    
                                                                                                                                                   
  GII Meningioma           surgery   117                7                           120.1   0.0     NR      93.4    39      120.1   0.0    97.1    60.2
  surgery + RT             51        6                  122.1                       1.0     NR      87.8    20      121.0   0.0     86.1   60.7    
  surgery + CRT            2         1                  99.0                        3.0     ND      ND      2       9.0     1.0     ND     ND      
  surgery + CTX            2         1                  97.1                        86.1    ND      ND      0       97.1    86.1    ND     ND      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
                                                                                                                                                   
  GIII Meningioma          surgery   23                 2                           115.1   0.0     NR      93.8    10      112.1   0.0    45.0    49.7
  surgery + RT             16        2                  107.0                       1.0     NR      83.3    6       89.1    1.0     89.1   63.6    
  surgery + CRT            1         1                  9.0                         9.0     ND      ND      1       6.0     6.0     ND     ND      
  surgery + CTX            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
                                                                                                                                                   
  Schwannoma               surgery   1,121              11                          130.1   0.0     NR      98.8    109     130.1   0.0    NR      88.9
  surgery + RT             100       0                  126.1                       0.0     NR      100.0   13      126.1   0.0     NR     86.5    
  surgery + CRT            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  surgery + CTX            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       100       3                  121.1                       0.0     NR      98.9    2       121.1   0.0     NR     97.3    
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        31        1                  118.0                       0.0     NR      90.9    0       118.0   0.0     NR     100.0   
                                                                                                                                                   
  GH pituitary adenoma     surgery   332                2                           119.0   0.0     NR      99.7    10      119.0   0.0    NR      96.6
  surgery + RT             13        0                  112.0                       4.0     NR      100.0   1       112.0   1.9     NR     92.3    
  surgery + CRT            26        0                  117.1                       5.0     NR      100.0   2       117.1   5.0     NR     91.6    
  surgery + CTX            99        2                  121.0                       0.0     NR      97.3    6       121.0   0.0     NR     94.2    
  CRT                      3         0                  120.1                       54.0    ND      ND      0       120.1   54.0    ND     ND      
  RT                       0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CTX                      4         0                  103.0                       1.0     ND      ND      0       103.0   1.0     ND     ND      
  observation alone        3         0                  105.1                       3.0     ND      ND      0       105.1   3.0     ND     ND      
                                                                                                                                                   
  PRL pituitary adenoma    surgery   296                2                           120.1   0.0     NR      99.5    14      120.1   0.0    NR      94.4
  surgery + RT             5         0                  109.0                       66.0    ND      ND      0       109.0   36.0    ND     ND      
  surgery + CRT            6         0                  101.0                       76.1    ND      ND      1       101.0   45.0    ND     ND      
  surgery + CTX            136       1                  120.1                       0.0     NR      99.1    7       120.1   0.0     NR     94.4    
  CRT                      2         0                  43.0                        6.0     ND      ND      0       36.0    6.0     ND     ND      
  RT                       0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CTX                      35        0                  112.1                       0.0     NR      100.0   2       112.1   0.0     NR     91.7    
  observation alone        4         0                  110.0                       1.0     ND      ND      0       110.0   1.0     ND     ND      
                                                                                                                                                   
  ACTH pituitary adenoma   surgery   107                3                           119.1   0.0     NR      97.4    14      119.1   0.0    NR      84.8
  surgery + RT             11        1                  115.0                       6.0     NR      100.0   3       115.0   6.0     NR     80.0    
  surgery + CRT            3         1                  101.1                       78.0    ND      ND      1       101.1   61.1    ND     ND      
  surgery + CTX            14        1                  103.1                       15.0    NR      92.9    3       103.1   15.0    NR     83.3    
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       1         0                  95.1                        95.1    ND      ND      0       95.1    95.1    ND     ND      
  CTX                      1         0                  79.1                        79.1    ND      ND      0       79.1    79.1    ND     ND      
  observation alone        2         0                  92.1                        7       ND      ND      0       92.1    6.0     ND     ND      
                                                                                                                                                   
  NF pituitary adenoma     surgery   1,229              20                          130.1   0.0     NR      98.4    188     130.1   0.0    NR      83.9
  surgery + RT             69        4                  124.0                       0.0     NR      98.4    3       124.0   0.0     NR     95.0    
  surgery + CRT            2         0                  96.1                        86.1    ND      ND      0       96.1    86.1    ND     ND      
  surgery + CTX            55        2                  122.1                       0.0     NR      94.8    5       117.0   0.0     NR     91.8    
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       6         1                  94.1                        1.0     ND      ND      0       82.1    1.0     ND     ND      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        41        0                  121.1                       0.0     NR      100.0   1       105.1   0.0     NR     94.1    
                                                                                                                                                   
  Craniopharyngioma        surgery   211                10                          120.1   0.0     NR      95.8    66      119.0   0.0    NR      66.2
  surgery + RT             87        2                  122.0                       1.0     NR      96.9    19      122.0   1.0     NR     80.0    
  surgery + CRT            6         0                  119.0                       2.0     ND      ND      2       91.0    2.0     ND     ND      
  surgery + CTX            17        1                  116.0                       3.9     NR      100.0   5       113.1   3.9     NR     67.5    
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       1         0                  42.0                        42.0    ND      ND      0       42.0    42.0    ND     ND      
  CTX                      1         0                  0.0                         0.0     ND      ND      0       0.0     0.0     ND     ND      
  observation alone        7         0                  102.1                       0.0     ND      ND      2       93.0    0.0     ND     ND      
                                                                                                                                                   
  Chordoma                 surgery   32                 3                           120.1   0.0     NR      90.0    18      107.1   0.0    24.0    31.8
  surgery + RT             25        3                  90.1                        0.0     NR      87.7    8       90.1    0.0     75.0   68.6    
  surgery + CRT            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  surgery + CTX            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        1         0                  93.0                        93.0    ND      ND      0       93.0    93.0    ND     ND      
                                                                                                                                                   
  Hemangioblastoma         surgery   178                2                           120.1   0.0     NR      98.0    18      120.1   0.0    NR      87.8
  surgery + RT             5         1                  122.1                       8.0     \-      \-      2       88.1    2.0     \-     \-      
  surgery + CRT            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  surgery + CTX            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       1         0                  0.0                         0.0     ND      ND      0       0.0     0.0     ND     ND      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        3         1                  32.1                        1.0     ND      ND      0       32.1    1.0     ND     ND      
                                                                                                                                                   
  Epidermoid               surgery   119                1                           122.1   0.0     NR      98.7    6       122.1   0.0    NR      92.8
  surgery + RT             0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  surgery + CRT            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  surgery + CTX            0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CRT                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  RT                       0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  CTX                      0         0                  \-                          \-      \-      \-      0       \-      \-      \-     \-      
  observation alone        2         0                  117.0                       53.1    ND      ND      0       117.0   53.1    ND     ND      

28). Overall survival and progression free survival depending on extent of resection {#S4.28}
------------------------------------------------------------------------------------

                            extent of resection   total   Overall survival   Progression free survival                                                           
  ------------------------- --------------------- ------- ------------------ --------------------------- ------- ------- ------- ------- ------- ------- ------- -------
  Pilocytic astrocytoma     none                  2       0                  100.1                       0.0     ND      ND      0       100.1   0.0     ND      ND
  1--50% (biopsy)           49                    8       116.1              0.0                         NR      86.2    17      116.1   0.0     NR      64.5    
  50--75%                   12                    0       124.1              1.0                         NR      100.0   1       124.1   1.0     NR      90.9    
  75--95%                   31                    3       122.0              1.9                         NR      87.7    8       122.0   1.9     NR      77.4    
  95--99%                   30                    1       120.1              0.0                         NR      92.9    10      110.1   0.0     NR      57.3    
  gross total resection     63                    2       122.1              0.0                         NR      95.7    5       122.1   0.0     NR      89.5    
                                                                                                                                                                 
  GII Diffuse astrocytoma   none                  20      8                  118.1                       0.0     28.0    48.2    10      118.1   0.0     17.0    33.9
  1--50% (biopsy)           147                   47      128.1              0.0                         NR      63.8    71      128.1   0.0     55.1    45.9    
  50--75%                   36                    14      102.0              1.0                         73.1    54.5    17      102.0   1.0     22.1    41.1    
  75--95%                   58                    14      109.1              0.0                         NR      80.8    21      108.1   0.0     84.1    57.6    
  95--99%                   52                    4       115.1              0.0                         NR      97.5    14      115.1   0.0     NR      76.6    
  gross total resection     58                    4       116.1              0.0                         NR      95.7    10      116.1   0.0     NR      80.5    
                                                                                                                                                                 
  GII OL&OA                 none                  2       0                  24.0                        12.0    ND      ND      1       12.0    0.0     ND      ND
  1--50% (biopsy)           31                    12      116.1              1.0                         NR      66.5    16      116.1   0.0     44.1    50.0    
  50--75%                   17                    5       110.1              2.0                         94.1    85.1    8       110.1   2.0     39.0    47.3    
  75--95%                   39                    4       116.1              0.9                         NR      89.7    11      116.1   0.9     NR      67.4    
  95--99%                   42                    3       121.1              1.0                         NR      97.3    9       114.1   1.0     109     88.1    
  gross total resection     76                    4       122.1              8.0                         NR      95.7    17      122.1   1.0     NR      86.9    
                                                                                                                                                                 
  GIII AA                   none                  13      7                  31.0                        0.0     16.1    0.0     8       22.1    0.0     5.0     0.0
  1--50% (biopsy)           210                   111     120.1              0.0                         25.0    26.4    110     115.1   0.0     14.0    21.2    
  50--75%                   60                    29      121.1              1.0                         64.1    50.4    31      118.1   0.0     36.0    33.3    
  75--95%                   86                    33      116.1              0.0                         59.0    49.8    53      116.1   0.0     14.0    22.1    
  95--99%                   67                    26      129.0              0.0                         58.0    48.1    35      129.0   0.0     21.0    34.5    
  gross total resection     62                    20      127.1              0.0                         NR      62.1    28      127.1   0.0     58.0    46.9    
                                                                                                                                                                 
  GIII AO&AOA               none                  5       1                  74.0                        1.0     ND      ND      4       74.0    1.0     ND      ND
  1--50% (biopsy)           21                    11      94.1               0.0                         46.0    30.1    13      94.1    0.0     23.0    33.4    
  50--75%                   39                    14      116.0              0.0                         74.0    59.4    17      98.1    0.0     33.0    45.9    
  75--95%                   53                    22      116.1              0.0                         77.1    54.4    29      116.1   0.0     45.0    41.1    
  95--99%                   39                    9       120.1              6.0                         NR      81.0    15      119.0   0.0     88.1    68.1    
  gross total resection     71                    18      120.1              0.0                         NR      80.7    26      120.1   0.0     NR      68.1    
                                                                                                                                                                 
  Glioblastoma              none                  52      20                 110.0                       0.0     9.0     5.8     17      110.0   0.0     9.0     8.7
  1--50% (biopsy)           335                   210     96.1               0.0                         12.0    3.8     182     88.0    0.0     6.0     5.8     
  50--75%                   203                   131     92.0               0.0                         15.0    7.6     126     92.0    0.0     8.0     6.7     
  75--95%                   362                   228     107.1              0.0                         14.0    3.7     221     94.1    0.0     8.0     3.7     
  95--99%                   251                   155     119.0              0.0                         18.0    14.6    158     119.0   0.0     10.1    12.6    
  gross total resection     260                   171     119.0              0.0                         19.0    20.4    169     119.0   0.0     11.0    15.1    
                                                                                                                                                                 
  Ependymoma                none                  1       0                  123.1                       123.1   ND      ND      0       123.1   123.1   ND      ND
  1--50% (biopsy)           3                     0       48.0               0.0                         ND      ND      0       39.0    0.0     ND      ND      
  50--75%                   3                     1       106.1              9.0                         ND      ND      1       106.1   7.0     ND      ND      
  75--95%                   18                    4       119.0              3.0                         NR      68.8    7       117.0   1.9     117.0   57.9    
  95--99%                   17                    2       117.0              2.0                         NR      90.0    4       117.0   2.0     NR      76.2    
  gross total resection     32                    1       108.1              0.0                         NR      96.9    4       108.1   0.0     NR      82.5    
                                                                                                                                                                 
  Anaplastic ependymoma     none                  0       0                  \-                          \-      \-      \-      0       \-      \-      \-      \-
  1--50% (biopsy)           2                     1       30.0               20.0                        ND      ND      1       15.9    5.0     ND      ND      
  50--75%                   5                     3       68.0               3.0                         ND      ND      3       68.0    2.0     ND      ND      
  75--95%                   13                    8       95.1               0.0                         44.1    33.6    8       92.1    0.0     35.0    20.5    
  95--99%                   12                    4       114.0              1.9                         NR      53.5    6       114.0   1.9     15.0    35.6    
  gross total resection     21                    3       119.0              2.0                         NR      82.5    10      119.0   1.0     28.0    45.6    
                                                                                                                                                                 
  Ganglioglioma             none                  1       0                  11.0                        11.0    ND      ND      0       11.0    11.0    ND      ND
  1--50% (biopsy)           7                     2       123.1              1.0                         ND      ND      3       94.1    1.0     ND      ND      
  50--75%                   4                     0       73.1               0.0                         ND      ND      1       73.1    0.0     ND      ND      
  75--95%                   6                     1       97.1               15.0                        ND      ND      1       97.1    3.0     ND      ND      
  95--99%                   3                     0       118.1              24.0                        ND      ND      1       49.0    24.0    ND      ND      
  gross total resection     39                    0       119.0              0.0                         NR      100.0   4       119.0   0.0     NR      86.2    
                                                                                                                                                                 
  Central neurocytoma       none                  2       0                  100.0                       6.0     ND      ND      0       100.0   6.0     ND      ND
  1--50% (biopsy)           8                     0       121.1              3.0                         ND      ND      3       121.1   3.0     ND      ND      
  50--75%                   5                     1       108.1              1.0                         ND      ND      2       91.0    1.0     ND      ND      
  75--95%                   12                    0       123.1              1.0                         NR      100.0   3       123.1   1.0     NR      81.8    
  95--99%                   15                    0       114.0              0.0                         NR      100.0   5       114.0   0.0     NR      64.2    
  gross total resection     22                    0       115.0              0.0                         NR      100.0   2       115.0   0.0     NR      94.1    
                                                                                                                                                                 
  Medulloblastoma           none                  1       0                  0.0                         0.0     ND      ND      0       0       0.0     ND      ND
  1--50% (biopsy)           1                     1       49.1               49.1                        ND      ND      0       49.1    49.1    ND      ND      
  50--75%                   6                     1       85.0               6.0                         ND      ND      2       85.0    5.0     ND      ND      
  75--95%                   13                    2       121.0              1.0                         NR      82.5    4       121.0   1.0     NR      67.7    
  95--99%                   28                    9       115.1              2.0                         NR      68.0    11      115.1   2.0     NR      61.7    
  gross total resection     50                    14      112.1              1.0                         NR      68.5    16      112.1   0.0     NR      63.6    
                                                                                                                                                                 
  Germinoma                 none                  31      2                  120.1                       1.0     NR      96.8    1       120.1   1.0     NR      96.0
  1--50% (biopsy)           140                   5       120.1              0.0                         NR      97.5    22      120.1   0.0     NR      86.1    
  50--75%                   18                    0       115.1              2.0                         NR      100.0   2       115.1   2.0     NR      93.3    
  75--95%                   14                    0       117.0              2.0                         NR      100.0   0       117.0   2.0     NR      100.0   
  95--99%                   11                    0       112.0              5.0                         NR      100.0   0       112.0   5.0     NR      100.0   
  gross total resection     5                     0       97.1               5.0                         ND      ND      0       88.1    0.0     ND      ND      
                                                                                                                                                                 
  PCNSL                     none                  81      34                 91.0                        0.0     28.0    22.7    28      91.0    0.0     21.0    25.2
  1--50% (biopsy)           291                   113     117.0              0.0                         45.1    44.8    102     117.0   0.0     37.1    37.5    
  50--75%                   23                    10      116.1              0.0                         40.0    35.7    9       116.1   0.0     54.0    31.5    
  75--95%                   28                    7       83.0               0.0                         61.1    54.1    10      78.0    0.0     19.0    36.1    
  95--99%                   20                    6       111.1              0.0                         61.1    54.0    7       91.0    0.0     45.0    32.1    
  gross total resection     24                    10      99.0               1.0                         38.0    40.2    11      99.0    1.0     31.0    21.3    
                                                                                                                                                                 
  GI Meningioma             none                  281     9                  125.0                       0.0     NR      97.3    12      125.0   0.0     NR      95.4
  1--50% (biopsy)           76                    4       116.1              0.0                         NR      93.9    14      116.1   0.0     NR      76.2    
  50--75%                   118                   9       121.1              0.0                         NR      91.4    28      121.1   0.0     NR      65.3    
  75--95%                   286                   11      120.1              0.0                         NR      95.9    55      119.1   0.0     116.0   77.7    
  95--99%                   639                   14      122.0              0.0                         NR      98.3    68      120.1   0.0     NR      88.4    
  gross total resection     1,597                 19      129.1              0.0                         NR      98.9    78      129.0   0.0     NR      95.5    
                                                                                                                                                                 
  GII Meningioma            none                  1       0                  76.0                        76.0    ND      ND      0       76.0    76.0    ND      ND
  1--50% (biopsy)           4                     0       74.0               0.0                         ND      ND      0       74.0    0.0     ND      ND      
  50--75%                   9                     3       92.1               2.0                         ND      ND      6       83.0    0.0     ND      ND      
  75--95%                   25                    3       111.0              0.0                         NR      88.6    11      87.0    0.0     60.1    50.5    
  95--99%                   45                    4       122.1              0.0                         NR      91.2    22      121.0   0.0     47.0    49.7    
  gross total resection     86                    5       120.1              0.9                         NR      94.5    20      120.1   0.9     NR      73.7    
                                                                                                                                                                 
  GIII Meningioma           none                  0       0                  \-                          \-      \-      \-      0       \-      \-      \-      \-
  1--50% (biopsy)           1                     0       3.0                3.0                         ND      ND      0       3.0     3.0     ND      ND      
  50--75%                   5                     0       51.0               1.0                         ND      ND      2       30.0    1.0     ND      ND      
  75--95%                   6                     1       80.0               1.0                         ND      ND      3       80.0    1.0     ND      ND      
  95--99%                   8                     2       83.0               4.0                         ND      ND      3       83.0    4.0     ND      ND      
  gross total resection     18                    1       115.1              0.0                         NR      91.7    7       112.1   0.0     89.1    55.5    
                                                                                                                                                                 
  Schwannoma                none                  131     4                  121.1                       0.0     NR      97.9    2       121.1   0.0     NR      97.7
  1--50% (biopsy)           44                    0       127.0              0.0                         NR      100.0   12      119.0   0.0     119.0   68.1    
  50--75%                   99                    1       126.1              0.0                         NR      98.5    20      126.1   0.0     NR      77.0    
  75--95%                   311                   7       130.1              0.0                         NR      97.4    49      130.1   0.0     NR      80.7    
  95--99%                   308                   0       123.0              0.0                         NR      100.0   31      123.0   0.0     NR      90.3    
  gross total resection     424                   1       124.1              0.0                         NR      99.7    8       124.1   0.0     NR      98.2    
                                                                                                                                                                 
  GH pituitary adenoma      none                  10      0                  120.1                       1.0     NR      100.0   0       120.1   1.0     NR      100.0
  1--50% (biopsy)           15                    0       107.0              0.0                         NR      100.0   0       107.0   0.0     NR      100.0   
  50--75%                   31                    1       121.0              0.0                         NR      95.5    4       121.0   0.0     NR      85.0    
  75--95%                   107                   1       119.0              0.0                         NR      98.8    7       119.0   0.0     NR      93.7    
  95--99%                   97                    0       118.1              0.0                         NR      100.0   4       118.1   0.0     NR      96.1    
  gross total resection     208                   2       118.1              0.0                         NR      99.5    3       118.1   0.0     NR      98.1    
                                                                                                                                                                 
  PRL pituitary adenoma     none                  43      0                  112.1                       0.0     NR      100.0   2       112.1   0.0     NR      93.2
  1--50% (biopsy)           20                    0       117.0              0.0                         NR      100.0   3       117.0   0.0     NR      88.1    
  50--75%                   38                    0       118.0              0.0                         NR      100.0   6       118.0   0.0     NR      79.7    
  75--95%                   87                    1       119.1              0.0                         NR      98.4    1       119.1   0.0     NR      98.4    
  95--99%                   77                    0       120.1              0.0                         NR      100.0   3       120.1   0.0     NR      94.8    
  gross total resection     201                   0       120.1              0.0                         NR      100.0   7       120.1   0.0     NR      96.4    
                                                                                                                                                                 
  ACTH pituitary adenoma    none                  4       0                  95.1                        7.0     ND      ND      0       95.1    6.0     ND      ND
  1--50% (biopsy)           3                     0       94.1               41.1                        ND      ND      2       94.1    38.0    ND      ND      
  50--75%                   9                     1       115.0              15.0                        ND      ND      3       115.0   15.0    ND      ND      
  75--95%                   17                    3       112.1              0.0                         NR      92.3    5       102.1   0.0     94.0    65.3    
  95--99%                   27                    1       115.0              0.0                         NR      100.0   7       115.0   0.0     NR      82.9    
  gross total resection     75                    1       119.1              0.0                         NR      97.8    4       119.1   0.0     NR      93.3    
                                                                                                                                                                 
  NF pituitary adenoma      none                  47      1                  121.1                       0.0     NR      96.9    1       105.1   0.0     NR      94.7
  1--50% (biopsy)           76                    2       120.1              0.0                         NR      98.6    22      119.1   0.0     NR      66.6    
  50--75%                   170                   8       130.1              0.0                         NR      96.5    48      130.1   0.0     119.0   70.2    
  75--95%                   386                   10      120.1              0.0                         NR      97.7    68      120.1   0.0     NR      82.4    
  95--99%                   352                   5       128.1              0.0                         NR      98.4    37      128.1   0.0     NR      88.9    
  gross total resection     343                   1       122.0              0.0                         NR      99.6    15      121.0   0.0     NR      96.1    
                                                                                                                                                                 
  Craniopharyngioma         none                  10      0                  102.1                       0.0     NR      100.0   2       93.0    0.0     51.0    45.0
  1--50% (biopsy)           31                    2       120.1              0.0                         114     96.0    8       113.1   0.0     NR      66.0    
  50--75%                   38                    4       122.0              0.0                         NR      87.3    12      122.0   0.0     95.0    62.5    
  75--95%                   78                    1       119.0              0.0                         NR      98.7    34      118.0   0.0     82.1    59.4    
  95--99%                   92                    1       119.0              0.0                         NR      98.6    25      114.1   0.0     NR      73.7    
  gross total resection     73                    4       119.0              0.0                         NR      97.0    12      119.0   0.0     NR      80.7    
                                                                                                                                                                 
  Chordoma                  none                  1       0                  93.0                        93.0    ND      ND      0       93.0    93.0    ND      ND
  1--50% (biopsy)           13                    3       76.1               1.0                         76.1    79.5    6       76.0    1.0     30.0    42.2    
  50--75%                   11                    2       90.1               0.0                         78.0    85.7    5       90.1    0.0     24.0    39.8    
  75--95%                   18                    1       120.1              0.0                         NR      90.0    10      107.1   0.0     50.1    46.8    
  95--99%                   9                     0       107.0              0.0                         ND      ND      2       107.0   0.0     ND      ND      
  gross total resection     3                     0       84.1               0.0                         ND      ND      1       84.1    0.0     ND      ND      
                                                                                                                                                                 
  Hemangioblastoma          none                  4       1                  32.1                        0.0     ND      ND      0       32.1    0.0     ND      ND
  1--50% (biopsy)           0                     0       \-                 \-                          \-      \-      0       \-      \-      \-      \-      
  50--75%                   6                     0       122.1              12.0                        ND      ND      5       49.1    2.0     ND      ND      
  75--95%                   7                     1       94.1               4.0                         ND      ND      3       71.0    3.9     ND      ND      
  95--99%                   20                    0       105.1              0.0                         NR      100.0   3       95.0    0.0     91.1    64.3    
  gross total resection     146                   1       120.1              0.0                         NR      98.9    8       120.1   0.0     NR      95.6    
                                                                                                                                                                 
  Epidermoid                none                  3       0                  117.0                       0.0     ND      ND      0       117.0   0.0     ND      ND
  1--50% (biopsy)           3                     1       76.1               8.1                         ND      ND      1       76.1    8.1     ND      ND      
  50--75%                   11                    0       122.1              1.0                         NR      100.0   1       122.1   1.0     NR      88.9    
  75--95%                   21                    0       110.1              0.0                         NR      100.0   2       110.1   0.0     NR      92.9    
  95--99%                   26                    0       113.1              0.0                         NR      100.0   0       113.1   0.0     NR      100.0   
  gross total resection     54                    0       122.0              0.0                         NR      100.0   2       114.1   0.0     NR      90.5    

29). Overall survival and progression free survival in adult and juvenile tumor {#S4.29}
-------------------------------------------------------------------------------

                           age        total   OS      PFS                                                          
  ------------------------ ---------- ------- ------- ------- ------ ------ ------- ------- ------- ------ ------- -------
  Pilocytic astrocytoma    Under 20   110     6       124.1   0.0    NR     95.6    31      124.1   0.0    NR      70.8
  20 and over              83         8       118.1   0.0     NR     87.0   14      118.1   0.0     NR     78.5    
                                                                                                                   
  GII DA                   Under 20   56      18      107.0   0.0    NR     60.0    19      107.0   0.0    NR      56.0
  20 and over              326        76      128.1   0.0     NR     77.6   128     128.1   0.0     82.1   57.2    
                                                                                                                   
  GII OL&OA                Under 20   11      0       122.1   14.0   NR     100.0   0       122.1   14.0   NR      100.0
  20 and over              200        29      122.0   0.9     NR     89.4   64      122.0   0.0     NR     73.1    
                                                                                                                   
  GIII AA                  Under 20   37      22      107.0   0.0    18.0   25.0    23      107.0   0.0    10.0    23.5
  20 and over              476        208     129.0   0.0     41.0   42.4   248     129.0   0.0     20.0   29.1    
                                                                                                                   
  GIII AO&AOA              Under 20   4       2       120.1   3.0    ND     ND      2       120.1   1.0    ND      ND
  20 and over              228        74      120.1   0.0     NR     68.5   105     120.1   0.0     71.0   54.1    
                                                                                                                   
  Glioblastoma             Under 20   50      36      108.1   0.0    17.0   11.9    36      108.1   0.0    9.0     10.6
  20 and over              1,439      893     119.0   0.0     15.0   10.1   852     119.0   0.0     8.1    9.1     
                                                                                                                   
  Ependymoma               Under 20   34      7       111.1   0.0    NR     72.7    11      111.1   0.0    NR      57.3
  20 and over              44         2       123.1   0.0     NR     97.7   7       123.1   0.0     NR     84.2    
                                                                                                                   
  Anaplastic ependymoma    Under 20   27      8       114.0   0.0    NR     66.3    15      114.0   0.0    28.0    35.5
  20 and over              28         11      119.0   1.9     44.1   48.5   14      119.0   1.9     21.0   35.0    
                                                                                                                   
  Ganglioglioma            Under 20   24      0       123.1   0.0    NR     100.0   3       119.0   0.0    NR      85.2
  20 and over              36         3       109.1   0.0     NR     96.7   7       109.1   0.0     NR     74.3    
                                                                                                                   
  Central neurocytoma      Under 20   8       0       95.0    3.0    ND     ND      1       95.0    3.0    ND      ND
  20 and over              57         1       123.1   0.0     NR     98.2   14      123.1   0.0     NR     78.1    
                                                                                                                   
  Medulloblastoma          Under 20   91      27      115.1   0.0    NR     66.7    30      115.1   0.0    NR      63.3
  20 and over              10         1       121.0   3.0     NR     88.9   4       121.0   2.0     NR     58.3    
                                                                                                                   
  Germinoma                Under 20   144     4       117.0   0.0    NR     98.3    20      117.0   0.0    NR      87.1
  20 and over              91         5       120.1   0.0     NR     95.2   6       120.1   0.0     NR     94.4    
                                                                                                                   
  PCNSL                    Under 20   8       1       105.1   2.0    ND     ND      3       105.1   1.0    ND      ND
  20 and over              467        180     117.0   0.0     41.1   41.6   165     117.0   0.0     34.0   34.2    
                                                                                                                   
  GI Meningioma            Under 20   31      1       116.1   0.0    NR     100.0   10      116.1   0.0    111.1   66.1
  20 and over              3,034      66      129.1   0.0     NR     97.9   253     129.0   0.0     NR     90.8    
                                                                                                                   
  GII Meningioma           Under 20   9       0       121.0   0.9    ND     ND      1       121.0   0.9    ND      ND
  20 and over              164        15      122.1   0.0     NR     90.7   60      120.1   0.0     86.1   59.0.   
                                                                                                                   
  GIII Meningioma          Under 20   2       0       77.1    5.0    ND     ND      1       77.1    5.0    ND      ND
  20 and over              38         5       115.1   0.0     NR     86.0   16      112.1   0.0     65.1   53.5    
                                                                                                                   
  Schwannoma               Under 20   34      2       113.1   0.0    NR     97.0    5       111.1   0.0    NR      88.1
  20 and over              1,318      13      130.1   0.0     NR     98.9   119     130.1   0.0     NR     89.6    
                                                                                                                   
  GH pituitary adenoma     Under 20   8       0       110.1   19.0   ND     ND      1       110.1   19.0   ND      ND
  20 and over              472        4       121.0   0.0     NR     99.2   18      121.0   0.0     NR     95.6    
                                                                                                                   
  PRL pituitary adenoma    Under 20   40      1       120.1   0.0    NR     100.0   3       120.1   0.0    NR      91.2
  20 and over              447        2       120.1   0.0     NR     99.4   21      120.1   0.0     NR     94.5    
                                                                                                                   
  ACTH pituitary adenoma   Under 20   6       1       101.1   76.1   ND     ND      1       101.1   18.1   ND      ND
  20 and over              133        5       119.1   0.0     NR     97.0   20      119.1   0.0     NR     85.1    
                                                                                                                   
  NF pituitary adenoma     Under 20   18      0       90.1    1.0    NR     100.0   3       90.1    1.0    NR      79.1
  20 and over              1,384      27      130.1   0.0     NR     98.2   194     130.1   0.0     NR     85.2    
                                                                                                                   
  Craniopharyngioma        Under 20   81      2       119.0   0.0    NR     98.7    35      116.1   0.0    80.1    57.2
  20 and over              250        11      122.0   0.0     NR     95.7   59      122.0   0.0     NR     74.1    
                                                                                                                   
  Chordoma                 Under 20   8       0       107.1   2.0    ND     ND      3       107.1   2.0    ND      ND
  20 and over              50         6       120.1   0.0     NR     87.0   23      93.0    0.0     45.1   46.2    
                                                                                                                   
  Hemangioblastoma         Under 20   11      1       122.1   0.0    NR     88.9    2       83.0    0.0    NR      76.2
  20 and over              176        3       120.1   0.0     NR     97.1   18      120.1   0.0     NR     87.5    
                                                                                                                   
  Epidermoid               Under 20   10      0       103.0   1.0    NR     100.0   0       97.1    1.0    NR      100.0
  20 and over              112        1       122.1   0.0     NR     98.7   6       122.1   0.0     NR     92.4    

30). Overall survival and progression free survival in supratentorial and infratentorial region {#S4.30}
-----------------------------------------------------------------------------------------------

                          region       total   OS      PFS                                                          
  ----------------------- ------------ ------- ------- ------- ------ ------ ------- ------- ------- ------- ------ -------
  Pilocytic astrocytoma   supratent.   98      8       124.1   0.0    NR     91.2    25      124.1   0.0     NR     73.1
  infratent.              92           6       122.1   0.0     NR     92.8   19      122.1   0.0     NR      75.2   
                                                                                                                    
  GII DA                  supratent.   320     65      116.1   0.0    NR     80.0    124     116.1   0.0     87.1   58.2
  infratent.              54           26      128.1   0.0     54.0   48.5   19      128.1   0.0     NR      55.0   
                                                                                                                    
  GII OL&OA               supratent.   210     28      122.1   0.9    NR     90.5    63      122.1   0.0     NR     75.1
  infratent.              0            0       \-      \-      \-     \-     0       \-      \-      \-      \-     
                                                                                                                    
  GIII AA                 supratent.   439     193     129.0   0.0    41.0   42.4    233     129.0   0.0     21.0   28.8
  infratent.              64           33      121.0   1.0     25.1   31.6   34      121.0   0.0     14.0    27.4   
                                                                                                                    
  GIII AO&AOA             supratent.   228     74      120.1   0.0    NR     68.3    103     120.1   0.0     71.0   55.1
  infratent.              4            2       78.1    0.0     48.6   50.0   4       17.0    0.0     11.0    0.0    
                                                                                                                    
  Glioblastoma            supratent.   1,412   883     119.0   0.0    15.0   10.2    841     119.0   0.0     9.0    9.3
  infratent.              58           32      94.1    0.0     14.0   13.2   36      94.1    0.0     7.0     11.0   
                                                                                                                    
  Ependymoma              supratent.   21      3       123.1   0.0    NR     82.4    6       123.1   0.0     NR     62.4
  infratent.              54           6       119.0   0.0     NR     87.1   11      117.0   0.0     117.0   77.3   
                                                                                                                    
  Anaplastic ependymoma   supratent.   35      12      119.0   0.0    NR     59.4    17      119.0   0.0     35.0   38.2
  infratent.              19           7       114.0   5.0     NR     56.0   12      114.0   5.0     15.0    30.1   
                                                                                                                    
  Ganglioglioma           supratent.   50      1       119.0   0.0    NR     100.0   6       119.0   0.0     NR     83.4
  infratent.              10           2       123.1   0.0     NR     88.9   4       94.1    0.0     NR      55.6   
                                                                                                                    
  Medulloblastoma         supratent.   1       0       3.0     3.0    NR     ND      1       2.0     2.0     2.0    0.0
  infratent.              97           27      121.0   0.0     NR     69.2   33      121.0   0.0     NR      62.6   
                                                                                                                    
  GI Meningioma           supratent.   1,683   36      129.1   0.0    NR     98.1    132     129.0   0.0     NR     91.5
  infratent.              1,091        23      122.0   0.0     NR     98.0   106     121.1   0.0     NR      89.3   
                                                                                                                    
  GII Meningioma          supratent.   124     10      122.1   0.0    NR     91.5    35      120.1   0.0     NR     66.9
  infratent.              32           3       121.0   0.9     NR     88.9   16      121.0   0.9     69.0    51.8   
                                                                                                                    
  Hemangioblastoma        supratent.   3       0       87.0    9.0    NR     100.0   1       87.0    8.0     NR     66.7
  infratent.              182          4       122.1   0.0     NR     96.3   19      120.1   0.0     NR      87.2   
                                                                                                                    
  Epidermoid              supratent.   8       0       117.0   1.0    NR     100.0   0       117.0   1.0     NR     100.0
  infratent.              104          1       122.1   0.0     NR     98.6   5       122.1   0.0     NR      93.8   

31). Cause of death {#S4.31}
-------------------

                           neuronal death except pneumonia and LMM   neuronal death with pneumonia   LMM   TRD except pneumonia   TRD (pneumonia)   cancer or other organ metastases   accident or other disease   others   unknown   number of death                                                             
  ------------------------ ----------------------------------------- ------------------------------- ----- ---------------------- ----------------- ---------------------------------- --------------------------- -------- --------- ----------------- ---- ------- ---- ------- ---- ------- ---- ------- ----- --------
  Pilocytic astrocytoma    4                                         (29%)                           6     (43%)                  \-                ( - )                              \-                          ( - )    \-        ( - )             1    (7%)    3    (21%)   \-   ( - )   \-   ( - )   14    (100%)
  GII DA                   39                                        (41%)                           37    (39%)                  3                 (3%)                               2                           (2%)     1         (1%)              2    (2%)    \-   ( - )   \-   ( - )   10   (11%)   94    (100%)
  GII OL&OA                6                                         (21%)                           15    (52%)                  \-                ( - )                              1                           (3%)     \-        ( - )             \-   ( - )   2    (7%)    2    (7%)    3    (10%)   29    (100%)
  GIII AA                  80                                        (35%)                           113   (49%)                  4                 (2%)                               6                           (3%)     8         (3%)              8    (3%)    2    (1%)    3    (1%)    6    (3%)    230   (100%)
  GIII AO&AOA              16                                        (21%)                           38    (50%)                  3                 (4%)                               \-                          ( - )    3         (4%)              6    (8%)    3    (4%)    2    (3%)    5    (7%)    76    (100%)
  Glioblastoma             305                                       (33%)                           447   (48%)                  16                (2%)                               23                          (2%)     16        (2%)              28   (3%)    14   (2%)    10   (1%)    70   (8%)    929   (100%)
  Ependymoma               5                                         (56%)                           3     (33%)                  \-                ( - )                              \-                          ( - )    \-        ( - )             \-   ( - )   1    (11%)   \-   ( - )   \-   ( - )   9     (100%)
  AE                       4                                         (21%)                           9     (47%)                  1                 (5%)                               \-                          ( - )    \-        ( - )             5    (26%)   \-   ( - )   \-   ( - )   \-   ( - )   19    (100%)
  Ganglioglioma            3                                         (100%)                          \-    ( - )                  \-                ( - )                              \-                          ( - )    \-        ( - )             \-   ( - )   \-   ( - )   \-   ( - )   \-   ( - )   3     (100%)
  Central neurocytoma      \-                                        ( - )                           \-    ( - )                  \-                ( - )                              1                           (100%)   \-        ( - )             \-   ( - )   \-   ( - )   \-   ( - )   \-   ( - )   1     (100%)
  Medulloblastoma          12                                        (43%)                           9     (32%)                  2                 (7%)                               1                           (4%)     \-        ( - )             4    (14%)   \-   ( - )   \-   ( - )   \-   ( - )   28    (100%)
  Germinoma                3                                         (33%)                           1     (11%)                  \-                ( - )                              \-                          ( - )    \-        ( - )             \-   ( - )   \-   ( - )   3    (33%)   2    (22%)   9     (100%)
  PCNSL                    54                                        (30%)                           58    (32%)                  5                 (3%)                               5                           (3%)     19        (10%)             20   (11%)   3    (2%)    3    (2%)    14   (8%)    181   (100%)
  GI Meningioma            2                                         (3%)                            9     (13%)                  \-                ( - )                              9                           (13%)    6         (9%)              7    (10%)   16   (24%)   9    (13%)   9    (13%)   67    (100%)
  GII Meningioma           5                                         (33%)                           4     (27%)                  \-                ( - )                              \-                          ( - )    \-        ( - )             1    (7%)    \-   ( - )   2    (13%)   3    (20%)   15    (100%)
  GIII Meningioma          1                                         (20%)                           4     (80%)                  \-                ( - )                              \-                          ( - )    \-        ( - )             \-   ( - )   \-   ( - )   \-   ( - )   \-   ( - )   5     (100%)
  Schwannoma               \-                                        ( - )                           4     (27%)                  \-                ( - )                              1                           (7%)     2         (13%)             1    (7%)    \-   ( - )   4    (27%)   3    (20%)   15    (100%)
  GH pituitary adenoma     \-                                        ( - )                           \-    ( - )                  \-                ( - )                              1                           (25%)    \-        ( - )             1    (25%)   1    (25%)   \-   ( - )   1    (25%)   4     (100%)
  PRL pituitary adenoma    \-                                        ( - )                           \-    ( - )                  \-                ( - )                              \-                          ( - )    \-        ( - )             \-   ( - )   \-   ( - )   1    (33%)   2    (67%)   3     (100%)
  ACTH pituitary adenoma   1                                         (17%)                           2     (33%)                  \-                ( - )                              1                           (17%)    \-        ( - )             \-   ( - )   1    (17%)   1    (17%)   \-   ( - )   6     (100%)
  NF pituitary adenoma     1                                         (4%)                            1     (4%)                   \-                ( - )                              \-                          ( - )    4         (15%)             5    (19%)   8    (30%)   4    (15%)   4    (15%)   27    (100%)
  Craniopharyngioma        3                                         (23%)                           2     (15%)                  \-                ( - )                              2                           (15%)    \-        ( - )             1    (8%)    3    (23%)   \-   ( - )   2    (15%)   13    (100%)
  Chordoma                 3                                         (50%)                           1     (17%)                  \-                ( - )                              \-                          ( - )    1         (17%)             \-   ( - )   1    (17%)   \-   ( - )   \-   ( - )   6     (100%)
  Hemangioblastoma         \-                                        ( - )                           2     (50%)                  \-                ( - )                              \-                          ( - )    \-        ( - )             \-   ( - )   \-   ( - )   2    (50%)   \-   ( - )   4     (100%)
  Epidermoid               \-                                        ( - )                           \-    ( - )                  1                 (100%)                             \-                          ( - )    \-        ( - )             \-   ( - )   \-   ( - )   \-   ( - )   \-   ( - )   1     (100%)

32). Place of death {#S4.32}
-------------------

  place of death           hospital with NSD   hospital without NSD   hospice   nursing home   home   others   unknown   number of death                                                  
  ------------------------ ------------------- ---------------------- --------- -------------- ------ -------- --------- ----------------- ---- ------- ---- -------- ----- ------- ----- --------
  Pilocytic astrocytoma    11                  (79%)                  \-        ( - )          \-     ( - )    \-        ( - )             1    (7%)    1    (7%)     1     (7%)    14    (100%)
  GII DA                   67                  (71%)                  5         (5%)           7      (7%)     \-        ( - )             3    (3%)    1    (1%)     11    (12%)   94    (100%)
  GII OL&OA                22                  (76%)                  1         (3%)           1      (3%)     \-        ( - )             2    (7%)    \-   ( - )    3     (10%)   29    (100%)
  GIII AA                  179                 (78%)                  17        (7%)           8      (3%)     \-        ( - )             5    (2%)    \-   ( - )    21    (9%)    230   (100%)
  GIII AO&AOA              49                  (64%)                  10        (13%)          3      (4%)     1         (1%)              1    (1%)    \-   ( - )    12    (16%)   76    (100%)
  Glioblastoma             646                 (70%)                  98        (11%)          44     (5%)     1         (0.1%)            28   (3%)    1    (0.1%)   111   (12%)   929   (100%)
  Ependymoma               8                   (89%)                  \-        ( - )          \-     ( - )    \-        ( - )             1    (11%)   \-   ( - )    \-    ( - )   9     (100%)
  AE                       18                  (95%)                  \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    1     (5%)    19    (100%)
  Ganglioglioma            3                   (100%)                 \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-    ( - )   3     (100%)
  Central neurocytoma      1                   (100%)                 \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-    ( - )   1     (100%)
  Medulloblastoma          26                  (93%)                  1         (4%)           \-     ( - )    \-        ( - )             1    (4%)    \-   ( - )    \-    ( - )   28    (100%)
  Germinoma                6                   (67%)                  \-        ( - )          \-     ( - )    \-        ( - )             1    (11%)   \-   ( - )    2     (22%)   9     (100%)
  PCNSL                    146                 (81%)                  17        (9%)           4      (2%)     \-        ( - )             5    (3%)    \-   ( - )    9     (5%)    181   (100%)
  GI Meningioma            47                  (70%)                  7         (10%)          1      (1%)     \-        ( - )             2    (3%)    1    (1%)     9     (13%)   67    (100%)
  GII Meningioma           11                  (73%)                  \-        ( - )          2      (13%)    \-        ( - )             \-   ( - )   \-   ( - )    2     (13%)   15    (100%)
  GIII Meningioma          5                   (100%)                 \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-    ( - )   5     (100%)
  Schwannoma               8                   (53%)                  2         (13%)          \-     ( - )    \-        ( - )             3    (20%)   \-   ( - )    2     (13%)   15    (100%)
  GH pituitary adenoma     3                   (75%)                  \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    1     (25%)   4     (100%)
  PRL pituitary adenoma    1                   (33%)                  \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    2     (67%)   3     (100%)
  ACTH pituitary adenoma   6                   (100%)                 \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-    ( - )   6     (100%)
  NF pituitary adenoma     22                  (81%)                  \-        ( - )          \-     ( - )    \-        ( - )             2    (7%)    \-   ( - )    3     (11%)   27    (100%)
  Craniopharyngioma        12                  (92%)                  1         (8%)           \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-    ( - )   13    (100%)
  Chordoma                 5                   (83%)                  \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    1     (17%)   6     (100%)
  Hemangioblastoma         4                   (100%)                 \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-    ( - )   4     (100%)
  Epidermoid               1                   (100%)                 \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-    ( - )   1     (100%)

33). Autopsy {#S4.33}
------------

  Autopsy                  ( -- )   ( + )    unknown   total death                         
  ------------------------ -------- -------- --------- ------------- ----- ------- ------- --------
  Pilocytic astrocytoma    13       (93%)    1         (7%)          \-    ( - )   14      (100%)
  GII DA                   77       (82%)    3         (3%)          14    (15%)   94      (100%)
  GII OL&OA                22       (76%)    3         (10%)         4     (14%)   29      (100%)
  GIII AA                  201      (87%)    15        (7%)          14    (6%)    230     (100%)
  GIII AO&AOA              68       (89%)    1         (1%)          7     (9%)    76      (100%)
  Glioblastoma             769      (83%)    49        (5%)          111   (12%)   929     (100%)
  Ependymoma               7        (78%)    1         (11%)         1     (11%)   9       (100%)
  AE                       17       (89%)    2         (11%)         \-    ( - )   19      (100%)
  Ganglioglioma            2        (67%)    1         (33%)         \-    ( - )   3       (100%)
  Central neurocytoma      1        (100%)   \-        ( - )         \-    ( - )   1       (100%)
  Medulloblastoma          21       (75%)    6         (21%)         1     (4%)    28      (100%)
  Germinoma                7        (78%)    1         (11%)         1     (11%)   9       (100%)
  PCNSL                    156      (86%)    13        (7%)          12    (7%)    181     (100%)
  GI Meningioma            49       (73%)    11        (16%)         7     (10%)   67      (100%)
  GII Meningioma           9        (60%)    3         (20%)         3     (20%)   15      (100%)
  GIII Meningioma          3        (60%)    1         (20%)         1     (20%)   5       (100%)
  Schwannoma               11       (73%)    1         (7%)          3     (20%)   15      (100%)
  GH pituitary adenoma     3        (75%)    \-        ( - )         1     (25%)   4       (100%)
  PRL pituitary adenoma    \-       ( - )    \-        ( - )         3     ( - )   3       (100%)
  ACTH pituitary adenoma   4        (67%)    2         (33%)         \-    ( - )   6       (100%)
  NF pituitary adenoma     20       (74%)    1         (4%)          6     (22%)   27      (100%)
  Craniopharyngioma        12       (92%)    1         (8%)          \-    ( - )   13      (100%)
  Chordoma                 4        (67%)    1         (17%)         1     (17%)   6       (100%)
  Hemangioblastoma         4        (100%)   \-        ( - )         \-    ( - )   4       (100%)
  Epidermoid               1        (100%)   \-        ( - )         \-    ( - )   1       (100%)
                                                                                           
  Total                    1,481    (83%)    117       (7%)          190   (11%)   1,788   

34). Transfer to another hospital {#S4.34}
---------------------------------

  transfer/reason          none    for further treatment   Palliative care   other reasons   total                                  
  ------------------------ ------- ----------------------- ----------------- --------------- ------- -------- ----- ------- ------- --------
  Pilocytic astrocytoma    166     (86%)                   13                (7%)            1       (1%)     13    (7%)    193     (100%)
  GII DA                   273     (71%)                   37                (10%)           37      (10%)    35    (9%)    382     (100%)
  GII OL&OA                162     (77%)                   20                (9%)            9       (4%)     20    (9%)    211     (100%)
  GIII AA                  303     (59%)                   73                (14%)           88      (17%)    49    (10%)   513     (100%)
  GIII AO&AOA              158     (68%)                   27                (12%)           25      (11%)    22    (9%)    232     (100%)
  Glioblastoma             740     (50%)                   202               (14%)           383     (26%)    164   (11%)   1,489   (100%)
  Ependymoma               58      (74%)                   11                (14%)           \-      ( - )    9     (12%)   78      (100%)
  AE                       42      (76%)                   7                 (13%)           1       (2%)     5     (9%)    55      (100%)
  Ganglioglioma            50      (83%)                   4                 (7%)            1       (2%)     5     (8%)    60      (100%)
  Central neurocytoma      52      (80%)                   7                 (11%)           \-      ( - )    6     (9%)    65      (100%)
  Medulloblastoma          87      (86%)                   6                 (6%)            5       (5%)     3     (3%)    101     (100%)
  Germinoma                202     (86%)                   18                (8%)            \-      ( - )    15    (6%)    235     (100%)
  PCNSL                    247     (52%)                   101               (21%)           66      (14%)    61    (13%)   475     (100%)
  GI Meningioma            2,524   (82%)                   185               (6%)            11      (0.4%)   345   (11%)   3,065   (100%)
  GII Meningioma           117     (68%)                   27                (16%)           5       (3%)     24    (14%)   173     (100%)
  GIII Meningioma          24      (60%)                   4                 (10%)           2       (5%)     10    (25%)   40      (100%)
  Schwannoma               1,162   (86%)                   80                (6%)            4       (0.3%)   106   (8%)    1,352   (100%)
  GH pituitary adenoma     439     (91%)                   10                (2%)            \-      ( - )    31    (6%)    480     (100%)
  PRL pituitary adenoma    430     (88%)                   12                (2%)            \-      ( - )    45    (9%)    487     (100%)
  ACTH pituitary adenoma   117     (84%)                   6                 (4%)            1       (1%)     15    (11%)   139     (100%)
  NF pituitary adenoma     1,289   (92%)                   36                (3%)            6       (0.4%)   71    (5%)    1,402   (100%)
  Craniopharyngioma        271     (82%)                   31                (9%)            \-      ( - )    29    (9%)    331     (100%)
  Chordoma                 36      (62%)                   11                (19%)           4       (7%)     7     (12%)   58      (100%)
  Hemangioblastoma         154     (82%)                   21                (11%)           \-      ( - )    12    (6%)    187     (100%)
  Epidermoid               102     (84%)                   9                 (7%)            1       (1%)     10    (8%)    122     (100%)

35). Complication during the whole treatment {#S4.35}
--------------------------------------------

                           none    intracranial hemorrhage   cerebral infarction   pneumonia   pulmonary embolization   deep vein thrombosis   bone fracture   second cancer   others   unknown   patient number                                                                            
  ------------------------ ------- ------------------------- --------------------- ----------- ------------------------ ---------------------- --------------- --------------- -------- --------- ---------------- -------- ---- -------- ---- -------- ----- ------- ----- ------- ------- --------
  Pilocytic astrocytoma    161     (83%)                     4                     (2%)        2                        (1%)                   \-              ( - )           \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    12    (6%)    16    (8%)    193     (100%)
  GII DA                   307     (80%)                     7                     (2%)        1                        (0.3%)                 15              (4%)            1        (0.3%)    3                (1%)     1    (0.3%)   \-   ( - )    21    (5%)    33    (9%)    382     (100%)
  GII OL&OA                179     (85%)                     3                     (1%)        3                        (1%)                   6               (3%)            \-       ( - )     1                (0.5%)   \-   ( - )    \-   ( - )    14    (7%)    8     (4%)    211     (100%)
  GIII AA                  348     (68%)                     21                    (4%)        5                        (1%)                   47              (9%)            2        (0.4%)    7                (1%)     1    (0.2%)   2    (0.4%)   38    (7%)    60    (12%)   513     (100%)
  GIII AO&AOA              142     (61%)                     4                     (2%)        8                        (3%)                   14              (6%)            1        (0.4%)    1                (0.4%)   \-   ( - )    5    (2%)     19    (8%)    45    (19%)   232     (100%)
  Glioblastoma             1,008   (68%)                     42                    (3%)        22                       (1%)                   148             (10%)           11       (1%)      23               (2%)     6    (0.4%)   2    (0.1%)   123   (8%)    171   (11%)   1,489   (100%)
  Ependymoma               61      (78%)                     2                     (3%)        1                        (1%)                   4               (5%)            \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    11    (14%)   1     (1%)    78      (100%)
  AE                       47      (85%)                     1                     (2%)        \-                       ( - )                  \-              ( - )           \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    5     (9%)    2     (4%)    55      (100%)
  Ganglioglioma            54      (90%)                     \-                    ( - )       1                        (2%)                   2               (3%)            \-       ( - )     \-               ( - )    1    (2%)     \-   ( - )    2     (3%)    1     (2%)    60      (100%)
  Central neurocytoma      53      (82%)                     1                     (2%)        2                        (3%)                   \-              ( - )           1        (2%)      \-               ( - )    \-   ( - )    \-   ( - )    6     (9%)    2     (3%)    65      (100%)
  Medulloblastoma          85      (84%)                     2                     (2%)        1                        (1%)                   1               (1%)            \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    11    (11%)   5     (5%)    101     (100%)
  Germinoma                203     (86%)                     \-                    ( - )       \-                       ( - )                  5               (2%)            \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    16    (7%)    13    (6%)    235     (100%)
  PCNSL                    342     (72%)                     6                     (1%)        4                        (1%)                   60              (13%)           7        (1%)      6                (1%)     \-   ( - )    \-   ( - )    36    (8%)    36    (8%)    475     (100%)
  GI Meningioma            2,566   (84%)                     37                    (1%)        48                       (2%)                   31              (1%)            10       (0.3%)    18               (1%)     4    (0.1%)   1    (0.0%)   244   (8%)    169   (6%)    3,065   (100%)
  GII Meningioma           131     (76%)                     3                     (2%)        3                        (2%)                   3               (2%)            \-       ( - )     2                (1%)     2    (1%)     \-   ( - )    22    (13%)   9     (5%)    173     (100%)
  GIII Meningioma          31      (78%)                     1                     (3%)        \-                       ( - )                  \-              ( - )           \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    5     (13%)   5     (13%)   40      (100%)
  Schwannoma               1,114   (82%)                     11                    (1%)        7                        (1%)                   8               (1%)            1        (0.1%)    5                (0.4%)   2    (0.1%)   \-   ( - )    177   (13%)   47    (3%)    1,352   (100%)
  GH pituitary adenoma     450     (94%)                     \-                    ( - )       2                        (0.4%)                 1               (0.2%)          1        (0.2%)    \-               ( - )    2    (0.4%)   \-   ( - )    21    (4%)    4     (1%)    480     (100%)
  PRL pituitary adenoma    445     (91%)                     2                     (0.4%)      1                        (0.2%)                 \-              ( - )           \-       ( - )     \-               ( - )    1    (0.2%)   \-   ( - )    28    (6%)    17    (3%)    487     (100%)
  ACTH pituitary adenoma   125     (90%)                     1                     (1%)        \-                       ( - )                  2               (1%)            \-       ( - )     \-               ( - )    2    (1%)     \-   ( - )    10    (7%)    1     (1%)    139     (100%)
  NF pituitary adenoma     1,275   (91%)                     16                    (1%)        10                       (1%)                   2               (0.1%)          1        (0.1%)    4                (0.3%)   1    (0.1%)   \-   ( - )    69    (5%)    39    (3%)    1,402   (100%)
  Craniopharyngioma        260     (79%)                     8                     (2%)        7                        (2%)                   4               (1%)            4        (1%)      6                (2%)     \-   ( - )    \-   ( - )    42    (13%)   11    (3%)    331     (100%)
  Chordoma                 51      (88%)                     \-                    ( - )       \-                       ( - )                  2               (3%)            \-       ( - )     \-               ( - )    1    (2%)     \-   ( - )    5     (9%)    1     (2%)    58      (100%)
  Hemangioblastoma         158     (84%)                     6                     (3%)        5                        (3%)                   5               (3%)            \-       ( - )     \-               ( - )    \-   ( - )    2    (1%)     9     (5%)    7     (4%)    187     (100%)
  Epidermoid               103     (84%)                     1                     (1%)        2                        (2%)                   1               (1%)            \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    10    (8%)    8     (7%)    122     (100%)

5.. Detailed survival data in major primary brain tumors (2001--2004) {#S5}
=====================================================================

1). Definition of major primary brain tumors {#S5.1}
--------------------------------------------

  --------------------------- ------------------------------------------------------
  **ALL Gliomas**             ID 1--59 (page 14)
  **ALL Meningioma**          ID 74--89, ALL grade I, II, III meningioma (page 33)
  **ALL Pituitary adenoma**   ID 141--147, ALL pituitary adenoma (page 33)
  **Other major tumors**      see top 25 primary brain tumors (page 33
  --------------------------- ------------------------------------------------------

2). Detailed overall survival and progression free survival in major primary tumors {#S5.2}
-----------------------------------------------------------------------------------

                          total   OS      PFS                                                                                                                                    
  ----------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------ ------- ------- ------- ------- ------- ------- ------- ------- ------
  All Gliomas             ALL     3,800   1,555   129.0   0.0     58.0    79.2    61.7    55.2    52.0    49.6   1,760   129.0   0.0     29.0    63.9    52.3    46.7    44.3    41.6
  0--4                    154     42      122.0   0.0     NR      83.3    78.8    75.6    73.2    71.5    59     122.0   0.0     NR      75.6    62.7    59.3    56.6    55.7    
  5--9                    167     58      124.1   0.0     NR      79.1    67.0    62.5    60.9    59.3    61     124.1   0.0     NR      73.5    63.9    57.8    57.8    54.9    
  10--14                  161     48      124.0   0.0     NR      86.1    77.5    70.6    68.3    66.0    63     124.0   0.0     NR      78.3    69.9    60.5    58.0    54.5    
  15--19                  124     35      120.1   0.0     NR      89.0    79.5    73.5    70.2    66.8    49     120.1   0.0     NR      73.9    65.2    59.2    57.1    55.9    
  20--29                  367     99      128.1   0.0     NR      93.4    87.0    81.2    78.4    73.9    159    128.1   0.0     72.0    83.6    70.1    61.5    58.2    53.3    
  30--39                  470     135     129.0   0.0     NR      91.9    82.9    76.1    73.2    69.6    199    129.0   0.0     79.0    80.3    70.7    65.2    61.5    57.6    
  40--49                  446     153     121.1   0.0     NR      87.2    73.2    69.0    64.4    59.8    205    121.1   0.0     55.1    68.2    59.3    54.3    51.3    48.5    
  50--59                  656     303     123.1   0.0     28.0    80.3    53.2    46.1    42.6    40.9    332    123.1   0.0     18.0    57.4    44.8    38.4    35.7    32.0    
  60--69                  732     402     122.0   0.0     18.0    69.1    39.3    28.2    24.2    23.6    398    122.0   0.0     10.1    45.4    30.5    26.3    25.0    23.9    
  70--79                  454     249     115.0   0.0     12.0    49.9    20.6    14.9    11.0    11.0    213    112.1   0.0     9.0     36.7    17.8    15.8    13.2    13.2    
  80--89                  67      31      45.0    0.0     8.0     36.5    19.5    9.7     ND      ND      22     45.0    0.0     8.0     43.1    23.1    11.6    ND      ND      
                                                                                                                                                                                 
  GII DA                  ALL     382     94      128.1   0.0     NR      95.4    84.2    78.7    78.0    75.0   147     128.1   0.0     84.1    84.0    71.8    66.5    61.6    57.0
  0--4                    8       4       107.0   0.0     NR      66.7    66.7    50.0    33.3    33.3    4      107.0   0.0     NR      50.0    33.3    33.3    33.3    33.3    
  5--9                    18      8       99.0    0.0     24.0    80.0    46.7    46.7    46.7    46.7    5      98.1    0.0     NR      86.7    63.0    63.0    63.0    63.0    
  10--14                  15      2       105.0   0.0     NR      100.0   90.9    81.8    81.8    81.8    3      105.0   0.0     NR      80.0    80.0    70.0    70.0    70.0    
  15--19                  15      4       99.1    0.0     NR      92.3    76.9    69.2    69.2    69.2    7      99.1    0.0     43.1    62.3    54.5    54.5    46.8    46.8    
  20--29                  75      19      128.1   0.0     NR      98.5    90.7    84.2    84.2    80.9    34     128.1   0.0     70.1    89.8    71.5    64.9    61.6    56.4    
  30--39                  95      15      118.1   0.0     NR      98.9    92.9    89.2    89.2    85.2    36     118.1   0.0     NR      92.9    81.9    75.4    70.1    63.3    
  40--49                  58      14      116.1   1.9     NR      100.0   96.1    90.1    88.0    83.6    23     116.1   1.0     NR      87.3    83.6    75.6    67.4    65.3    
  50--59                  48      10      116.0   0.0     NR      97.8    85.1    81.7    81.7    77.8    18     116.0   0.0     59.0    78.3    68.1    64.5    56.7    43.9    
  60--69                  33      11      112.1   0.0     36.0    96.7    60.3    49.1    49.1    49.1    11     112.1   0.0     NR      66.4    52.2    52.2    52.2    52.2    
  70--79                  17      7       23.0    0.0     16.0    37.5    0.0     0.0     0.0     0.0     6      19.0    0.0     11.1    44.2    0.0     0.0     0.0     0.0     
  80--89                  \-      \-      \-      \-      \-      \-      \-      \-      \-      \-      \-     \-      \-      \-      \-      \-      \-      \-      \-      
                                                                                                                                                                                 
  GII OL&OA               ALL     211     29      122.1   0.9     NR      98.0    95.9    93.0    91.2    90.0   64      122.1   0.0     NR      94.9    87.6    78.8    76.4    74.6
  0--4                    1       0       89.1    89.1    NR      100.0   100.0   100.0   100.0   100.0   0      89.1    89.1    NR      100.0   100.0   100.0   100.0   100.0   
  5--9                    3       0       122.1   14.0    NR      100.0   100.0   100.0   100.0   100.0   0      122.1   14.0    NR      100.0   100.0   100.0   100.0   100.0   
  10--14                  4       0       116.1   57.0    NR      100.0   100.0   100.0   100.0   100.0   0      116.1   54.0    NR      100.0   100.0   100.0   100.0   100.0   
  15--19                  3       0       109.1   63.0    NR      100.0   100.0   100.0   100.0   100.0   0      109.1   59.0    NR      100.0   100.0   100.0   100.0   100.0   
  20--29                  25      1       116.1   2.9     NR      100.0   100.0   100.0   100.0   100.0   8      116.1   2.9     NR      100.0   91.7    79.2    79.2    79.2    
  30--39                  65      5       121.1   0.9     NR      100.0   100.0   98.1    96.2    96.2    22     116.1   0.0     109.1   96.8    93.4    86.1    82.5    80.6    
  40--49                  44      5       114.1   2.0     NR      100.0   100.0   97.1    94.3    91.2    10     114.1   2.0     NR      97.4    91.9    83.3    83.3    80.2    
  50--59                  41      9       118.1   1.0     NR      97.6    94.7    88.0    88.0    88.0    16     118.1   0.0     NR      89.0    76.4    63.7    57.3    54.1    
  60--69                  19      5       122.0   1.0     NR      94.7    82.1    74.6    74.6    67.2    6      122.0   0.0     NR      86.7    73.3    66.0    66.0    66.0    
  70--79                  6       4       79.1    8.0     20.1    62.5    41.7    41.7    20.8    20.8    2      23.0    1.0     23.0    83.3    0.0     0.0     0.0     0.0     
  80--89                  \-      \-      \-      \-      \-      \-      \-      \-      \-      \-      \-     \-      \-      \-      \-      \-      \-      \-      \-      
                                                                                                                                                                                 
  GIII AA                 ALL     513     230     129.0   0.0     38.0    80.8    63.1    51.8    44.8    41.1   271     129.0   0.0     19.0    60.7    45.1    36.9    32.8    28.7
  0--4                    7       2       107.0   2.0     NR      66.7    66.7    66.7    66.7    66.7    2      107.0   2.0     NR      80.0    60.0    60.0    60.0    60.0    
  5--9                    11      6       89.1    3.0     20.1    64.9    26.0    26.0    26.0    26.0    6      89.1    0.0     10.0    31.8    31.8    15.9    15.9    15.9    
  10--14                  9       8       35.0    6.0     23.5    50.0    25.0    0.0     0.0     0.0     8      27.0    0.0     8.0     44.4    14.8    0.0     0.0     0.0     
  15--19                  10      6       88.1    0.0     15.9    66.7    40.0    20.0    20.0    20.0    7      88.1    0.0     4.0     22.2    22.2    22.2    22.2    22.2    
  20--29                  50      22      118.1   1.0     66.1    91.4    82.4    72.6    60.1    54.3    29     118.1   0.0     29.0    80.5    63.5    42.5    37.2    31.0    
  30--39                  82      38      129.0   1.0     64.1    88.0    72.9    59.9    56.7    51.2    46     129.0   1.0     36.0    73.5    55.1    48.7    43.7    40.2    
  40--49                  71      23      121.0   0.0     87.0    93.5    76.9    70.4    63.8    56.6    36     121.0   0.0     42.0    68.5    54.4    52.3    43.5    33.9    
  50--59                  97      41      109.1   0.0     41.0    81.4    63.0    54.1    44.3    40.1    49     109.1   0.0     20.0    62.1    45.8    36.5    32.6    28.8    
  60--69                  106     47      121.1   0.9     30.0    80.0    63.2    41.3    30.8    30.8    53     109.1   0.0     12.0    49.5    35.9    27.4    27.4    24.0    
  70--79                  58      30      74.0    0.0     14.0    60.8    25.3    25.3    20.3    20.3    29     74.0    0.0     7.1     30.8    17.6    17.6    11.7    11.7    
  80--89                  12      7       32.0    0.0     9.1     40.4    40.4    0.0     0.0     0.0     6      26.0    0.0     14.1    61.1    20.4    0.0     0.0     0.0     
                                                                                                                                                                                 
  GIII AO&AOA             ALL     232     76      120.1   0.0     NR      92.3    82.5    78.7    75.4    68.2   107     120.1   0.0     71.0    79.0    69.9    60.4    55.9    54.0
  0--4                    2       2       11.0    3.0     7.0     0.0     0.0     0.0     0.0     0.0     2      11.0    1.0     6.0     0.0     0.0     0.0     0.0     0.0     
  5--9                    0       0       \-      \-      \-      \-      \-      \-      \-      \-      0      \-      \-      \-      \-      \-      \-      \-      \-      
  10--14                  0       0       \-      \-      \-      \-      \-      \-      \-      \-      0      \-      \-      \-      \-      \-      \-      \-      \-      
  15--19                  2       0       120.1   82.1    NR      100.0   100.0   100.0   100.0   100.0   0      120.1   82.1    NR      100.0   100.0   100.0   100.0   100.0   
  20--29                  17      5       116.1   1.0     NR      100.0   93.3    93.3    86.7    64.2    8      116.1   1.0     64.1    93.3    80.0    66.7    53.3    53.3    
  30--39                  46      10      120.1   0.0     110.1   97.8    95.3    92.7    92.7    81.1    16     120.1   0.0     NR      88.2    85.7    75.9    70.7    70.7    
  40--49                  53      15      120.1   0.0     NR      95.5    86.0    86.0    80.8    69.8    28     119.0   0.0     44.1    71.7    61.0    52.0    49.6    49.6    
  50--59                  62      21      120.1   0.0     102.1   94.8    79.6    73.8    67.4    64.8    25     120.1   0.0     79.0    85.5    71.8    61.6    61.6    56.5    
  60--69                  37      14      112.1   1.0     97.1    87.5    77.6    70.6    70.6    70.6    19     104.1   1.0     71.0    74.9    71.6    60.9    53.7    50.1    
  70--79                  11      8       115.0   1.0     21.0    58.3    46.7    35.0    35.0    35.0    8      48.0    1.0     7.0     36.0    24.0    24.0    0.0     0.0     
  80--89                  2       1       19.0    17.0    19.0    100.0   0.0     0.0     0.0     0.0     1      17.0    15.0    17.0    100.0   0.0     0.0     0.0     0.0     
                                                                                                                                                                                 
  Glioblastoma            ALL     1,489   929     119.0   0.0     15.0    60.3    25.4    15.9    11.1    10.1   888     119.0   0.0     8.1     34.7    17.5    13.1    11.9    9.2
  0--4                    4       3       17.0    4.9     12.0    37.5    0.0     0.0     0.0     0.0     2      17.0    1.0     NR      50.0    ND      ND      ND      ND      
  5--9                    14      8       108.1   0.0     18.0    62.9    25.1    12.6    12.6    12.6    10     108.1   0.0     7.0     22.4    11.2    11.2    11.2    11.2    
  10--14                  18      14      57.0    2.0     14.0    54.2    20.3    13.5    6.8     ND      13     57.0    1.0     9.0     32.7    16.3    8.2     8.2     0.0     
  15--19                  14      11      97.1    2.0     18.0    69.2    30.8    30.8    20.5    20.5    11     97.1    0.9     10.0    26.5    17.7    17.7    17.7    17.7    
  20--29                  57      40      109.1   0.0     31.0    74.8    57.8    38.5    34.3    27.8    43     77.1    0.0     10.0    48.4    32.9    25.8    25.8    11.7    
  30--39                  85      53      119.0   0.0     23.0    71.2    44.5    31.5    18.6    16.7    57     119.0   0.0     9.0     43.2    25.3    21.1    16.9    10.6    
  40--49                  140     85      119.0   0.0     16.1    67.3    35.0    30.2    21.4    20.1    91     119.0   0.0     9.0     36.3    24.6    19.1    19.1    17.8    
  50--59                  321     200     108.1   0.0     17.0    69.3    26.2    15.6    13.0    12.4    205    108.1   0.0     9.0     34.4    17.9    12.0    9.5     7.7     
  60--69                  461     305     114.1   0.0     14.1    59.5    20.9    10.0    5.2     4.7     283    114.1   0.0     8.0     33.1    12.2    8.3     7.1     7.1     
  70--79                  328     190     86.1    0.0     12.0    44.3    13.5    6.8     3.5     3.5     159    80.1    0.0     8.0     31.5    11.2    9.3     9.3     9.3     
  80--89                  45      20      45.0    0.0     7.0     24.1    8.0     8.0     ND      ND      14     45.0    0.0     7.0     27.7    27.7    27.7    ND      ND      
                                                                                                                                                                                 
  PCNSL                   ALL     475     181     117.0   0.0     41.1    73.4    64.1    54.4    44.9    42.3   168     117.0   0.0     35.0    70.6    56.9    48.4    40.4    34.7
  0--4                    1       1       57.1    57.1    57.1    100.0   100.0   100.0   100.0   0.0     1      54.0    54.0    54.0    100.0   100.0   100.0   100.0   0.0     
  5--9                    2       0       64.0    2.0     NR      100.0   100.0   100.0   100.0   100.0   0      64.0    2.0     NR      100.0   100.0   100.0   100.0   100.0   
  10--14                  2       0       105.1   77.1    NR      100.0   100.0   100.0   100.0   100.0   0      105.1   77.1    NR      100.0   100.0   100.0   100.0   100.0   
  15--19                  3       0       69.0    2.0     NR      100.0   100.0   100.0   100.0   100.0   2      21.0    1.0     21.0    66.7    0.0     0.0     0.0     0.0     
  20--29                  7       3       108.1   9.0     93.0    85.7    71.4    71.4    71.4    71.4    4      85.1    1.9     46.0    57.1    57.1    57.1    42.9    42.9    
  30--39                  5       3       88.1    19.0    52.1    100.0   80.0    60.0    60.0    40.0    4      88.1    6.0     50.1    80.0    60.0    60.0    60.0    20.0    
  40--49                  30      7       116.1   3.0     NR      89.1    89.1    83.8    73.0    73.0    13     116.1   3.0     74.0    78.5    73.9    68.6    68.6    68.6    
  50--59                  93      36      117.0   0.0     46.1    83.8    77.4    59.9    47.2    40.3    44     117.0   0.0     26.1    70.7    51.9    42.3    36.1    26.9    
  60--69                  157     67      106.1   0.0     41.1    71.1    59.1    55.5    43.5    43.5    63     99.0    0.0     34.0    66.4    56.4    46.0    35.0    31.0    
  70--79                  138     50      108.1   0.0     27.0    62.8    54.7    36.3    29.1    29.1    31     108.1   0.0     36.0    73.9    57.1    46.3    34.0    34.0    
  80--89                  35      13      59.0    0.0     15.1    53.9    27.7    27.7    27.7    ND      6      59.0    0.0     21.0    79.7    44.3    44.3    44.3    ND      
                                                                                                                                                                                 
  ALL Meningioma          ALL     3,278   87      129.1   0.0     NR      99.0    98.4    98.1    97.8    97.4   341     129.0   0.0     NR      97.3    95.1    92.0    90.3    88.3
  0--4                    8       0       106.1   0.0     NR      100.0   100.0   100.0   100.0   100.0   2      106.1   0.0     NR      87.5    87.5    70.0    70.0    70.0    
  5--9                    7       1       116.1   57.1    NR      100.0   100.0   100.0   100.0   100.0   3      116.1   10.0    NR      71.4    57.1    57.1    57.1    57.1    
  10--14                  13      0       109.1   0.0     NR      100.0   100.0   100.0   100.0   100.0   4      109.1   0.0     100.0   100.0   100.0   90.9    81.8    72.7    
  15--19                  14      0       121.0   0.0     NR      100.0   100.0   100.0   100.0   100.0   3      121.0   0.0     111     88.9    88.9    76.2    76.2    76.2    
  20--29                  85      3       120.1   0.0     NR      97.4    97.4    97.4    97.4    97.4    16     120.1   0.0     NR      94.9    90.9    89.5    85.1    83.6    
  30--39                  167     3       129.0   0.0     NR      98.6    98.6    98.6    98.6    98.6    27     129.0   0.0     116.0   97.1    94.7    90.3    89.4    86.4    
  40--49                  478     12      129.1   0.0     NR      99.0    98.7    98.7    98.4    98.1    48     122.0   0.0     NR      97.5    94.9    92.0    89.4    88.0    
  50--59                  913     18      126.1   0.0     NR      98.9    98.8    98.5    98.3    98.1    86     124.0   0.0     NR      97.7    95.6    93.7    91.7    90.1    
  60--69                  930     21      126.1   0.0     NR      99.4    99.0    98.7    98.5    97.7    83     126.1   0.0     NR      97.6    96.6    93.8    92.7    91.0    
  70--79                  571     21      125.0   0.0     NR      99.0    97.6    97.3    96.7    95.9    65     125.0   0.0     NR      97.0    93.6    88.3    86.6    83.0    
  80--89                  83      8       100.1   0.0     NR      95.0    87.4    84.4    80.9    80.9    4      100.1   0.0     NR      97.8    92.1    88.7    88.7    88.7    
                                                                                                                                                                                 
  ALL Pituitary adenoma   ALL     2,581   41      130.1   0.0     NR      99.6    99.3    99.2    98.8    98.7   265     130.1   0.0     NR      97.2    95.3    93.9    91.2    89.2
  0--4                    4       0       119.1   41.0    NR      100.0   100.0   100.0   100.0   100.0   1      119.1   41.0    NR      100.0   100.0   100.0   75.0    75.0    
  5--9                    1       0       87.1    87.1    NR      100.0   100.0   100.0   100.0   100.0   0      87.1    87.1    NR      100.0   100.0   100.0   100.0   100.0   
  10--14                  14      1       110.1   1.0     NR      100.0   100.0   100.0   100.0   100.0   1      110.1   1.0     NR      100.0   100.0   100.0   100.0   100.0   
  15--19                  57      1       120.1   0.0     NR      100.0   100.0   100.0   100.0   100.0   6      120.1   0.0     NR      91.9    87.3    87.3    87.3    87.3    
  20--29                  332     1       122.0   0.0     NR      99.7    99.7    99.7    99.7    99.7    27     121.0   0.0     NR      98.6    96.1    94.3    91.9    90.4    
  30--39                  421     2       128.1   0.0     NR      100.0   100.0   100.0   100.0   99.6    39     128.1   0.0     NR      97.3    95.5    94.3    93.2    91.4    
  40--49                  398     3       119.1   0.0     NR      100.0   100.0   100.0   99.3    99.3    60     119.1   0.0     NR      95.8    94.2    91.1    86.9    83.9    
  50--59                  631     9       130.1   0.0     NR      99.7    99.7    99.4    99.2    99.0    68     130.1   0.0     NR      97.8    96.1    94.8    91.6    89.4    
  60--69                  485     15      121.1   0.0     NR      99.2    97.5    97.5    97.2    96.9    49     120.1   0.0     NR      96.7    94.2    93.6    91.1    89.5    
  70--79                  225     7       120.1   0.0     NR      99.4    98.7    98.7    97.2    97.2    12     120.1   0.0     NR      98.9    98.2    98.2    95.8    93.2    
  80--89                  13      2       116.1   0.0     NR      90.9    90.9    80.8    80.8    80.8    2      116.1   0.0     NR      90.9    90.9    80.8    80.8    80.8    
                                                                                                                                                                                 
  Schwannoma              ALL     1,352   15      130.1   0.0     NR      99.5    99.4    99.2    99.0    98.8   124     130.1   0.0     NR      97.7    95.6    93.3    91.2    89.5
  0--4                    4       0       111.1   40.0    NR      100.0   100.0   100.0   100.0   100.0   0      111.1   40.0    NR      100.0   100.0   100.0   100.0   100.0   
  5--9                    2       0       109.1   61.0    NR      100.0   100.0   100.0   100.0   100.0   1      109.1   17.0    NR      100.0   50.0    50.0    50.0    50.0    
  10--14                  8       0       81.0    1.0     NR      100.0   100.0   100.0   100.0   100.0   0      81.0    1.0     NR      100.0   100.0   100.0   100.0   100.0   
  15--19                  20      2       113.1   0.0     NR      94.7    94.7    94.7    94.7    94.7    4      102.0   0.0     NR      93.3    86.2    86.2    86.2    86.2    
  20--29                  77      0       119.0   0.0     NR      100.0   100.0   100.0   100.0   100.0   16     119.0   0.0     NR      95.3    92.1    86.6    80.5    80.5    
  30--39                  184     2       130.1   0.0     NR      99.4    99.4    98.6    98.6    98.6    21     130.1   0.0     NR      97.4    92.3    90.6    87.1    87.1    
  40--49                  238     1       124.1   0.0     NR      100.0   100.0   100.0   100.0   100.0   23     124.1   0.0     NR      95.9    94.2    91.9    91.3    87.9    
  50--59                  396     1       127.0   0.0     NR      99.7    99.7    99.7    99.7    99.7    28     120.1   0.0     NR      98.2    97.2    95.4    94.2    92.5    
  60--69                  292     6       121.1   0.0     NR      99.2    99.2    98.7    97.8    97.2    24     121.1   0.0     NR      99.6    97.7    95.3    91.6    89.9    
  70--79                  117     3       126.1   0.0     NR      99.0    97.8    97.8    97.8    97.8    7      126.1   0.0     NR      97.9    96.5    93.7    93.7    91.6    
  80--89                  14      0       79.1    0.0     NR      100.0   100.0   100.0   100.0   100.0   0      79.1    0.0     NR      100.0   100.0   100.0   100.0   100.0   
                                                                                                                                                                                 
  Craniopharyngioma       ALL     331     13      122.0   0.0     NR      98.1    97.3    97.3    96.9    96.5   94      122.0   0.0     NR      88.6    82.7    78.0    73.5    69.7
  0--4                    18      1       114.1   1.0     114.1   100.0   100.0   100.0   100.0   100.0   9      102.0   1.0     80.1    88.2    76.5    70.6    64.7    52.9    
  5--9                    27      1       116.1   0.0     NR      96.0    96.0    96.0    96.0    96.0    17     116.1   0.0     44.0    82.5    58.3    53.4    34.0    34.0    
  10--14                  24      0       119.0   1.0     NR      100.0   100.0   100.0   100.0   100.0   6      102.1   1.0     NR      86.2    86.2    86.2    81.2    75.4    
  15--19                  12      0       116.1   1.0     NR      100.0   100.0   100.0   100.0   100.0   3      116.1   1.0     NR      80.8    80.8    80.8    80.8    80.8    
  20--29                  27      1       115.1   0.0     NR      100.0   95.7    95.7    95.7    95.7    3      114.1   0.0     NR      100.0   100.0   90.0    90.0    84.7    
  30--39                  34      3       120.1   0.0     NR      97.1    97.1    97.1    93.0    93.0    11     112.1   0.0     NR      81.2    78.1    71.0    71.0    62.7    
  40--49                  43      2       118.1   0.0     NR      97.6    97.6    97.6    97.6    94.1    7      118.1   0.0     NR      89.5    89.5    86.1    82.8    82.8    
  50--59                  54      0       119.0   0.0     NR      100.0   100.0   100.0   100.0   100.0   16     115.1   0.0     NR      90.0    83.9    79.5    72.8    68.3    
  60--69                  67      1       122.0   0.0     NR      98.4    98.4    98.4    98.4    98.4    20     122.0   0.0     NR      91.2    82.2    76.6    74.5    72.4    
  70--79                  19      3       89.1    0.0     NR      92.9    84.4    84.4    84.4    84.4    2      89.1    0.0     NR      86.7    86.7    86.7    86.7    86.7    
  80--89                  6       1       96.1    0.0     NR      80.0    80.0    80.0    80.0    80.0    0      92.1    0.0     NR      100.0   100.0   100.0   100.0   100.0   

6.. General features of brainstem gliomas {#S6}
=========================================

1). Frequency of gliomas originated in midbrain, pons and medulla oblongata {#S6.1}
---------------------------------------------------------------------------

Tumors which were also located in IVth ventricle, cerebellum, thalamus or hypothalamus were excluded.

                                                               All cases   Midbrain   Pons   Medulla   all regions                               
  ------------------------------------------------------------ ----------- ---------- ------ --------- ------------- -------- ---- -------- ---- --------
  Pilocytic astrocytoma                                        16          (9%)       5      (14%)     4             (4%)     7    (19%)    \-   ( - )
  Pilomyxoid astrocytoma                                       1           (1%)       \-     ( - )     \-            ( - )    1    (3%)     \-   ( - )
  GII DA                                                       37          (20%)      9      (25%)     23            (21%)    5    (14%)    \-   ( - )
  GIII AA                                                      38          (20%)      9      (25%)     24            (21%)    5    (14%)    \-   ( - )
  GIII AO                                                      1           (1%)       \-     ( - )     1             (1%)     \-   ( - )    \-   ( - )
  Glioblastoma                                                 19          (10%)      3      (8%)      13            (12%)    2    (5%)     1    (100%)
  Unknown Glioma                                               63          (34%)      7      (19%)     47            (42%)    9    (24%)    \-   ( - )
  Ependymoma                                                   6           (3%)       1      (3%)      \-            ( - )    5    (14%)    \-   ( - )
  Ganglioglioma                                                4           (2%)       1      (3%)      \-            ( - )    3    (8%)     \-   ( - )
  Rosette-forming glioneuronal tumor of the fourth ventricle   1           (1%)       1      (3%)      \-            ( - )    \-   ( - )    \-   ( - )
                                                                                                                                                 
  Total                                                        186         (100%)     36     (100%)    112           (100%)   37   (100%)   1    (100%)

2). Age distribution of brainstem gliomas {#S6.2}
-----------------------------------------

Brainstem gliomas in this analyses includes pilomyxoid astrocytoma, GII DA, GIII AA, GIII AO, GBM and unknown gliomas (159 cases).

  age      m      f      total   (%)
  -------- ------ ------ ------- -------
  0        \-     \-     \-      ( - )
  1        \-     1      1       (1%)
  2        1      \-     1       (1%)
  3        \-     4      4       (3%)
  4        5      3      8       (5%)
                                 
  5--9     17     19     36      (23%)
  10--14   7      6      13      (8%)
  15--19   5      8      13      (8%)
  20--24   4      5      9       (6%)
  25--29   4      7      11      (7%)
                                 
  30--34   6      3      9       (6%)
  35--39   7      2      9       (6%)
  40--44   2      2      4       (3%)
  45--49   1      4      5       (3%)
  50--54   7      6      13      (8%)
                                 
  55--59   2      2      4       (3%)
  60--64   3      1      4       (3%)
  65--69   5      2      7       (4%)
  70--74   3      \-     3       (2%)
  75--79   2      1      3       (2%)
                                 
  80--84   1      1      2       (1%)
  85--90   \-     \-     \-      ( - )
                                 
  total    82     77     159     
                                 
  mean     31.3   25.2   28.4    

3). Overall survival and progression free survival depending on histology {#S6.3}
-------------------------------------------------------------------------

                          no.   Overall survival   Progression free survival                                                 
  ----------------------- ----- ------------------ --------------------------- ----- ------ ------ ---- ------- ----- ------ ------
  All brainstem gliomas   159   86                 128.1                       0.0   18.1   33.1   79   128.1   0.0   16.0   35.1
  GII DA                  37    19                 128.1                       0.0   54.0   48.0   15   128.1   0.0   55.1   49.7
  GIII AA                 38    18                 98.1                        1.0   20.1   20.7   19   98.1    0.0   10.0   22.7
  Glioblastoma            19    11                 18.0                        1.0   11.0   0.0    13   17.0    1.0   6.0    0.0
  Unknown gliomas         63    38                 117.0                       0.0   12.0   32.4   31   117.0   0.0   16.0   38.2

4). Overall survival and progression free survival depending on region {#S6.4}
----------------------------------------------------------------------

                      no.   Overall survival   Progression free survival                                                  
  ------------------- ----- ------------------ --------------------------- ----- ------ ------- ---- ------- ----- ------ ------
  midbrain            28    9                  117.0                       0.0   ND     58.71   8    117.0   0.0   ND     62.9
  pons                108   69                 128.1                       0.0   15.0   21.0    62   128.1   0.0   10.0   22.9
  medulla oblongata   22    7                  118.1                       1.0   ND     60.7    8    118.1   1.0   ND     53.8

5). Overall survival and progression free survival in adult and juvenile tumor {#S6.5}
------------------------------------------------------------------------------

                no.   Overall survival   Progression free survival                                                 
  ------------- ----- ------------------ --------------------------- ----- ------ ------ ---- ------- ----- ------ ------
  under 20      76    54                 102.1                       0.0   11.0   17.6   47   99.1    0.0   9.0    23.3
  20 and over   83    32                 128.1                       0.0   61.1   50.4   32   128.1   0.0   51.0   47.1

6). Overall survival and progression free survival in initial treatment {#S6.6}
-----------------------------------------------------------------------

                      no.   Overall survival   Progression free survival                                                    
  ------------------- ----- ------------------ --------------------------- ------ ------ ------- ---- ------- ------ ------ -------
  Surgery             13    1                  117.0                       0.0    NR     92.3    0    117.0   0.0    NR     100.0
  Surgery + RT        26    14                 102.1                       1.0    15.9   35.6    10   98.1    0.0    34.0   49.4
  Surgery + CRT       46    28                 128.1                       0.0    18.0   17.0    29   128.1   0.0    11.0   18.0
  Surgery + CTX       5     1                  99.1                        36.0   ND     80.0    1    99.1    29.1   NR     80.0
  CRT                 41    31                 88.1                        1.0    9.0    16.2    27   88.1    0.0    7.0    18.2
  RT                  22    11                 118.1                       1.0    28.0   18.8    11   118.1   1.0    17.0   12.8
  CTX                 2     0                  28.0                        28.0   NR     ND      1    28.0    22.1   NR     ND
  observation alone   3     0                  96.1                        59.0   NR     100.0   0    96.1    59.0   NR     100.0
  others              1     0                  0.0                         0.0    NR     ND      0    0.0     0.0    NR     ND

7.. General features of brain metastases (2001--2004) {#S7}
=====================================================

1). Origin of brain metastases {#S7.1}
------------------------------

  origin            total   
  ----------------- ------- ---------
  lung              1,326   (45.6%)
  breast            373     (12.8%)
  colon             166     (5.7%)
  kidney            152     (5.2%)
  unknown primary   138     (4.7%)
  rectum, anus      113     (3.9%)
  stomach           96      (3.3%)
  head and neck     62      (2.1%)
  esophagus         60      (2.1%)
  others            60      (2.1%)
  liver             57      (2.0%)
  thyroid           46      (1.6%)
  ovary             46      (1.6%)
  uterus            42      (1.4%)
  skin (melanoma)   38      (1.3%)
  bladder           23      (0.8%)
  lymphatic gland   23      (0.8%)
  hematopoietic     22      (0.8%)
  testis            16      (0.6%)
  pancreas          11      (0.4%)
  bone              11      (0.4%)
  soft tissue       11      (0.4%)
  optical           5       (0.2%)
  nervuos tissue    5       (0.2%)
  gall bladder      4       (0.1%)
  spleen            1       (0.0%)
                            
  total             2,907   

2). Location of tumor {#S7.2}
---------------------

  patient number            2907    
  ------------------------- ------- ---------
  frontal lobe              1,317   (45.3%)
  temporal lobe             583     (20.1%)
  parietal lobe             791     (27.2%)
  occipital lobe            639     (22.0%)
  insular cortex            19      (0.7%)
  cerebellum                799     (27.5%)
  midbrain                  35      (1.2%)
  pons                      48      (1.7%)
  medulla oblongata         13      (0.4%)
  lateral ventricle         46      (1.6%)
  third ventricle           7       (0.2%)
  cerebral aqueduct         1       (0.0%)
  fourth ventricle          5       (0.2%)
  basal ganglia             82      (2.8%)
  thalamus•hypothalamus     65      (2.2%)
  corpus callosum           20      (0.7%)
  pineal region             11      (0.4%)
  intraorbital              14      (0.5%)
  pituitary gland           23      (0.8%)
  optic nerve               2       (0.1%)
  cerebello-pontine angle   20      (0.7%)
  clivus                    20      (0.7%)
  cavernous sinus           15      (0.5%)
  cranial nerve             3       (0.1%)
  other skull base          26      (0.9%)
  skull base                68      (2.3%)
  LMM                       90      (3.1%)
  others                    42      (1.4%)

3). Histology of brain metastases {#S7.3}
---------------------------------

                                ALL     Lung      Breast   Stomach   Colon   Head and Neck   Unknown primary                                           
  ----------------------------- ------- --------- -------- --------- ------- --------------- ----------------- ------- ----- ------- ---- ------- ---- -------
  adenocarcinoma                1,393   (47.9%)   699      (53%)     234     (63%)           67                (70%)   133   (80%)   11   (18%)   41   (30%)
  squamous cell carcinoma       253     (8.7%)    169      (13%)     4       (1%)            1                 (1%)    \-    ( - )   20   (32%)   5    (4%)
  small cell carcinoma          146     (5.0%)    131      (10%)     1       (0.3%)          2                 (2%)    \-    ( - )   \-   ( - )   5    (4%)
  large cell carcinoma          54      (1.9%)    52       (4%)      \-      ( - )           \-                ( - )   \-    ( - )   \-   ( - )   \-   ( - )
  clear cell                    53      (1.8%)    \-       ( - )     \-      ( - )           \-                ( - )   \-    ( - )   \-   ( - )   \-   ( - )
  lymphoma                      48      (1.7%)    \-       ( - )     \-      ( - )           3                 (3%)    1     (1%)    3    (5%)    \-   ( - )
  melanoma                      39      (1.3%)    1        (0.1%)    \-      ( - )           \-                ( - )   \-    ( - )   3    (5%)    \-   ( - )
  NSCLC                         33      (1.1%)    33       (2%)      \-      ( - )           \-                ( - )   \-    ( - )   \-   ( - )   \-   ( - )
  sarcoma                       30      (1.0%)    2        (0.2%)    \-      ( - )           \-                ( - )   \-    ( - )   \-   ( - )   3    (2%)
  transitional cell carcinoma   16      (0.6%)    \-       ( - )     1       (0.3%)          \-                ( - )   \-    ( - )   1    (2%)    \-   ( - )
  neuroblastoma                 10      (0.3%)    \-       ( - )     \-      ( - )           \-                ( - )   \-    ( - )   3    (5%)    \-   ( - )
  leukemia                      7       (0.2%)    \-       ( - )     \-      ( - )           \-                ( - )   \-    ( - )   \-   ( - )   \-   ( - )
  retinoblastoma                \-      ( - )     \-       ( - )     \-      ( - )           \-                ( - )   \-    ( - )   \-   ( - )   \-   ( - )
  others                        241     (8.3%)    22       (2%)      47      (13%)           2                 (2%)    \-    (-)     13   (21%)   10   (7%)
  unknown                       584     (20.1%)   217      (16%)     86      (23%)           21                (22%)   32    (19%)   8    (13%)   74   (54%)
                                                                                                                                                       
  total                         2,907   1,326     373      96        166     62              138                                                       

4). Age distribution {#S7.4}
--------------------

  age      All brain metastases   lung        breast      esophagus   stomach                                                                                                                                        
  -------- ---------------------- ----------- ----------- ----------- --------- --------- ----------- --------- ------- --------- --------- --------- -------- ------- -------- --------- -------- -------- -------- ---------
  0        6                      1           7           (0.2)       2         1         3           (0.2)     \-      \-        \-        ( - )     \-       \-      \-       ( - )     \-       \-       \-       ( - )
  1        \-                     1           1           (0.0)       \-        \-        \-          ( - )     \-      \-        \-        ( - )     \-       \-      \-       ( - )     \-       \-       \-       ( - )
  2        \-                     1           1           (0.0)       \-        \-        \-          ( - )     \-      \-        \-        ( - )     \-       \-      \-       ( - )     \-       \-       \-       ( - )
  3        1                      1           2           (0.1)       \-        \-        \-          ( - )     \-      \-        \-        ( - )     \-       \-      \-       ( - )     \-       \-       \-       ( - )
  4        1                      \-          1           (0.0)       \-        \-        \-          ( - )     \-      \-        \-        ( - )     \-       \-      \-       ( - )     \-       \-       \-       ( - )
                                                                                                                                                                                                                     
  5--9     \-                     3           3           (0.1)       \-        \-        \-          ( - )     \-      1         1         (0.3)     \-       \-      \-       ( - )     \-       \-       \-       ( - )
  10--14   2                      1           3           (0.1)       \-        \-        \-          ( - )     \-      \-        \-        ( - )     \-       \-      \-       ( - )     \-       \-       \-       ( - )
  15--19   3                      6           9           (0.3)       \-        \-        \-          ( - )     \-      \-        \-        ( - )     \-       \-      \-       ( - )     \-       \-       \-       ( - )
  20--24   5                      6           11          (0.4)       \-        \-        \-          ( - )     \-      1         1         (0.3)     \-       \-      \-       ( - )     \-       \-       \-       ( - )
  25--29   16                     8           24          (0.8)       1         \-        1           (0.1)     \-      2         2         (0.5)     \-       \-      \-       ( - )     3        \-       3        (3.1)
                                                                                                                                                                                                                     
  30--34   13                     21          34          (1.2)       1         1         2           (0.2)     \-      11        11        (3.0)     \-       \-      \-       ( - )     1        1        2        (2.1)
  35--39   22                     30          52          (1.8)       9         4         13          (1.0)     \-      16        16        (4.3)     1        \-      1        (1.7)     1        \-       1        (1.0)
  40--44   39                     66          105         (3.6)       19        17        36          (2.7)     \-      31        31        (8.3)     \-       \-      \-       ( - )     1        \-       1        (1.0)
  45--49   87                     107         194         (6.7)       50        22        72          (5.4)     \-      60        60        (16.1)    1        1       2        (3.3)     6        1        7        (7.3)
  50--54   173                    168         341         (11.7)      99        47        146         (11.0)    1       67        68        (18.2)    6        2       8        (13.3)    4        2        6        (6.3)
                                                                                                                                                                                                                     
  55--59   251                    193         444         (15.3)      153       57        210         (15.8)    \-      68        68        (18.2)    11       \-      11       (18.3)    10       2        12       (12.5)
  60--64   273                    166         439         (15.1)      150       62        212         (16.0)    2       46        48        (12.9)    12       2       14       (23.3)    9        2        11       (11.5)
  65--69   299                    172         471         (16.2)      162       73        235         (17.7)    2       33        35        (9.4)     8        \-      8        (13.3)    13       4        17       (17.7)
  70--74   253                    148         401         (13.8)      144       60        204         (15.4)    \-      24        24        (6.4)     9        2       11       (18.3)    17       2        19       (19.8)
  75--79   171                    83          254         (8.7)       100       32        132         (10.0)    \-      5         5         (1.3)     4        \-      4        (6.7)     10       4        14       (14.6)
                                                                                                                                                                                                                     
  80--84   56                     29          85          (2.9)       37        12        49          (3.7)     \-      3         3         (0.8)     1        \-      1        (1.7)     1        1        2        (2.1)
  85--89   11                     9           20          (0.7)       6         2         8           (0.6)     \-      \-        \-        ( - )     \-       \-      \-       ( - )     1        \-       1        (1.0)
  90--94   2                      1           3           (0.1)       1         1         2           (0.2)     \-      \-        \-        ( - )     \-       \-      \-       ( - )     \-       \-       \-       ( - )
  95-      1                      1           2           (0.1)       \-        1         1           (0.1)     \-      \-        \-        ( - )     \-       \-      \-       ( - )     \-       \-       \-       ( - )
                                                                                                                                                                                                                     
  total    **1,685**              **1,222**   **2,907**   (100.0)     **934**   **392**   **1,326**   (100.0)   **5**   **368**   **373**   (100.0)   **53**   **7**   **60**   (100.0)   **77**   **19**   **96**   (100.0)
                                                                                                                                                                                                                     
  mean     62.7                   59.4        61.3        63.9        63.0      63.6      62.1        54.6      54.7    63.5      60.1      63.1      63.4     64.7    63.6                                          

  age      colon    rectum · anus   liver     gallbladder   pancreas                                                                                                                                
  -------- -------- --------------- --------- ------------- ---------- -------- --------- --------- -------- -------- -------- --------- ------- ------- ------- --------- ------- ------- -------- ---------
  0        1        \-              1         (0.6)         \-         \-       \-        ( - )     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  1        \-       \-              \-        ( - )         \-         \-       \-        ( - )     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  2        \-       \-              \-        ( - )         \-         \-       \-        ( - )     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  3        \-       \-              \-        ( - )         \-         \-       \-        ( - )     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  4        \-       \-              \-        ( - )         \-         \-       \-        ( - )     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
                                                                                                                                                                                                    
  5--9     \-       \-              \-        ( - )         \-         \-       \-        ( - )     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  10--14   \-       \-              \-        ( - )         \-         \-       \-        ( - )     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  15--19   \-       \-              \-        ( - )         \-         \-       \-        ( - )     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  20--24   \-       \-              \-        ( - )         \-         \-       \-        ( - )     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  25--29   \-       \-              \-        ( - )         2          1        3         (2.7)     1        \-       1        (1.8)     \-      \-      \-      ( - )     \-      \-      \-       ( - )
                                                                                                                                                                                                    
  30--34   \-       \-              \-        ( - )         2          \-       2         (1.8)     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  35--39   1        2               3         (1.8)         \-         2        2         (1.8)     \-       \-       \-       ( - )     \-      \-      \-      ( - )     1       1       2        (18.2)
  40--44   8        \-              8         (4.8)         2          \-       2         (1.8)     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      1       1        (9.1)
  45--49   7        2               9         (5.4)         2          5        7         (6.2)     4        1        5        (8.8)     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  50--54   4        7               11        (6.6)         4          9        13        (11.5)    3        \-       3        (5.3)     \-      \-      \-      ( - )     \-      1       1        (9.1)
                                                                                                                                                                                                    
  55--59   9        12              21        (12.7)        4          8        12        (10.6)    7        2        9        (15.8)    2       \-      2       (50.0)    2       \-      2        (18.2)
  60--64   19       7               26        (15.7)        11         6        17        (15.0)    8        1        9        (15.8)    \-      \-      \-      ( - )     1       1       2        (18.2)
  65--69   19       13              32        (19.3)        19         6        25        (22.1)    6        5        11       (19.3)    1       \-      1       (25.0)    \-      \-      \-       ( - )
  70--74   15       14              29        (17.5)        10         4        14        (12.4)    7        4        11       (19.3)    1       \-      1       (25.0)    2       1       3        (27.3)
  75--79   10       7               17        (10.2)        7          2        9         (8.0)     5        1        6        (10.5)    \-      \-      \-      ( - )     \-      \-      \-       ( - )
                                                                                                                                                                                                    
  80--84   4        3               7         (4.2)         3          1        4         (3.5)     1        1        2        (3.5)     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  85--89   2        \-              2         (1.2)         \-         3        3         (2.7)     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  90--94   \-       \-              \-        ( - )         \-         \-       \-        ( - )     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
  95-      \-       \-              \-        ( - )         \-         \-       \-        ( - )     \-       \-       \-       ( - )     \-      \-      \-      ( - )     \-      \-      \-       ( - )
                                                                                                                                                                                                    
  total    **99**   **67**          **166**   (100.0)       **66**     **47**   **113**   (100.0)   **42**   **15**   **57**   (100.0)   **4**   **-**   **4**   (100.0)   **6**   **5**   **11**   (100.0)
                                                                                                                                                                                                    
  mean     63.0     64.6            63.7      63.8          60.7       62.5     62.9      67.3      64.0     64.3     \-       64.3      60.6    54.9    58.0                                       

  age      spleen   hematopoietic   bone    soft tissue   skin                                                                                                                                  
  -------- -------- --------------- ------- ------------- -------- -------- -------- --------- ------- ------- -------- --------- ------- ------- -------- --------- -------- -------- -------- ---------
  0        \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      \-      \-       ( - )     \-      \-      \-       ( - )     \-       \-       \-       ( - )
  1        \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      \-      \-       ( - )     \-      \-      \-       ( - )     \-       \-       \-       ( - )
  2        \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      \-      \-       ( - )     \-      \-      \-       ( - )     \-       \-       \-       ( - )
  3        \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      \-      \-       ( - )     \-      \-      \-       ( - )     \-       \-       \-       ( - )
  4        \-       \-              \-      ( - )         1        \-       1        (4.6)     \-      \-      \-       ( - )     \-      \-      \-       ( - )     \-       \-       \-       ( - )
                                                                                                                                                                                                
  5--9     \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      \-      \-       ( - )     \-      \-      \-       ( - )     \-       \-       \-       ( - )
  10--14   \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      1       1        (9.1)     1       \-      1        (9.1)     \-       \-       \-       ( - )
  15--19   \-       \-              \-      ( - )         \-       \-       \-       ( - )     1       1       2        (18.2)    \-      1       1        (9.1)     \-       \-       \-       ( - )
  20--24   \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      \-      \-       ( - )     \-      1       1        (9.1)     \-       \-       \-       ( - )
  25--29   \-       \-              \-      ( - )         \-       1        1        (4.6)     2       \-      2        (18.2)    1       \-      1        (9.1)     1        \-       1        (2.6)
                                                                                                                                                                                                
  30--34   \-       \-              \-      ( - )         1        \-       1        (4.6)     \-      \-      \-       ( - )     1       1       2        (18.2)    1        \-       1        (2.6)
  35--39   \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      \-      \-       ( - )     \-      \-      \-       ( - )     2        1        3        (7.9)
  40--44   \-       \-              \-      ( - )         \-       1        1        (4.6)     1       \-      1        (9.1)     \-      \-      \-       ( - )     1        \-       1        (2.6)
  45--49   \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      1       1        (9.1)     \-      \-      \-       ( - )     \-       2        2        (5.3)
  50--54   \-       \-              \-      ( - )         1        2        3        (13.6)    2       \-      2        (18.2)    \-      \-      \-       ( - )     4        2        6        (15.8)
                                                                                                                                                                                                
  55--59   \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      1       1        (9.1)     \-      1       1        (9.1)     1        3        4        (10.5)
  60--64   1        \-              1       (100.0)       5        1        6        (27.3)    \-      \-      \-       ( - )     1       \-      1        (9.1)     3        1        4        (10.5)
  65--69   \-       \-              \-      ( - )         1        2        3        (13.6)    \-      \-      \-       ( - )     2       \-      2        (18.2)    5        \-       5        (13.2)
  70--74   \-       \-              \-      ( - )         2        \-       2        (9.1)     \-      \-      \-       ( - )     \-      \-      \-       ( - )     1        4        5        (13.2)
  75--79   \-       \-              \-      ( - )         \-       3        3        (13.6)    \-      \-      \-       ( - )     1       \-      1        (9.1)     1        2        3        (7.9)
                                                                                                                                                                                                
  80--84   \-       \-              \-      ( - )         1        \-       1        (4.6)     \-      1       1        (9.1)     \-      \-      \-       ( - )     1        \-       1        (2.6)
  85--89   \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      \-      \-       ( - )     \-      \-      \-       ( - )     2        \-       2        (5.3)
  90--94   \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      \-      \-       ( - )     \-      \-      \-       ( - )     \-       \-       \-       ( - )
  95-      \-       \-              \-      ( - )         \-       \-       \-       ( - )     \-      \-      \-       ( - )     \-      \-      \-       ( - )     \-       \-       \-       ( - )
                                                                                                                                                                                                
  total    **1**    **-**           **1**   (100.0)       **12**   **10**   **22**   (100.0)   **6**   **5**   **11**   (100.0)   **7**   **4**   **11**   (100.0)   **23**   **15**   **38**   (100.0)
                                                                                                                                                                                                
  mean     60.8     \-              60.8    57.8          60.3     58.9     36.5     43.5      39.7    49.9    33.1     43.8      59.7    60.7    60.1                                          

  age      head and neck   thyroid   testis   bladder   uterus                                                                                                                                 
  -------- --------------- --------- -------- --------- -------- -------- -------- --------- -------- ------- -------- --------- -------- ------- -------- --------- ------- -------- -------- ---------
  0        \-              \-        \-       ( - )     \-       \-       \-       ( - )     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
  1        \-              \-        \-       ( - )     \-       \-       \-       ( - )     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
  2        \-              \-        \-       ( - )     \-       \-       \-       ( - )     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
  3        \-              1         1        (1.6)     \-       \-       \-       ( - )     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
  4        \-              \-        \-       ( - )     \-       \-       \-       ( - )     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
                                                                                                                                                                                               
  5--9     \-              \-        \-       ( - )     \-       \-       \-       ( - )     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
  10--14   \-              \-        \-       ( - )     \-       \-       \-       ( - )     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
  15--19   \-              \-        \-       ( - )     \-       2        2        (4.4)     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
  20--24   1               \-        1        (1.6)     \-       \-       \-       ( - )     3        \-      3        (18.8)    \-       \-      \-       ( - )     \-      \-       \-       ( - )
  25--29   \-              \-        \-       ( - )     \-       \-       \-       ( - )     3        \-      3        (18.8)    \-       \-      \-       ( - )     \-      1        1        (2.4)
                                                                                                                                                                                               
  30--34   2               \-        2        (3.2)     \-       \-       \-       ( - )     3        \-      3        (18.8)    \-       \-      \-       ( - )     \-      2        2        (4.8)
  35--39   1               \-        1        (1.6)     2        \-       2        (4.4)     1        \-      1        (6.3)     \-       \-      \-       ( - )     \-      \-       \-       ( - )
  40--44   \-              2         2        (3.2)     0        2        2        (4.4)     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      5        5        (11.9)
  45--49   6               2         8        (12.9)    \-       \-       \-       ( - )     2        \-      2        (12.5)    1        \-      1        (4.4)     \-      2        2        (4.8)
  50--54   2               4         6        (9.7)     3        2        5        (10.9)    1        \-      1        (6.3)     \-       1       1        (4.4)     \-      8        8        (19.1)
                                                                                                                                                                                               
  55--59   8               3         11       (17.7)    3        2        5        (10.9)    1        \-      1        (6.3)     4        \-      4        (17.4)    \-      11       11       (26.2)
  60--64   8               \-        8        (12.9)    1        5        6        (13.0)    \-       \-      \-       ( - )     3        2       5        (21.7)    \-      6        6        (14.3)
  65--69   4               4         8        (12.9)    2        5        7        (15.2)    1        \-      1        (6.3)     6        \-      6        (26.1)    \-      6        6        (14.3)
  70--74   4               3         7        (11.3)    2        8        10       (21.7)    1        \-      1        (6.3)     4        \-      4        (17.4)    \-      \-       \-       ( - )
  75--79   3               4         7        (11.3)    3        4        7        (15.2)    \-       \-      \-       ( - )     2        \-      2        (8.7)     \-      1        1        (2.4)
                                                                                                                                                                                               
  80--84   \-              \-        \-       ( - )     \-       \-       \-       ( - )     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
  85--89   \-              \-        \-       ( - )     \-       \-       \-       ( - )     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
  90--94   \-              \-        \-       ( - )     \-       \-       \-       ( - )     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
  95-      \-              \-        \-       ( - )     \-       \-       \-       ( - )     \-       \-      \-       ( - )     \-       \-      \-       ( - )     \-      \-       \-       ( - )
                                                                                                                                                                                               
  total    **39**          **23**    **62**   (100.0)   **16**   **30**   **46**   (100.0)   **16**   **-**   **16**   (100.0)   **20**   **3**   **23**   (100.0)   **-**   **42**   **42**   (100.0)
                                                                                                                                                                                               
  mean     58.0            59.4      58.5     61.2      62.9     62.3     39.3     \-        39.3     65.0    58.9     64.2      \-       55.2    55.2                                         

  age      ovary   kidney   optical   lymph gland   nervous tissue                                                                                                                              
  -------- ------- -------- --------- ------------- ---------------- -------- --------- --------- ------- ------- ------- --------- ------- -------- -------- --------- ------- ------- ------- ---------
  0        \-      \-       \-        ( - )         1                \-       1         (0.7)     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      \-      \-      ( - )
  1        \-      \-       \-        ( - )         \-               1        1         (0.7)     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      \-      \-      ( - )
  2        \-      \-       \-        ( - )         \-               \-       \-        ( - )     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      \-      \-      ( - )
  3        \-      \-       \-        ( - )         \-               \-       \-        ( - )     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      \-      \-      ( - )
  4        \-      \-       \-        ( - )         \-               \-       \-        ( - )     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      \-      \-      ( - )
                                                                                                                                                                                                
  5--9     \-      \-       \-        ( - )         \-               \-       \-        ( - )     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      1       1       (20.0)
  10--14   \-      \-       \-        ( - )         1                \-       1         (0.7)     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      \-      \-      ( - )
  15--19   \-      2        2         (4.4)         \-               \-       \-        ( - )     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      \-      \-      ( - )
  20--24   \-      \-       \-        ( - )         \-               \-       \-        ( - )     \-      \-      \-      ( - )     \-      2        2        (8.7)     1       1       2       (40.0)
  25--29   \-      1        1         (2.2)         \-               \-       \-        ( - )     \-      \-      \-      ( - )     \-      \-       \-       ( - )     1       \-      1       (20.0)
                                                                                                                                                                                                
  30--34   \-      2        2         (4.4)         \-               1        1         (0.7)     \-      \-      \-      ( - )     1       \-       1        (4.4)     \-      \-      \-      ( - )
  35--39   \-      1        1         (2.2)         \-               \-       \-        ( - )     \-      1       1       (20.0)    \-      \-       \-       ( - )     \-      \-      \-      ( - )
  40--44   \-      4        4         (8.7)         3                2        5         (3.3)     \-      \-      \-      ( - )     1       \-       1        (4.4)     \-      \-      \-      ( - )
  45--49   \-      5        5         (10.9)        4                \-       4         (2.6)     \-      \-      \-      ( - )     1       1        2        (8.7)     1       \-      1       (20.0)
  50--54   \-      5        5         (10.9)        24               7        31        (20.4)    \-      \-      \-      ( - )     1       \-       1        (4.4)     \-      \-      \-      ( - )
                                                                                                                                                                                                
  55--59   \-      8        8         (17.4)        20               6        26        (17.1)    \-      \-      \-      ( - )     \-      1        1        (4.4)     \-      \-      \-      ( - )
  60--64   \-      5        5         (10.9)        14               6        20        (13.2)    2       \-      2       (40.0)    2       6        8        (34.8)    \-      \-      \-      ( - )
  65--69   \-      7        7         (15.2)        25               4        29        (19.1)    1       1       2       (40.0)    2       1        3        (13.0)    \-      \-      \-      ( - )
  70--74   \-      4        4         (8.7)         16               8        24        (15.8)    \-      \-      \-      ( - )     \-      2        2        (8.7)     \-      \-      \-      ( - )
  75--79   \-      2        2         (4.4)         4                2        6         (4.0)     \-      \-      \-      ( - )     1       1        2        (8.7)     \-      \-      \-      ( - )
                                                                                                                                                                                                
  80--84   \-      \-       \-        ( - )         2                1        3         (2.0)     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      \-      \-      ( - )
  85--89   \-      \-       \-        ( - )         \-               \-       \-        ( - )     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      \-      \-      ( - )
  90--94   \-      \-       \-        ( - )         \-               \-       \-        ( - )     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      \-      \-      ( - )
  95-      \-      \-       \-        ( - )         \-               \-       \-        ( - )     \-      \-      \-      ( - )     \-      \-       \-       ( - )     \-      \-      \-      ( - )
                                                                                                                                                                                                
  total    **-**   **46**   **46**    (100.0)       **114**          **38**   **152**   (100.0)   **3**   **2**   **5**   (100.0)   **9**   **14**   **23**   (100.0)   **3**   **2**   **5**   (100.0)
                                                                                                                                                                                                
  mean     \-      54.9     54.9      61.0          60.2             60.8     63.4      53.5      59.5    56.2    58.6    57.7      32.4    15.8     25.7                                       

  age      unknown primary   others                                                  
  -------- ----------------- -------- --------- --------- -------- -------- -------- ---------
  0        \-                \-       \-        ( - )     2        \-       2        (3.3)
  1        \-                \-       \-        ( - )     \-       \-       \-       ( - )
  2        \-                \-       \-        ( - )     \-       1        1        (1.7)
  3        \-                \-       \-        ( - )     1        \-       1        (1.7)
  4        \-                \-       \-        ( - )     \-       \-       \-       ( - )
                                                                                     
  5--9     \-                \-       \-        ( - )     \-       1        1        (1.7)
  10--14   \-                \-       \-        ( - )     \-       \-       \-       ( - )
  15--19   \-                \-       \-        ( - )     2        \-       2        (3.3)
  20--24   \-                \-       \-        ( - )     \-       1        1        (1.7)
  25--29   1                 1        2         (1.5)     \-       1        1        (1.7)
                                                                                     
  30--34   \-                1        1         (0.7)     \-       1        1        (1.7)
  35--39   \-                1        1         (0.7)     3        1        4        (6.7)
  40--44   2                 \-       2         (1.5)     1        1        2        (3.3)
  45--49   2                 1        3         (2.2)     \-       1        1        (1.7)
  50--54   \-                1        10        (7.3)     5        1        6        (10.0)
                                                                                     
  55--59   11                4        15        (10.9)    5        4        9        (15.0)
  60--64   15                3        18        (13.0)    6        4        10       (16.7)
  65--69   13                7        20        (14.5)    7        1        8        (13.3)
  70--74   12                6        18        (13.0)    6        2        8        (13.3)
  75--79   20                12       32        (23.2)    \-       1        1        (1.7)
                                                                                     
  80--84   4                 6        10        (7.3)     1        \-       1        (1.7)
  85--89   \-                4        4         (2.9)     \-       \-       \-       ( - )
  90--94   1                 \-       1         (0.7)     \-       \-       \-       ( - )
  95-      1                 \-       1         (0.7)     \-       \-       \-       ( - )
                                                                                     
  total    **91**            **47**   **138**   (100.0)   **39**   **21**   **60**   (100.0)
                                                                                     
  mean     66.6              70.3     67.9      54.1      49.6     52.5              

5). Initial symptoms {#S7.5}
--------------------

  patient number                                          2,907   
  ------------------------------------------------------- ------- --------
  no clinical symptoms (medical check-up)                 377     (13%)
  no clinical symptoms (detailed test of brain disease)   48      (2%)
  subjective symptoms (headache etc)                      725     (25%)
  seizures                                                209     (7%)
  focal symptoms                                          1,354   (47%)
  intracranial hypertension                               257     (9%)
  disturbance of consciousness                            216     (7%)
  cranial nerve symptoms                                  171     (6%)
  hormone degradation • excess                            10      (0.3%)
  intracerebral hemorrhage                                30      (1%)
  others                                                  127     (4%)

6). Seizures during the whole treatment {#S7.6}
---------------------------------------

  patient number   2,907   (100%)
  ---------------- ------- --------
  ( + )            430     (15%)
  ( - )            2,082   (72%)
  unknown          395     (14%)

7). Diagnostic methods {#S7.7}
----------------------

  patient number                                     2,907   (100%)
  -------------------------------------------------- ------- --------
  histopathology                                     1,521   (52%)
  diagnostic imaging                                 1,325   (46%)
  cerebrospinal fluid cytology diagnosis             39      (1%)
  biochemical test of cerebrospinal fluid or blood   15      (1%)
  genetic diagnosis                                  \-      ( - )
  autopsy                                            \-      ( - )
  others                                             7       (0.2%)

8). Number of brain metastases {#S7.8}
------------------------------

  pt.no.   2,907   (100%)
  -------- ------- --------
  Single   1,485   (51%)
  2--4     919     (32%)
  5--9     254     (9%)
  10-      163     (6%)
  LMM      86      (3%)

9). Laterality {#S7.9}
--------------

  patient number      2,907   (100%)
  ------------------- ------- --------
  right               876     (30%)
  left                888     (31%)
  across both sides   158     (5%)
  on both sides       827     (28%)
  central neuraxis    85      (3%)
  others              38      (1%)
  unknown             35      (1%)

10). Maximum tumor diameter {#S7.10}
---------------------------

  Diameter (mm)          1--9   10--19   20--29   30--39   40--49   50--59   60--150   total   Unknown                                                       
  ---------------------- ------ -------- -------- -------- -------- -------- --------- ------- --------- ------- ----- ------- ---- ------- ------- -------- -----
  All brain metastases   114    (5%)     348      (16%)    595      (27%)    591       (27%)   304       (14%)   153   (7%)    86   (4%)    2,191   (100%)   716
  lung                   83     (8%)     222      (20%)    300      (28%)    241       (22%)   145       (13%)   55    (5%)    37   (3%)    1,083   (100%)   243
  breast                 9      (3%)     28       (10%)    79       (28%)    87        (31%)   41        (15%)   24    (9%)    12   (4%)    280     (100%)   93
  esophagus              \-     ( - )    6        (14%)    5        (12%)    12        (28%)   7         (16%)   11    (26%)   2    (5%)    43      (100%)   17
  stomach                3      (5%)     9        (14%)    18       (28%)    20        (31%)   7         (11%)   5     (8%)    3    (5%)    65      (100%)   31
  colon                  1      (1%)     13       (10%)    37       (29%)    49        (39%)   19        (15%)   6     (5%)    2    (2%)    127     (100%)   39
  rectum, anus           1      (1%)     11       (13%)    23       (26%)    36        (41%)   8         (9%)    7     (8%)    1    (1%)    87      (100%)   26
  liver                  1      (3%)     3        (9%)     6        (18%)    9         (27%)   9         (27%)   2     (6%)    3    (9%)    33      (100%)   24
  skin (melanoma)        3      (13%)    \-       ( - )    10       (42%)    5         (21%)   3         (13%)   3     (13%)   \-   ( - )   24      (100%)   14
  head and neck          \-     ( - )    6        (13%)    12       (27%)    12        (27%)   6         (13%)   7     (16%)   2    (4%)    45      (100%)   17
  thyroid                \-     ( - )    8        (23%)    11       (31%)    4         (11%)   5         (14%)   4     (11%)   3    (9%)    35      (100%)   11
  bladder                \-     ( - )    2        (13%)    2        (13%)    7         (47%)   2         (13%)   1     (7%)    1    (7%)    15      (100%)   8
  uterus                 \-     ( - )    2        (6%)     3        (10%)    13        (42%)   7         (23%)   5     (16%)   1    (3%)    31      (100%)   11
  ovary                  \-     ( - )    3        (9%)     11       (34%)    8         (25%)   8         (25%)   1     (3%)    1    (3%)    32      (100%)   14
  kidney                 6      (6%)     24       (23%)    32       (30%)    28        (27%)   9         (9%)    3     (3%)    3    (3%)    105     (100%)   47
  unknown primary        3      (3%)     7        (8%)     31       (34%)    30        (33%)   9         (10%)   8     (9%)    4    (4%)    92      (100%)   46

11). Other metastases {#S7.11}
---------------------

                         none    lung    liver   abdominal organ   lymph node   bone    others   unknown   patient number                                                              
  ---------------------- ------- ------- ------- ----------------- ------------ ------- -------- --------- ---------------- -------- ----- ------- ----- ------- ----- ------- ------- --------
  All brain metastases   1,100   (38%)   630     (22%)             274          (9%)    170      (6%)      358              (12%)    396   (14%)   141   (5%)    470   (16%)   2,907   (100%)
                                                                                                                                                                                       
  lung                   673     (51%)   89      (7%)              57           (4%)    74       (6%)      145              (11%)    147   (11%)   50    (4%)    241   (18%)   1,326   (100%)
  breast                 103     (28%)   101     (27%)             58           (16%)   5        (1%)      82               (22%)    123   (33%)   24    (6%)    40    (11%)   373     (100%)
  esophagus              16      (27%)   21      (35%)             9            (15%)   5        (8%)      14               (23%)    4     (7%)    5     (8%)    11    (18%)   60      (100%)
  stomach                26      (27%)   23      (24%)             17           (18%)   7        (7%)      16               (17%)    8     (8%)    3     (3%)    18    (19%)   96      (100%)
  colon                  24      (14%)   95      (57%)             60           (36%)   12       (7%)      11               (7%)     15    (9%)    6     (4%)    12    (7%)    166     (100%)
  rectum•anus            15      (13%)   71      (63%)             34           (30%)   4        (4%)      9                (8%)     8     (7%)    7     (6%)    10    (9%)    113     (100%)
  liver                  12      (21%)   20      (35%)             1            (2%)    5        (9%)      3                (5%)     8     (14%)   1     (2%)    12    (21%)   57      (100%)
  gall bladder           2       (50%)   2       (50%)             1            (25%)   \-       ( - )     1                (25%)    \-    ( - )   \-    ( - )   \-    ( - )   4       (100%)
  pancreas               1       (9%)    5       (45%)             1            (9%)    2        (18%)     1                (9%)     \-    ( - )   1     (9%)    2     (18%)   11      (100%)
  spleen                 \-      ( - )   \-      ( - )             \-           ( - )   \-       ( - )     1                (100%)   \-    ( - )   \-    ( - )   \-    ( - )   1       (100%)
  hematopoietic          11      (50%)   2       (9%)              1            (5%)    4        (18%)     2                (9%)     4     (18%)   2     (9%)    2     (9%)    22      (100%)
  bone                   3       (27%)   6       (55%)             1            (9%)    1        (9%)      \-               ( - )    4     (36%)   1     (9%)    1     (9%)    11      (100%)
  soft tissue            3       (27%)   7       (64%)             1            (9%)    1        (9%)      1                (9%)     4     (36%)   1     (9%)    \-    ( - )   11      (100%)
  skin                   10      (26%)   12      (32%)             1            (3%)    1        (3%)      6                (16%)    \-    ( - )   6     (16%)   7     (18%)   38      (100%)
  head and neck          32      (52%)   16      (26%)             1            (2%)    \-       ( - )     4                (6%)     3     (5%)    3     (5%)    8     (13%)   62      (100%)
  thyroid                15      (33%)   15      (33%)             \-           ( - )   \-       ( - )     9                (20%)    9     (20%)   4     (9%)    2     (4%)    46      (100%)
  testis                 2       (13%)   9       (56%)             1            (6%)    1        (6%)      4                (25%)    \-    ( - )   1     (6%)    3     (19%)   16      (100%)
  bladder                8       (35%)   6       (26%)             1            (4%)    2        (9%)      4                (17%)    2     (9%)    \-    ( - )   3     (13%)   23      (100%)
  uterus                 9       (21%)   10      (24%)             3            (7%)    3        (7%)      9                (21%)    2     (5%)    2     (5%)    9     (21%)   42      (100%)
  ovary                  18      (39%)   9       (20%)             5            (11%)   11       (24%)     7                (15%)    2     (4%)    \-    ( - )   6     (13%)   46      (100%)
  kidney                 34      (22%)   71      (47%)             7            (5%)    12       (8%)      10               (7%)     29    (19%)   11    (7%)    23    (15%)   152     (100%)
  optical                2       (40%)   \-      ( - )             \-           ( - )   \-       ( - )     \-               ( - )    \-    ( - )   1     (20%)   2     (40%)   5       (100%)
  lymphatic gland        8       (35%)   3       (13%)             1            (4%)    2        (9%)      6                (26%)    2     (9%)    1     (4%)    5     (22%)   23      (100%)
  nervous tissue         2       (40%)   2       (40%)             \-           ( - )   1        (20%)     \-               ( - )    1     (20%)   1     (20%)   \-    ( - )   5       (100%)
  unknown primary        52      (38%)   25      (18%)             6            (4%)    12       (9%)      9                (7%)     7     (5%)    5     (4%)    44    (32%)   138     (100%)
  others                 19      (32%)   10      (17%)             7            (12%)   5        (8%)      4                (7%)     14    (23%)   5     (8%)    9     (15%)   60      (100%)

12). Initial KPS before treatment {#S7.12}
---------------------------------

  Origin/ KPS            0    10       20   30       40   50      60   70      80    90      100   unknown   total                                                                                         
  ---------------------- ---- -------- ---- -------- ---- ------- ---- ------- ----- ------- ----- --------- ------- ------- ----- ------- ----- ------- ----- ------- ----- ------- ----- ------- ------- --------
  All brain metastases   1    (0.0%)   22   (1%)     41   (1%)    35   (1%)    141   (5%)    237   (8%)      322     (11%)   402   (14%)   509   (18%)   589   (20%)   308   (11%)   300   (10%)   2,907   (100%)
  lung                   1    (0.1%)   6    (0.5%)   9    (1%)    16   (1%)    58    (4%)    100   (8%)      133     (10%)   159   (12%)   230   (17%)   300   (23%)   177   (13%)   137   (10%)   1,326   (100%)
  breast                 \-   ( - )    1    (0.3%)   4    (1%)    3    (1%)    15    (4%)    35    (9%)      45      (12%)   60    (16%)   73    (20%)   73    (20%)   30    (8%)    34    (9%)    373     (100%)
  esophagus              \-   ( - )    1    (2%)     1    (2%)    2    (3%)    3     (5%)    9     (15%)     5       (8%)    14    (23%)   7     (12%)   10    (17%)   2     (3%)    6     (10%)   60      (100%)
  stomach                \-   ( - )    1    (1%)     2    (2%)    1    (1%)    7     (7%)    8     (8%)      19      (20%)   17    (18%)   20    (21%)   9     (9%)    4     (4%)    8     (8%)    96      (100%)
  colon                  \-   ( - )    \-   ( - )    4    (2%)    \-   ( - )   7     (4%)    17    (10%)     20      (12%)   26    (16%)   33    (20%)   29    (17%)   11    (7%)    19    (11%)   166     (100%)
  rectum•anus            \-   ( - )    1    (1%)     \-   ( - )   1    (1%)    11    (10%)   11    (10%)     6       (5%)    16    (14%)   20    (18%)   22    (19%)   8     (7%)    17    (15%)   113     (100%)
  liver                  \-   ( - )    1    (2%)     2    (4%)    1    (2%)    5     (9%)    3     (5%)      6       (11%)   7     (12%)   6     (11%)   14    (25%)   5     (9%)    7     (12%)   57      (100%)
  gall bladder           \-   ( - )    \-   ( - )    \-   ( - )   \-   ( - )   \-    ( - )   \-    ( - )     \-      ( - )   \-    ( - )   1     (25%)   2     (50%)   1     (25%)   \-    ( - )   4       (100%)
  pancreas               \-   ( - )    \-   ( - )    \-   ( - )   \-   ( - )   1     (9%)    1     (9%)      \-      ( - )   \-    ( - )   1     (9%)    1     (9%)    2     (18%)   5     (45%)   11      (100%)
  spleen                 \-   ( - )    \-   ( - )    \-   ( - )   \-   ( - )   \-    ( - )   1     (100%)    \-      ( - )   \-    ( - )   \-    ( - )   \-    ( - )   \-    ( - )   \-    ( - )   1       (100%)
  hematopoietic          \-   ( - )    1    (5%)     \-   ( - )   1    (5%)    1     (5%)    1     (5%)      4       (18%)   1     (5%)    6     (27%)   5     (23%)   \-    ( - )   2     (9%)    22      (100%)
  bone                   \-   ( - )    1    (9%)     \-   ( - )   \-   ( - )   1     (9%)    \-    ( - )     2       (18%)   \-    ( - )   \-    ( - )   3     (27%)   2     (18%)   2     (18%)   11      (100%)
  soft tissue            \-   ( - )    \-   ( - )    \-   ( - )   \-   ( - )   1     (9%)    \-    ( - )     1       (9%)    3     (27%)   3     (27%)   1     (9%)    2     (18%)   \-    ( - )   11      (100%)
  skin                   \-   ( - )    1    (3%)     \-   ( - )   \-   ( - )   2     (5%)    1     (3%)      6       (16%)   6     (16%)   4     (11%)   4     (11%)   9     (24%)   5     (13%)   38      (100%)
  head and neck          \-   ( - )    \-   ( - )    1    (2%)    \-   ( - )   2     (3%)    5     (8%)      3       (5%)    10    (16%)   14    (23%)   17    (27%)   7     (11%)   3     (5%)    62      (100%)
  thyroid                \-   ( - )    1    (2%)     1    (2%)    \-   ( - )   1     (2%)    2     (4%)      5       (11%)   3     (7%)    9     (20%)   12    (26%)   8     (17%)   4     (9%)    46      (100%)
  testis                 \-   ( - )    \-   ( - )    \-   ( - )   \-   ( - )   2     (13%)   2     (13%)     5       (31%)   3     (19%)   1     (6%)    2     (13%)   1     (6%)    \-    ( - )   16      (100%)
  bladder                \-   ( - )    \-   ( - )    \-   ( - )   \-   ( - )   2     (9%)    \-    ( - )     4       (17%)   8     (35%)   5     (22%)   2     (9%)    \-    ( - )   2     (9%)    23      (100%)
  uterus                 \-   ( - )    \-   ( - )    3    (7%)    1    (2%)    2     (5%)    6     (14%)     1       (2%)    6     (14%)   10    (24%)   9     (21%)   1     (2%)    3     (7%)    42      (100%)
  ovary                  \-   ( - )    \-   ( - )    \-   ( - )   1    (2%)    2     (4%)    3     (7%)      10      (22%)   6     (13%)   9     (20%)   4     (9%)    4     (9%)    7     (15%)   46      (100%)
  kidney                 \-   ( - )    2    (1%)     6    (4%)    3    (2%)    8     (5%)    12    (8%)      23      (15%)   17    (11%)   27    (18%)   26    (17%)   15    (10%)   13    (9%)    152     (100%)
  optical                \-   ( - )    \-   ( - )    \-   ( - )   \-   ( - )   \-    ( - )   1     (20%)     \-      ( - )   2     (40%)   \-    ( - )   2     (40%)   \-    ( - )   \-    ( - )   5       (100%)
  lymphatic gland        \-   ( - )    \-   ( - )    1    (4%)    1    (4%)    1     (4%)    1     (4%)      2       (9%)    6     (26%)   4     (17%)   2     (9%)    \-    ( - )   5     (22%)   23      (100%)
  nervous tissue         \-   ( - )    1    (20%)    1    (20%)   \-   ( - )   1     (20%)   1     (20%)     \-      ( - )   1     (20%)   \-    ( - )   \-    ( - )   \-    ( - )   \-    ( - )   5       (100%)
  unknown primary        \-   ( - )    3    (2%)     5    (4%)    4    (3%)    7     (5%)    12    (9%)      18      (13%)   19    (14%)   17    (12%)   28    (20%)   8     (6%)    17    (12%)   138     (100%)
  others                 \-   ( - )    1    (2%)     1    (2%)    \-   ( - )   1     (2%)    5     (8%)      4       (7%)    12    (20%)   9     (15%)   12    (20%)   11    (18%)   4     (7%)    60      (100%)

13). KPS after initial treatment {#S7.13}
--------------------------------

  Origin/ KPS            0     10      20   30       40   50      60   70      80    90      100   unknown   total                                                                                         
  ---------------------- ----- ------- ---- -------- ---- ------- ---- ------- ----- ------- ----- --------- ------- ------- ----- ------- ----- ------- ----- ------- ----- ------- ----- ------- ------- --------
  All brain metastases   121   (4%)    19   (1%)     24   (1%)    27   (1%)    104   (4%)    138   (5%)      252     (9%)    330   (11%)   479   (16%)   692   (24%)   420   (14%)   301   (10%)   2,907   (100%)
  lung                   50    (4%)    6    (0.5%)   9    (1%)    12   (1%)    42    (3%)    59    (4%)      101     (8%)    135   (10%)   220   (17%)   330   (25%)   221   (17%)   141   (11%)   1,326   (100%)
  breast                 9     (2%)    2    (1%)     2    (1%)    2    (1%)    11    (3%)    19    (5%)      38      (10%)   51    (14%)   66    (18%)   90    (24%)   51    (14%)   32    (9%)    373     (100%)
  esophagus              2     (3%)    1    (2%)     1    (2%)    1    (2%)    2     (3%)    7     (12%)     4       (7%)    14    (23%)   9     (15%)   9     (15%)   5     (8%)    5     (8%)    60      (100%)
  stomach                7     (7%)    \-   ( - )    \-   ( - )   1    (1%)    7     (7%)    8     (8%)      11      (11%)   12    (13%)   18    (19%)   16    (17%)   9     (9%)    7     (7%)    96      (100%)
  colon                  8     (5%)    \-   ( - )    2    (1%)    1    (1%)    6     (4%)    8     (5%)      12      (7%)    22    (13%)   29    (17%)   42    (25%)   18    (11%)   18    (11%)   166     (100%)
  rectum•anus            1     (1%)    \-   ( - )    2    (2%)    1    (1%)    8     (7%)    1     (1%)      8       (7%)    13    (12%)   19    (17%)   29    (26%)   14    (12%)   17    (15%)   113     (100%)
  liver                  7     (12%)   \-   ( - )    \-   ( - )   \-   ( - )   4     (7%)    4     (7%)      5       (9%)    4     (7%)    4     (7%)    13    (23%)   9     (16%)   7     (12%)   57      (100%)
  gall bladder           \-    ( - )   \-   ( - )    \-   ( - )   \-   ( - )   \-    ( - )   \-    ( - )     \-      ( - )   1     (25%)   1     (25%)   1     (25%)   1     (25%)   \-    ( - )   4       (100%)
  pancreas               \-    ( - )   \-   ( - )    \-   ( - )   \-   ( - )   \-    ( - )   1     (9%)      \-      ( - )   1     (9%)    1     (9%)    2     (18%)   1     (9%)    5     (45%)   11      (100%)
  spleen                 \-    ( - )   1    (100%)   \-   ( - )   \-   ( - )   \-    ( - )   \-    ( - )     \-      ( - )   \-    ( - )   \-    ( - )   \-    ( - )   \-    ( - )   \-    ( - )   1       (100%)
  hematopoietic          3     (14%)   \-   ( - )    \-   ( - )   1    (5%)    \-    ( - )   1     (5%)      4       (18%)   2     (9%)    2     (9%)    6     (27%)   \-    ( - )   3     (14%)   22      (100%)
  bone                   \-    ( - )   \-   ( - )    \-   ( - )   \-   ( - )   1     (9%)    \-    ( - )     2       (18%)   \-    ( - )   \-    ( - )   4     (36%)   2     (18%)   2     (18%)   11      (100%)
  soft tissue            \-    ( - )   1    (9%)     \-   ( - )   1    (9%)    2     (18%)   \-    ( - )     \-      ( - )   1     (9%)    1     (9%)    3     (27%)   2     (18%)   \-    ( - )   11      (100%)
  skin                   5     (13%)   \-   ( - )    \-   ( - )   \-   ( - )   1     (3%)    \-    ( - )     3       (8%)    5     (13%)   4     (11%)   7     (18%)   9     (24%)   4     (11%)   38      (100%)
  head and neck          1     (2%)    \-   ( - )    \-   ( - )   \-   ( - )   2     (3%)    4     (6%)      2       (3%)    4     (6%)    16    (26%)   20    (32%)   8     (13%)   5     (8%)    62      (100%)
  thyroid                1     (2%)    \-   ( - )    \-   ( - )   \-   ( - )   \-    ( - )   3     (7%)      4       (9%)    1     (2%)    10    (22%)   11    (24%)   10    (22%)   6     (13%)   46      (100%)
  testis                 1     (6%)    \-   ( - )    \-   ( - )   1    (6%)    1     (6%)    \-    ( - )     3       (19%)   3     (19%)   3     (19%)   2     (13%)   2     (13%)   \-    ( - )   16      (100%)
  bladder                2     (9%)    \-   ( - )    \-   ( - )   \-   ( - )   1     (4%)    \-    ( - )     3       (13%)   6     (26%)   3     (13%)   6     (26%)   1     (4%)    1     (4%)    23      (100%)
  uterus                 2     (5%)    1    (2%)     \-   ( - )   1    (2%)    \-    ( - )   3     (7%)      2       (5%)    7     (17%)   6     (14%)   13    (31%)   5     (12%)   2     (5%)    42      (100%)
  ovary                  1     (2%)    \-   ( - )    \-   ( - )   \-   ( - )   \-    ( - )   2     (4%)      5       (11%)   9     (20%)   9     (20%)   8     (17%)   6     (13%)   6     (13%)   46      (100%)
  kidney                 3     (2%)    3    (2%)     3    (2%)    1    (1%)    9     (6%)    7     (5%)      23      (15%)   6     (4%)    29    (19%)   32    (21%)   22    (14%)   14    (9%)    152     (100%)
  optical                \-    ( - )   \-   ( - )    \-   ( - )   \-   ( - )   \-    ( - )   1     (20%)     \-      ( - )   1     (20%)   1     (20%)   2     (40%)   \-    ( - )   \-    ( - )   5       (100%)
  lymphatic gland        1     (4%)    \-   ( - )    \-   ( - )   1    (4%)    \-    ( - )   1     (4%)      2       (9%)    6     (26%)   6     (26%)   2     (9%)    \-    ( - )   4     (17%)   23      (100%)
  nervous tissue         2     (40%)   \-   ( - )    1    (20%)   \-   ( - )   \-    ( - )   \-    ( - )     \-      ( - )   \-    ( - )   \-    ( - )   2     (40%)   \-    ( - )   \-    ( - )   5       (100%)
  unknown primary        10    (7%)    3    (2%)     4    (3%)    3    (2%)    6     (4%)    9     (7%)      18      (13%)   14    (10%)   13    (9%)    26    (19%)   14    (10%)   18    (13%)   138     (100%)
  others                 5     (8%)    1    (2%)     \-   ( - )   \-   ( - )   1     (2%)    \-    ( - )     2       (3%)    12    (20%)   9     (15%)   16    (27%)   10    (17%)   4     (7%)    60      (100%)

14). Initial treatment {#S7.14}
----------------------

  patient number      2,907   (100%)
  ------------------- ------- --------
  surgery             596     (21%)
  surgery + RT        895     (31%)
  surgery + CRT       140     (5%)
  surgery + CTX       80      (3%)
  CRT                 90      (3%)
  RT                  948     (33%)
  CT                  19      (1%)
  observation alone   126     (4%)
  others              13      (0.4%)

15). Initial surgery {#S7.15}
--------------------

  patient number              2,907   (100%)
  --------------------------- ------- --------
  none                        1,192   (41%)
  decompressive craniectomy   7       (0.2%)
  biopsy                      109     (4%)
  1--50% resection            41      (1%)
  50--75% resection           70      (2%)
  75--95% resection           158     (5%)
  95--99% resection           245     (8%)
  100% resection              874     (30%)
  extended tumor resection    6       (0.2%)
  shunt                       26      (1%)
  drainage                    87      (3%)
  others                      92      (3%)

16). Initial radiotherapy {#S7.16}
-------------------------

  radiotherapy           none   RT (+)   total   timing of radiotherapy                                                                                  
  ---------------------- ------ -------- ------- ------------------------ ------- -------- ------- ------- ---- -------- ----- ------- ---- ------- ---- -------
  All brain metastases   829    (29%)    2,078   (71%)                    2,907   (100%)   1,074   (37%)   1    (0.0%)   889   (31%)   66   (2%)    48   (2%)
                                                                                                                                                         
  lung                   310    (23%)    1,016   (77%)                    1,326   (100%)   585     (44%)   \-   ( - )    375   (28%)   32   (2%)    24   (2%)
  breast                 88     (24%)    285     (76%)                    373     (100%)   136     (36%)   1    (0.3%)   131   (35%)   11   (3%)    6    (2%)
  esophagus              17     (28%)    43      (72%)                    60      (100%)   16      (27%)   \-   ( - )    23    (38%)   2    (3%)    2    (3%)
  stomach                37     (39%)    59      (61%)                    96      (100%)   29      (30%)   \-   ( - )    26    (27%)   2    (2%)    2    (2%)
  colon                  47     (28%)    119     (72%)                    166     (100%)   61      (37%)   \-   ( - )    50    (30%)   4    (2%)    4    (2%)
  rectum•anus            29     (26%)    84      (74%)                    113     (100%)   48      (42%)   \-   ( - )    33    (29%)   3    (3%)    \-   ( - )
  liver                  29     (51%)    28      (49%)                    57      (100%)   18      (32%)   \-   ( - )    10    (18%)   \-   ( - )   \-   ( - )
  gall bladder           1      (25%)    3       (75%)                    4       (100%)   1       (25%)   \-   ( - )    2     (50%)   \-   ( - )   \-   ( - )
  pancreas               4      (36%)    7       (64%)                    11      (100%)   3       (27%)   \-   ( - )    4     (36%)   \-   ( - )   \-   ( - )
  spleen                 1      (100%)   \-      ( - )                    1       (100%)   \-      ( - )   \-   ( - )    \-    ( - )   \-   ( - )   \-   ( - )
  hematopoietic          12     (55%)    10      (45%)                    22      (100%)   5       (23%)   \-   ( - )    4     (18%)   \-   ( - )   1    (5%)
  bone                   5      (45%)    6       (55%)                    11      (100%)   4       (36%)   \-   ( - )    2     (18%)   \-   ( - )   \-   ( - )
  soft tissue            8      (73%)    3       (27%)                    11      (100%)   2       (18%)   \-   ( - )    1     (9%)    \-   ( - )   \-   ( - )
  skin                   14     (37%)    24      (63%)                    38      (100%)   11      (29%)   \-   ( - )    13    (34%)   \-   ( - )   \-   ( - )
  head and neck          23     (37%)    39      (63%)                    62      (100%)   14      (23%)   \-   ( - )    22    (35%)   2    (3%)    1    (2%)
  thyroid                19     (41%)    27      (59%)                    46      (100%)   13      (28%)   \-   ( - )    13    (28%)   1    (2%)    \-   ( - )
  testis                 7      (44%)    9       (56%)                    16      (100%)   2       (13%)   \-   ( - )    7     (44%)   \-   ( - )   \-   ( - )
  bladder                9      (39%)    14      (61%)                    23      (100%)   5       (22%)   \-   ( - )    8     (35%)   \-   ( - )   1    (4%)
  uterus                 7      (17%)    35      (83%)                    42      (100%)   10      (24%)   \-   ( - )    24    (57%)   \-   ( - )   1    (2%)
  ovary                  15     (33%)    31      (67%)                    46      (100%)   9       (20%)   \-   ( - )    21    (46%)   1    (2%)    \-   ( - )
  kidney                 51     (34%)    101     (66%)                    152     (100%)   53      (35%)   \-   ( - )    41    (27%)   5    (3%)    2    (1%)
  optical                2      (40%)    3       (60%)                    5       (100%)   1       (20%)   \-   ( - )    2     (40%)   \-   ( - )   \-   ( - )
  lymphatic gland        12     (52%)    11      (48%)                    23      (100%)   5       (22%)   \-   ( - )    5     (22%)   \-   ( - )   1    (4%)
  nervous tissue         3      (60%)    \-      ( - )                    5       (100%)   \-      ( - )   \-   ( - )    1     (20%)   1    (20%)   \-   ( - )
  unknown primary        51     (37%)    87      (63%)                    138     (100%)   29      (21%)   \-   ( - )    55    (40%)   1    (1%)    2    (1%)
  others                 28     (47%)    32      (53%)                    60      (100%)   14      (23%)   \-   ( - )    16    (27%)   1    (2%)    1    (2%)

17). Mode of initial radiotherapy {#S7.17}
---------------------------------

                         pt. No.   WBRT   LBRT    WBRT+ LBRT /SRT/SRS   LBRT+ SRT/SRS   SRS/SRT   internal RT   others                                               
  ---------------------- --------- ------ ------- --------------------- --------------- --------- ------------- -------- -------- ------- ------- ---- -------- ---- --------
  All brain metastases   2,907     548    (19%)   189                   (7%)            107       (4%)          14       (0.5%)   1,200   (41%)   2    (0.1%)   18   (1%)
  lung                   1,326     262    (20%)   65                    (5%)            43        (3%)          6        (0.5%)   632     (48%)   \-   ( - )    8    (1%)
  breast                 373       116    (31%)   27                    (7%)            18        (5%)          4        (1%)     118     (32%)   1    (0.3%)   1    (0.3%)
  esophagus              60        15     (25%)   4                     (7%)            1         (2%)          \-       ( - )    22      (37%)   \-   ( - )    1    (2%)
  stomach                96        13     (14%)   7                     (7%)            7         (7%)          \-       ( - )    30      (31%)   \-   ( - )    2    (2%)
  colon                  166       20     (12%)   10                    (6%)            7         (4%)          \-       ( - )    81      (49%)   \-   ( - )    1    (1%)
  rectum•anus            113       9      (8%)    8                     (7%)            4         (4%)          1        (1%)     61      (54%)   \-   ( - )    1    (1%)
  liver                  57        6      (11%)   6                     (11%)           \-        ( - )         \-       ( - )    15      (26%)   \-   ( - )    1    (2%)
  gall bladder           4         2      (50%)   \-                    ( - )           1         (25%)         \-       ( - )    \-      ( - )   \-   ( - )    \-   ( - )
  pancreas               11        3      (27%)   1                     (9%)            \-        ( - )         \-       ( - )    3       (27%)   \-   ( - )    \-   ( - )
  spleen                 1         \-     ( - )   \-                    ( - )           \-        ( - )         \-       ( - )    \-      ( - )   \-   ( - )    \-   ( - )
  hematopoietic          22        6      (27%)   2                     (9%)            2         (9%)          \-       ( - )    \-      ( - )   \-   ( - )    \-   ( - )
  bone                   11        3      (27%)   1                     (9%)            1         (9%)          \-       ( - )    1       (9%)    \-   ( - )    \-   ( - )
  soft tissue            11        \-     ( - )   1                     (9%)            \-        ( - )         \-       ( - )    2       (18%)   \-   ( - )    \-   ( - )
  skin                   38        5      (13%)   3                     (8%)            \-        ( - )         \-       ( - )    16      (42%)   \-   ( - )    \-   ( - )
  head and neck          62        4      (6%)    11                    (18%)           \-        ( - )         1        (2%)     23      (37%)   \-   ( - )    \-   ( - )
  thyroid                46        8      (17%)   1                     (2%)            1         (2%)          \-       ( - )    16      (35%)   1    (2%)     \-   ( - )
  testis                 16        4      (25%)   2                     (13%)           2         (13%)         \-       ( - )    1       (6%)    \-   ( - )    \-   ( - )
  bladder                23        4      (17%)   4                     (17%)           \-        ( - )         \-       ( - )    6       (26%)   \-   ( - )    \-   ( - )
  uterus                 42        12     (29%)   3                     (7%)            6         (14%)         \-       ( - )    14      (33%)   \-   ( - )    \-   ( - )
  ovary                  46        7      (15%)   3                     (7%)            2         (4%)          \-       ( - )    19      (41%)   \-   ( - )    \-   ( - )
  kidney                 152       10     (7%)    7                     (5%)            2         (1%)          1        (1%)     80      (53%)   \-   ( - )    1    (1%)
  optical                5         1      (20%)   2                     (40%)           \-        ( - )         \-       ( - )    \-      ( - )   \-   ( - )    \-   ( - )
  lymphatic gland        23        6      (26%)   \-                    ( - )           2         (9%)          \-       ( - )    2       (9%)    \-   ( - )    1    (4%)
  nervous tissue         5         \-     ( - )   1                     (20%)           1         (20%)         \-       ( - )    \-      ( - )   \-   ( - )    \-   ( - )
  unknown primary        138       24     (17%)   13                    (9%)            6         (4%)          1        (1%)     42      (30%)   \-   ( - )    1    (1%)
  others                 60        8      (13%)   7                     (12%)           1         (2%)          \-       ( - )    16      (27%)   \-   ( - )    \-   ( - )

18). Any therapy during the whole treatment {#S7.18}
-------------------------------------------

  mode of therapy        patient number   surgery   WBRT    LBRT   SRS/SRT   particle beam therapy   CTX     molecular targeting drug   immunotherapy   steroid   anti-convulsants                                                                   
  ---------------------- ---------------- --------- ------- ------ --------- ----------------------- ------- -------------------------- --------------- --------- ------------------ ----- ------- ---- ------- ---- -------- ------- -------- ----- -------
  All brain metastases   2,907            1,540     (53%)   636    (22%)     244                     (8%)    1,234                      (42%)           1         (0.0%)             402   (14%)   77   (3%)    2    (0.1%)   1,367   (47%)    950   (33%)
  lung                   1,326            642       (48%)   310    (23%)     85                      (6%)    634                        (48%)           \-        ( - )              179   (13%)   36   (3%)    \-   ( - )    649     (49%)    446   (34%)
  breast                 373              208       (56%)   118    (32%)     42                      (11%)   133                        (36%)           \-        ( - )              77    (21%)   31   (8%)    \-   ( - )    179     (48%)    116   (31%)
  esophagus              60               33        (55%)   15     (25%)     2                       (3%)    23                         (38%)           \-        ( - )              7     (12%)   \-   ( - )   \-   ( - )    28      (47%)    22    (37%)
  stomach                96               51        (53%)   17     (18%)     6                       (6%)    37                         (39%)           \-        ( - )              15    (16%)   \-   ( - )   1    (1%)     46      (48%)    34    (35%)
  colon                  166              85        (51%)   22     (13%)     15                      (9%)    80                         (48%)           \-        ( - )              15    (9%)    2    (1%)    \-   ( - )    85      (51%)    55    (33%)
  rectum•anus            113              52        (46%)   16     (14%)     9                       (8%)    58                         (51%)           \-        ( - )              3     (3%)    1    (1%)    1    (1%)     69      (61%)    44    (39%)
  liver                  57               33        (58%)   6      (11%)     8                       (14%)   13                         (23%)           \-        ( - )              2     (4%)    \-   ( - )   1    (2%)     17      (30%)    11    (19%)
  gall bladder           4                3         (75%)   3      (75%)     \-                      ( - )   2                          (50%)           \-        ( - )              \-    ( - )   \-   ( - )   \-   ( - )    1       (25%)    2     (50%)
  pancreas               11               5         (45%)   3      (27%)     1                       (9%)    2                          (18%)           \-        ( - )              \-    ( - )   \-   ( - )   \-   ( - )    1       (9%)     4     (36%)
  spleen                 1                \-        ( - )   \-     ( - )     \-                      ( - )   \-                         ( - )           \-        ( - )              \-    ( - )   \-   ( - )   \-   ( - )    1       (100%)   \-    ( - )
  hematopoietic          22               15        (68%)   8      (36%)     5                       (23%)   \-                         ( - )           \-        ( - )              13    (59%)   4    (18%)   \-   ( - )    9       (41%)    3     (14%)
  bone                   11               7         (64%)   3      (27%)     2                       (18%)   4                          (36%)           \-        ( - )              2     (18%)   \-   ( - )   \-   ( - )    3       (27%)    3     (27%)
  soft tissue            11               9         (82%)   \-     ( - )     2                       (18%)   2                          (18%)           \-        ( - )              3     (27%)   \-   ( - )   \-   ( - )    6       (55%)    5     (45%)
  skin                   38               22        (58%)   3      (8%)      2                       (5%)    18                         (47%)           \-        ( - )              6     (16%)   \-   ( - )   \-   ( - )    14      (37%)    13    (34%)
  head and neck          62               39        (63%)   4      (6%)      9                       (15%)   22                         (35%)           1         (2%)               12    (19%)   \-   ( - )   1    (2%)     19      (31%)    14    (23%)
  thyroid                46               26        (57%)   9      (20%)     2                       (4%)    20                         (43%)           \-        ( - )              \-    ( - )   \-   ( - )   \-   ( - )    16      (35%)    14    (30%)
  testis                 16               13        (81%)   8      (50%)     5                       (31%)   1                          (6%)            \-        ( - )              10    (63%)   \-   ( - )   \-   ( - )    8       (50%)    6     (38%)
  bladder                23               14        (61%)   5      (22%)     2                       (9%)    8                          (35%)           \-        ( - )              2     (9%)    \-   ( - )   \-   ( - )    11      (48%)    6     (26%)
  uterus                 42               28        (67%)   15     (36%)     6                       (14%)   17                         (40%)           \-        ( - )              5     (12%)   \-   ( - )   \-   ( - )    22      (52%)    17    (40%)
  ovary                  46               29        (63%)   11     (24%)     3                       (7%)    21                         (46%)           \-        ( - )              6     (13%)   \-   ( - )   \-   ( - )    16      (35%)    13    (28%)
  kidney                 152              85        (56%)   14     (9%)      6                       (4%)    75                         (49%)           \-        ( - )              10    (7%)    \-   ( - )   9    (6%)     71      (47%)    55    (36%)
  optical                5                2         (40%)   1      (20%)     2                       (40%)   \-                         ( - )           \-        ( - )              2     (40%)   \-   ( - )   \-   ( - )    2       (40%)    1     (20%)
  lymphatic gland        23               17        (74%)   8      (35%)     1                       (4%)    3                          (13%)           \-        ( - )              15    (65%)   1    (4%)    \-   ( - )    11      (48%)    4     (17%)
  nervous tissue         5                4         (80%)   2      (40%)     1                       (20%)   2                          (40%)           \-        ( - )              1     (20%)   \-   ( - )   \-   ( - )    3       (60%)    2     (40%)
  unknown primary        138              81        (59%)   27     (20%)     18                      (13%)   43                         (31%)           \-        ( - )              6     (4%)    \-   ( - )   \-   ( - )    60      (43%)    45    (33%)
  others                 60               37        (62%)   8      (13%)     10                      (17%)   16                         (27%)           \-        ( - )              11    (18%)   2    (3%)    \-   ( - )    20      (33%)    15    (25%)

19). Overall survival and progression free survival {#S7.19}
---------------------------------------------------

                              total   Overall survival   Progression free survival                                                                                                          
  --------------------------- ------- ------------------ --------------------------- ----- ------ ------ ------ ------ ------ ------ ----- ------- ----- ------ ------ ------ ------ ------ ------
  All brain metastases        2,907   1,145              125.1                       0.0   17.1   58.8   41.4   33.8   28.5   26.3   843   125.1   0.0   16.0   55.9   41.9   33.9   31.3   29.2
  lung                        1,326   505                119.0                       0.0   20.0   60.9   42.6   33.3   27.5   24.8   395   119.0   0.0   16.0   55.4   40.6   31.1   27.9   26.3
    adenocarcinoma            699     263                104.1                       0.0   23.0   65.5   47.4   37.3   31.6   27.7   215   98.1    0.0   19.0   59.8   44.1   33.9   28.5   25.9
    squamous cell carcinoma   169     75                 109.1                       0.0   13.0   50.9   35.3   28.8   23.4   23.4   58    109.1   0.0   11.0   44.4   31.8   31.8   31.8   31.8
    small cell carcinoma      131     50                 72.0                        0.0   16.0   60.4   39.3   34.0   26.5   26.5   39    71.0    0.0   19.0   59.3   42.5   14.6   14.6   14.6
  breast                      373     164                111.1                       0.0   18.0   60.0   42.5   33.0   26.5   24.0   124   108.1   0.0   17.0   55.4   40.4   33.8   29.9   25.7
  esophagus                   60      27                 112.1                       0.0   11.0   45.9   17.9   11.9   11.9   11.9   18    112.1   0.0   6.0    37.0   27.7   27.7   27.7   27.7
  stomach                     96      41                 90.0                        0.0   9.1    42.9   26.6   26.6   26.6   17.8   21    90.0    0.0   12.0   49.7   38.7   19.4   19.4   19.4
  colon                       166     55                 65.1                        0.0   16.0   60.8   27.6   18.4   14.7   9.8    43    64.0    0.0   12.0   44.9   32.9   21.9   21.9   11.0
  rectum•anus                 113     46                 76.1                        0.0   11.0   45.1   14.7   4.9    4.9    4.9    38    76.1    0.0   10.0   43.3   21.7   21.7   21.7   21.7
  liver                       57      23                 79.1                        0.0   9.1    41.5   41.5   41.5   41.5   41.5   7     79.1    0.0   NR     70.2   70.2   70.2   70.2   70.2
  gall bladder                4       1                  34.0                        1.9   NR     66.7   66.7   ND     ND     ND     1     14.0    0.0   NR     75.0   ND     ND     ND     ND
  pancreas                    11      3                  21.0                        0.0   NR     25.0   ND     ND     ND     ND     1     21.0    0.0   NR     83.3   ND     ND     ND     ND
  spleen                      1       1                  1.0                         1.0   1.0    0.0    0.0    0.0    0.0    0.0    0     1.0     1.0   ND     ND     ND     ND     ND     0.0
  hematopoietic               22      10                 92.1                        0.0   15.0   55.6   38.1   38.1   38.1   28.6   3     92.1    0.0   NR     82.0   68.4   68.4   68.4   68.4
  bone                        11      7                  63.1                        0.0   12.0   48.0   48.0   48.0   24.0   24.0   4     28.9    0.0   28.0   77.8   51.9   ND     ND     ND
  soft tissue                 11      6                  33.1                        1.0   13.0   51.1   38.4   ND     ND     ND     7     33.1    0.0   6.0    16.4   16.4   ND     ND     ND
  skin                        38      21                 117.0                       0.0   10.0   42.7   32.9   27.4   22.0   22.0   21    117.0   0.0   6.0    32.1   21.4   16.0   16.0   16.0
  head and neck               62      21                 125.1                       0.0   70.1   75.1   75.1   71.2   62.5   62.5   20    125.1   0.0   25.1   61.7   54.3   49.7   39.8   39.8
  thyroid                     46      14                 102.1                       0.0   42.0   79.5   63.1   57.3   39.3   39.3   8     102.1   0.0   36.0   84.6   84.6   39.1   39.1   39.1
  testis                      16      8                  92.1                        0.0   8.0    32.8   21.9   21.9   21.9   21.9   3     92.1    0.0   NR     58.3   58.3   58.3   58.3   58.3
  bladder                     23      11                 31.0                        0.0   6.0    39.1   13.0   0.0    0.0    0.0    5     15.0    0.0   NR     53.8   ND     ND     ND     ND
  uterus                      42      19                 116.1                       0.0   14.0   50.6   38.9   38.9   34.6   34.6   12    116.1   0.0   18.0   60.7   40.5   40.5   40.5   40.5
  ovary                       46      19                 105.1                       0.0   18.0   68.0   43.4   38.6   38.6   38.6   17    88.1    0.0   18.1   52.3   38.1   38.1   38.1   38.1
  kidney                      152     52                 111.1                       0.0   32.1   68.6   54.1   47.6   41.9   39.7   41    107.1   0.0   19.0   61.6   49.5   44.7   44.7   38.3
  optical                     5       2                  38.1                        0.0   38.1   66.7   66.7   66.7   0.0    0.0    3     22.0    0.0   22.0   66.7   0.0    0.0    0.0    0.0
  lymphatic gland             23      11                 81.0                        0.0   30.0   54.0   54.0   16.9   16.9   16.9   5     81.0    0.0   27.0   65.9   65.9   49.4   49.4   49.4
  nervous tissue              5       4                  76.0                        5.0   10.0   40.0   40.0   40.0   20.0   20.0   3     34.0    5.0   14.0   75.0   37.5   0.0    0.0    0.0
  unknown primary             138     48                 113.1                       0.0   14.0   59.6   38.6   33.7   33.7   33.7   31    113.1   0.0   22.0   58.3   47.8   41.8   35.9   35.9
  others                      60      26                 98.1                        0.0   15.0   56.9   42.3   42.3   42.3   37.6   12    98.1    0.0   20.0   79.7   50.0   50.0   50.0   50.0

20). Outcome at investigation {#S7.20}
-----------------------------

  **patient number**   2,907   (100%)
  -------------------- ------- --------
  alive                199     (7%)
  dead                 1,145   (39%)
  unknown              1,563   (54%)

21). Pattern of recurrence at investigation {#S7.21}
-------------------------------------------

  **patient number**   2,907   (100%)
  -------------------- ------- --------
  none                 890     (31%)
  local recurrence     354     (12%)
  new lesions          489     (17%)
  unknown              1,174   (40%)

22). Overall survival and progression free survival depending on number of tumors {#S7.22}
---------------------------------------------------------------------------------

                         total   Overall survival   Progression free survival                                                  
  ---------------------- ------- ------------------ --------------------------- ----- ------ ------ ----- ------- ----- ------ ------
  All brain metastases   2,907   1,145              125.1                       0.0   17.1   26.3   843   125.1   0.0   16.0   29.2
  single                 1,485   553                125.1                       0.0   23.0   32.7   444   125.1   0.0   20.0   34.3
  2--4                   919     334                115.0                       0.0   15.0   23.8   264   115.0   0.0   13.0   22.9
  5--9                   254     110                96.1                        0.0   11.0   15.9   69    78.1    0.0   14.0   16.6
  10-                    163     92                 91.1                        0.0   7.0    3.8    45    41.0    0.0   12.0   ND
  LMM                    86      56                 81.0                        0.0   4.9    6.8    21    81.0    0.0   14.0   23.4

23). Overall survival and progression free survival depending on mode of radiotherapy {#S7.23}
-------------------------------------------------------------------------------------

                               total   Overall survival   Progression free survival                                                  
  ---------------------------- ------- ------------------ --------------------------- ----- ------ ------ ----- ------- ----- ------ ------
  WBRT                         548     281                101.0                       0.0   12.0   18.3   148   97.1    0.0   22.0   33.3
  WBRT + SRS/SRT               107     52                 119.0                       0.0   13.0   22.3   27    119.0   0.0   87.0   51.2
  LBRT                         189     90                 125.1                       0.0   20.0   26.5   69    125.1   0.0   22.1   26.4
  LBRT + SRS/SRT               14      6                  34.1                        0.0   19.1   ND     6     33.0    0.0   31.1   ND
  SRS/SRT                      1,200   397                111.1                       0.0   22.0   27.9   424   107.1   0.0   12.0   16.8
  internal radiation therapy   2       1                  38.0                        2.0   ND     ND     1     37.0    2.0   37.0   0.0
  particle beam irradiation    \-      \-                 \-                          \-    \-     \-     \-    \-      \-    \-     \-

24). Overall survival and progression free survival depending on initial treatment {#S7.24}
----------------------------------------------------------------------------------

                                 total     Overall survival   Progression free survival                                                              
  ------------------------------ --------- ------------------ --------------------------- ------- ------ ------ ------ ------- ------- ------ ------ ------
  All brain metastases           surgery   596                207                         117.0   0.0    19.0   34.2   128     117.0   0.0    35.0   46.7
  surgery + RT                   895       351                116.1                       0.0     21.0   31.6   315    116.1   0.0     15.1   28.9   
  surgery + CRT                  140       70                 125.1                       0.0     23.0   27.6   62     125.1   0.0     20.1   24.1   
  surgery + CTX                  80        45                 105.0                       0.0     14.0   24.9   25     105.0   0.0     18.0   44.1   
  CRT                            90        59                 98.0                        0.0     16.0   9.4    33     98.0    0.0     21.1   14.3   
  RT alone                       948       351                104.1                       0.0     17.0   18.0   266    101.1   0.0     13.0   17.7   
    WBRT alone                   148       72                 38.0                        0.0     7.0    0.0    32     27.0    0.0     19.0   ND     
    SRS/SRT alone                721       239                104.1                       0.0     20.1   21.2   217    101.1   0.0     12.0   18.1   
  CTX                            19        8                  92.1                        0.0     12.0   26.1   4      11.0    0.0     11.0   0.0    
  observation alone              126       51                 64.0                        0.0     3.0    13.0   7      33.0    0.0     32.0   ND     
                                                                                                                                                     
  Lung ALL                       surgery   238                80                          99.1    0.0    22.0   31.8   51      95.0    0.0    20.1   45.2
  surgery + RT                   389       143                101.0                       0.0     23.0   34.0   131    96.1    0.0     18.0   28.5   
  surgery + CRT                  57        28                 119.0                       0.0     28.0   29.4   31     119.0   0.0     20.0   15.7   
  surgery + CTX                  18        9                  60.0                        1.0     20.0   0.0    6      60.0    1.0     NR     51.9   
  CRT                            49        33                 77.1                        0.0     15.0   9.8    19     71.0    0.0     25.0   14.6   
  RT alone                       519       193                104.1                       0.0     19.0   16.9   154    95.0    0.0     14.0   16.0   
    WBRT alone                   80        38                 38.0                        0.0     9.0    0.0    17     27.0    0.0     19.0   ND     
    SRS/SRT alone                402       133                104.1                       0.0     22.0   20.0   130    95.0    0.0     13.0   13.4   
  CTX                            5         1                  14.0                        1.0     ND     ND     1      11.0    1.0     ND     ND     
  observation alone              44        16                 26.0                        0.0     4.0    ND     1      26.0    0.0     NR     ND     
                                                                                                                                                     
  Lung adenocarcinoma            surgery   120                34                          99.1    0.0    25.0   37.3   26      90.1    0.0    20.0   49.2
  surgery + RT                   213       78                 101.0                       0.0     29.0   38.7   75     96.1    0.0     18.0   29.3   
  surgery + CRT                  29        19                 65.1                        0.0     28.0   21.0   16     50.0    0.0     30.0   ND     
  surgery + CTX                  7         2                  60.0                        3.0     55.0   0.0    1      60.0    2.0     ND     75.0   
  CRT                            28        20                 77.1                        0.0     20.0   12.3   9      71.0    0.0     26.0   23.0   
  RT alone                       282       104                104.1                       0.0     20.1   19.4   87     95.0    0.0     16.1   9.7    
    WBRT alone                   29        14                 25.1                        0.0     6.0    0.0    7      19.0    0.0     19.0   0.0    
    SRS/SRT alone                234       76                 104.1                       0.0     22.0   24.1   78     95.0    0.0     15.9   10.2   
  CTX                            1         0                  2.0                         2.0     ND     ND     0      2.0     2.0     ND     ND     
  observation alone              15        5                  26.0                        0.0     7.0    ND     0      26.0    0.0     ND     ND     
                                                                                                                                                     
  Lung squamous cell carcinoma   surgery   34                 14                          95.0    0.0    14.0   35.5   8       95.0    0.0    ND     53.5
  surgery + RT                   65        26                 93.1                        0.0     13.1   16.8   24     55.0    0.0     10.1   ND     
  surgery + CRT                  9         5                  109.1                       0.0     18.0   35.7   6      109.1   0.0     7.0    19.4   
  surgery + CTX                  4         3                  14.0                        6.0     11.0   0.0    3      14.0    3.9     ND     ND     
  CRT                            2         1                  33.0                        15\.    ND     ND     2      20.0    11.0    15.5   0.0    
  RT alone                       52        24                 103.1                       0.0     7.0    20.3   15     85.0    0.0     12.0   32.8   
    WBRT alone                   10        7                  15.0                        1.0     4.0    0.0    2      12.0    1.0     12.0   0.0    
    SRS/SRT alone                40        16                 103.1                       0.0     9.0    20.5   12     75.0    0.0     12.0   31.6   
  CTX                            0         0                  ND                          ND      ND     ND     0      ND      ND      ND     ND     
  observation alone              3         2                  2.0                         0.0     2.0    0.0    0      2.0     0.0     ND     ND     
                                                                                                                                                     
  Lung small cell carcinoma      surgery   30                 10                          71.0    0.0    32.1   36.1   4       71.0    0.0    28.0   33.2
  surgery + RT                   36        12                 68.1                        0.0     48.0   36.7   12     48.0    0.0     25.0   ND     
  surgery + CRT                  10        2                  53.1                        2.0     24.0   ND     6      24.0    2.0     11.1   ND     
  surgery + CTX                  1         1                  10.0                        10.0    10.0   0.0    1      6.0     6.0     6.0    0.0    
  CRT                            16        11                 25.0                        1.0     11.0   ND     7      25.0    1.0     12.0   ND     
  RT alone                       32        12                 72.0                        0.0     15.0   18.5   7      66.0    0.0     19.0   23.5   
    WBRT alone                   17        10                 38.0                        0.0     9.0    0.0    4      26.0    0.0     26.0   0.0    
    SRS/SRT alone                13        2                  72.0                        0.0     ND     50.0   3      19.0    0.0     9.0    0.0    
  CTX                            3         1                  14.0                        1.0     14.0   0.0    1      11.0    1.0     11.0   0.0    
  observation alone              3         1                  2.0                         0.0     2.0    0.0    1      2.0     0.0     2.0    0.0    
                                                                                                                                                     
  Breast                         surgery   60                 27                          94.1    0.0    25.0   25.7   14      94.1    0.0    ND     51.5
  surgery + RT                   130       53                 111.1                       0.0     22.0   35.7   50     108.1   0.0     15.1   31.6   
  surgery + CRT                  25        14                 98.0                        1.0     18.0   16.5   12     87.0    1.0     26.0   10.2   
  surgery + CTX                  15        7                  97.1                        0.0     9.0    33.3   5      97.1    0.0     9.0    36.2   
  CRT                            24        15                 96.1                        1.0     18.0   6.8    10     51.0    1.0     20.1   0.0    
  RT alone                       105       45                 77.1                        0.0     13.0   16.0   32     77.1    0.0     13.0   8.1    
    WBRT alone                   29        19                 35.0                        0.0     10.0   0.0    8      22.0    0.0     19.0   0.0    
    SRS/SRT alone                65        20                 77.1                        0.0     19.0   24.4   19     77.1    0.0     12.0   13.5   
  CTX                            4         1                  18.0                        1.0     ND     ND     1      11.0    1.0     ND     ND     
  observation alone              8         2                  46.0                        0.0     ND     ND     0      9.0     0.0     ND     ND     
                                                                                                                                                     
  Esophagus                      surgery   11                 3                           112.1   0.0    21.0   38.9   4       112.1   0.0    ND     55.6
  surgery + RT                   22        12                 100.1                       1.0     6.0    13.1   6      13.9    1.0     6.0    0.0    
  surgery + CRT                  5         1                  14.1                        2.0     ND     ND     1      14.1    2.0     ND     ND     
  surgery + CTX                  1         1                  4.9                         4.9     ND     ND     1      4.9     4.9     ND     ND     
  CRT                            2         2                  1.0                         1.0     ND     ND     0      1.0     1.0     ND     ND     
  RT alone                       13        8                  28.0                        0.0     4.0    0.0    4      28.0    0.0     5.0    ND     
    WBRT alone                   5         1                  5.0                         0.0     ND     ND     1      4.0     0.0     4.0    0.0    
    SRS/SRT alone                6         5                  28.0                        1.0     14.0   0.0    3      28.0    1.0     5.0    ND     
  CTX                            0         0                  ND                          ND      ND     ND     0      ND      ND      ND     ND     
  observation alone              5         0                  6.0                         0.0     ND     ND     1      6.0     0.0     ND     ND     
                                                                                                                                                     
  Stomach                        surgery   26                 13                          53.0    0.0    8.0    ND     4       23.0    0.0    NR     ND
  surgery + RT                   24        10                 90.0                        1.0     12.0   14.0   9      90.0    0.0     7.0    24.4   
  surgery + CRT                  4         0                  32.0                        4.0     ND     ND     2      32.0    4.0     ND     ND     
  surgery + CTX                  3         2                  8.1                         3.9     ND     ND     0      8.1     3.9     ND     ND     
  CRT                            2         1                  7.0                         6.0     ND     ND     1      7.0     3.9     ND     ND     
  RT alone                       29        12                 33.0                        0.0     8.0    ND     5      27.0    0.0     22.0   0.0    
    WBRT alone                   7         4                  5.0                         1.0     3.0    ND     1      5.0     1.0     ND     ND     
    SRS/SRT alone                16        5                  33.0                        0.0     8.0    ND     2      27.0    0.0     27.0   0.0    
  CTX                            0         0                  ND                          ND      ND     ND     0      ND      ND      ND     ND     
  observation alone              8         3                  25.0                        0.0     ND     ND     0      25.0    0.0     ND     ND     
                                                                                                                                                     
  Colon                          surgery   37                 7                           65.1    0.0    20.0   32.8   7       64.0    0.0    49.1   32.4
  surgery + RT                   50        17                 46.0                        0.0     14.0   ND     14     31.0    0.0     10.1   ND     
  surgery + CRT                  8         5                  23.0                        4.0     ND     ND     3      23.0    2.0     ND     ND     
  surgery + CTX                  4         2                  20.0                        0.9     ND     ND     2      10.0    0.9     ND     ND     
  CRT                            1         0                  12.0                        12.0    ND     ND     0      12.0    12.0    ND     ND     
  RT alone                       60        19                 40.0                        0.0     15.0   0.0    16     36.0    0.0     12.0   0.0    
    WBRT alone                   3         1                  3.0                         0.0     ND     ND     0      3.0     0.0     ND     ND     
    SRS/SRT alone                53        16                 40.0                        0.0     15.0   0.0    15     13.0    0.0     9.0    0.0    
  CTX                            1         1                  1.0                         1.0     ND     ND     0      0.0     0.0     ND     ND     
  observation alone              5         4                  4.0                         1.0     ND     ND     1      4.0     0.0     ND     ND     
                                                                                                                                                     
  Rectum Anus                    surgery   23                 11                          18.0    1.0    11.0   ND     7       18.0    1.0    13.1   ND
  surgery + RT                   36        15                 76.1                        0.0     11.1   10.3   18     76.1    0.0     5.0    18.5   
  surgery + CRT                  1         0                  6.0                         6.0     ND     ND     0      6.0     6.0     ND     ND     
  surgery + CTX                  1         0                  1.0                         1.0     ND     ND     0      1.0     1.0     ND     ND     
  CRT                            2         2                  7.0                         3.0     ND     ND     0      3.0     2.0     ND     ND     
  RT                             45        17                 29.0                        0.0     11.0   0.0    13     15.1    0.0     10.0   ND     
    WBRT                         2         0                  2.0                         0.0     ND     ND     1      0.0     0.0     ND     ND     
    SRS/SRT                      42        17                 29.0                        0.0     11.0   0.0    12     15.1    0.0     10.0   ND     
  CTX                            1         0                  0.9                         0.9     ND     ND     0      0.9     0.9     ND     ND     
  observation alone              4         1                  2.0                         1.0     ND     ND     0      2.0     1.0     ND     ND     
                                                                                                                                                     
  Liver                          surgery   21                 8                           79.1    0.0    8.0    37.5   2       79.1    0.0    ND     72.0
  surgery + RT                   10        2                  76.1                        1.0     ND     72.9   2      76.1    1.0     ND     75.0   
  surgery + CRT                  1         1                  7.1                         7.1     ND     ND     0      5.0     5.0     ND     ND     
  surgery + CTX                  1         1                  10.0                        10.0    ND     ND     0      10.0    10.0    ND     ND     
  CRT                            0         0                  \-                          \-      \-     \-     0      \-      \-      \-     \-     
  RT                             17        6                  34.1                        0.0     ND     ND     3      34.1    0.0     9.0    ND     
    WBRT                         2         0                  7.0                         2.0     ND     ND     0      7.0     2.0     ND     ND     
    SRS/SRT                      13        5                  34.1                        0.0     4.0    ND     2      34.1    0.0     ND     ND     
  CTX                            0         0                  \-                          \-      \-     \-     0      \-      \-      \-     \-     
  observation alone              7         5                  2.0                         0.0     ND     ND     0      2.0     0.0     ND     ND     
                                                                                                                                                     
  Head and Neck                  surgery   12                 4                           80.1    1.0    63.1   73.3   5       80.1    1.0    4.0    47.6
  surgery + RT                   22        7                  96.1                        0.0     73.1   63.5   8      96.1    0.0     25.1   31.1   
  surgery + CRT                  3         1                  125.1                       39.0    ND     ND     2      125.1   12.0    ND     ND     
  surgery + CTX                  5         3                  81.1                        1.0     ND     ND     1      81.1    1.0     ND     ND     
  CRT                            0         0                  \-                          \-      \-     \-     0      \-      \-      \-     \-     
  RT                             14        4                  70.1                        0.0     64.0   75.0   3      70.1    0.0     38.0   30.0   
    WBRT                         1         0                  2.0                         2.0     ND     ND     0      2.0     2.0     ND     ND     
    SRS/SRT                      11        4                  70.1                        0.0     64.0   71.4   3      70.1    0.0     ND     25.0   
  CTX                            1         1                  12.0                        12.0    \-     \-     1      3.9     3.9     \-     \-     
  observation alone              5         1                  6.0                         0.0     ND     ND     0      1.0     0.0     ND     ND     
                                                                                                                                                     
  Kidney                         surgery   42                 13                          97.1    0.0    85.1   51.8   10      97.1    0.0    25.1   42.1
  surgery + RT                   43        16                 111.1                       0.0     34.0   41.8   14     107.1   0.0     15.0   36.6   
  surgery + CRT                  3         2                  24.0                        2.0     ND     ND     1      11.0    2.0     ND     ND     
  surgery + CTX                  4         3                  101.1                       2.0     ND     ND     2      86.1    0.0     ND     ND     
  CRT                            1         0                  98.0                        98.0    ND     ND     0      98.0    98.0    ND     ND     
  RT                             54        17                 100.1                       0.0     27.1   24.2   13     100.1   0.0     51.0   38.1   
    WBRT                         2         1                  1.0                         0.0     1.0    0.0    0      1.0     0.0     ND     ND     
    SRS/SRT                      47        14                 100.1                       0.0     27.1   26.0   13     100.1   0.0     15.9   36.1   
  CTX                            0         0                  \-                          \-      \-     \-     0      \-      \-      \-     \-     
  observation alone              5         1                  64.0                        1.0     ND     ND     1      32.0    1.0     ND     ND     
                                                                                                                                                     
  Unknown primary                surgery   34                 14                          113.1   0.0    8.0    27.3   6       113.1   0.0    NR     54.7
  surgery + RT                   55        17                 90.1                        0.0     17.0   44.8   15     90.1    0.0     31.1   33.4   
  surgery + CRT                  4         2                  13.0                        1.0     ND     ND     1      9.1     1.0     ND     ND     
  surgery + CTX                  1         1                  2.0                         2.0     ND     ND     0      2.0     2.0     ND     ND     
  CRT                            1         0                  17.1                        17.1    ND     ND     0      17.1    17.1    ND     ND     
  RT                             26        7                  35.0                        0.0     11.0   0.0    6      20.0    0.0     10.0   ND     
    WBRT                         5         1                  12.0                        2.0     ND     ND     0      12.0    2.0     ND     ND     
    SRS/SRT                      18        5                  35.0                        0.0     35.0   0.0    5      20.0    0.0     10.0   ND     
  CTX                            1         0                  2.0                         2.0     ND     ND     0      2.0     2.0     ND     ND     
  observation alone              15        7                  4.0                         0.0     3.0    0.0    3      3.9     0.0     NR     ND     

25). Cause of death {#S7.25}
-------------------

                         neuronal death except pneumonia and LMM   neuronal death with pneumonia   LMM   TRD except pneumoniae   TRD (pneumoniae)   primary cancer   accident or other disease   others   unknown   number of death                                                                
  ---------------------- ----------------------------------------- ------------------------------- ----- ----------------------- ------------------ ---------------- --------------------------- -------- --------- ----------------- ----- -------- ---- ------ ---- ------- ---- ------- ------- --------
  All brain metastases   102                                       (9%)                            121   (11%)                   89                 (8%)             21                          (2%)     49        (4%)              641   (56%)    10   (1%)   26   (2%)    86   (8%)    1,145   (100%)
  lung                   38                                        (8%)                            53    (10%)                   35                 (7%)             7                           (1%)     32        (6%)              282   (56%)    4    (1%)   11   (2%)    43   (9%)    505     (100%)
  breast                 15                                        (9%)                            11    (7%)                    26                 (16%)            4                           (2%)     1         (1%)              89    (54%)    \-   (-)    4    (2%)    14   (9%)    164     (100%)
  esophagus              3                                         (11%)                           2     (7%)                    4                  (15%)            \-                          (-)      2         (7%)              13    (48%)    1    (4%)   1    (4%)    1    (4%)    27      (100%)
  stomach                1                                         (2%)                            5     (12%)                   6                  (15%)            \-                          (-)      1         (2%)              24    (59%)    2    (5%)   \-   (-)     2    (5%)    41      (100%)
  colon                  6                                         (11%)                           11    (20%)                   2                  (4%)             4                           (7%)     1         (2%)              28    (51%)    \-   (-)    \-   (-)     3    (5%)    55      (100%)
  rectum•anus            7                                         (15%)                           4     (9%)                    \-                 (-)              \-                          (-)      4         (9%)              30    (65%)    \-   (-)    \-   (-)     1    (2%)    46      (100%)
  liver                  2                                         (9%)                            2     (9%)                    \-                 (-)              1                           (4%)     \-        (-)               14    (61%)    \-   (-)    2    (9%)    2    (9%)    23      (100%)
  gall bladder           \-                                        (-)                             \-    (-)                     \-                 (-)              \-                          (-)      \-        (-)               1     (100%)   \-   (-)    \-   (-)     \-   (-)     1       (100%)
  pancreas               \-                                        (-)                             \-    (-)                     \-                 (-)              \-                          (-)      \-        (-)               3     (100%)   \-   (-)    \-   (-)     \-   (-)     3       (100%)
  spleen                 1                                         (100%)                          \-    (-)                     \-                 (-)              \-                          (-)      \-        (-)               \-    (-)      \-   (-)    \-   (-)     \-   (-)     1       (100%)
  hematopoietic          1                                         (10%)                           1     (10%)                   \-                 (-)              \-                          (-)      \-        (-)               6     (60%)    \-   (-)    1    (10%)   1    (10%)   10      (100%)
  bone                   1                                         (14%)                           \-    (-)                     \-                 (-)              \-                          (-)      \-        (-)               6     (86%)    \-   (-)    \-   (-)     \-   (-)     7       (100%)
  soft tissue            \-                                        (-)                             1     (17%)                   1                  (17%)            1                           (17%)    \-        (-)               3     (50%)    \-   (-)    \-   (-)     \-   (-)     6       (100%)
  skin                   3                                         (14%)                           4     (19%)                   3                  (14%)            \-                          (-)      \-        (-)               7     (33%)    1    (5%)   1    (5%)    2    (10%)   21      (100%)
  head and neck          \-                                        (-)                             5     (24%)                   \-                 (-)              \-                          (-)      3         (14%)             13    (62%)    \-   (-)    \-   (-)     \-   (-)     21      (100%)
  thyroid                3                                         (21%)                           2     (14%)                   1                  (7%)             \-                          (-)      \-        (-)               5     (36%)    \-   (-)    \-   (-)     3    (21%)   14      (100%)
  testis                 \-                                        (-)                             1     (13%)                   1                  (13%)            \-                          (-)      \-        (-)               6     (75%)    \-   (-)    \-   (-)     \-   (-)     8       (100%)
  bladder                \-                                        (-)                             1     (9%)                    1                  (9%)             \-                          (-)      \-        (-)               8     (73%)    \-   (-)    \-   (-)     1    (9%)    11      (100%)
  uterus                 1                                         (5%)                            1     (5%)                    \-                 (-)              \-                          (-)      1         (5%)              13    (68%)    \-   (-)    1    (5%)    2    (11%)   19      (100%)
  ovary                  1                                         (5%)                            \-    (-)                     4                  (21%)            \-                          (-)      \-        (-)               12    (63%)    \-   (-)    1    (5%)    1    (5%)    19      (100%)
  kidney                 6                                         (12%)                           5     (10%)                   1                  (2%)             \-                          (-)      1         (2%)              36    (69%)    1    (2%)   1    (2%)    1    (2%)    52      (100%)
  optical                1                                         (50%)                           \-    (-)                     \-                 (-)              \-                          (-)      \-        (-)               1     (50%)    \-   (-)    \-   (-)     \-   (-)     2       (100%)
  lymphatic gland        \-                                        (-)                             1     (9%)                    1                  (9%)             1                           (9%)     \-        (-)               6     (55%)    \-   (-)    \-   (-)     2    (18%)   11      (100%)
  nervous tissue         1                                         (25%)                           \-    (-)                     \-                 (-)              \-                          (-)      \-        (-)               3     (75%)    \-   (-)    \-   (-)     \-   (-)     4       (100%)
  unknown primary        8                                         (17%)                           9     (19%)                   2                  (4%)             2                           (4%)     2         (4%)              16    (33%)    1    (2%)   3    (6%)    5    (10%)   48      (100%)
  others                 3                                         (12%)                           2     (8%)                    1                  (4%)             1                           (4%)     1         (4%)              16    (62%)    \-   (-)    \-   (-)     2    (8%)    26      (100%)

26). Place of death {#S7.26}
-------------------

                         hospital with NSD   hospital without NSD   hospice   nursing home   home   others   unknown   number of death                                                   
  ---------------------- ------------------- ---------------------- --------- -------------- ------ -------- --------- ----------------- ---- ------- ---- -------- ---- ------- ------- --------
  All brain metastases   914                 (80%)                  71        (6%)           57     (5%)     1         (0.1%)            32   (3%)    3    (0.3%)   67   (6%)    1,145   (100%)
  lung                   400                 (79%)                  37        (7%)           25     (5%)     1         (0.2%)            10   (2%)    1    (0.2%)   31   (6%)    505     (100%)
  breast                 130                 (79%)                  10        (6%)           9      (5%)     \-        ( - )             4    (2%)    \-   ( - )    11   (7%)    164     (100%)
  esophagus              19                  (70%)                  2         (7%)           1      (4%)     \-        ( - )             3    (11%)   \-   ( - )    2    (7%)    27      (100%)
  stomach                36                  (88%)                  1         (2%)           1      (2%)     \-        ( - )             1    (2%)    \-   ( - )    2    (5%)    41      (100%)
  colon                  45                  (82%)                  3         (5%)           4      (7%)     \-        ( - )             \-   ( - )   \-   ( - )    3    (5%)    55      (100%)
  rectum•anus            36                  (78%)                  4         (9%)           \-     ( - )    \-        ( - )             5    (11%)   1    (2%)     \-   ( - )   46      (100%)
  liver                  22                  (96%)                  \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    1    (4%)    23      (100%)
  gall bladder           1                   (100%)                 \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-   ( - )   1       (100%)
  pancreas               3                   (100%)                 \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-   ( - )   3       (100%)
  spleen                 1                   (100%)                 \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-   ( - )   1       (100%)
  hematopoietic          8                   (80%)                  1         (10%)          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    1    (10%)   10      (100%)
  bone                   5                   (71%)                  1         (14%)          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    1    (14%)   7       (100%)
  soft tissue            5                   (83%)                  1         (17%)          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-   ( - )   6       (100%)
  skin                   19                  (90%)                  \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    2    (10%)   21      (100%)
  head and neck          13                  (62%)                  2         (10%)          2      (10%)    \-        ( - )             2    (10%)   \-   ( - )    2    (10%)   21      (100%)
  thyroid                8                   (57%)                  2         (14%)          3      (21%)    \-        ( - )             \-   ( - )   \-   ( - )    1    (7%)    14      (100%)
  testis                 8                   (100%)                 \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-   ( - )   8       (100%)
  bladder                10                  (91%)                  \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    1    (9%)    11      (100%)
  uterus                 16                  (84%)                  \-        ( - )          2      (11%)    \-        ( - )             \-   ( - )   \-   ( - )    1    (5%)    19      (100%)
  ovary                  12                  (63%)                  1         (5%)           3      (16%)    \-        ( - )             \-   ( - )   \-   ( - )    3    (16%)   19      (100%)
  kidney                 38                  (73%)                  3         (6%)           3      (6%)     \-        ( - )             5    (10%)   1    (2%)     2    (4%)    52      (100%)
  optical                1                   (50%)                  \-        ( - )          1      (50%)    \-        ( - )             \-   ( - )   \-   ( - )    \-   ( - )   2       (100%)
  lymphatic gland        10                  (91%)                  \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    1    (9%)    11      (100%)
  nervous tissue         4                   (100%)                 \-        ( - )          \-     ( - )    \-        ( - )             \-   ( - )   \-   ( - )    \-   ( - )   4       (100%)
  unknown primary        41                  (85%)                  3         ( )            1      (2%)     \-        ( - )             2    (4%)    \-   ( - )    1    (2%)    48      (100%)
  others                 23                  (88%)                  \-        ( - )          2      (8%)     \-        ( - )             \-   ( - )   \-   ( - )    1    (4%)    26      (100%)

27). Autops {#S7.27}
-----------

  Autopsy                ( - )   ( + )    unknown   death                         
  ---------------------- ------- -------- --------- ------- ----- ------- ------- --------
  All brain metastases   979     (86%)    31        (3%)    135   (12%)   1,145   (100%)
  lung                   430     (85%)    12        (2%)    63    (12%)   505     (100%)
  breast                 141     (86%)    3         (2%)    20    (12%)   164     (100%)
  esophagus              24      (89%)    \-        ( - )   3     (11%)   27      (100%)
  stomach                36      (88%)    1         (2%)    4     (10%)   41      (100%)
  colon                  47      (85%)    2         (4%)    6     (11%)   55      (100%)
  rectum•anus            42      (91%)    \-        ( - )   4     (9%)    46      (100%)
  liver                  18      (78%)    \-        ( - )   5     (22%)   23      (100%)
  gall bladder           1       (100%)   \-        ( - )   \-    ( - )   1       (100%)
  pancreas               2       (67%)    \-        ( - )   1     (33%)   3       (100%)
  spleen                 1       (100%)   \-        ( - )   \-    ( - )   1       (100%)
  hematopoietic          8       (80%)    1         (10%)   1     (10%)   10      (100%)
  bone                   7       (100%)   \-        ( - )   \-    ( - )   7       (100%)
  soft tissue            5       (83%)    1         (17%)   \-    ( - )   6       (100%)
  skin                   16      (76%)    1         (5%)    4     (19%)   21      (100%)
  head and neck          18      (86%)    \-        ( - )   3     (14%)   21      (100%)
  thyroid                12      (86%)    \-        ( - )   2     (14%)   14      (100%)
  testis                 7       (88%)    1         (13%)   \-    ( - )   8       (100%)
  bladder                8       (73%)    1         (9%)    2     (18%)   11      (100%)
  uterus                 16      (84%)    \-        ( - )   3     (16%)   19      (100%)
  ovary                  16      (84%)    \-        ( - )   3     (16%)   19      (100%)
  kidney                 47      (90%)    2         (4%)    3     (6%)    52      (100%)
  optical                2       (100%)   \-        ( - )   \-    ( - )   2       (100%)
  lymphatic gland        10      (91%)    \-        ( - )   1     (9%)    11      (100%)
  nervous tissue         3       (75%)    1         (25%)   \-    ( - )   4       (100%)
  unknown primary        41      (85%)    4         (8%)    3     (6%)    48      (100%)
  others                 21      (81%)    1         (4%)    4     (15%)   26      (100%)

28). Transfer to another hospital {#S7.28}
---------------------------------

                         none    for further treatment   Palliative care   other reasons   total                                 
  ---------------------- ------- ----------------------- ----------------- --------------- ------- ------- ----- ------- ------- --------
  All brain metastases   1,697   (58%)                   603               (21%)           329     (11%)   278   (10%)   2,907   (100%)
  lung                   756     (57%)                   290               (22%)           145     (11%)   135   (10%)   1,326   (100%)
  breast                 228     (61%)                   73                (20%)           41      (11%)   31    (8%)    373     (100%)
  esophagus              34      (57%)                   9                 (15%)           13      (22%)   4     (7%)    60      (100%)
  stomach                49      (51%)                   22                (23%)           19      (20%)   6     (6%)    96      (100%)
  colon                  99      (60%)                   31                (19%)           19      (11%)   17    (10%)   166     (100%)
  rectum•anus            71      (63%)                   22                (19%)           10      (9%)    10    (9%)    113     (100%)
  liver                  33      (58%)                   16                (28%)           3       (5%)    5     (9%)    57      (100%)
  gall bladder           1       (25%)                   1                 (25%)           1       (25%)   1     (25%)   4       (100%)
  pancreas               7       (64%)                   3                 (27%)           \-      ( - )   1     (9%)    11      (100%)
  spleen                 1       (100%)                  \-                ( - )           \-      ( - )   \-    ( - )   1       (100%)
  hematopoietic          14      (64%)                   5                 (23%)           2       (9%)    1     (5%)    22      (100%)
  bone                   6       (55%)                   1                 (9%)            \-      ( - )   4     (36%)   11      (100%)
  soft tissue            8       (73%)                   2                 (18%)           1       (9%)    \-    ( - )   11      (100%)
  skin                   21      (55%)                   8                 (21%)           6       (16%)   3     (8%)    38      (100%)
  head and neck          39      (63%)                   6                 (10%)           12      (19%)   5     (8%)    62      (100%)
  thyroid                29      (63%)                   10                (22%)           5       (11%)   2     (4%)    46      (100%)
  testis                 10      (63%)                   5                 (31%)           1       (6%)    \-    ( - )   16      (100%)
  bladder                12      (52%)                   5                 (22%)           1       (4%)    5     (22%)   23      (100%)
  uterus                 24      (57%)                   8                 (19%)           5       (12%)   5     (12%)   42      (100%)
  ovary                  31      (67%)                   9                 (20%)           3       (7%)    3     (7%)    46      (100%)
  kidney                 83      (55%)                   37                (24%)           13      (9%)    19    (13%)   152     (100%)
  optical                1       (20%)                   1                 (20%)           2       (40%)   1     (20%)   5       (100%)
  lymphatic gland        17      (74%)                   2                 (9%)            3       (13%)   1     (4%)    23      (100%)
  nervous tissue         4       (80%)                   1                 (20%)           \-      ( - )   \-    ( - )   5       (100%)
  unknown primary        81      (59%)                   25                (18%)           20      (14%)   12    (9%)    138     (100%)
  others                 38      (63%)                   11                (18%)           4       (7%)    7     (12%)   60      (100%)

29). Complication during the whole treatment {#S7.29}
--------------------------------------------

                         none    intracranial hemorrhage   cerebral infarction   pneumonia   pulmonary embolization   deep vein thrombosis   bone fracture   second cancer   others   unknown   patient number                                                                             
  ---------------------- ------- ------------------------- --------------------- ----------- ------------------------ ---------------------- --------------- --------------- -------- --------- ---------------- -------- ---- -------- ---- -------- ----- ------- ----- -------- ------- --------
  All brain metastases   2,138   (74%)                     56                    (2%)        22                       (1%)                   180             (6%)            5        (0.2%)    14               (0.5%)   21   (1%)     3    (0.1%)   114   (4%)    402   (14%)    2,907   (100%)
  lung                   967     (73%)                     18                    (1%)        7                        (1%)                   101             (8%)            2        (0.2%)    3                (0.2%)   6    (0.5%)   1    (0.1%)   41    (3%)    198   (15%)    1,326   (100%)
  breast                 288     (77%)                     4                     (1%)        4                        (1%)                   14              (4%)            \-       ( - )     2                (1%)     6    (2%)     1    (0.3%)   21    (6%)    41    (11%)    373     (100%)
  esophagus              50      (83%)                     \-                    ( - )       \-                       ( - )                  4               (7%)            \-       ( - )     \-               ( - )    1    (2%)     \-   ( - )    \-    ( - )   7     (12%)    60      (100%)
  stomach                77      (80%)                     2                     (2%)        \-                       ( - )                  4               (4%)            \-       ( - )     1                (1%)     1    (1%)     \-   ( - )    1     (1%)    11    (11%)    96      (100%)
  colon                  122     (73%)                     1                     (1%)        1                        (1%)                   10              (6%)            \-       ( - )     \-               ( - )    \-   ( - )    1    (1%)     8     (5%)    24    (14%)    166     (100%)
  rectum • anus          81      (72%)                     \-                    ( - )       1                        (1%)                   7               (6%)            \-       ( - )     \-               ( - )    1    (1%)     \-   ( - )    2     (2%)    25    (22%)    113     (100%)
  liver                  38      (67%)                     4                     (7%)        1                        (2%)                   3               (5%)            \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    4     (7%)    7     (12%)    57      (100%)
  gall bladder           4       (100%)                    \-                    ( - )       \-                       ( - )                  \-              ( - )           \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    \-    ( - )   \-    ( - )    4       (100%)
  pancreas               7       (64%)                     \-                    ( - )       \-                       ( - )                  \-              ( - )           \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    \-    ( - )   4     (36%)    11      (100%)
  spleen                 \-      ( - )                     \-                    ( - )       \-                       ( - )                  \-              ( - )           \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    \-    ( - )   1     (100%)   1       (100%)
  hematopoietic          14      (64%)                     2                     (9%)        \-                       ( - )                  \-              ( - )           \-       ( - )     \-               ( - )    1    (5%)     \-   ( - )    1     (5%)    4     (18%)    22      (100%)
  bone                   7       (64%)                     \-                    ( - )       \-                       ( - )                  \-              ( - )           \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    2     (18%)   2     (18%)    11      (100%)
  soft tissue            10      (91%)                     \-                    ( - )       \-                       ( - )                  \-              ( - )           \-       ( - )     \-               ( - )    1    (9%)     \-   ( - )    \-    ( - )   \-    ( - )    11      (100%)
  skin                   23      (61%)                     5                     (13%)       2                        (5%)                   1               (3%)            \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    4     (11%)   4     (11%)    38      (100%)
  head and neck          52      (84%)                     \-                    ( - )       \-                       ( - )                  4               (6%)            \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    4     (6%)    3     (5%)     62      (100%)
  thyroid                36      (78%)                     3                     (7%)        \-                       ( - )                  1               (2%)            \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    \-    ( - )   6     (13%)    46      (100%)
  testis                 6       (38%)                     3                     (19%)       \-                       ( - )                  \-              ( - )           1        (6%)      1                (6%)     \-   ( - )    \-   ( - )    \-    ( - )   5     (31%)    16      (100%)
  bladder                15      (65%)                     \-                    ( - )       \-                       ( - )                  2               (9%)            \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    2     (9%)    5     (22%)    23      (100%)
  uterus                 34      (81%)                     1                     (2%)        \-                       ( - )                  \-              ( - )           \-       ( - )     1                (2%)     \-   ( - )    \-   ( - )    3     (7%)    3     (7%)     42      (100%)
  ovary                  36      (78%)                     \-                    ( - )       \-                       ( - )                  1               (2%)            \-       ( - )     1                (2%)     \-   ( - )    \-   ( - )    1     (2%)    7     (15%)    46      (100%)
  kidney                 115     (76%)                     8                     (5%)        1                        (1%)                   6               (4%)            \-       ( - )     2                (1%)     2    (1%)     \-   ( - )    4     (3%)    15    (10%)    152     (100%)
  optical                4       (80%)                     \-                    ( - )       \-                       ( - )                  \-              ( - )           \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    1     (20%)   \-    ( - )    5       (100%)
  lymphatic gland        13      (57%)                     \-                    ( - )       1                        (4%)                   2               (9%)            \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    1     (4%)    7     (30%)    23      (100%)
  nervous tissue         2       (40%)                     2                     (40%)       \-                       ( - )                  2               (40%)           \-       ( - )     \-               ( - )    \-   ( - )    \-   ( - )    \-    ( - )   1     (20%)    5       (100%)
  unknown primary        90      (65%)                     2                     (1%)        3                        (2%)                   15              (11%)           2        (1%)      3                (2%)     1    (1%)     \-   ( - )    11    (8%)    16    (12%)    138     (100%)
  others                 47      (78%)                     1                     (2%)        1                        (2%)                   3               (5%)            \-       ( - )     \-               ( - )    1    (2%)     \-   ( - )    3     (5%)    6     (10%)    60      (100%)

8.. Kaplan-Meier survival curve (OS and PFS) {#S8}
============================================

![OS Grade I/II gliomas](nmc-54-suppl1-g001){#f1}

![PFS Grade I/II gliomas](nmc-54-suppl1-g002){#f2}

![OS Grade III/IV gliomas](nmc-54-suppl1-g003){#f3}

![PFS Grade III/IV gliomas](nmc-54-suppl1-g004){#f4}

![OS Meningioma Schwannoma, Chordoma](nmc-54-suppl1-g005){#f5}

![PFS Meningioma Schwannoma, Chordoma](nmc-54-suppl1-g006){#f6}

![OS Medulloblastoma, Germ cell tumor, PCNSL](nmc-54-suppl1-g007){#f7}

![PFS Medulloblastoma, Germ cell tumor, PCNSL](nmc-54-suppl1-g008){#f8}

![OS Brain metastases](nmc-54-suppl1-g009){#f9}

![PFS Brain metastases](nmc-54-suppl1-g010){#f10}

9.. REGISTERED HOSPITALS (2001--2004) {#S9}
=====================================

  No.     Hospitals & Doctors                                                                                                                                                                            2001    2002    2003    2004
  ------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------- ------- ------- ------
  1       Asahikawa Medical University Anei R, Hododuka A.                                                                                                                                               26      16              
  2       Hokkaido University Kobayashi H, Terasaka S.                                                                                                                                                   12      17      4       14
  3       Sapporo Medical University Wanibuchi M, Kanno A, Sugino T, Momota H                                                                                                                            30      40      39      34
  4       Hirosaki University Ohkuma H, Nakano T, Asano K, Kudo K, Munakata A, Naraoka M, Matsuda N.                                                                                                     35      48      67      64
  5       Akita University Sasajima T, Yanagisawa T, Takahashi M, Higashiyama N, Shimada N, Takahashi Y, Oda M, Hanyu N, Suzuki A, Shibata K.                                                            91      86      99      94
  6       Iwate Medical University Beppu T, Wada T.                                                                                                                                                      49      43      43      32
  7       Tohoku University Kumabe T, Sonoda Y, Kanamori M, Saito R, Murakami K, Endo T .                                                                                                                116     144     104     96
  8       Yamagata University Sakurada K, Sato A, Kikuchi Z, Matsuda K.                                                                                                                                  52      54      49      45
  9       Fukushima Medical University Saito K, Sato T, Watanabe T, Sakuma J, Ichikawa M.                                                                                                                42      44      30      28
  10      Gunma University Sugawara K, Tosaka M, Watanabe K.                                                                                                                                             41      36      57      38
  11      University of Tsukuba Takano S, Nakai K, Ayuzawa S, Ihara S, Yamamoto T, Tsurushima H, Akutsu H.                                                                                               35      59      64      72
  12      Saitama Medical University International Medical Center Nishikawa R, Mishima K, Suzuki T, Adachi J, Wakiya K, Fukuoka K.                                                                       53      65      6       46
  13      National Defense Medical College Uozumi Y, Nagatani K.                                                                                                                                         38                      
  14      Chiba University Iwadate Y.                                                                                                                                                                    4       2               
  15      Juntendo University Kasuga C, Yamamoto M, Sugano H, Ishii H, Ohara Y, Nakajima M, Akiyama O, Nakanishi H, Ohkura H, Ito Y, Miyajima M, Yatomi K, Hara T.                                       109     90      92      96
  16      Keio University Sasaki H, Hara K, Kitamura Y, Akiyama T, Yoshida K, Saga I, Kano T Ichimura S, Onozuka S, Takahashi S, Muto J, Ueda R, Fukaya R.                                               12      27      60      96
  17      Nihon University Itabashi Hospital Yoshino A, Fukushima T, Ohta T, Yachi K, Ogino A.                                                                                                           67      76      72      82
  18      Nippon Medical School Adachi K.                                                                                                                                                                99      82      125     133
  19      Tokyo Women\'s Medical University Muragaki Y, Maruyama T, Amano K, Tanaka M.                                                                                                                   162     134     166     205
  20      Toho University, Omori Medical Center Kano T, Nemoto M, Sugo N.                                                                                                                                74      72      60      39
  21      Showa University Tanioka D.                                                                                                                                                                    33      25      24      19
  22      Tokyo Medical and Dental University Tanaka Y, Aoyagi M, Nariai T, Maehara T, Ishii Y, Sugawara T, Obata Y, Kawano Y.                                                                           61      63      61      69
  23      The University of Tokyo Saito N, Mukasa A, Saito K, Kouga T, Takahashi M, Tanaka M.                                                                                                            59      82      88      92
  24      Kyorin University Nagane M, Kobayashi K, Maruyama K, Shiokawa Y, Noguchi A, Yamaguchi R, Kawai T, Sato E.                                                                                      75      74      85      43
  25      Teikyo University Nakagomi T.                                                                                                                                                                  31      29      46      28
  26      St. Marianna University School of Medicine Yoshida Y, Uchida M, Tanaka K.                                                                                                                      37      36      37      39
  27      Kitasato University Utsuki S, Miyajima Y, Okazawa R, Suzuki R,                                                                                                                                 88      71      62      74
  28      Tokai University Tsugu A, Matsumae M.                                                                                                                                                          53      42      51      26
  29      Yokohama City University Tateishi K, Kawahara N, Yamada S.                                                                                                                                     34      35      46      43
  30      Hamamatsu University School of Medicine Namba H, Sakai N.                                                                                                                                      21      22      31      38
  31      Niigata University Uzuka T, Nishino K, Yoshimura J, Yoneoka Y, Fukuda M, Saito A, Aoki H.                                                                                                      97      114     96      4
  32      University of Yamanashi Sato E.                                                                                                                                                                37      36      25      33
  33      Shinshu University Sakai K, Kobayashi T.                                                                                                                                                       5       45      2       
  34      University of Toyama Kurimoto M.                                                                                                                                                               38      38      36      38
  35      Kanazawa University Nakada M, Sugihara T, Hayashi Y, Tanaka S, Kamide T.                                                                                                                       56      88      63      55
  36      University of Fukui Takeuchi H.                                                                                                                                                                36      39      33      27
  37      Kanazawa Medical University Akai T, Shiraga S, Okamoto K, Sasagawa Y.                                                                                                                          37      36      13      21
  38      Nagoya University Momota H, Wakabayashi T, Ohka F.                                                                                                                                             52      53      78      83
  39      Nagoya City University Yamada K.                                                                                                                                                               39      47      45      45
  40      Aichi Medical University Osuka K, Takayasu M.                                                                                                                                                  32      35      40      36
  41      Fujita Health University Hirose Y, Kawase T, Hasegawa M, Yoshida K, Nagahisa S.                                                                                                                81      10              
  42      Gifu University Yano H, Nakayama N, Ikegame Y, Ohe N, Okada M.                                                                                                                                 30      44      47      57
  43      Mie University Matsubara T.                                                                                                                                                                    12                      
  44      Nara Medical University Hirabayashi H, Mishima H, Yamada S, Boku E, Hironaka Y, Miyake H, Horiuchi K, Matsuda R, Takeshima Y, Nishimura F, Wajima D, Tamura K, Nakagawa I.                     68      58      46      48
  45      Shiga University of Medical Science Fukami T.                                                                                                                                                  48      36      39      47
  46      Kyoto University Mikuni N, Arakawa Y, Kanemoto M, Yamaguchi M.                                                                                                                                 95      31      108     3
  47      Kyoto Prefectural University of Medicine Aita K.                                                                                                                                               2                       
  49      Osaka Medical College Kuroiwa T, Matsushita Y.                                                                                                                                                 112     107     97      105
  49      Osaka University Kagawa N, Fujimoto Y, Yamamoto F, Kijima N, Kinoshita M, Arita H.                                                                                                             45      44      35      43
  50      Kinki University Kato A, Uchiyama T, Nakanishi K, Sanada Y, Nakano N, Yabuuchi T, Lin Y, Tsuji K.                                                                                              43      66      61      51
  51      Wakayama Medical University Uematsu Y, Tamura M, Nishibayashi H, Okita R, Fukai J.                                                                                                             61      79      76      74
  52      Hyogo College of Medicine Izumoto S, Mori K, Tomogane Y, Fujita S.                                                                                                                             31      44      62      19
  53      Kobe University Sasayama T.                                                                                                                                                                    47      54      61      66
  54      The University of Tokushima Kurashiki Y, Kageji T.                                                                                                                                             54      20      35      56
  55      Kagawa University Okada M, Miyake K.                                                                                                                                                           42      31      29      37
  56      Kochi University Shimizu K, Kawanishi Y.                                                                                                                                                       21      25      19      17
  57      Ehime University Kohno S.                                                                                                                                                                      56      76      78      60
  58      Okayama University Date I, Kurozumi K, Ichikawa T.                                                                                                                                             41      72      68      67
  59      Hiroshima University Yamasaki F, Watanabe Y, Sinagawa K, Kajiwara Y, Takayasu T, Okazaki T, Kinoshita Y, Usui S, Mitsuhara T, Yamaguchi S, Kiura Y.                                            89      92      88      115
  60      Tottori University Kambe A.                                                                                                                                                                    2       2       2       1
  61      Shimane University Sugimoto K.                                                                                                                                                                 2                       
  62      Yamaguchi University Yoshikawa K.                                                                                                                                                              28      45      38      32
  63      Kyushu University Shouno T, Mizoguchi M, Kuga D.                                                                                                                                               49      43      89      86
  64      Saga University Nakahara Y.                                                                                                                                                                    40      31      33      28
  65      Kumamoto University Nakamura H, Makino K.                                                                                                                                                      32      27      33      35
  66      Nagasaki University Matsuo T, Ujifuku K, Baba S, Yamasaki R.                                                                                                                                   20      41      51      52
  67      Oita University Morishige M, Momii Y.                                                                                                                                                          48      31      1       1
  68      University of Miyazaki Uehara H, Takeishi G, Takeshima H, Yamashita S.                                                                                                                         33      35      31      51
  69      Kagoshima University Hirano H, Hanaya R, Tokimura H, Yonezawa H, Shinsato Y, Habu M, Mori M, Niiro T, Fujio S, Yatsushiro K, Oyoshi T, Hirabaru M, Yamahata H, Yunoue S, Hosoyama H, Kubo F.   85      73      86      80
  70      University of the Ryukyus Ishiuchi S, Nagamine H, Miyagi T.                                                                                                                                    24      25      31      21
  71      Research Institute for Brain and Blood Vessels-Akita Moroi J.                                                                                                                                  3                       
  72      Kitano Hospital Takahashi J, Murakami M.                                                                                                                                                       31      104     100     89
  73      Toyama Prefectural Central Hospital Hondo H.                                                                                                                                                   26      31      28      36
  74      Nakamura Memorial Hospital Oikawa M.                                                                                                                                                           73      79      91      93
  75      Hiroshima City Hospital Terada K, Nishino S.                                                                                                                                                   19      28      32      17
  76      Toho University, Ohashi Medical Center Saito N.                                                                                                                                                                        3
  77      Ohkawara Neurosurgical Hospital Yamaguchi H.                                                                                                                                                   9       17      16      10
  78      Maebashi Red Cross Hospital Miyagishima T.                                                                                                                                                     10      3       8       9
  79      Okayama Medical Center Namba Y.                                                                                                                                                                9       10      9       7
  80      Kashiwaba Neurosurgical Hospital Otaki T, Kaneko S.                                                                                                                                            26      25      31      30
  81      Minami Wakayama Medical Center Inui Y.                                                                                                                                                         2               5       2
  82      Tokyo Medical University Ibaraki Medical Center Nakamura T.                                                                                                                                                            4
  83      Toyokawa City Hospital Matsumoto T.                                                                                                                                                                    2               
  84      Yamaguchi Grand Medical Center Yamashita T.                                                                                                                                                    14      20      14      22
  85      Rinku General Medical Center Moriuchi S.                                                                                                                                                       11      12      16      
  86      Tokyo Women\'s Medical University Medical Center East Tanaka N.                                                                                                                                10      17      7       1
  87      Kawasaki Saiwai Hospital Iwai R.                                                                                                                                                               4       5       11      10
  88      Niigata Prefectural Shibata Hospital Aiba T.                                                                                                                                                   6       3               
  89      NTT Medical Center Tokyo Morita A, Sameshima T.                                                                                                                                                132     111     173     46
  90      Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Tabei Y, Yamada R.                                                                                                          1       1       9
  91      Chiba Rosai Hospital Ozawa Y.                                                                                                                                                                  21      18      10      13
  92      Miyoshi Central Hospital Isobe N.                                                                                                                                                              14      10      7       4
  93      National Cancer Center Hospital Shibui S, Narita Y, Miyakita Y, Okita Y, Ohno M, Aihara K, Takizawa T, Shinomiya A,                                                                            77      61      101     112
  94      Ohta Nishinouchi Hospital Kawakami M.                                                                                                                                                          27      1               11
  95      JA Toride Medical Center Tsuruoka S.                                                                                                                                                           5       1       3       1
  96      Miyakonojo Medical Association Hospital Ohta H, Yamasaki K.                                                                                                                                    2       5       11      6
  97      Kanagawa Cancer Center Hayashi A.                                                                                                                                                              34      18      26      
  98      Fujioka General Hospital Kohga H.                                                                                                                                                                              24      2
  99      Chuno Kosei Hospital Inoue S.                                                                                                                                                                  10      8       9       11
  100     The Jikei University Kashiwa Hospital Arai T.                                                                                                                                                  1               10      9
  101     Akiru Municipal Medical Center Ito N.                                                                                                                                                          7       8       5       13
  102     Hakodate Central General Hospital Kato T.                                                                                                                                                              7       2       17
  103     Nippon Medical School Musashi Kosugi Hospital Takahashi H.                                                                                                                                     19                      
  104     Saitama Medical University Fujimaki T.                                                                                                                                                         1       1       8       
  105     Tokyo Metropolitan Health and Medical Corporation Toshima Hospital Seida M.                                                                                                                    8       11      13      7
  106     Naga Hospital Kuwata T, Tsuji N, Izawa D.                                                                                                                                                      7       4       7       7
  107     National Center for Child Health and Development Morota N, Ogiwara H.                                                                                                                                  6       10      9
  108     Shizuoka Cancer Center Oishi T, Nakasu Y, Mitsuya K.                                                                                                                                           1       7       55      110
  109     Tamakyuryo Hospital Yokoyama H.                                                                                                                                                                2               2       
  total   4,030                                                                                                                                                                                          4,021   4,288   3,999   
